INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19167, 'Floxia disco - spot and complexion control micro emulsion 40ml', 'فلوكسيا ديسكو - مستحلب دقيق للتحكم في البقع والبشرة 40 مل', '179', NULL, 'Whitening topical', NULL, 'Floxia international sarl > bio-earth egypt', 'Unknown', 'غير محدد', '40ml', '1', NULL, 'high technological emulsion : - helps prevent hyperpigmentation and spots - brightens dull skin tone - empowered with protecting hydrating and mild peeling agents. melanostatine 5 a speci c biomimetic peptide. by its -msh antagonist activity it opposes t', NULL, NULL, 730, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19168, 'Floxia exfac - exfoliating cream 40 ml', 'فلوكسيا اكزفاك - كريم مقشر 40 مل', '94', NULL, 'Skin care', NULL, 'Floxia international sarl > bio-earth egypt', 'Cream', 'كريم', '40 ml', '1', NULL, 'based on association of vitamin c and ahas exfac cream recharges skin with energy and fi ghts against dull complexion and tiredness. to counter to the harmful eff ects of photodamage exfac brings a smooth peeling which helps to tone the skin up and stimul', NULL, NULL, 840, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19169, 'Floxia hair serum 50 ml', 'فلوكسيا سيروم منشط للشعر 50 مل', '395', NULL, 'Hair care', NULL, 'Floxia international sarl > bio-earth egypt', 'Serum', 'سيروم', '50 ml', '1', NULL, NULL, NULL, NULL, 1133, '2022-11-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19170, 'Floxia hair shampoo 200 ml', 'فلوكسيا شامبو الشعر 200 مل', '134', NULL, 'Hair care', NULL, 'Floxia international sarl > bio-earth egypt', 'Amp', 'أمبول', '200 ml', '1', NULL, NULL, NULL, NULL, 697, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19171, 'Floxia juvenia - rejuvenating cream 40 ml', 'فلوكسيا جوفينا 40 مل', '210', NULL, 'Skin care', NULL, 'Floxia international sarl > bio-earth egypt', 'Cream', 'كريم', '40 ml', '1', NULL, 'a unique rich formulation with 3 main active ingredients (argireline matrixyl and thalassine) to help decrease wrinkles and lines and bring the famous bx effect due to a triple action relaxing firming and filling. argireline : is a messenger peptide that', NULL, NULL, 828, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19172, 'Floxia osmosia - deep moisturizing fluid 125ml', 'فلوكسيا اسموزيا - سائل ترطيب عميق 125 مل', '134', NULL, 'Skin care', NULL, 'Floxia international sarl > bio-earth egypt', 'Unknown', 'غير محدد', '125ml', '1', NULL, 'osmosia improves and regulates daily moisturization reinforces natural defenses (skin barrier) and contributes unifying skin complexion. is is specifically formulated to soothe chronically dry skin and lighten skin complexion. allergen free paraben-free a', NULL, NULL, 780, '2022-07-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19173, 'Floxia protexio - clear emulsion spf 50 - 50ml', 'فلوكسيا بروتكسيو - مستحلب شفاف بعامل حماية 50-50 مل', '194', NULL, 'Sun block', NULL, 'Floxia international sarl > bio-earth egypt', 'Unknown', 'غير محدد', '50ml', '1', NULL, 'this new sunscreen formula spf 50 protection organo-mineral fragrance paraben free water resistant protects against uva and uvb rays while keeping a soft skin due to 5 sunfilters several active ingredients with anti oxidant anti free radical and nutrient', NULL, NULL, 906, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19174, 'Floxia protexio - clear fluid spf 50 - 125ml', 'فلوكسيا بروتكسيو - سائل شفاف بعامل حماية 50 - 125 مل', '194', NULL, 'Sun block', NULL, 'Floxia international sarl > bio-earth egypt', 'Unknown', 'غير محدد', '125ml', '1', NULL, 'this new sunscreen formula spf 50 protection organo-mineral fragrance paraben free water resistant protects against uva and uvb rays while keeping a soft skin due to one mineral sunfilter coconut oil sesame oil and vitamin e. fragrance & paraben free use:', NULL, NULL, 772, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19175, 'Floxia protexio - tinted emulsion spf 50 - 50ml', 'فلوكسيا بروتكسيو - مستحلب ملون بمعامل حماية 50-50 مل', '194', NULL, 'Sun block', NULL, 'Floxia international sarl > bio-earth egypt', 'Unknown', 'غير محدد', '50ml', '1', NULL, 'this new sunscreen formula spf 50 protection organo-mineral fragrance paraben free water resistant protects against uva and uvb rays while keeping a soft skin due to 5 sunfilters several active ingredients with anti oxidant anti free radical and nutrient', NULL, NULL, 938, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19176, 'Floxia regard - intense eye gel 15ml', 'فلوكسيا ريجارد- جل عيون مكثف 15 مل', '184', NULL, 'Eye contour', NULL, 'Floxia international sarl > bio-earth egypt', 'Gel', 'جل', '15ml', '1', NULL, 'regard gel helps decongesting decreasing redness and also helps to maintain a balanced hydration to that thin epidermis. regard will make the eye surrounding area lighter and clearer. gel texture of regard is immediately absorbed by the epidermis bringing', '3760074270170', NULL, 707, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19177, 'Floxia regenia - gentle cleansing gel 200 ml', 'فلوكسيا ريجينيا - جل منظف 200 مل', '85', NULL, 'Body cleanser', NULL, 'Floxia international sarl > bio-earth egypt', 'Gel', 'جل', '200 ml', '1', NULL, 'especially formulated for damaged and reactive skin. regenia gel contains a special mix of vegetal extract mild anionic and amphoteric washing basis. enriched with aloe vera extract with soothing anti-inflammatory and softening properties regenia gel prot', NULL, NULL, 811, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19178, 'Floxia regenia - regenerating and redness control cream 40 ml', 'فلوكسيا ريجينيا - كريم تجديد 40 مل', '85', NULL, 'Healing topical', NULL, 'Floxia international sarl > bio-earth egypt', 'Cream', 'كريم', '40 ml', '1', NULL, 'regenia the new anti redness cream new formulation helping to : - reinforce blood capillaries - boost microcirculation - inhibit the propagation of inflammatory reactions - diminish redness - protect the epidermis from external aggression. clinical study', NULL, NULL, 1013, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19179, 'Floxia regulator - balancing gel 40ml', 'فلوكسيا جل منظم 40 مل', '129', NULL, 'Skin care', NULL, 'Floxia international sarl > bio-earth egypt', 'Gel', 'جل', '40ml', '1', NULL, 'floxia decided to focus on sebum regulation to off er a complementary product to medical treatment and a cosmetic approach to manage oily skin and its unplesant appearance. on skin surface : salycilic acid brings an exfoliating action that works to treat', NULL, NULL, 854, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19180, 'Floxia regulator - exfoliating dermocosmetic soap 125 gm', 'فلوكسيا صابون تقشير الجلد 125 جم', '109', NULL, 'Soap', NULL, 'Floxia international sarl > bio-earth egypt', 'Soap', 'صابون', '125 gm', '1', NULL, 'on skin surface dry algae as chondrus crispus algae very rich in mineral elements iodine and sulfur generate a mechanical and invigorating peeling. triclocarban acts deeper by a smooth antiseptic action. use: use for daily cleansing morning and evening. a', NULL, NULL, 771, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19181, 'Floxia regulator - purifying gel 200ml', 'فلوكسيا جل منظم 200 مل', '129', NULL, 'Facial wash', NULL, 'Floxia international sarl > bio-earth egypt', 'Gel', 'جل', '200ml', '1', NULL, 'this gentle washing gel fights against the causes of oily and acne prone skin by a triple action. it smoothly removes impurities and excess sebum while maintaining a balanced skin due to targeted action of selected ingredients such as aha allantoin and te', NULL, NULL, 827, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19182, 'Floxia striex - cleansing intimate fluid 200 ml', 'فلوكسيا ستريكس - سائل منظف للمناطق الحساسة 200 مل', '190', NULL, 'Vaginal wash', NULL, 'Floxia international sarl > bio-earth egypt', 'Unknown', 'غير محدد', '200 ml', '1', NULL, 'specially designed for sensitive skin and mucosa floxia intimate cleansing fluid protects and soothes intimate areas of your body. its light texture is adjusted to the sensitivity of your microflora balance. this intimate fluid contains a special mix of v', NULL, NULL, 823, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19183, 'Floxia striex - restructing cream 125 ml', 'فلوكسيا ستريكس - كريم مجدد 125 مل', '270', NULL, 'Firming topical', NULL, 'Floxia international sarl > bio-earth egypt', 'Cream', 'كريم', '125 ml', '1', NULL, 'a unique association of active cosmetics agents which helps prevent the appearance of stretch marks caused by pregnancy or weight reduction and improve skin s elasticity. use: best results come with application from month minus 5 before giving first birth', NULL, NULL, 730, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19184, 'Flu cut n 20 tab.', 'فلو كت ان 20 قرص', '14', NULL, 'Cold drugs', 'Caffeine+chlorpheniramine+paracetamol(acetaminophen)+pseudoephedrine', 'Sigma > egyptian pharmacists company', 'Tab', 'أقراص', NULL, '2', NULL, NULL, NULL, NULL, 1276, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19187, 'Fluarix 15 mcg/0.5ml i.m. or s.c. injection in prefilled syringe.', 'فلاريكس 15 ميكروجرام / 0.5 مل حقن مملوءة مسبقًا', '32', NULL, 'Vaccine', 'Vaccine influenza', 'Glaxo smithkline', 'Injection', 'حقن', '15 mcg', '1', NULL, NULL, NULL, NULL, 902, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19188, 'Flub 100mg 6 tab.', 'فلوب 100مجم 6 اقراص', '19', '13', 'Anthelmintic', 'Flubendazole', 'Unipharma co.', 'Tab', 'أقراص', '100mg', '1', 'للديدان', 'indication: flubendazol is used in the treatment of single or mixed infections caused by: enterobiasis ascariasis hookworm and trichuriasis contraindications: hypersensitivity to the drug pregnancy and lactation side effects: flubendazol is well tolerated', '6224001183270', NULL, 1526, '2024-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19189, 'Flub 20mg/ml susp. 30ml', 'فلوب 20مجم/مل معلق 30 مل', '36', '25', 'Anthelmintic', 'Flubendazole', 'Unipharma co.', 'Susp', 'معلق', '20mg', '1', 'للديدان', NULL, '6224000730543', NULL, 2941, '2024-06-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19190, 'Fluben 100mg 6 tab.', 'فلوبين من 100 مجم 6 اقراص', '4', NULL, 'Anthelmintic', 'Flubendazole', 'Eipico', 'Tab', 'أقراص', '100mg', '1', NULL, 'indication: flubendazol is used in the treatment of single or mixed infections caused by: enterobiasis ascariasis hookworm and trichuriasis contraindications: hypersensitivity to the drug pregnancy and lactation side effects: flubendazol is well tolerated', NULL, NULL, 1054, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19191, 'Flubenzole 100mg 6 tab.', 'فلوبنزول 100 مجم 6 اقراص', '4', NULL, 'Anthelmintic', 'Flubendazole', 'Alfacure pharmaceuticals', 'Tab', 'أقراص', '100mg', '1', NULL, 'indication: flubendazol is used in the treatment of single or mixed infections caused by: enterobiasis ascariasis hookworm and trichuriasis contraindications: hypersensitivity to the drug pregnancy and lactation side effects: flubendazol is well tolerated', NULL, NULL, 890, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19192, 'Flubenzole 2% oral susp. 30ml', 'فلوبنزول 2% معلق 30 مل', '4', NULL, 'Anthelmintic', 'Flubendazole', 'Marcyrl co. > alfacure pharmaceuticals', 'Susp', 'معلق', '2%', '1', NULL, 'indication: flubendazol is used in the treatment of single or mixed infections caused by: enterobiasis ascariasis hookworm and trichuriasis contraindications: hypersensitivity to the drug pregnancy and lactation side effects: flubendazol is well tolerated', NULL, NULL, 870, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19193, 'Flu-c 6 sachets.', 'فلو-سي 6 اكياس', '39', '27', 'Cold drugs', 'Caffeine+chlorpheniramine+paracetamol(acetaminophen)+vitamin c', 'Rameda', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, '6223003970420', NULL, 2616, '2025-11-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19197, 'Flucamox 250mg 12 caps.', 'فلوكاموكس 250 مجم 12 كبسولة', '8', NULL, 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+flucloxacillin', 'Sedico', 'Cap', 'كبسولة', '250mg', '2', NULL, NULL, '6221042154047', NULL, 975, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19200, 'Chartoreg plus 80 / 12.5 mg 28 tabs.', 'شارتوريج بلس 80/12.5مجم 28 قرص', '158', '120', 'Anti-hypertensive.combined angiotensin blocker with diuretic', 'Hydrochlorothiazide+telmisartan', 'Utopia', 'Tab', 'أقراص', '12.5 mg', '2', NULL, NULL, '6221042559019', NULL, 3842, '2025-06-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19201, 'Flucand 2mg/ml vial for inf.', 'فلوكاند 2مجم/مل فيال للتسريب الوريدي', '60', NULL, 'Antifungals.triazoles', 'Fluconazole', 'Hikma pharma', 'Vial', 'فيال', '2mg', '1', NULL, 'about fluconazole a triazole derivative a board range antifungal. mechanism of action of fluconazole fluconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', NULL, NULL, 922, '2022-06-24', 0, 'Fluconazole can be administered in the treatment of the following fungal infections[L11043]:



 1) Vaginal yeast infections caused by Candida

 2) Systemic Candida infections

 3) Both esophageal and oropharyngeal candidiasis 

 4) Cryptococcal meningitis

 5) UTI (urinary tract infection) by Candida

 6) Peritonitis (inflammation of the peritoneum) caused by Candida



**A note on fungal infection prophylaxis**



Patients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.[L11043]



**A note on laboratory testing**



Obtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.[L11043]

', 'Fluconazole is a very selective inhibitor of fungal cytochrome P450 dependent enzyme _lanosterol 14-α-demethylase_. This enzyme normally works to convert _lanosterol_ to _ergosterol_, which is necessary for fungal cell wall synthesis.  The free nitrogen atom located on the azole ring of fluconazole binds with a single iron atom located in the heme group of lanosterol 14-α-demethylase.[A178774] This prevents oxygen activation and, as a result, inhibits the demethylation of lanosterol, halting the process of ergosterol biosynthesis.[A178777]  Methylated sterols are then found to accumulate in the fungal cellular membrane, leading to an arrest of fungal growth.[A178774] These accumulated sterols negatively affect the structure and function of the fungal cell plasma membrane.[A16632]



Fluconazole resistance may arise from an alteration in the amount or function of the target enzyme (lanosterol 14-α-demethylase), altered access to this enzyme, or a combination of the above.[A16632] Other mechanisms may also be implicated, and studies are ongoing.[A178783]', 'Fluconazole has been demonstrated to show fungistatic activity against the majority of strains of the following microorganisms, curing fungal infections[L11043]:



_Candida albicans, Candida glabrata (Many strains are intermediately susceptible), Candida parapsilosis, Candida tropicalis, Cryptococcus neoformans_



This is achieved through steroidal inhibition in fungal cells, interfering with cell wall synthesis and growth as well as cell adhesion, thereby treating fungal infections and their symptoms.[L11043,A174325,A174343]



The fungistatic activity of fluconazole has also been shown in normal and immunocompromised animal models with both systemic and intracranial fungal infections caused by _Cryptococcus neoformans_ and for systemic infections caused by Candida albicans.[L11043]  It is important to note that resistant organisms have been found against various strains of organisms treated with fluconazole.[A178759,A178762,A178765] This further substantiates the need to perform susceptibility testing when fluconazole is considered as an antifungal therapy.[A178768,A178786] 





**A note on steroidal effects of fluconazole**



There has been some concern that fluconazole may interfere with and inactivate human steroids/hormones due to the inhibition of hepatic cytochrome enzymes.[L11034]  Fluconazole has demonstrated to be more selective for _fungal_ cytochrome P-450 enzymes than for a variety of mammalian cytochrome P-450 enzymes. Fluconazole 50 mg administered daily for up to 28 days in individuals of reproductive age has been show to have no effect on testosterone plasma concentrations of males and plasma concentrations of steroids in females. A 200-400 mg dose of fluconazole showed no clinically relevant effect on steroid levels or on ACTH-stimulated steroid response in healthy males, in one clinical study mentioned on the European Medicines Agency label.[L11034] Other studies have shown no significant effects of fluconazole on steroid levels, further confirming these data.[A174358,A178780]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19202, 'Flucazonil 25mg/5ml syrup 70 ml', 'فلوكازونيل 25 مجم / 5 مل شراب 70 مل', '29', NULL, 'Antifungals.triazoles', 'Fluconazole', 'El nile.', 'Syrup', 'شراب', '25mg', '1', NULL, 'about fluconazole a triazole derivative a board range antifungal. mechanism of action of fluconazole fluconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', NULL, NULL, 1032, '2022-07-18', 0, 'Fluconazole can be administered in the treatment of the following fungal infections[L11043]:



 1) Vaginal yeast infections caused by Candida

 2) Systemic Candida infections

 3) Both esophageal and oropharyngeal candidiasis 

 4) Cryptococcal meningitis

 5) UTI (urinary tract infection) by Candida

 6) Peritonitis (inflammation of the peritoneum) caused by Candida



**A note on fungal infection prophylaxis**



Patients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.[L11043]



**A note on laboratory testing**



Obtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.[L11043]

', 'Fluconazole is a very selective inhibitor of fungal cytochrome P450 dependent enzyme _lanosterol 14-α-demethylase_. This enzyme normally works to convert _lanosterol_ to _ergosterol_, which is necessary for fungal cell wall synthesis.  The free nitrogen atom located on the azole ring of fluconazole binds with a single iron atom located in the heme group of lanosterol 14-α-demethylase.[A178774] This prevents oxygen activation and, as a result, inhibits the demethylation of lanosterol, halting the process of ergosterol biosynthesis.[A178777]  Methylated sterols are then found to accumulate in the fungal cellular membrane, leading to an arrest of fungal growth.[A178774] These accumulated sterols negatively affect the structure and function of the fungal cell plasma membrane.[A16632]



Fluconazole resistance may arise from an alteration in the amount or function of the target enzyme (lanosterol 14-α-demethylase), altered access to this enzyme, or a combination of the above.[A16632] Other mechanisms may also be implicated, and studies are ongoing.[A178783]', 'Fluconazole has been demonstrated to show fungistatic activity against the majority of strains of the following microorganisms, curing fungal infections[L11043]:



_Candida albicans, Candida glabrata (Many strains are intermediately susceptible), Candida parapsilosis, Candida tropicalis, Cryptococcus neoformans_



This is achieved through steroidal inhibition in fungal cells, interfering with cell wall synthesis and growth as well as cell adhesion, thereby treating fungal infections and their symptoms.[L11043,A174325,A174343]



The fungistatic activity of fluconazole has also been shown in normal and immunocompromised animal models with both systemic and intracranial fungal infections caused by _Cryptococcus neoformans_ and for systemic infections caused by Candida albicans.[L11043]  It is important to note that resistant organisms have been found against various strains of organisms treated with fluconazole.[A178759,A178762,A178765] This further substantiates the need to perform susceptibility testing when fluconazole is considered as an antifungal therapy.[A178768,A178786] 





**A note on steroidal effects of fluconazole**



There has been some concern that fluconazole may interfere with and inactivate human steroids/hormones due to the inhibition of hepatic cytochrome enzymes.[L11034]  Fluconazole has demonstrated to be more selective for _fungal_ cytochrome P-450 enzymes than for a variety of mammalian cytochrome P-450 enzymes. Fluconazole 50 mg administered daily for up to 28 days in individuals of reproductive age has been show to have no effect on testosterone plasma concentrations of males and plasma concentrations of steroids in females. A 200-400 mg dose of fluconazole showed no clinically relevant effect on steroid levels or on ACTH-stimulated steroid response in healthy males, in one clinical study mentioned on the European Medicines Agency label.[L11034] Other studies have shown no significant effects of fluconazole on steroid levels, further confirming these data.[A174358,A178780]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19203, 'Flucon 0.1% eye drops 5 ml', 'فلوكون 0.1% نقط للعين 5 مل', '13', NULL, 'Glucocorticoid', 'Fluorometholone', 'Novartis > novartis scientific office', 'Drops', 'نقط', '0.1%', '1', NULL, 'about fluorometholone (eye.prep.) a synthetic glucocorticoid in steroid responsive inflammations of eye( topical anti-inflammatory). mechanism of action of fluorometholone (eye.prep.) the drug exerts its pharmacological action by penetrating and binding t', '7612797427507', NULL, 1287, '2022-12-05', 0, 'For the ophthalmic treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.', 'There is no generally accepted explanation for the mechanism of action of ocular corticosteroids. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Their primary target is the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes.', 'Corticosteroids such as fluorometholone inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19204, 'Limitless lactoferrin 100 mg 14 sachets', 'ليميتلس لاكتوفيرين 100 مجم 14 كيس', '245', '195', 'Iron supplement', 'Lactoferrin', 'Eva pharma', 'Sachet', 'أكياس', '100 mg', '1', 'علاج الانيميا -- مصدر للحديد -- مصدر للطاقة', 'ï- supports a healthy immune system for all family.', '6223012481733', NULL, 1947, '2025-11-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19206, 'Fludara 10 mg 20 f.c. tab', 'فلودارا 10مجم 20 قرص', '2,618', NULL, 'Antineoplastic', 'Fludarabine', 'Soficopharm', 'Tab', 'أقراص', '10 mg', '2', NULL, NULL, NULL, NULL, 713, '2022-06-14', 0, 'For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen', 'Fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite appears to act by inhibiting DNA polymerase alpha, ribonucleotide reductase and DNA primase, thus inhibiting DNA synthesis. The mechanism of action of this antimetabolite is not completely characterized and may be multi-faceted.', 'Fludarabine is a chemotherapy drug used in the treatment of chronic lymphocytic leukemia. It acts at DNA polymerase alpha, ribonucleotide reductase and DNA primase, results in the inhibition of DNA synthesis, and destroys the cancer cells.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19208, 'Fludconrizole 150mg 1 caps.', 'فلودكونريزول 150 مجم 1 كبسولات', '6', NULL, 'Antifungals.triazoles', 'Fluconazole', 'Riva pharma s.a.e.', 'Cap', 'كبسولة', '150mg', '1', NULL, NULL, NULL, NULL, 1172, '2022-07-11', 0, 'Fluconazole can be administered in the treatment of the following fungal infections[L11043]:



 1) Vaginal yeast infections caused by Candida

 2) Systemic Candida infections

 3) Both esophageal and oropharyngeal candidiasis 

 4) Cryptococcal meningitis

 5) UTI (urinary tract infection) by Candida

 6) Peritonitis (inflammation of the peritoneum) caused by Candida



**A note on fungal infection prophylaxis**



Patients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.[L11043]



**A note on laboratory testing**



Obtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.[L11043]

', 'Fluconazole is a very selective inhibitor of fungal cytochrome P450 dependent enzyme _lanosterol 14-α-demethylase_. This enzyme normally works to convert _lanosterol_ to _ergosterol_, which is necessary for fungal cell wall synthesis.  The free nitrogen atom located on the azole ring of fluconazole binds with a single iron atom located in the heme group of lanosterol 14-α-demethylase.[A178774] This prevents oxygen activation and, as a result, inhibits the demethylation of lanosterol, halting the process of ergosterol biosynthesis.[A178777]  Methylated sterols are then found to accumulate in the fungal cellular membrane, leading to an arrest of fungal growth.[A178774] These accumulated sterols negatively affect the structure and function of the fungal cell plasma membrane.[A16632]



Fluconazole resistance may arise from an alteration in the amount or function of the target enzyme (lanosterol 14-α-demethylase), altered access to this enzyme, or a combination of the above.[A16632] Other mechanisms may also be implicated, and studies are ongoing.[A178783]', 'Fluconazole has been demonstrated to show fungistatic activity against the majority of strains of the following microorganisms, curing fungal infections[L11043]:



_Candida albicans, Candida glabrata (Many strains are intermediately susceptible), Candida parapsilosis, Candida tropicalis, Cryptococcus neoformans_



This is achieved through steroidal inhibition in fungal cells, interfering with cell wall synthesis and growth as well as cell adhesion, thereby treating fungal infections and their symptoms.[L11043,A174325,A174343]



The fungistatic activity of fluconazole has also been shown in normal and immunocompromised animal models with both systemic and intracranial fungal infections caused by _Cryptococcus neoformans_ and for systemic infections caused by Candida albicans.[L11043]  It is important to note that resistant organisms have been found against various strains of organisms treated with fluconazole.[A178759,A178762,A178765] This further substantiates the need to perform susceptibility testing when fluconazole is considered as an antifungal therapy.[A178768,A178786] 





**A note on steroidal effects of fluconazole**



There has been some concern that fluconazole may interfere with and inactivate human steroids/hormones due to the inhibition of hepatic cytochrome enzymes.[L11034]  Fluconazole has demonstrated to be more selective for _fungal_ cytochrome P-450 enzymes than for a variety of mammalian cytochrome P-450 enzymes. Fluconazole 50 mg administered daily for up to 28 days in individuals of reproductive age has been show to have no effect on testosterone plasma concentrations of males and plasma concentrations of steroids in females. A 200-400 mg dose of fluconazole showed no clinically relevant effect on steroid levels or on ACTH-stimulated steroid response in healthy males, in one clinical study mentioned on the European Medicines Agency label.[L11034] Other studies have shown no significant effects of fluconazole on steroid levels, further confirming these data.[A174358,A178780]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19209, 'Flugenil 600 - 10 vaginal ovules', 'فلوجينيل 600 - 10 اقماع مهبلية', '537', '390', 'Vaginal care', 'Boric acid+tea tree oil+dragocalm (avena sativa oat)', 'Sakura italia srl > brother pharma', 'Unknown', 'غير محدد', NULL, '2', 'مضاد للفطريات المهبلية -- تقليل الحكة والاحمرار المهبلي --التخلص من الروائح الكريهة', 'indications: -useful adjunct in women with recurrent vulvovaginal yeast infection. -relief from yeast infection symptoms: itching burning and irritation of the vagina. -in the case of localized vaginal allergic response due to candida.', '8055348700152', NULL, 15175, '2025-01-30', 0, 'No FDA- or EMA-approved therapeutic indications on its own.', 'Information regarding the mechanism of action of boric acid in mediating its antibacterial or antifungal actions is limited. Boric acid inhibits biofilm formation and hyphal transformation of _Candida albicans_, which are critical virulence factors [A32457]. In addition, arrest of fungal growth was observed with the treatment of boric acid [A32457].', 'Boric acid exhibits minimal bacteriostatic and antifungal activities [L2140]. Boric acid is likely to mediate antifungal actions at high concentrations over prolonged exposures [A32457]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19210, 'Flugenil vaginal gel 5 applicators 30 ml', 'فلوجينيل جل مهبلي مع 5 أدوات 30 مل', '569', '410', 'Vaginal care', 'Hyaluronic acid+soy extract+mallow glycolic extract+boric acid+calendula water+tea tree oil+aloe ver', 'Sakura italia srl > brother pharma', 'Gel', 'جل', '30 ml', '1', 'يخفف من اعراض الاحمرار والحكة في المناطق الحساسة للسيدات -- ويساعد في اعادة توازن pH ومنع الإلتهابات المهبلية', 'indications:- *relief from burning itching and irritation associated with vaginal dryness. *helps to restore the normal vaginal mucosal hydration. *pain-free intercourse and sexual activity. *rebalancing the vaginal ph and prevent the vulvovaginal infecti', '8055348700022', NULL, 5957, '2024-12-11', 0, 'The intra-articular preparations of hyaluronic acid are indicated for knee pain associated with osteoarthritis.[L32228] Hyaluronic acid is used in cosmetic applications to prevent and reduce the appearance of wrinkles on the face, and as a dermal filler to correct facial imperfections or other imperfections on other parts of the body.[L32208,L32223] It is frequently an ingredient in topical applications for wound healing and symptomatic treatment of skin irritation from various causes.[L32198] Hyaluronic acid may also be indicated in ophthalmological preparations or oral capsules to treat discomfort caused by dry eyes or conjunctivitis and for its protective qualities during and before eye surgery.[A230128,L32213] Finally, hyaluronic acid can be used off-label to coat the bladder for relief of interstitial cystitis symptoms.[A230533]', 'General principles and hyaluronic acid receptor binding 



Hyaluronic acid works by two basic mechanisms: serving as a passive structural molecule or serving as signaling molecule, depending on the molecule size. The physicochemical properties of high molecular weight HA contribute to passive structural effects, demonstrating hygroscopicity and viscoelasticity and improving hydration, water balance, and structural integrity. As a signalling  molecule interacting with proteins, HA causes several opposing effects based on molecular weight: pro- or anti-inflammatory effects, promotion or inhibition of cell migration, and activating or inhibiting cell division.[A230133] 



Hyaluronic acid exerts its therapeutic effects through binding to three primary types of cell surface receptors: CD44 (a membrane glycoprotein), the receptor for hyaluronate-mediated motility (RHAMM), and the Intercellular Adhesion Molecule 1 (ICAM-1). CD44 is considered the most widely distributed receptor for hyaluronic acid, demonstrating cellular interactions with osteopontin, collagen, and matrix metalloproteinases (MMPs).  High and low molecular weight hyaluronic acids demonstrate differing molecular and cellular mechanisms in their interaction with CD44 receptors. Some examples of these effects include modification of chondrocyte survival pathways in addition to alteration of apoptosis pathways.  Lymphatic vessel endothelial hyaluronan receptor (LYVE-1), and hyaluronic acid receptor for endocytosis (HARE), (also known as Stabilin-2) also bind to hyaluronic acid.[A230128] 



Hyaluronic acid for skin conditions and cosmetics



Hyaluronic acid''s anionic proprieties cause it to attract water and induce swelling, increasing tissue volume and skin structural integrity. The aging process is associated with reduced production of skin hyaluronic acid and collagen, causing the appearance of wrinkles and the loss of facial volume. Dermal fillers of hyaluronic acid replace lost tissue volume, imparting a full and youthful appearance to skin that has lost its elasticity. Hyaluronic acid fillers contain cross-linked hyaluronic acid particles, rendering a concentrated substance with resistance to various forms of physical and chemical breakdown. The cosmetic benefits of hyaluronic acid filler may last up to 6 months, depending on the brand and technique used for injection.[L32193] Additionally, dermal hyaluronic acid fillers are known to increase the production of fibroblasts[L32193], supporting wound healing and offering relief from irritating and inflammatory skin conditions.[A230118]





Hyaluronic acid for joint pain



Most cells in the human body are capable of synthesizing HA. It is a primary component of the extracellular matrix (ECM) and can be found in bone marrow, cartilage, and synovial fluid in joints.[A230128] In osteoarthritis, the concentration of naturally occurring hyaluronic acid gradually decreases, lowering the viscosity of synovial fluid that protects joints from excess friction. Administration of intra-articular hyaluronic acid increases viscosity of synovial joint fluid, reducing friction and subsequently relieving painful arthritic symptoms.[L32193]





Hyaluronic acid for ophthalmic conditions and ophthalmological procedures



Solutions of hyaluronic acid with a concentration greater than 0.1% moisturize the surface of the eyes to treat symptoms of dry eye while improving the stabilization of tear film, replenishing deficiencies of HA, reducing friction, and preventing binding of foreign substances to the ocular tissue.[A230128,L32193] Hyaluronic acid is frequently used during and after ophthalmological surgeries and plays important roles by virtue of its moisturizing, viscoelastic, and protective properties. It promotes tissue healing of the corneal epithelium and other parts of the eye following ophthalmological surgery, minimizing the risk of adhesions and free radical formation.[A230128]

', 'HA has long-acting lubricant, shock absorbing, joint stabilizing, and water balancing properties.[A230128,L32193] It is similar to the naturally occurring glycosaminoglycan (GAG) in joints. Hyaluronic acid works by acting as a lubricant and shock absorber, facilitating joint mobility and thereby reducing osteoarthritic pain.  Hyaluronic acid has antioxidative, anti-inflammatory, and analgesic effects.[A230128] The water-balancing properties and viscoelasticity of hyaluronic acid are beneficial in cosmetic injections, imparting volume and reducing the appearance of imperfections and wrinkles.[L32193] Due to the abovementioned properties, HA has a protective effect on the eyes and cornea.[A230133]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19211, 'Fluimucil 300mg/3ml 5 ampoules', 'فلوموسيل 300مجم/3مل 5 امبولات', '262', '182.5', 'Mucolytic', 'Acetylcysteine', 'Zambon > pharmacon', 'Ampoule', 'أمبول', '300mg', '5', 'مذيب بلغم', NULL, NULL, NULL, 8427, '2024-08-25', 0, 'Acetylcysteine is indicated for mucolytic therapy and in the management of [acetaminophen] overdose.[L31378,L31383,L31388,L31478]', 'A number of possible mechanisms for the mucolytic activity of acetylcysteine have been proposed. Acetylcysteine''s sulfhydryl groups may hydrolize disulfide bonds within mucin, breaking down the oligomers, and making the mucin less viscous.[A228173,L31388] Acetylcysteine has also been shown to reduce mucin secretion in rat models.[A228173] It is an antioxidant in its own right but is also deacetylated to cysteine, which participates in the synthesis of the antioxidant glutathione.[A228173] The antioxidant activity may also alter intracellular redox reactions, decreasing phosphorylation of EGFR and MAPK, which decrease transcription of the gene MUC5AC which produces mucin.[A228173]



In the case of acetaminophen overdoses, a portion of the drug is metabolized by CYP2E1 to form the potentially toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI).[L31388] The amount of NAPQI produced in an overdose saturates and depletes glutathione stores.[L31388] The free NAPQI promiscuously binds to proteins in hepatocytes, leading to cellular necrosis.[L31388] Acetylcysteine can directly conjugate NAPQI or provide cysteine for glutathione production and NAPQI conjugation.[L31388]', 'Acetylcysteine is indicated for mucolytic therapy and in the management of acetaminophen overdose.[L31378,L31383,L31388,L31478] It has a short duration of action as it is given every 1-8 hours depending on route of administration, and has a wide therapeutic window.[L31378,L31383,L31388,L31478] Patients should be counselled regarding diluting oral solutions in cola for taste masking,[A228153] the risk of hypersensitivity, and the risk of upper gastrointestinal hemorrhage.[L31378,L31383,L31388,L31478]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19212, 'Fluimucil 600mg 10 eff. tabs.', 'فلوموسيل 600مجم 10 اقراص فوارة', '135', '78.5', 'Mucolytic', 'Acetylcysteine', 'Zambon > pharmacon', 'Tab', 'أقراص', '600mg', '1', 'مذيب بلغم', 'description acetylcysteine (also known as n-acetylcysteine or n-acetyl-l-cysteine or nac) is primarily used as a mucolytic agent and in the management of acetaminophen poisoning. it is a derivative of cysteine with an acetyl group attached to the amino gr', NULL, NULL, 18282, '2024-06-18', 0, 'Acetylcysteine is indicated for mucolytic therapy and in the management of [acetaminophen] overdose.[L31378,L31383,L31388,L31478]', 'A number of possible mechanisms for the mucolytic activity of acetylcysteine have been proposed. Acetylcysteine''s sulfhydryl groups may hydrolize disulfide bonds within mucin, breaking down the oligomers, and making the mucin less viscous.[A228173,L31388] Acetylcysteine has also been shown to reduce mucin secretion in rat models.[A228173] It is an antioxidant in its own right but is also deacetylated to cysteine, which participates in the synthesis of the antioxidant glutathione.[A228173] The antioxidant activity may also alter intracellular redox reactions, decreasing phosphorylation of EGFR and MAPK, which decrease transcription of the gene MUC5AC which produces mucin.[A228173]



In the case of acetaminophen overdoses, a portion of the drug is metabolized by CYP2E1 to form the potentially toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI).[L31388] The amount of NAPQI produced in an overdose saturates and depletes glutathione stores.[L31388] The free NAPQI promiscuously binds to proteins in hepatocytes, leading to cellular necrosis.[L31388] Acetylcysteine can directly conjugate NAPQI or provide cysteine for glutathione production and NAPQI conjugation.[L31388]', 'Acetylcysteine is indicated for mucolytic therapy and in the management of acetaminophen overdose.[L31378,L31383,L31388,L31478] It has a short duration of action as it is given every 1-8 hours depending on route of administration, and has a wide therapeutic window.[L31378,L31383,L31388,L31478] Patients should be counselled regarding diluting oral solutions in cola for taste masking,[A228153] the risk of hypersensitivity, and the risk of upper gastrointestinal hemorrhage.[L31378,L31383,L31388,L31478]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19213, 'Fluires nasal spray 65 ml', 'فلوريس بخاخ للانف 65 مل', '79', NULL, 'Nasal decongestant', 'Isotonic seawater+methylsulphonyl methane+resveratrol+sodium hyaluronate', 'Pharmaluce s.r.l > globe international pharmaceuticals', 'Spray', 'بخاخ', '65 ml', '1', NULL, NULL, NULL, NULL, 902, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19214, 'Flukit 20 tab.', 'فلوكيت 20 قرص', '12', NULL, 'Cold drugs', 'Paracetamol(acetaminophen)+phenylephrine+promethazine+salicylamide', 'Julphar', 'Tab', 'أقراص', NULL, '2', NULL, 'about paracetamol acetanilide derivative non narcotic analgesic antipyretic. mechanism of action of paracetamol paracetamol has analgesic and antipyretic action. it is more active on cyclo-oxygenase enzyme in brain. peripherally it is a poor inhibitor of', NULL, NULL, 952, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19215, 'Flumazenil inresa 0.5mg/5ml 5 i.v. amps.ss', 'فلومازينيل اينريسا 0.5 مجم / 5 مل 5 امبولات', '460', NULL, 'Antidote.benzodiazepine overdoses.gaba modulators', 'Flumazenil', 'Inresa arzneimittel gmbh > oncopharm egypt', 'Amp', 'أمبول', '0.5mg', '5', NULL, 'flumazenil is indicated for the complete or partial reversal of the central sedative effects of benzodiazepines. it may therefore be used in anaesthesia and in the intensive care in the following situations: in anaesthesia: - termination of hypnosedative', NULL, NULL, 1497, '2022-07-18', 0, 'For the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, and where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures. Also for the management of benzodiazepine overdose as an adjunct for appropriate supportive and symptomatic measures.', 'Flumazenil, an imidazobenzodiazepine derivative, is a benzodiazepine antagonist. It competitively inhibits the benzodiazepine binding site on the GABA/benzodiazepine receptor complex. Flumazenil is a weak partial agonist in some animal models of activity, but has little or no agonist activity in man.', 'Flumazenil antagonizes the CNS effects produced by benzodiazepines, but does not antagonize the central nervous system effects of drugs affecting GABA-ergic neurons by means other than the benzodiazepine receptor (including ethanol, barbiturates, or general anesthetics) and does not reverse the effects of opioids.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19216, 'Flumetol s 0.1% sterile eye drops', 'فلوميتول اس 0.1% قطرة معقمة للعين', '4', NULL, 'Glucocorticoid', 'Fluorometholone', 'Kahira', 'Drops', 'نقط', '0.1%', '1', NULL, 'about fluorometholone (eye.prep.) a synthetic glucocorticoid in steroid responsive inflammations of eye( topical anti-inflammatory). mechanism of action of fluorometholone (eye.prep.) the drug exerts its pharmacological action by penetrating and binding t', NULL, NULL, 1079, '2022-07-26', 0, 'For the ophthalmic treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.', 'There is no generally accepted explanation for the mechanism of action of ocular corticosteroids. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Their primary target is the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes.', 'Corticosteroids such as fluorometholone inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19218, 'Flumocin 250mg 12caps.', 'فلوموسين 250 مجم 12 كبسولة', '6', NULL, 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+flucloxacillin', 'T3a pharma', 'Cap', 'كبسولة', '250mg', '1', NULL, 'amoxycillin and flucloxacillin ï¿½ generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination showing that antagonism does not occur when the two', NULL, NULL, 1003, '2022-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19221, 'Flumol syrup 120ml', 'فلومول شراب 120 مل', '8', NULL, 'Cold drugs', 'Chlorpheniramine+paracetamol(acetaminophen)+pseudoephedrine', 'Eva pharma', 'Syrup', 'شراب', '120ml', '1', NULL, 'indication: runny noses blocked noses and sinus sneezing watery itchy eyes sinus pain fever headache body aches & pain information: pseudoephedrine hydrochloride belongs to a group of medicines called sympathomimetic decongestants. it works by reducing co', '6223002450299', NULL, 1234, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19222, 'Flumox 1gm i.m/i.v. vial', 'فلوموكس 1جم فيال عضل/وريد', '26', '12.75', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+flucloxacillin', 'Eipico', 'Vial', 'فيال', '1gm', '1', NULL, NULL, '6221032311399', NULL, 2128, '2024-10-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19223, 'Medexanerv 30 tab', 'ميدكسانيرف 30 قرص', '135', '117', 'Multivitamin', 'Vitb1 thiamin 100mg+vit b6 pyridoxin 100mg+vitb12 cyanocobalamine 200 mcg', 'P.medex', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1519, '2025-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19225, 'Flumox 250mg/5ml susp. 100ml', 'فلوموكس 250مجم/5مل معلق 100 مل', '46', '30', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+flucloxacillin', 'Eipico', 'Susp', 'معلق', '250mg', '1', NULL, NULL, '6221032150608', NULL, 1517, '2025-05-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19228, 'Flunzapine 12/25 mg 20 caps.', 'فلونزابين 12/25مجم 20 كبسولة', '174', '92', 'Psychiatric.antipsychotics', 'Fluoxetine+olanzapine', 'Delta pharma', 'Cap', 'كبسولة', '25 mg', '2', 'نفسية - مضاد للذهان', 'this medication is a combination of 2 drugs olanzapine (an antipsychotic drug) and fluoxetine (a selective serotonin reuptake inhibitor-ssri). it is used to treat a certain type of mental/mood disorder (depression associated with bipolar disorder). it is', '6221163015227', NULL, 3944, '2025-01-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19229, 'Flunzapine 12/50 mg 20 capsules', 'فلونزابين 12/50 مجم 20 كبسولة', '200', '152', 'Psychiatric.antipsychotics', 'Fluoxetine+olanzapine', 'Delta pharma', 'Capsule', 'كبسولة', '50 mg', '2', 'امراض نفسية - مضاد للذهان', NULL, NULL, NULL, 2379, '2025-01-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19230, 'Flunzapine 6/25 mg 20 capsules', 'فلونزابين 6/25 مجم 20 كبسولة', '122', '92', 'Psychiatric.antipsychotics', 'Fluoxetine+olanzapine', 'Delta pharma', 'Capsule', 'كبسولة', '25 mg', '2', 'امراض نفسية - مضاد للذهان', NULL, NULL, NULL, 4408, '2025-01-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19231, 'Flunzapine 6/50 mg 20 caps.', 'فلونزابين 6/50مجم 20 كبسولة', '144', '109', 'Psychiatric.antipsychotics', 'Fluoxetine+olanzapine', 'Delta pharma', 'Cap', 'كبسولة', '50 mg', '2', 'علاج الامراض النفسية', 'this medication is a combination of 2 drugs olanzapine (an antipsychotic drug) and fluoxetine (a selective serotonin reuptake inhibitor-ssri). it is used to treat a certain type of mental/mood disorder (depression associated with bipolar disorder). it is', '6221163015227', NULL, 3165, '2025-01-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19232, 'Fluorescein 500 mg i.v. amp.', 'فلورسين 500 مجم امبول', '120', '35', 'Radiographic procedures.contrast agent', 'Fluorescein sodium', 'Cid', 'Amp', 'أمبول', '500 mg', '1', NULL, 'about fluorescein sodium fluorone dye fluorescent dye dibasic acid xanthine dye diagnostic agent(angiography or angioscopy of fundus and of iris vasculature of eye)', '6221043011127', NULL, 1958, '2025-07-09', 0, 'For diagnostic imaging. Primarily indicated in diagnostic fluorescein angiography or angioscopy of the fundus and of the iris vasculature.', 'Fluorescein sodium is used extensively as a diagnostic tool in the field of ophthalmology. Fluorescein is a fluorescent compound or fluorophore having a maximum absorbance of 494 m and an emission maximum of 521 nm. The yellowish-green fluorescence of the compound  can be used to demarcate the vascular area under observation, distinguishing it from adjacent areas. It is applied topically in the form of a drop or it can be injected intravenously to produce a fluorescein angiogram. Topical fluorescein is a useful tool in the diagnosis of corneal abrasions, corneal ulcers, herpetic corneal infections, and dry eye. Fluorescein angiography is used to diagnose and categorize macular degeneration, diabetic retinopathy, inflammatory intraocular conditions, and intraocular tumors.



', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19233, 'Limitless allzyme max 20 e.c. tab.', 'ليميتلس اولزايم ماكس 20 قرص', '145', '112', 'Anti-inflammatory', 'Chemotrypsin+trypsin+bromelain', 'Eva pharma', 'Tab', 'أقراص', NULL, '2', '1- التهابات واحتقان الصدر أثناء نزلات البرد.', NULL, '6223012482990', NULL, 14714, '2024-08-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19235, 'Fluoxetine 20 mg h.g. caps', 'فلوكسيتين 20مجم كبسولات', '8', NULL, 'Psychiatric.antidepressants', 'Fluoxetine', 'Sigma', 'Cap', 'كبسولة', '20 mg', '1', NULL, NULL, NULL, NULL, 1503, '2022-06-15', 0, 'Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present.[L7664] Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar I Disorder, and treatment resistant depression.[L7664] Fluoxetine is additionally indicated for the treatment of female patients with premenstrual dysphoric disorder (PMDD).[L40833]', 'The monoaminergic hypothesis of depression emerged in 1965 and linked depression with dysfunction of neurotransmitters such as noradrenaline and serotonin.[L7721] Indeed, low levels of serotonin have been observed in the cerebrospinal fluid of patients diagnosed with depression.[A181793] As a result of this hypothesis, drugs that modulate levels of serotonin such as fluoxetine were developed.[L7721]



Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and as the name suggests, it exerts it''s therapeutic effect by inhibiting the presynaptic reuptake of the neurotransmitter serotonin.[A181673] As a result, levels of 5-hydroxytryptamine (5-HT) are increased in various parts of the brain.[L7721] Further, fluoxetine has high affinity for 5-HT transporters, weak affinity for noradrenaline transporters and no affinity for dopamine transporters indicating that it is 5-HT selective.[L7721]



Fluoxetine interacts to a degree with the 5-HT<sub>2C</sub> receptor and it has been suggested that through this mechanism, it is able to increase noradrenaline and dopamine levels in the prefrontal cortex.[L7721]', 'Fluoxetine blocks the serotonin reuptake transporter in the presynaptic terminal, which ultimately results in sustained levels of 5-hydroxytryptamine (5-HT) in certain brain areas.[L7721] However, fluoxetine binds with relatively poor affinity to 5-HT, dopaminergic, adrenergic, cholinergic, muscarinic, and histamine receptors which explains why it has a far more desirable adverse effect profile compared to earlier developed classes of antidepressants such as tricyclic antidepressants.[L7721][A181673] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19236, 'Mixogreat 30 ml oil', 'ميكسوجريت زيت 30 مل', '270', NULL, 'Healing topical', 'Hypericum+neem', 'Novocare', 'Oil', 'زيت', '30 ml', '1', NULL, NULL, NULL, NULL, 1015, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19237, 'Fluozac 40mg 10 caps.', 'فلوزاك 40 مجم 10 كبسولات', '20', NULL, 'Psychiatric.antidepressants', 'Fluoxetine', 'Jedco int. co. for pharmaceuticals', 'Cap', 'كبسولة', '40mg', '1', NULL, 'about fluoxetine selective serotonin reuptake inhibitor antidepressant. mechanism of action of fluoxetine fluoxetine preferentially inhibits the re-uptake of serotonin (5 ht) in the cns nerve terminals .this will result in an increased concentration of ne', NULL, NULL, 1984, '2022-07-27', 0, 'Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present.[L7664] Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar I Disorder, and treatment resistant depression.[L7664] Fluoxetine is additionally indicated for the treatment of female patients with premenstrual dysphoric disorder (PMDD).[L40833]', 'The monoaminergic hypothesis of depression emerged in 1965 and linked depression with dysfunction of neurotransmitters such as noradrenaline and serotonin.[L7721] Indeed, low levels of serotonin have been observed in the cerebrospinal fluid of patients diagnosed with depression.[A181793] As a result of this hypothesis, drugs that modulate levels of serotonin such as fluoxetine were developed.[L7721]



Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and as the name suggests, it exerts it''s therapeutic effect by inhibiting the presynaptic reuptake of the neurotransmitter serotonin.[A181673] As a result, levels of 5-hydroxytryptamine (5-HT) are increased in various parts of the brain.[L7721] Further, fluoxetine has high affinity for 5-HT transporters, weak affinity for noradrenaline transporters and no affinity for dopamine transporters indicating that it is 5-HT selective.[L7721]



Fluoxetine interacts to a degree with the 5-HT<sub>2C</sub> receptor and it has been suggested that through this mechanism, it is able to increase noradrenaline and dopamine levels in the prefrontal cortex.[L7721]', 'Fluoxetine blocks the serotonin reuptake transporter in the presynaptic terminal, which ultimately results in sustained levels of 5-hydroxytryptamine (5-HT) in certain brain areas.[L7721] However, fluoxetine binds with relatively poor affinity to 5-HT, dopaminergic, adrenergic, cholinergic, muscarinic, and histamine receptors which explains why it has a far more desirable adverse effect profile compared to earlier developed classes of antidepressants such as tricyclic antidepressants.[L7721][A181673] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19239, 'Fluroflox 400mg 5 f.c. tabs.', 'فلوروفلوكس 400مجم 5 قرص', '92', '77.75', 'Antibiotic.quinolone', 'Moxifloxacin', 'Global napi pharmaceuticals > ta pharma', 'Tab', 'أقراص', '400mg', '1', 'مضاد حيوي', 'about moxifloxacin a third generation synthetic fluoroquinolone antibiotic a broad spectrum antibiotic. mechanism of action of moxifloxacin moxifloxacin acts by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.dna gyrase helps in the', '6225000351110', NULL, 11194, '2024-06-29', 0, 'For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye).', 'The bactericidal action of moxifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division.', 'Moxifloxacin is a quinolone/fluoroquinolone antibiotic. Moxifloxacin can be used to treat infections caused by the following bacteria: Aerobic Gram-positive microorganisms: _Corynebacterium_ species, _Micrococcus luteus_, _Staphylococcus aureus_, _Staphylococcus epidermidis_, _Staphylococcus haemolyticus_, _Staphylococcus hominis_, _Staphylococcus warneri_, _Streptococcus pneumoniae_, and _Streptococcus viridans_ group. Aerobic Gram-negative microorganisms: _Acinetobacter lwoffii_, _Haemophilus influenzae_, and _Haemophilus parainfluenzae_. Other microorganisms: _Chlamydia trachomatis_. Moxifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Moxifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19241, 'Flustat 20 tab.', 'فلوستات 20 قرص', '34', '15', 'Cold drugs', 'Chlorpheniramine+paracetamol(acetaminophen)+pseudoephedrine', 'Hi-pharm', 'Tab', 'أقراص', NULL, '1', NULL, NULL, '6224001050176', NULL, 1981, '2025-03-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19242, 'Flustop 20 tab.', 'فلوستوب 20 قرص', '4', NULL, 'Cold drugs', 'Caffeine+chlorpheniramine+paracetamol(acetaminophen)+pseudoephedrine', 'Glaxo smithkline', 'Tab', 'أقراص', NULL, '2', NULL, NULL, '6221045008743', NULL, 1473, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19243, 'Flutiform inhaler 125/5mcg 120 metered actuations', 'فلوتيفورم استنشاق 125/5ميكروجرام 120 جرعة', '318', NULL, 'Bronchodilator.glucocorticoid steroid and long-acting b2 agonist', 'Fluticasone+formoterol', 'Mundipharma > multipharma', 'Inhaler', 'جهاز استنشاق', '5mcg', '1', NULL, 'about fluticasone synthetic topical glucocorticoid anti inflammatory and antipruritic in corticosteroid-responsive dermatoses; atopic dermatitis. mechanism of action of fluticasone it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes b', NULL, NULL, 1573, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19244, 'Flutiform inhaler 250/10mcg 120 metered actuations', 'فلوتيفورم استنشاق 10/250ميكروجرام 120 جرعه متساوية', '481', NULL, 'Bronchodilator.glucocorticoid steroid and long-acting b2 agonist', 'Fluticasone+formoterol', 'Mundipharma > multipharma', 'Inhaler', 'جهاز استنشاق', '10mcg', '1', NULL, 'about fluticasone synthetic topical glucocorticoid anti inflammatory and antipruritic in corticosteroid-responsive dermatoses; atopic dermatitis. mechanism of action of fluticasone it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes b', NULL, NULL, 1210, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19245, 'Flutiform inhaler 50/5mcg 120 metered actuations', 'فلوتيفورم 50/5 ميكروجرام جهاز استنشاق', '249', NULL, 'Bronchodilator.glucocorticoid steroid and long-acting b2 agonist', 'Fluticasone+formoterol', 'Mundipharma > multipharma', 'Inhaler', 'جهاز استنشاق', '5mcg', '1', NULL, 'about fluticasone synthetic topical glucocorticoid anti inflammatory and antipruritic in corticosteroid-responsive dermatoses; atopic dermatitis. mechanism of action of fluticasone it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes b', NULL, NULL, 819, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19246, 'Revital hair stimulating system', 'ريفيتال محفز لنمو لشعر', '240', NULL, 'Hair care', NULL, 'Mash premiere', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 680, '2022-10-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19247, 'Fluvastatin 80mg 14 f.c.tab.', 'فلوفاستاتين 80 مجم 14 قرص', '46', NULL, 'Statins.hmgcoa reductase inhibitor', 'Fluvastatin', 'Copad pharma', 'Tab', 'أقراص', '80mg', '2', NULL, 'about fluvastatin hmgcoa reductase inhibitor statins antilipemi agent mechanism of action of fluvastatin fluvastatin selectively and competitively inhibits the hepatic enzyme hydroxymethylglutaryl-coenzyme a (hmg-coa) reductase. hmg-coa reductase is respo', NULL, NULL, 1016, '2022-07-08', 0, 'To be used as an adjunct to dietary therapy to prevent cardiovascular events. May be used as secondary prevention in patients with coronary heart disease (CHD) to reduce the risk of requiring coronary revascularization procedures, for reducing progression of coronary atherosclerosis in hypercholesterolemic patients with CHD, and for the treatment of primary hypercholesterolemia and mixed dyslidipidemia. ', 'Fluvastatin selectively and competitively inhibits the hepatic enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase is responsible for converting HMG-CoA to mevalonate, the rate-limiting step in cholesterol biosynthesis. Inhibition results in a decrease in hepatic cholesterol levels which stimulates the synthesis of LDL receptors and increases hepatic uptake of LDL cholesterol. The end result is decreased levels of plasma total and LDL cholesterol. ', 'Fluvastatin, the first synthetically-derived HMG-CoA reductase inhibitor, is a hydrophilic, acidic, antilipemic agent used to lower cholesterol and triglyceride levels associated with primary hypercholesterolemia and mixed dyslipidemia (Fredrickson types IIa and IIb), to slow the progression of coronary atherosclerosis in patients with CHD and as secondary prevention therapy in patients with CHD to reduce the risk of requiring coronary revascularization procedures. Although similar to lovastatin, simvastatin, and pravastatin, fluvastatin has a shorter half-life, no active metabolites, extensive protein binding, and minimal CSF penetration. Fluvastatin acts primarily in the liver. It is prepared as a racemate of two erythro enantiomers of which the 3R,5S enantiomer exerts the pharmacologic effect. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19248, 'Fluver 100mg 6 tablets', 'فلوفير 100مجم 6 قرص', '19', '12', 'Anthelmintic', 'Flubendazole', 'Alexandria', 'Tablet', 'أقراص', '100mg', '1', 'مضاد للديدان', NULL, '6223000171400', NULL, 6063, '2024-10-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19251, 'Fluvermal 20mg/ml susp. 30ml', 'فلوفيرمال 20مجم/مل معلق 30 مل', '11', NULL, 'Anthelmintic', 'Flubendazole', 'Mina pharm > janssen cilag', 'Susp', 'معلق', '20mg', '1', NULL, 'indication: flubendazol is used in the treatment of single or mixed infections caused by: enterobiasis ascariasis hookworm and trichuriasis contraindications: hypersensitivity to the drug pregnancy and lactation side effects: flubendazol is well tolerated', NULL, NULL, 1185, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19253, 'Evoplex 30 tabs', 'ايفوبلكس 30 قرص', '130', '115', 'Multivitamin', 'Iron+biotin+folic acid+vitamin b12+vitamin c', 'Health for life international pharmaceutical', 'Tab', 'أقراص', NULL, '3', NULL, NULL, '6224009553082', NULL, 1212, '2025-05-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19254, 'Fabuglycina syrup 120 ml', 'فابوجليسينا شراب 120 مل', '45', NULL, 'Iron supplement', 'Iron', 'Praxo pharm', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 801, '2022-07-18', 0, 'For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.', 'After iron dextran is injected, the circulating iron dextran is removed from the plasma by cells of the reticuloendothelial system, which split the complex into its components of iron and dextran. The iron is immediately bound to the available protein moieties to form hemosiderin or ferritin, the physiological forms of iron, or to a lesser extent to transferrin. This iron which is subject to physiological control replenishes hemoglobin and depleted iron stores.', 'Iron dextran is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. It is for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Iron is essential to the formation of hemoglobin and to the function and formation of other heme and nonheme compounds. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and, in turn, to iron deficiency anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19255, 'Flux free 16 chewable tab', 'فلاكس فري 16 قرص للمضغ', '9', NULL, 'Antacid', 'Aluminium hydroxide+ magnesium trisilicate + sodium alginate', 'Alexandria > millenium pharma-egypt', 'Tab', 'أقراص', NULL, '2', 'مضاد للحموضة لعلاح وتخفيف حالات حرقان المعدة', NULL, NULL, NULL, 1059, '2022-10-08', 0, NULL, 'Aluminum Acetate is an astringent.  An astrignent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application.  The shrinkage or constriction is through osmotic flow of water (or other fluids) away from the area where the astringent was applied.  Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete''s foot. ', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19256, 'Fluxamine 100mg 10 f.c.tab.', 'فلوكسامين 100مجم 10 اقراص', '30', NULL, 'Antidepressant', 'Fluvoxamine maleate', 'Pharopharma > pharma dessau gmbh - germany', 'Tab', 'أقراص', '100mg', '1', NULL, 'description fluvoxamine is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. though it is in the same class as other ssri drugs it is most often used to treat obsessive-compulsive disorder. indication for man', '6221094036001', NULL, 1101, '2022-12-05', 0, 'Indicated predominantly for the management of depression and for Obsessive Compulsive Disorder (OCD) [FDA Label]. Has also been used in the management of bulimia nervosa [A250].', 'The exact mechanism of action of fluvoxamine has not been fully determined, but appears to be linked to its inhibition of CNS neuronal uptake of serotonin [FDA Label, A249, A250]. Fluvoxamine blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT<sub>1A</sub> autoreceptors [FDA Label, A249, A250]. Studies have also demonstrated that fluvoxamine has virtually no affinity for α<sub>1</sub>- or α<sub>2</sub>-adrenergic, β-adrenergic, muscarinic, dopamine D<sub>2</sub>, histamine H<sub>1</sub>, GABA-benzodiazepine, opiate, 5-HT<sub>1</sub>, or 5-HT<sub>2</sub> receptors, despite having an affinity for binding to σ1 receptors [A250].', 'Fluvoxamine, an aralkylketone-derivative agent [FDA Label], is one of a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) that differs structurally from other SSRIs [A249]. It is used to treat the depression associated with mood disorders. It is also used on occassion in the treatment of body dysmorphic disorder and anxiety [A249]. The antidepressant, antiobsessive-compulsive, and antibulimic actions of Fluvoxamine are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin [FDA Label, A249, A250]. <i>In vitro</i> studies show that Fluvoxamine is a potent and selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake [A250]. Moreover, apart from binding to σ1 receptors [A250], fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT<sub>1A</sub>, 5HT<sub>1B</sub>, 5HT<sub>2</sub>), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs [A249]. Furthermore, some studies have demonstrated that the chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors (as has been observed with other drugs effective in the treatment of major depressive disorder), while others suggest the opposite [A31914].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19257, 'Fluxamine 50mg 10 tab.', 'فلوكسامين 50 مجم 10 اقراص', '19', NULL, 'Ssri', 'Fluvoxamine maleate', 'Pharopharma', 'Tab', 'أقراص', '50mg', '1', NULL, 'description fluvoxamine is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. though it is in the same class as other ssri drugs it is most often used to treat obsessive-compulsive disorder. indication for man', '6221094035974', NULL, 1231, '2022-12-05', 0, 'Indicated predominantly for the management of depression and for Obsessive Compulsive Disorder (OCD) [FDA Label]. Has also been used in the management of bulimia nervosa [A250].', 'The exact mechanism of action of fluvoxamine has not been fully determined, but appears to be linked to its inhibition of CNS neuronal uptake of serotonin [FDA Label, A249, A250]. Fluvoxamine blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT<sub>1A</sub> autoreceptors [FDA Label, A249, A250]. Studies have also demonstrated that fluvoxamine has virtually no affinity for α<sub>1</sub>- or α<sub>2</sub>-adrenergic, β-adrenergic, muscarinic, dopamine D<sub>2</sub>, histamine H<sub>1</sub>, GABA-benzodiazepine, opiate, 5-HT<sub>1</sub>, or 5-HT<sub>2</sub> receptors, despite having an affinity for binding to σ1 receptors [A250].', 'Fluvoxamine, an aralkylketone-derivative agent [FDA Label], is one of a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) that differs structurally from other SSRIs [A249]. It is used to treat the depression associated with mood disorders. It is also used on occassion in the treatment of body dysmorphic disorder and anxiety [A249]. The antidepressant, antiobsessive-compulsive, and antibulimic actions of Fluvoxamine are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin [FDA Label, A249, A250]. <i>In vitro</i> studies show that Fluvoxamine is a potent and selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake [A250]. Moreover, apart from binding to σ1 receptors [A250], fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT<sub>1A</sub>, 5HT<sub>1B</sub>, 5HT<sub>2</sub>), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs [A249]. Furthermore, some studies have demonstrated that the chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors (as has been observed with other drugs effective in the treatment of major depressive disorder), while others suggest the opposite [A31914].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19258, 'Lipopent 600 mg 20 tabs', 'ليبوبنت 600مجم 20 قرص', '180', '100', 'Antioxidant', 'Thioctic acid(alpha lipoic acid)', 'Penta pharma', 'Tab', 'أقراص', '600 mg', '2', 'حموضة المعدة -- ارتجاع المرئ -- متلازمة القولون العصبي -- التهاب المعدة', NULL, NULL, NULL, 3168, '2024-06-29', 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19259, 'Fml liquifilm 0.1% eye drops 5 ml', 'اف ام ال قطرة للعين 5 مل', '6', NULL, 'Glucocorticoid', 'Fluorometholone', 'Eipico > allergan', 'Drops', 'نقط', '0.1%', '1', NULL, 'about fluorometholone (eye.prep.) a synthetic glucocorticoid in steroid responsive inflammations of eye( topical anti-inflammatory). mechanism of action of fluorometholone (eye.prep.) the drug exerts its pharmacological action by penetrating and binding t', '6221032330369', NULL, 975, '2022-07-26', 0, 'For the ophthalmic treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.', 'There is no generally accepted explanation for the mechanism of action of ocular corticosteroids. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Their primary target is the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes.', 'Corticosteroids such as fluorometholone inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19260, 'Fml neo eye drops 5 ml', 'اف ام ال نيو قطرة للعين 5 مل', '6', NULL, 'Antibiotic with glucocorticoid', 'Fluorometholone+neomycin', 'Eipico > allergan', 'Drops', 'نقط', '5 ml', '1', NULL, 'about neomycin an aminoglycoside antibiotic ammonium detoxicant. mechanism of action of neomycin this aminoglycoside cause protein synthesis inhibition by irreversibly bind to specific 30s-subunit proteins and 16s rrna. specifically neomycin binds to four', '6221032330383', NULL, 826, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19261, 'Fodavir 10mg 30 tab.', 'فودافير 10 مجم 30 قرص', '225', NULL, 'Antiviral.nucleoside', 'Adefovir', 'Eva pharma', 'Tab', 'أقراص', '10mg', '3', NULL, 'about adefovir antiretroviral agent reverse transcriptase inhibitor (nucleoside) mechanism of action of adefovir adefovir undergoes phosphorylation in the presence of cellular kinase enzyme to adefovir diphosphate. this adefovir diphosphate competitively', NULL, NULL, 780, '2022-07-22', 0, 'Indicated for the treatment of chronic hepatitis B in adult patients with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease; this is based on histological, virological, biochemical, and serological responses in adult patients with HBeAg+ and HBeAg- chronic hepatitis B with compensated liver function, and in adult patients with clinical evidence of lamivudine-resistant hepatitis B virus with either compensated or decompensated liver function.', 'Adefovir dipivoxil is a prodrug of adefovir. Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is phosphorylated to the active metabolite adefovir diphosphate by cellular kinases. Adefovir diphosphate inhibits HBV DNA polymerase (reverse transcriptase) by competing with the natural substrate deoxyadenosine triphosphate and by causing DNA chain termination after its incorporation into viral DNA. The inhibition constant (Ki) for adefovir diphosphate for HBV DNA polymerase was 0.1 &mu;M. Adefovir diphosphate is a weak inhibitor of human DNA polymerases &alpha; and &gamma; with Ki values of 1.18 &mu;M and 0.97&mu;M, respectively.', 'Adefovir dipivoxil a diester prodrug of adefovir. Adefovir is an acyclic nucleotide analog with activity against human hepatitis B virus (HBV). The concentration of adefovir that inhibited 50% of viral DNA synthesis (IC50) in vitro ranged from 0.2 to 2.5 &mu;M in HBV transfected human hepatoma cell lines. The combination of adefovir with lamivudine showed additive anti-HBV activity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19262, 'Biolegam 50/30 mg 8 f.c. tabs.', 'بيولجام 50/30مجم 8 اقراص', '164', NULL, 'Tonic for men.delay', 'Sildenafil+dapoxetine', 'Biomed', 'Tab', 'أقراص', '30 mg', '8', 'مقوى و للتأخير', NULL, '6224003225015', NULL, 11515, '2022-09-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19263, 'Foldex ph5 cream 50 ml', 'فولدكس ph5 كريم 50 مل', '45', NULL, 'Whitening topical', NULL, 'Leader cosmetics > purex health care', 'Cream', 'كريم', '50 ml', '1', NULL, '-natural cream that helps to light sll types of skin. -hydroquinone free.', '6224001085086', NULL, 1336, '2022-09-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19264, 'Folex 30 chew. tabs.', 'فوليكس 30 قرص للمضغ', '55', '45', 'Folic acid supplement', 'Folic acid+vitamin b12', 'Medcare > vortex pharmaceuticals', 'Tab', 'أقراص', NULL, '1', 'فيتامينات حمض الفوليك', NULL, '6224001079375', NULL, 6392, '2023-10-13', 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19267, 'Folic acid 400 mcg 250 tablets (illegal import)', 'فوليك اسيد 400 ميكروجرام 250 قرص', '0', NULL, 'Folic acid supplement', 'Folic acid', 'Puritans pride', 'Tablet', 'أقراص', '400 mcg', '1', NULL, 'it is well known that folic acid is important for pregnant women but did you also know that this essential b vitamin also supports cardiovascular health in women and men? folic acid is part of a triad of b vitamins - along with vitamins b-6 and b-12 - tha', NULL, NULL, 1035, '2022-07-12', 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19269, 'Folic acid (amoun) 5mg 20 tab.', 'فوليك اسيد امون 5مجم 20 قرص', '20', NULL, 'Folic acid supplement', 'Folic acid', 'Amoun', 'Tab', 'أقراص', '5mg', '2', NULL, NULL, '6221077011513', NULL, 1478, '2022-07-12', 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19270, 'Folic acid (eipico) 5 mg 20 tab.', 'فوليك اسيد ايبيكو 5مجم 20 قرص', '24', '10.5', 'Folic acid supplement', 'Folic acid', 'Eipico', 'Tab', 'أقراص', '5 mg', '2', NULL, NULL, '6221032112699', NULL, 1765, '2025-05-26', 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19271, 'Folic acid (memphis) 5 mg 30 tab.', 'فوليك اسيد ممفيس 5مجم 30 قرص', '16', '15.75', 'Folic acid supplement', 'Folic acid', 'Memphis', 'Tab', 'أقراص', '5 mg', '3', NULL, NULL, '6221077010615', NULL, 1291, '2024-10-18', 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19275, 'Rotaguard 200 mg 30 caps.', 'روتاجارد 200مجم 30 كبسولة', '54', NULL, 'Immunity inhancer', 'Echinacea dry extract', 'Rotabiogen', 'Cap', 'كبسولة', '200 mg', '3', NULL, NULL, NULL, NULL, 949, '2022-09-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19277, 'Folicron 30 caps.', 'فوليكرون 30 كبسولة', '13', NULL, 'Anemia.iron supplement combined with folic acid', 'Ferrous sulphate+folic acid', 'Julphar', 'Cap', 'كبسولة', NULL, '3', NULL, 'about folic acid dietary supplement folate derivative( b9 ) water soluble vitamin. mechanism of action of folic acid folic acid reduced by enzymes folate reductase and dihydrofolate reductase and forms dihydrofolic acid tetrahydrofolic acid respectively.', '6291100082988', NULL, 1277, '2022-07-12', 0, 'Ferrous sulfate is used for the prevention and treatment of iron deficiency anemia in adults and children.[A190804,L2240,L11800]

', 'Iron is required to maintain optimal health, particularly for helping to form red blood cells (RBC) that carry oxygen around the body. A deficiency in iron indicates that the body cannot produce enough normal red blood cells.[A32514,L11800] Iron deficiency anemia occurs when body stores of iron decrease to very low levels, and the stored iron is insufficient to support normal red blood cell (RBC) production. Insufficient dietary iron, impaired iron absorption, bleeding, pregnancy, or loss of iron through the urine can lead to iron deficiency.[A32514,L11794]  Symptoms of iron deficiency anemia include fatigue, breathlessness, palpitations, dizziness, and headache.



Taking iron in supplement form, such as ferrous sulfate, allows for more rapid increases in iron levels when dietary supply and stores are not sufficient.[L2175] Iron is transported by the divalent metal transporter 1 (DMT1) across the endolysosomal membrane to enter the macrophage. It can then can be incorporated into ferritin and be stored in the macrophage or carried of the macrophage by ferroportin. This exported iron is  oxidized by the enzyme to ceruloplasmin to Fe3+, followed by sequestration by transferrin for transport in the serum to various sites, including the bone marrow for hemoglobin synthesis or into the liver.[A32524] Iron combines with porphyrin and globin chains to form hemoglobin, which is critical for oxygen delivery from the lungs to other tissues.[L2263]', 'Ferrous sulfate replenishes iron, an essential component in hemoglobin, myoglobin, and various enzymes. It replaces the iron that is usually found in hemoglobin and myoglobin. Iron participates in oxygen transport and storage, electron transport and energy metabolism, antioxidant and beneficial pro-oxidant functions, oxygen sensing, tissue proliferation and growth, as well as DNA replication and repair.[A32524,A32514]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19279, 'Folinobiogen 100mg/10ml vial', 'فولينوبيوجين 100 مجم / 10 مل فيال', '65', NULL, 'Folic acid supplement', 'Leucovorin calcium=folinic acid=calcium folinate', 'Arabcomed-egypt > biocapital pharma', 'Vial', 'فيال', '100mg', '1', 'تستخدم في علاج فقر الدم الضخم الأرومات الناجم عن نقص حمض الفوليك بسبب سوء التغذية ومتلازمات سوء الامتصاص وزيادة استخدامه أثناء الحمل.', 'indication for the treatment of osteosarcoma (after high dose methotrexate therapy). used to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists and to treat megalo', NULL, NULL, 1171, '2022-07-10', 0, 'For the treatment of osteosarcoma (after high dose methotrexate therapy). Used to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists, and to treat megaloblastic anemias due to folic acid deficiency. Also used in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.', 'As leucovorin is a derivative of folic acid, it can be used to increase levels of folic acid under conditions favoring folic acid inhibition (following treatment of folic acid antagonists such as methotrexate). Leucovorin enhances the activity of fluorouracil by stabilizing the bond of the active metabolite (5-FdUMP) to the enzyme thymidylate synthetase.', 'Leucovorin is one of several active, chemically reduced derivatives of folic acid. It is useful as an antidote to drugs which act as folic acid antagonists. Leucovorin is a mixture of the diastereoisomers of the 5-formyl derivative of tetrahydrofolic acid (THF). The biologically active compound of the mixture is the (-)-l-isomer, known as Citrovorum factor or (-)-folinic acid. Leucovorin does not require reduction by the enzyme dihydrofolate reductase in order to participate in reactions utilizing folates as a source of &ldquo;one-carbon&rdquo; moieties. Administration of leucovorin can counteract the therapeutic and toxic effects of folic acid antagonists such as methotrexate, which act by inhibiting dihydrofolate reductase. Leucovorin has also been used to enhance the activity of fluorouracil.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19280, 'Folinobiogen 300mg/30ml vial(n/a yet)', 'فولينوبيوجين 300 مجم / 30 مل فيال', '100', NULL, 'Folic acid supplement', 'Leucovorin calcium=folinic acid=calcium folinate', 'Arabcomed-egypt > biocapital pharma', 'Vial', 'فيال', '300mg', '1', NULL, 'indication for the treatment of osteosarcoma (after high dose methotrexate therapy). used to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists and to treat megalo', NULL, NULL, 833, '2022-07-16', 0, 'For the treatment of osteosarcoma (after high dose methotrexate therapy). Used to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists, and to treat megaloblastic anemias due to folic acid deficiency. Also used in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.', 'As leucovorin is a derivative of folic acid, it can be used to increase levels of folic acid under conditions favoring folic acid inhibition (following treatment of folic acid antagonists such as methotrexate). Leucovorin enhances the activity of fluorouracil by stabilizing the bond of the active metabolite (5-FdUMP) to the enzyme thymidylate synthetase.', 'Leucovorin is one of several active, chemically reduced derivatives of folic acid. It is useful as an antidote to drugs which act as folic acid antagonists. Leucovorin is a mixture of the diastereoisomers of the 5-formyl derivative of tetrahydrofolic acid (THF). The biologically active compound of the mixture is the (-)-l-isomer, known as Citrovorum factor or (-)-folinic acid. Leucovorin does not require reduction by the enzyme dihydrofolate reductase in order to participate in reactions utilizing folates as a source of &ldquo;one-carbon&rdquo; moieties. Administration of leucovorin can counteract the therapeutic and toxic effects of folic acid antagonists such as methotrexate, which act by inhibiting dihydrofolate reductase. Leucovorin has also been used to enhance the activity of fluorouracil.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19281, 'Folinobiogen 50mg/5ml vial(n/a yet)', 'فلوينوبيوجين 50 مجم / 5 مل فيال', '35', NULL, 'Folic acid supplement', 'Leucovorin calcium=folinic acid=calcium folinate', 'Arabcomed-egypt > biocapital pharma', 'Vial', 'فيال', '50mg', '1', 'مصدر للفوليك اسيد --مصدر للكالسيوم -- مكمل غذائي -- مصدر للطاقة', NULL, NULL, NULL, 1099, '2023-06-21', 0, 'For the treatment of osteosarcoma (after high dose methotrexate therapy). Used to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists, and to treat megaloblastic anemias due to folic acid deficiency. Also used in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.', 'As leucovorin is a derivative of folic acid, it can be used to increase levels of folic acid under conditions favoring folic acid inhibition (following treatment of folic acid antagonists such as methotrexate). Leucovorin enhances the activity of fluorouracil by stabilizing the bond of the active metabolite (5-FdUMP) to the enzyme thymidylate synthetase.', 'Leucovorin is one of several active, chemically reduced derivatives of folic acid. It is useful as an antidote to drugs which act as folic acid antagonists. Leucovorin is a mixture of the diastereoisomers of the 5-formyl derivative of tetrahydrofolic acid (THF). The biologically active compound of the mixture is the (-)-l-isomer, known as Citrovorum factor or (-)-folinic acid. Leucovorin does not require reduction by the enzyme dihydrofolate reductase in order to participate in reactions utilizing folates as a source of &ldquo;one-carbon&rdquo; moieties. Administration of leucovorin can counteract the therapeutic and toxic effects of folic acid antagonists such as methotrexate, which act by inhibiting dihydrofolate reductase. Leucovorin has also been used to enhance the activity of fluorouracil.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19282, 'Foliplex 24 lozenges', 'فوليبلكس 24 قطعة', '80', '60', 'Folic acid with vitamin b', 'Folic acid+vitamin b complex', 'Pharma zad > famila medifood', 'Lozenges', 'استحلاب', NULL, '1', 'مكمل غذائي -- فيتامينات متعددة -- مصدر للطاقة', '-it is a dietary supplement mainly for women who are or intend to become pregnant. orange flavour. - dose: 1 or more fast dissolve tablets daily.', '6225000605619', NULL, 7048, '2025-08-02', 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19283, 'Follifactor 75 i.u. vial', 'فوليفاكتور حقن', '51', NULL, 'Infertility drugs.follicle stimulating hormone', 'Follitropin (recombinant fsh)', 'Biofactor gmbh pharmaceuticals-germany > marcyrl co.', 'Vial', 'فيال', NULL, '1', 'تحفيز عملية التبويض -- علاج القم عند السيدات -- علاج العقم عند الرجال -- تحفز تصنيع الحيوانات المنوية وزيادة عددها', NULL, NULL, NULL, 1256, '2022-05-13', 0, 'In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).', 'Follitropin is a recombinant form of endogenous follicle stimulating hormone (FSH). FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, Follitropin beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Follitropin beta is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19284, 'Folligant hair cream 100 gm', 'فوليجانت كريم شعر 100 جم', '160', '148', 'Hair care', 'Caffeine+zinc acetate+jojoba ext.+vitamin e+saw palmetto ext.+ginkgo ext.+rosemary ext.+bees wax+pan', 'Hi-care > novex', 'Cream', 'كريم', '100 gm', '1', NULL, 'caffeine + zinc acetate + jojoba ext. + vitamin e + saw palmetto ext. + ginkgo ext. + rosemary ext. + bees wax + panthenol + nettle root ext. + thyme ext. *indications : hair loss for men and women. damaged and brittle hair. split ended hair.', '769503325378', NULL, 1609, '2025-01-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19285, 'Folligant hair lotion spray 250 ml', 'فوليجانت سبراي للشعر 250 مل', '218', '198', 'Hair care', 'Saw palmetto+caffeine+rosemary+ginkgo+nettle+jojoba+thyme+beta-sitosterol+vit.e+panthenol+zinc aceta', 'Hi-care > novex', 'Lotion', 'لوشن', '250 ml', '1', NULL, '*indications : hair loss for men and women. damaged and brittle hair. split ended hair.', '769503325354', NULL, 2821, '2025-01-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19287, 'Folligant hair serum spray 120 ml', 'فوليجانت سبراي سيروم للشعر 120 مل', '240', '219', 'Hair care', 'Silicone oil+wheat germ oil+rosemary+jojoba+thyme+vitamin e', 'Hi-care > novex', 'Spray', 'بخاخ', '120 ml', '1', NULL, 'stimulates hair growth - rejuvenates hair & scalp. *indications : hair loss for men and women. damaged and brittle hair. split ended hair.', '769503325385', NULL, 1569, '2025-01-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19288, 'Folligant hair shampoo 250 ml', 'فوليجانت شامبو للشعر 250 مل', '190', '178', 'Hair care', 'Saw palmetto+caffeine+rosemary+ginkgo+nettle root+jojoba+thyme+b-sitosterol+vit.e+panthenol+zn aceta', 'Hi-care > novex', 'Amp', 'أمبول', '250 ml', '1', NULL, 'intensively nutritive shampoo - for strong & healthy hair - for hair loss *indications : hair loss for men and women. damaged and brittle hair. split ended hair.', NULL, NULL, 3914, '2025-01-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19289, 'Follitone hair bath oil 150 ml', 'فوليتون زيت حمام للشعر 150 مل', '65', NULL, 'Hair care', 'Rosemary extract+jojoba oil+thyme extract+olive oil+eureca sativa extract+chamomile extract+pantheno', 'Leader cosmetics > original pharma group', 'Oil', 'زيت', '150 ml', '1', NULL, 'follicles stimulating oil that prevent hair loss and brittlness', NULL, NULL, 667, '2022-08-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19290, 'Wadibradin 7.5 mg 20 tabs', 'واديبرادين 7.5 مجم 20 قرص', '124', NULL, NULL, NULL, 'Wadi elneel benta', 'Tab', 'أقراص', '7.5 mg', '2', NULL, NULL, NULL, NULL, 2465, '2022-08-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19291, 'Ivy cyst syrup 100 ml', 'ايفي سيست شراب 100 مل', '75', '65', 'Cough products', 'Ivy extract+acetylcysteine+zinc', 'Marvel', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, '6224000738358', NULL, 1191, '2025-10-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19292, 'Follitone hair oil 60ml', 'فوليتون زيت شعر 60 مل', '25', NULL, 'Hair care', 'Rosemary extract+jojoba oil+thyme extract+olive oil+eureca sativa extract+chamomile extract+pantheno', 'Leader cosmetics > original pharma group', 'Hair oil', 'زيت شعر', '60ml', '1', NULL, 'follicles stimulating oil that prevent hair loss and brittlness', NULL, NULL, 845, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19293, 'Flexana 30 capsules', 'فليكسانا 30 كبسولة', '69', NULL, 'Joints health', 'Glucosamine+collagen', 'Company', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 884, '2022-08-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19294, 'Follitrope 150 i.u. prefilled syringe', 'فوليتروب 150 وحدة دولية حقنة مملوءة', '210', NULL, 'Infertility drugs.follicle stimulating hormone', 'Follitropin (recombinant fsh)', 'Biopharma > pharma over seas', 'Syringe', 'حقنة', NULL, '1', NULL, NULL, NULL, NULL, 921, '2022-07-12', 0, 'In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).', 'Follitropin is a recombinant form of endogenous follicle stimulating hormone (FSH). FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, Follitropin beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Follitropin beta is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19295, 'Follitrope 150 i.u. vial', 'فوليتروب 150 وحدة دولية فيال', '182', NULL, 'Infertility drugs.follicle stimulating hormone', 'Follitropin (recombinant fsh)', 'Biopharma > pharma over seas', 'Vial', 'فيال', NULL, '1', NULL, NULL, NULL, NULL, 1309, '2022-06-16', 0, 'In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).', 'Follitropin is a recombinant form of endogenous follicle stimulating hormone (FSH). FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, Follitropin beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Follitropin beta is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19296, 'Follitrope 225 i.u. prefilled syringe', 'فوليتروب 225 وحدة دولية حقن مملوءة', '329', NULL, 'Infertility drugs.follicle stimulating hormone', 'Follitropin (recombinant fsh)', 'Biopharma > pharma over seas', 'Syringe', 'حقنة', NULL, '1', NULL, NULL, NULL, NULL, 941, '2022-07-12', 0, 'In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).', 'Follitropin is a recombinant form of endogenous follicle stimulating hormone (FSH). FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, Follitropin beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Follitropin beta is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19297, 'Follitrope 300 i.u. prefilled syringe', 'فوليتروب 300 وحدة دولية حقن مملوءة', '511', NULL, 'Infertility drugs.follicle stimulating hormone', 'Follitropin (recombinant fsh)', 'Biopharma > pharma over seas', 'Syringe', 'حقنة', NULL, '1', NULL, NULL, NULL, NULL, 1204, '2022-07-13', 0, 'In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).', 'Follitropin is a recombinant form of endogenous follicle stimulating hormone (FSH). FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, Follitropin beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Follitropin beta is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19298, 'Follitrope 75 i.u. prefilled syringe', 'فوليتروب 75 وحدة دولية حقن مملوءة', '147', NULL, 'Infertility drugs.follicle stimulating hormone', 'Follitropin (recombinant fsh)', 'Biopharma > pharma over seas', 'Syringe', 'حقنة', NULL, '1', NULL, NULL, NULL, NULL, 1298, '2022-07-12', 0, 'In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).', 'Follitropin is a recombinant form of endogenous follicle stimulating hormone (FSH). FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, Follitropin beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Follitropin beta is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19299, 'Follitrope 75 i.u. vial', 'فوليتروب 75 وحدة دولية فيال', '133', NULL, 'Infertility drugs.follicle stimulating hormone', 'Follitropin (recombinant fsh)', 'Biopharma > pharma over seas', 'Vial', 'فيال', NULL, '1', NULL, NULL, NULL, NULL, 1613, '2022-05-31', 0, 'In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).', 'Follitropin is a recombinant form of endogenous follicle stimulating hormone (FSH). FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, Follitropin beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Follitropin beta is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19302, 'Folotyn 20mg/ml vial for i.v. inf.', 'فولوتين 20 مجم / مل فيال وريد', '52,057', NULL, 'Antineoplastic', 'Pralatrexate', 'Mundipharma > multipharma', 'Vial', 'فيال', '20mg', '1', NULL, 'pralatrexate is an antimetabolite for the treatment of relapsed or refractory peripheral t-cell lymphoma. it is more efficiently retained in cancer cells than methotrexate. the selectivity of pralatrexate for cancer cells is based upon the observation tha', NULL, NULL, 645, '2022-08-05', 0, 'Pralatrexate is indicated for the treatment of relapsed or refractory peripheral T-cell lymphoma.[L37674]', 'Pralatrexate is a folate analog metabolic inhibitor that competitively inhibits dihydrofolate reductase (DHFR) selectively in cancer cells overexpressing the reduced folate carrier protein-1 (RFC-1).[L37674] Folate is a water-soluble vitamin required for DNA synthesis and maintenance as well as DNA, RNA, and protein methylation. As cancer cells are rapidly replicating, they require a lot of folates to accommodate an accelerated cell division and DNA and protein modification for cellular transformation.[A246654, A246659] Therefore, interruption with folate metabolism can inhibit tumor growth.[L37674]



Additionally, pralatrexate also undergoes polyglutamylation catalyzed by folyopolyglutamate synthase (FPGS).[L37674] This reaction both increases cellular retention of pralatrexate for extended drug action and impedes the uptake of folate, also a substrate of FPGS, to further inhibit folate metabolism in cancer cells.[A5138]

', 'Pralatrexate is a folate analog that inhibits folate metabolism, thus impeding the synthesis of amino acids and nucleic acid.[A246678] Additionally, pralatrexate also competes for enzymatic processing by folyopolyglutamate synthase (FPGS)with folate to increase cellular retention.[A246678] Compared to methotrexate, pralatrexate binds to the reduced folate carrier protein-1 (RFC-1) for cellular uptake with 10-times the affinity and is a more potent substrate for FPGS.[A246693] The K<sub>m</sub> value for RFC-1 was calculated to be 0.3 μmol/L and 4.8 μmol/L for pralatrexate and methotrexate respectively, while the K<sub>m</sub> value for FPGS was estimated to be 5.9 and 32.3 µmol/l for pralatrexate and methotrexate respectively[A246693]. As a result, pralatrexate is more cytotoxic and better retained in cancer cells.[A246693]



Due to its anti-folate activity, pralatrexate''s main toxicity is manifested as mucositis that can require dose interruption or reduction[A246693,L41559]. In 5 patients with non-small-cell lung carcinoma receiving a supratherapeutic dose of 230 mg/m<sup>2</sup>, the mean change from pre-injection QTcF interval at the end of infusion was 6.1 ms (90%CI: -0.6, 12.7), and at 1-hour post-injection was 7.8 ms (90%CI: 3.0, 12.6).[L41559] However, no patient exceeded a QTcF of 470 msec and exhibited an absolute increase from baseline in QTcF exceeding 30 msec.[L41559] As well, the study dose far exceeded the target dose for patients with peripheral T-cell lymphoma and pralatrexate does not inhibit the human ether-a-go-go-related gene (hERG) K<sup>+</sup> channel[L41559]. Therefore, pralatrexate uses are unlikely to cause cardiac repolarization delays.[A246678, L41559].

  ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19303, 'Foltene antidandruff treatment 12*8.3ml', 'فولتين شامبو مضاد للقشرة 12 * 8.3 مل', '449', NULL, 'Hair care', NULL, 'Foltene laboratories > biotech egypt', 'Unknown', 'غير محدد', '8.3ml', '1', NULL, NULL, NULL, NULL, 603, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19304, 'Foltene eyelash & eyebrow treatment 10 ml', 'فولتين معالج الرموش والحواجب 10 مل', '375', '285', 'Skin care', NULL, 'Foltene laboratories > biotech egypt', 'Unknown', 'غير محدد', '10 ml', '1', NULL, 'regular use of make-up external aggressors (pollution sun) stress drastic diets alter the quality of keratin making eyelashes fragile damaged and weak. to fight these problems foltene developed a real strengthening and restructuring eyelash treatment. fol', NULL, NULL, 869, '2023-09-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19305, 'Foltene men foam anti-hair loss 70ml', 'فولتين فوم رجالي مضاد لتساقط الشعر 70 مل', '275', NULL, 'Hair care', NULL, 'Foltene laboratories > biotech egypt', 'Foam', 'فوم', '70ml', '1', NULL, 'reduces and prevents male hair loss tricosaccarideï¿½ patented active of foltene ï¿½ that enhances hair growth strengthens thin and weak hair and restores the natural balance of the scalp. revitalizing complex vitamin b1 - nourishes the hair shaft vitamin', '8013134140315', NULL, 590, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19306, 'Foltene men treatment 12*6.5ml', 'فولتين للرجال 12 * 6.5 مل', '799', '575', 'Hair care', NULL, 'Foltene laboratories > biotech egypt', 'Unknown', 'غير محدد', '6.5ml', '12', NULL, NULL, NULL, NULL, 594, '2023-09-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19307, 'Mumlac ultra nutrition 2 milk 400 gm', 'ماملاك الترا 2 لبن اطفال 400 جم', '139', '269', 'Infant milk formula', 'Infant milk formula', 'Copad egypt', 'Unknown', 'غير محدد', '400 gm', '1', NULL, NULL, '7613200204135', NULL, 647, '2023-09-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19308, 'Foltene revitalizing conditioner 150 ml', 'فولتين بلسم مجدد للشعر 150 مل', '185', NULL, 'Hair care', NULL, 'Foltene laboratories > biotech egypt', 'Conditioner', 'بلسم', '150 ml', '1', NULL, 'specially formulated new formula encriched with jojoba oil aloe vera and ceramides that deeply hydrate and repair the hair fiber. vitamin e with anti-oxidant & anti-ageing action revitalizes hair & prevents the formations of split ends. soft emulsion cond', '8013134002613', NULL, 757, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19309, 'Foltene shampoo anti-dandruff 200 ml', 'فولتين شامبو مضاد للقشرة 200 مل', '259', '185', 'Hair care', NULL, 'Foltene laboratories > biotech egypt', 'Amp', 'أمبول', '200 ml', '1', NULL, 'active ingredient is piroctone olamine ï¿½ a non-toxic antibacterial agent that controls dandruff formulated for all causes of dandruff i.e greasy or dry after a few washes hair regains health vitality and shine. directions for use: ï¿½ apply to wet hair', '8013134001685', NULL, 598, '2023-09-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19310, 'Foltene shampoo men 200 ml', 'فولتين شامبو للرجال 200 مل', '259', '185', 'Hair care', NULL, 'Foltene laboratories > biotech egypt', 'Amp', 'أمبول', '200 ml', '1', NULL, 'a treating shampoo studied expressly for men who suffer from weakening of the hair and hair loss due to hereditary factors stress overwork nutritional problems. its formulation based on the combined action of tricosaccarideï¿½ and the biovitamin complex m', NULL, NULL, 728, '2023-09-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19311, 'Foltene shampoo women 200 ml', 'فولتين شامبو للنساء 200 مل', '259', '185', 'Hair care', NULL, 'Foltene laboratories > biotech egypt', 'Amp', 'أمبول', '200 ml', '1', NULL, 'a treating shampoo specifically studied for weak and/or falling hair caused by drastic diets stress weakness hormonal unbalance post-partum menopause chemical treatments (colours and perms). its formulation based on the combined action of tricalgoxylï¿½ a', '8013134001814', NULL, 637, '2023-09-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19313, 'Foltene women treatment 12*6ml', 'فولتين للعناية بالسيدات 12 * 6 مل', '799', '595', 'Hair care', NULL, 'Foltene laboratories > biotech egypt', 'Unknown', 'غير محدد', '6ml', '12', NULL, NULL, NULL, NULL, 572, '2023-09-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19314, 'Foot smart cream 60 gm', 'فوت سمارت كريم 60 جرام', '65', '50', 'Moisturizing topicals', 'Lactic acid+urea+almond oil+glycerin', 'Pharma cure pharmaceuticals', 'Cream', 'كريم', '60 gm', '1', 'مرطب للجلد', 'moisturizing cream for roughness and foot splits', '6224008966104', NULL, 8765, '2025-04-03', 0, 'For use as an alkalinizing agent.', 'Lactate ions are metabolized ultimately to carbon dioxide and water, which requires the consumption of hydrogen cations.', 'Lactic acid produces a metabolic alkalinizing effect.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19315, 'For crack cream 50 gm', 'فور كراك كريم 50 جم', '80', NULL, 'Dietary supplement', 'Urea 10%+lactic acid+glycerin+lanoline+honey+almond oil', 'Italian cosmetics company > feel good canada', 'Cream', 'كريم', '50 gm', '1', NULL, '** ph5.5 soft healthy skin - softens soothes & repairs - dry & cracked heels ** directions: apply morning and evening onto clean dry feet', NULL, NULL, 744, '2022-07-24', 0, 'Urea is used topically for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, devitalized and ingrown nails.[L41484]', NULL, 'Urea is a keratolytic emollient that works to treat or prevent dry, rough, scaly, itchy skin.[L41484]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19317, 'For you cleanser foam 100 ml', 'فور يو فوم منظف 100 مل', '90', NULL, 'Skin care', NULL, 'Leader cosmetics > purex health care', 'Cleanser', 'منظف', '100 ml', '1', NULL, 'indications * acne vulgaris * adjuvant to corticosteroids therapy * atopic and non-atopic dermatitis * controls excessive sebum secretions in oily & sensitive skin. * manages all cases & forms of acne. * protects from further breakouts of acne. * manages', NULL, NULL, 1060, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19318, 'Foract massage cream 100 gm', 'فوراكت كريم مساج 100 جم', '125', '79', 'Massage cream', 'Glucosamine hcl+chondroitin sulfate+msm+methyl salicylate+ginger+menthol+eucalyptus oil+camphor oil', 'Italian cosmetics company > elixir international', 'Cream', 'كريم', '100 gm', '1', NULL, 'massage cream provides a rapid relief of pain due to joint arthritis muscles spasm & low back pain. it helps improving mobility and reducing inflammation in joints and muscles.', NULL, NULL, 1169, '2024-06-01', 0, 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-κB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19319, 'Foract massage cream 50 gm', 'فوراكت مساج كريم 50 جرام', '75', '45', 'Massage', 'Glucosamine hcl+chondroitin sulfate+msm+methyl salicylate+ginger+menthol+eucalyptus oil+camphor oil', 'Italian cosmetics company > elixir international', 'Cream', 'كريم', '50 gm', '1', NULL, 'massage cream provides a rapid relief of pain due to joint arthritis muscles spasm & low back pain. it helps improving mobility and reducing inflammation in joints and muscles.', NULL, NULL, 851, '2024-06-01', 0, 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-κB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19320, 'Foradil 12 mcg 60 caps.+inhaler', 'فوراديل 12 مكجم 60 كبسولة', '560', '162', 'Bronchodilator.long acting beta 2 agonist', 'Formoterol fumarate', 'Novartis > sandoz', 'Cap', 'كبسولة', '12 mcg', '6', NULL, 'mechanism of action the pharmacologic effects of beta2-adrenoceptor agonist drugs including formoterol are at least in part attributable to stimulation of intracellular adenyl cyclase the enzyme that catalyzes the conversion of adenosine triphosphate (atp', NULL, NULL, 2429, '2022-11-05', 0, 'Formoterol is indicated in various formulations for the treatment of asthma and COPD. For the treatment of COPD, formoterol is available as a single-entity inhalation solution,[L10986] in combination with the long-acting muscarinic antagonists (LAMAs) [aclidinium][L10992] and [glycopyrronium],[L10989] and in combination with the corticosteroid [budesonide].[L10619] For the treatment of asthma, formoterol is available in combination with [mometasone furoate] for patients 5 years and older[L10995] and with budesonide for patients 6 years and older.[L10619] Formoterol may also be used on an as-needed basis for prophylaxis against exercise-induced bronchospasm.[L10998]', 'Formoterol is a relatively selective long-acting agonist of beta<sub>2</sub>-adrenergic receptors,[L10986,L11223] although it does carry some degree of activity at beta<sub>1</sub> and beta<sub>3</sub> receptors.[A15544] Beta<sub>2</sub> receptors are found predominantly in bronchial smooth muscle (with a relatively minor amount found in cardiac tissue) whereas beta<sub>1</sub> receptors are the predominant adrenergic receptors found in the heart - for this reason, selectivity for beta<sub>2</sub> receptors is desirable in the treatment of pulmonary diseases such as COPD and asthma.[L10986] Formoterol has demonstrated an approximately 200-fold greater activity at beta<sub>2</sub> receptors over beta<sub>1</sub> receptors.[L10986]



On a molecular level, activation of beta receptors by agonists like formoterol stimulates intracellular adenylyl cyclase, an enzyme responsible for the conversion of ATP to cyclic AMP (cAMP). The increased levels of cAMP in bronchial smooth muscle tissue result in relaxation of these muscles and subsequent dilation of the airways, as well as inhibition of the release of hypersensitivity mediators (e.g. histamine, leukotrienes) from culprit cells, especially mast cells.[L10986]', 'Formoterol works locally in the lungs as a bronchodilator, relaxing smooth muscle and opening up the airways. It possesses both a rapid onset of action (approximately 2-3 minutes)[A189636] and a long duration of action (up to 12 hours).[L11223] The use of long-acting beta-agonists (LABAs), such as formoterol, without concomitant inhaled corticosteroids in asthmatic patients should be avoided, as LABA monotherapy has been associated with an increased risk of asthma-related death.[L11223]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19321, 'Forana gel 60 gm', 'فورانا جل 60 جم', '33', NULL, 'Massage', 'Clove oil+camphor oil+ascorbic acid+allantoin', 'Egyption co for cosmetics > pharaohs', 'Gel', 'جل', '60 gm', '1', 'جل للجسم __تقلل الالام العظام و المفاصل __ يساعد علي استرخاء الجسم', NULL, NULL, NULL, 896, '2022-04-09', 0, 'Clove oil is primarily indicated in conditions like colic, flatulence, and toothache [L2849].', 'The chief constituent present in clove oil is the phenol "_eugenol_" which is present in amounts up to 85%. Clove oil acts as a germicide [L2849] to Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa [A24841]. 



Clove oil is thought to inhibit prostaglandin synthesis, thereby reducing painful symptoms [A33145].



Eugenol, the main constituent of clove oil is purported to have anticancer action. In one study, eugenol-treated HL-60 cells showed features of apoptosis including DNA fragmentation and formation of DNA ladders in agarose gel electrophoresis. It was observed that eugenol transduced the apoptotic signal via reactive oxygen species (ROS) generation, inducing mitochondrial permeability transition (MPT), decreasing anti-apoptotic protein _bcl-2_ level, inducing _cytochrome c_ release to the cytosol, and subsequent apoptotic cell death. When taken together, the study showed that ROS plays a critical role in eugenol-induced apoptosis in _HL-60_, and this is the first report on the mechanism of the anticancer effect of eugenol [A33146].', 'Clove (Eugenia caryophyllata Thunb. [Myrtaceae]) essential oil (CEO) has been demonstrated to possess antimicrobial, antifungal, antiviral, antioxidant, anti-inflammatory, anti-histamine, and anticancer properties. However, few studies have focused on its topical use [A33133], [L2850].



Clove essential oil, used as an antiseptic in oral infections, inhibits gram-negative and gram-positive bacteria as well as yeast [A24841].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19322, 'Foratec dp 12 mcg 30 caps. for inh.+inhaler', 'فوراتيك 12ميكروجرام 30 كبسولة استنشاق', '93', NULL, 'Bronchodilator.long acting beta 2 agonist', 'Formoterol fumarate', 'Cipla ltd. - india > star international company', 'Cap', 'كبسولة', '12 mcg', '3', 'موسع للشعب الهوائية ومضاد حساسية', 'mechanism of action the pharmacologic effects of beta2-adrenoceptor agonist drugs including formoterol are at least in part attributable to stimulation of intracellular adenyl cyclase the enzyme that catalyzes the conversion of adenosine triphosphate (atp', NULL, NULL, 1836, '2022-12-26', 0, 'Formoterol is indicated in various formulations for the treatment of asthma and COPD. For the treatment of COPD, formoterol is available as a single-entity inhalation solution,[L10986] in combination with the long-acting muscarinic antagonists (LAMAs) [aclidinium][L10992] and [glycopyrronium],[L10989] and in combination with the corticosteroid [budesonide].[L10619] For the treatment of asthma, formoterol is available in combination with [mometasone furoate] for patients 5 years and older[L10995] and with budesonide for patients 6 years and older.[L10619] Formoterol may also be used on an as-needed basis for prophylaxis against exercise-induced bronchospasm.[L10998]', 'Formoterol is a relatively selective long-acting agonist of beta<sub>2</sub>-adrenergic receptors,[L10986,L11223] although it does carry some degree of activity at beta<sub>1</sub> and beta<sub>3</sub> receptors.[A15544] Beta<sub>2</sub> receptors are found predominantly in bronchial smooth muscle (with a relatively minor amount found in cardiac tissue) whereas beta<sub>1</sub> receptors are the predominant adrenergic receptors found in the heart - for this reason, selectivity for beta<sub>2</sub> receptors is desirable in the treatment of pulmonary diseases such as COPD and asthma.[L10986] Formoterol has demonstrated an approximately 200-fold greater activity at beta<sub>2</sub> receptors over beta<sub>1</sub> receptors.[L10986]



On a molecular level, activation of beta receptors by agonists like formoterol stimulates intracellular adenylyl cyclase, an enzyme responsible for the conversion of ATP to cyclic AMP (cAMP). The increased levels of cAMP in bronchial smooth muscle tissue result in relaxation of these muscles and subsequent dilation of the airways, as well as inhibition of the release of hypersensitivity mediators (e.g. histamine, leukotrienes) from culprit cells, especially mast cells.[L10986]', 'Formoterol works locally in the lungs as a bronchodilator, relaxing smooth muscle and opening up the airways. It possesses both a rapid onset of action (approximately 2-3 minutes)[A189636] and a long duration of action (up to 12 hours).[L11223] The use of long-acting beta-agonists (LABAs), such as formoterol, without concomitant inhaled corticosteroids in asthmatic patients should be avoided, as LABA monotherapy has been associated with an increased risk of asthma-related death.[L11223]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19323, 'Forbudes 400/12mcg 60 inhalation caps.+inhaler', 'فوربيودس 400/12مكجم 60 كبسولة استنشاق+ جهاز استنشاق', '334', '254', 'Bronchodilator.glucocorticoid steroid and long-acting b2 agonist', 'Budesonide+formoterol', 'European egyptian pharm. ind.', 'Cap', 'كبسولة', '12mcg', '6', 'موسع للشعب الهوائية -- علاج الازمات التنفسية -- علاج الالتهابات و الحساسية', NULL, '6221076021711', NULL, 39793, '2024-06-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19324, 'Mounjaro injection 12.5mg/0.5ml 4 single dose prefilled pens', 'مونجارو حقن 12.5مجم/0.5 مل 4 اقلام معبأة للحقن', '18,150', '14000', 'Anti-diabetic.glp-1 receptor agonist', 'Tirazepatide', 'Eli lilly', 'Injection', 'حقن', '12.5mg', '4', NULL, NULL, NULL, NULL, 1438, '2025-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19325, 'Forcetex 2 gm pd. for i.m./i.v. inj.', 'فورسيتكس 2 جم فيال', '48', NULL, 'Antibiotic.cephalosporin.fourth-generation', 'Cefepime', 'Pharco b > sandoz', 'Inj', 'حقن', '2 gm', '1', NULL, 'about cefepime fourth generation cephalosporin antibiotic. mechanism of action of cefepime cefepime is a 3rd generation cephalosporin which exerts its bactericidal action by inhibiting bacterial cell wall synthesis. cefepime inhibits transpeptidase & thus', NULL, NULL, 726, '2022-07-24', 0, 'Cefepime is indicated for the treatment of pneumonia caused by susceptible bacteria, and for empiric therapy for febrile neutropenic patients. Cefepime is also indicated for the treatment of uncomplicated and complicated urinary tract infections (cUTI) including pyelonephritis, uncomplicated skin and skin structure infections, and complicated intra-abdominal infections (used in combination with [metronidazole]) in adults caused by susceptible bacteria.[L42095,L42100]



Cefepime is also used in combination with [enmetazobactam] to treat cUTI.[L50117]', 'Cefepime is a bactericidal cephalosporin with a mode of action similar to other beta-lactam antibiotics.[L42095,L42100] Cefepime disrupts bacterial cell walls by binding and inhibiting transpeptidases known as penicillin-binding proteins (PBPs), which are enzymes involved in the final stages of peptidoglycan layer synthesis. This results in the lysis and death of susceptible microorganisms.[A249050] Cefepime has a broad spectrum of _in vitro_ activity that includes both Gram-positive and Gram-negative bacteria.[L42095,L42100] Cefepime has affinity for PBP-3 and PBP-1 in _Escherichia coli_ and _Pseudomonas aeruginosa_, as well as PBP-2 in _E. coli_ and _Enterobacter cloacae_.[A249050]', 'Cefepime is a fourth-generation cephalosporin antibiotic.[L42095,L42100] It is active against Gram-negative bacteria such as _Enterobacter_ spp., _Escherichia coli_, _Klebsiella pneumoniae_, _Proteus mirabilis_ and _Pseudomonas aeruginosa_, and Gram-positive bacteria such as _Staphylococcus aureus_ (methicillin-susceptible isolates only), _Streptococcus pneumoniae_, _Streptococcus pyogenes_ and Viridans group streptococci.[L42095,L42100] Compared to third-generation cephalosporins, cefepime has an extended Gram-negative coverage. Whereas other cephalosporins are degraded by plasmid- and chromosome-mediated beta-lactamases, cefepime is stable and not significantly hydrolyzed by these enzymes.[A2457,A249050] Cefepime is also a poor inducer of type 1 beta-lactamases and, therefore, a good alternative against bacteria resistant to third-generation cephalosporins.[A2457] 



In animal models of infection, the time that the unbound plasma concentration of cefepime exceeds the minimum inhibitory concentration (MIC) of infecting organisms has been shown to correlate with treatment efficacy.[L42095,L42100] It has been suggested that cefepime can cross the inflamed blood-brain barrier.[L42095,L42100] This, along with its ability to inhibit γ-aminobutyric acid (GABA), could lead to the neurotoxic effects observed in some of the patients treated with cefepime.[A249045,A249050]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19326, 'Tyrodopa 30 tabs', 'تيرودوبا 30 قرص', '195', NULL, NULL, NULL, 'Biomed pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1184, '2024-06-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19327, 'Forderm cream 40 gm', 'فورديرم كريم 40 جم', '80', '68', 'Healing topical', NULL, 'Leader cosmetics > farabi', 'Cream', 'كريم', '40 gm', '1', 'يساعد على التئام الجلد.', 'topical renovation & epithelialization formula that promote skin healing', NULL, NULL, 971, '2024-11-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19328, 'Forflozin 10mg 30 f.c. tabs', 'فورفلوزين 10مجم 30 قرص', '306', '231', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin', 'Atco pharma', 'Tab', 'أقراص', '10mg', '3', 'لمرضى السكر', NULL, '6223004042102', NULL, 23876, '2024-07-09', 0, 'Dapagliflozin is indicated as an adjunct treatment, alongside diet and exercise, to improve glycemic control in patients ≥10 years of age with type 2 diabetes mellitus.[L51023,A6757,A6758] For patients with chronic kidney disease at risk of progression, dapagliflozin in used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure.[L46372] Dapagliflozin is also indicated to either reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors.[L46372] Combination products with dapagliflozin also exist, either as a dapagliflozin-saxagliptin or dapagliflozin-metformin hydrochloride formulation.[L38724,L38729] Both are used as an adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes.[L38724,L38729]', 'Dapagliflozin inhibits the sodium-glucose cotransporter 2(SGLT2) which is primarily located in the proximal tubule of the nephron.[A6757] SGLT2 facilitates 90% of glucose reabsorption in the kidneys and so its inhibition allows for glucose to be excreted in the urine.[A6757] This excretion allows for better glycemic control and potentially weight loss in patients with type 2 diabetes mellitus.[A6757] ', 'Dapagliflozin also reduces sodium reabsorption and increases the delivery of sodium to the distal tubule. This may influence several physiological functions including, but not restricted to, lowering both pre- and afterload of the heart and downregulation of sympathetic activity, and decreased intraglomerular pressure which is believed to be mediated by increased tubuloglomerular feedback.[L48246]



Increases in the amount of glucose excreted in the urine were observed in healthy subjects and in patients with type 2 diabetes mellitus following the administration of dapagliflozin. Dapagliflozin doses of 5 or 10 mg per day in patients with type 2 diabetes mellitus for 12 weeks resulted in excretion of approximately 70 grams of glucose in the urine per day at Week 12. A near-maximum glucose excretion was observed at the dapagliflozin daily dose of 20 mg. This urinary glucose excretion with dapagliflozin also results in increases in urinary volume. After discontinuation of dapagliflozin, on average, the elevation in urinary glucose excretion approaches baseline by about 3 days for the 10 mg dose.[L48246]



Dapagliflozin was not associated with clinically meaningful prolongation of QTc interval at daily doses up to 150 mg (15 times the recommended maximum dose) in a study of healthy subjects. In addition, no clinically meaningful effect on QTc interval was observed following single doses of up to 500 mg (50 times the recommended maximum dose) of dapagliflozin in healthy subjects.[L48246]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19329, 'Forgenap 10/160/12.5mg 10 f.c. tab.', 'فورجيناب 10/160/12.5مجم 10 قرص', '34', NULL, 'Antihypertensive. combined angiotensin blocker with calcium channel blocker', 'Amlodipine+hydrochlorothiazide+valsartan', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '12.5mg', '1', NULL, 'valsartan is a nonpeptide orally active and specific angiotensin ii antagonist acting on the at1 receptor subtype. (amlodipine and valsartan) is indicated for the treatment of hypertension to lower blood pressure. lowering blood pressure reduces the risk', NULL, NULL, 2148, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19330, 'Forgenap 5/160/12.5mg 10 f.c. tab.', 'فورجيناب 5/160/12.5مجم 10 قرص', '32', NULL, 'Antihypertensive. combined angiotensin blocker with calcium channel blocker', 'Amlodipine+hydrochlorothiazide+valsartan', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '12.5mg', '1', 'علاج ارتفاع ضغط الدم', 'valsartan is a nonpeptide orally active and specific angiotensin ii antagonist acting on the at1 receptor subtype. (amlodipine and valsartan) is indicated for the treatment of hypertension to lower blood pressure. lowering blood pressure reduces the risk', NULL, NULL, 993, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19331, 'Formigliptin 5mg 30 tablets', 'فورميجليبتين 5مجم 30 قرص', '176', NULL, 'Anti-diabetic.secretagogues.dpp-4 inhibitors', 'Saxagliptin', 'Debeiky > multicare', 'Tablet', 'أقراص', '5mg', '3', NULL, NULL, '6224007326213', NULL, 829, '2022-07-24', 0, 'Treatment of type 2 diabetes mellitus to improve glycemic control in combination with other agents or as monotherapy. ', 'Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor antidiabetic for the treatment of type 2 diabetes. DPP-4 inhibitors are a class of compounds that work by affecting the action of natural hormones in the body called incretins. Incretins decrease blood sugar by increasing consumption of sugar by the body, mainly through increasing insulin production in the pancreas, and by reducing production of sugar by the liver. [Bristol-Myers Squibb Press Release]

DPP-4 is a membrane associated peptidase which is found in many tissues, lymphocytes and plasma. DPP-4 has two main mechanisms of action, an enzymatic function and another mechanism where DPP-4 binds adenosine deaminase, which conveys intracellular signals via dimerization when activated. Saxagliptin forms a reversible, histidine-assisted covalent bond between its nitrile group and the S630 hydroxyl oxygen on DPP-4. The inhibition of DPP-4 increases levels active of glucagon like peptide 1 (GLP-1), which inhibits glucagon production from pancreatic alpha cells and increases production of insulin from pancreatic beta cells.

', 'Post-administration of saxagliptin, GLP-1 and GIP levels rise up to 2- to 3- fold. Because it is very selective of DPP-4 inhibition, there are fewer systemic side effects. Saxagliptin inhibits DPP-4 enzyme activity for a 24-hour period. It also decreased glucagon concentrations and increased glucose-dependent insulin secretion from pancreatic beta cells. The half maximal inhibitory concentration (IC50) is 0.5 nmol/L.  Saxagliptin did not prolong the QTc interval to a clinically significant degree. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19333, 'Forpregab 75 mg 30 caps.', 'فوربيجاب 75 مجم 30 كبسولة', '45', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Grand pharma > parkville pharmaceuticals', 'Cap', 'كبسولة', '75 mg', '3', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', '6224008073000', NULL, 825, '2022-07-29', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19334, 'Forsure hair conditioning lotion 200 ml', 'فور شور لوشن لتكثيف الشعر 200 مل', '42', NULL, 'Hair care', 'Panthenol+chamomile ext+aloe vera ext+thyme ext+wheat germ+rosemary ext', 'Hi-care > castle care', 'Lotion', 'لوشن', '200 ml', '1', NULL, 'for daily use', '6225000156159', NULL, 517, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19335, 'Fortamind 100mg/ml oral drops 30 ml', 'فورتاميند 100مجم/مل نقط للفم 300 مل', '99', '59.5', 'Cerebral circulatory inhancer', 'Citicholine', 'Globe international pharmaceuticals', 'Drops', 'نقط', '100mg', '1', 'يعمل على تحسين الدورة الدموية بالمخ.', 'citicoline is a brain chemical that occurs naturally in the body. as a medicine it is taken by mouth as a supplement or given by iv or as a shot. citicoline is used for alzheimer s disease and other types of dementia head trauma cerebrovascular disease su', '6223004901324', NULL, 2301, '2024-11-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19336, 'Fortamind 500mg/4ml 5 amp for iv/im inj', 'فورتاميند 500مجم/4مل 5 أمبولات للحقن العضلي / الوريدي', '145', '65', 'Cerebral circulatory inhancer', 'Citicholine', 'Globe international pharmaceuticals', 'Inj', 'حقن', '500mg', '5', 'مقوى للذاكرة ويستخدم فى علاج اضرابات الحركة الفارطة و بعض الامراض العصبية مثل الزهايمر والخرف ومرض الباركنسون وزرق العين', NULL, '6223004900617', NULL, 2663, '2024-11-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19337, 'Fortatec 10 gm 20 sachets', 'فورتاتيك 10جرام 20 كيس', '140', '50', 'Iron supplement', 'Ferrous fumarate+lactoferrin+folic acid+vitamin(b1+b6+b12+c)+calcium', 'Novotec pharma', 'Sachet', 'أكياس', '10 gm', '1', NULL, 'dose: 1 sachet daily to be dissolved in 100 ml of warm water or milk.', NULL, NULL, 1451, '2025-12-13', 0, 'Ferrous sulfate is used for the prevention and treatment of iron deficiency anemia in adults and children.[A190804,L2240,L11800]

', 'Iron is required to maintain optimal health, particularly for helping to form red blood cells (RBC) that carry oxygen around the body. A deficiency in iron indicates that the body cannot produce enough normal red blood cells.[A32514,L11800] Iron deficiency anemia occurs when body stores of iron decrease to very low levels, and the stored iron is insufficient to support normal red blood cell (RBC) production. Insufficient dietary iron, impaired iron absorption, bleeding, pregnancy, or loss of iron through the urine can lead to iron deficiency.[A32514,L11794]  Symptoms of iron deficiency anemia include fatigue, breathlessness, palpitations, dizziness, and headache.



Taking iron in supplement form, such as ferrous sulfate, allows for more rapid increases in iron levels when dietary supply and stores are not sufficient.[L2175] Iron is transported by the divalent metal transporter 1 (DMT1) across the endolysosomal membrane to enter the macrophage. It can then can be incorporated into ferritin and be stored in the macrophage or carried of the macrophage by ferroportin. This exported iron is  oxidized by the enzyme to ceruloplasmin to Fe3+, followed by sequestration by transferrin for transport in the serum to various sites, including the bone marrow for hemoglobin synthesis or into the liver.[A32524] Iron combines with porphyrin and globin chains to form hemoglobin, which is critical for oxygen delivery from the lungs to other tissues.[L2263]', 'Ferrous sulfate replenishes iron, an essential component in hemoglobin, myoglobin, and various enzymes. It replaces the iron that is usually found in hemoglobin and myoglobin. Iron participates in oxygen transport and storage, electron transport and energy metabolism, antioxidant and beneficial pro-oxidant functions, oxygen sensing, tissue proliferation and growth, as well as DNA replication and repair.[A32524,A32514]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19338, 'Fortatec children 10 gm 10 sachets', 'فورتاتيك للاطفال 10 جم 10 اكياس', '45', NULL, 'Iron supplement', 'Ferrous fumarate+lactoferrin+folic acid+vitamin(b1+b6+b12+c)+calcium', 'Medcare > novotec pharma', 'Sachet', 'أكياس', '10 gm', '1', NULL, 'dose: 1 sachet daily to be dissolved in 100 ml of warm water or milk.', NULL, NULL, 712, '2022-07-23', 0, 'Ferrous sulfate is used for the prevention and treatment of iron deficiency anemia in adults and children.[A190804,L2240,L11800]

', 'Iron is required to maintain optimal health, particularly for helping to form red blood cells (RBC) that carry oxygen around the body. A deficiency in iron indicates that the body cannot produce enough normal red blood cells.[A32514,L11800] Iron deficiency anemia occurs when body stores of iron decrease to very low levels, and the stored iron is insufficient to support normal red blood cell (RBC) production. Insufficient dietary iron, impaired iron absorption, bleeding, pregnancy, or loss of iron through the urine can lead to iron deficiency.[A32514,L11794]  Symptoms of iron deficiency anemia include fatigue, breathlessness, palpitations, dizziness, and headache.



Taking iron in supplement form, such as ferrous sulfate, allows for more rapid increases in iron levels when dietary supply and stores are not sufficient.[L2175] Iron is transported by the divalent metal transporter 1 (DMT1) across the endolysosomal membrane to enter the macrophage. It can then can be incorporated into ferritin and be stored in the macrophage or carried of the macrophage by ferroportin. This exported iron is  oxidized by the enzyme to ceruloplasmin to Fe3+, followed by sequestration by transferrin for transport in the serum to various sites, including the bone marrow for hemoglobin synthesis or into the liver.[A32524] Iron combines with porphyrin and globin chains to form hemoglobin, which is critical for oxygen delivery from the lungs to other tissues.[L2263]', 'Ferrous sulfate replenishes iron, an essential component in hemoglobin, myoglobin, and various enzymes. It replaces the iron that is usually found in hemoglobin and myoglobin. Iron participates in oxygen transport and storage, electron transport and energy metabolism, antioxidant and beneficial pro-oxidant functions, oxygen sensing, tissue proliferation and growth, as well as DNA replication and repair.[A32524,A32514]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19339, 'Fortazedim 1 gm vial', 'فورتازيديم 1جم فيال.', '59', '41', 'Antibiotic.cephalosporin.third-generation', 'Ceftazidime', 'Mup', 'Vial', 'فيال', '1 gm', '1', 'مضاد حيوي يستخدم لعلاج --الاتهاب السحايي--عدوى الجلد والجروح --الحروق--عدوى الجهاز التنفسي.', 'about ceftazidime third generation cephalosporin antibiotic parenteral antibiotic. mechanism of action of ceftazidime ceftazidime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms b', '6221508163514', NULL, 2013, '2024-11-17', 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19340, 'Fortazedim 250 mg vial', 'فورتازيديم 250مجم فيال.', '14', '11.75', 'Antibiotic.cephalosporin.third-generation', 'Ceftazidime', 'Mup', 'Vial', 'فيال', '250 mg', '1', 'مضاد حيوي يستخدم لعلاج--عدوى الجهاز التنفسي--عدوى الجهاز البولي--الحروق--الاتهاب السحائي.', 'about ceftazidime third generation cephalosporin antibiotic parenteral antibiotic. mechanism of action of ceftazidime ceftazidime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms b', NULL, NULL, 1001, '2024-08-25', 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19341, 'Fortazedim 500 mg vial', 'فورتازيديم 500مجم فيال', '34', '18', 'Antibiotic.cephalosporin.third-generation', 'Ceftazidime', 'Mup', 'Vial', 'فيال', '500 mg', '1', NULL, 'about ceftazidime third generation cephalosporin antibiotic parenteral antibiotic. mechanism of action of ceftazidime ceftazidime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms b', NULL, NULL, 1029, '2024-08-24', 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19342, 'Forte seas 20 capsules', 'فورتي سيز 20 كبسولة', '120', '34', 'Omega 3', 'Cod liver oil', 'Medizen pharmaceutical industries > international medical guide', 'Capsule', 'كبسولة', NULL, '2', 'يطيل عمر الخلايا العصبية بالدماغ', NULL, '6224007308226', NULL, 3265, '2025-05-04', 0, 'Cod liver oil is predominantly manufactured, marketed, and used by the population at large as a general nutraceutical dietary supplement [A27154, A33159, L2872].



Historically, cod liver oil was often given to children because the vitamin d content in the oil had been shown to prevent or treat vitamin D deficiency and condition of rickets associated with it [A33159]. Over time, this common use in children growing up may have conferred upon cod liver oil its identity as a healthy and useful all-purpose dietary supplement.



However, since cod liver oil is a composite of several other nutritional compounds including the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as well as vitamin A and vitamin D [A33159, L2872, L2871], the presence in varying amounts of all of these compounds at once makes it difficult to recommend or use cod liver oil as an appropriate supplement to confer any one particular health effect or for any one particular nutritional deficiency.



Regardless, because it does contain a combination of a number of important and healthy nutritional compounds, cod liver oil has sometimes been recommended in the literature for conferring the health effects of some of these compounds, such as the potential use of cod liver oil supplements in post-heart attack patients for secondary prophylaxis associated with the use of omega-3 fatty acids [A33165].', 'As cod liver oil consists of the component compounds of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), vitamin A, and vitamin D [A33159, L2872, L2871] further information about the mechanisms of action of these cod liver oil components can be found by searching for fish oil, vitamin A, and vitamin D on DrugBank.', 'As cod liver oil is a composite of several other nutritional compounds including the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as well as vitamin A and vitamin D [A33159, L2872, L2871], the presence in varying amounts of all of these compounds at once makes it difficult to recommend or use cod liver oil as an appropriate supplement to confer any one particular health effect or for any one particular nutritional deficiency.



For example, one tablespoon of cod liver oil contains approximately 4,080 ug of retinol (vitamin A) and 34 ug (1,360 IU) of vitamin D [L2871]. Since the general dietary reference intake of vitamin A is only 900 ug per day for adult men, 700 ug per day for women, and 3000 ug per day as the tolerable upper intake level, the regular intake of cod liver oil as a regular supplement can result in harmful levels of vitamin A accumulating in the liver and sufficient to cause hypervitaminosis A [A33163], which is associated with various symptoms such as blurred vision, changes in consciousness, skin and hair changes, liver damage, among many others.



Moreover, while cod liver oil only contains a certain percentage of the omega-3 fatty acids EPA and DHA per amount of the oil [L2871], separate fish oils supplement products that exclusively consist of only EPA and DHA are available in a great variety of different percentage content formulations, even including prescription strength formulations should certain patients need such a level of therapy. Furthermore, such exclusive omega-3 fatty acid supplement products do not contain any vitamin A or D either, which allows patients to use the supplements without any concern about affecting their vitamin A or D levels or exposing themselves to the unnecessary excess intake of vitamins.



Subsequently, although cod liver oil contains a combination of healthy dietary supplements like EPA, DHA, vitamin A, and vitamin D, the presence in varying amounts of all of these compounds all at once makes it difficult to effectively titrate for appropriate amounts of intake for all the compounds involved when using cod liver oil as a general supplement, often resulting in either an excess or insufficient amount of one or more the aforementioned compounds.



Nevertheless, because cod liver oil does consist of the component compounds of EPA, DHA, vitamin A, and vitamin D, further information about the pharmacodynamics of these cod liver oil components can be found by searching for fish oil, vitamin A, and vitamin D on DrugBank.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19343, 'Forflozin plus 5/1000 mg 30 ext. rel . f.c. tabs.', 'فورفلوزين بلس 5/1000مجم 30 قرص', '171', NULL, 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin+metformin', 'Atco pharma', 'Tab', 'أقراص', '1000 mg', '3', NULL, NULL, NULL, NULL, 884, '2024-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19344, 'Decidu happy 60ml spray', 'ديسيدو هابي سبراي 60 مل', '140', NULL, 'Cosmetics', 'Propolis+manuka honey+echinacea+vitamin c+zinc+probioitics', 'Gmcks pharma', 'Spray', 'بخاخ', '60ml', '1', NULL, NULL, NULL, NULL, 2230, '2024-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19345, 'Fortenor 20 tabs.', 'فورتينور 20 قرص', '15', NULL, 'Multivitamins', 'Zinc+copper+vitamin a+vitamin e+vitamin c', 'Egpi', 'Tab', 'أقراص', NULL, '2', NULL, 'zinc+copper+vitamin a+vitamin e+vitamin c', NULL, NULL, 968, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19346, 'Forteo (20mcg/80mcl) pre-filled pen 2.4 ml', 'فورتيو (20مكجم/80مل ) قلم 2.4 مل', '6,327', '4867', 'Osteoporosis', 'Teriparatide', 'Eli lilly', 'Pen', 'قلم', '20mcg', '1', NULL, 'teriparatide is a recombinant form of parathyroid hormone. it is an effective anabolic (i.e. bone growing) agent used in the treatment of some forms of osteoporosis. it is also occasionally used off-label to speed fracture healing.', NULL, NULL, 12768, '2024-07-31', 0, 'Teriparatide is indicated:



- for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, teriparatide reduces the risk of vertebral and nonvertebral fractures.[L42590, L42595, L46178, L46183]

- to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy.[L42590, L42595, L46178, L46183]

- for the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy.[L42590, L42595, L46178, L46183]', 'Parathyroid hormone (PTH) is an endogenous hormone that regulates calcium and phosphate metabolism in bone and kidney. It regulates bone metabolism, renal tubular reabsorption of calcium and phosphate, and intestinal calcium absorption. It mediates its physiological actions by binding to the PTH receptors.[L42590] Excess PTH - such as in certain disease states like hyperparathyroidism - can cause increased osteoclast activity and accelerated bone resorption. Interestingly, the effects of PTH depend on the dose and pattern of exposure of PTH to the bone. Continuous exposure to PTH promotes bone resorption, whereas intermittent exposure to low-dose PTH can induce bone formation more favourably than bone resorption.[A251395]



Similarly, teriparatide''s skeletal effects depend upon the systemic exposure pattern. Once-daily administration of teriparatide stimulates new bone formation on trabecular and cortical (periosteal and/or endosteal) bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity.[L42590] Teriparatide mediates its osteoanabolic actions by binding to the N-terminal moiety to PTH type 1 receptors (PTH type 1R), which are G-protein coupled receptors expressed on various cells, including osteoblasts, osteocytes, and renal tubular cells.[A251395] Binding of teriparatide to PTH receptors on osteoblasts activates the downstream PKA- and PKC-dependent signaling pathways that promotes anabolic effects on bone.[A6748, A251395] For example, teriparatide increases expression of pro-osteoclastogenic cytokines like receptor activator of nuclear factor kappa-B ligand (RANKL) and macrophage colony-stimulating factor. It also upregulates transcriptional expression of pro-osteoblastogenic growth factors like insulin-like growth factor 1 (IGF1) and fibroblast growth factor 2 (FGF2). Teriparatide also downregulates the synthesis of sclerostin, which is a negative regulator of bone formation. It also promotes the differentiation of osteoblasts.[A251395]', 'Teriparatide is a PTH analog that works to stimulate bone formation in both men and women. It increases skeletal mass, increases markers of bone formation such as bone-specific alkaline phosphatase (BSAP) and procollagen I carboxy-terminal propeptide (PICP), and increases bone strength.[L42590] 



Like endogenous PTH, teriparatide affects calcium and phosphate homeostasis. It causes a transient increase in serum calcium levels and increases urinary calcium excretion. In clinical trials, it also produced transient phosphaturia and mild transient reductions in serum phosphorus concentration.[L42590]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19347, 'Fortibiotic 1500 mg i.m./i.v. vial', 'فورتبيوتك 1500مجم فيال حقن عضل/وريد', '51', '35', 'Penicillins.penicillin with b-lactamase inhibitor', 'Ampicillin+sulbactam', 'Sedico > amoun', 'Vial', 'فيال', '1500 mg', '1', NULL, 'other indications & uses beta-lactamase-producing: s. aureus e. coli klebsiella spp p. mirabilis bacteroides fragilis enterobacter spp acinetobacter calcoaceticus systemic adverse reactions systemic reactions reported in less than 1% of the patients were:', '6221025033338', NULL, 2583, '2024-12-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19348, 'Fortibone 10 sachets', 'فورتيبون 10 اكياس', '380', '335', 'Calcium with vitamin d supplemnt', 'Bioactive collagen peptides+calcium lactate+vitamin d3(cholecalciferol)', 'Gelita health > biotech pharma ltd.', 'Sachet', 'أكياس', NULL, '1', 'كالسيوم وفيتامين دال للعظام', 'promotes bone health. use: once daily', NULL, NULL, 5397, '2024-06-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19349, 'Forticare (cappuccino flavor) susp. 125 ml', 'فورتيكير (بطعم الكابتشينو) معلق 125 مل', '75', NULL, 'Dietary supplement', NULL, 'Nutricia > united company for trading & distribution', 'Cap', 'كبسولة', '125 ml', '1', 'مكمل غذائي', NULL, NULL, NULL, 4758, '2022-12-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19351, 'Fortrans 4 sachets', 'فورترانس 4 اكياس', '66', NULL, 'Laxative', 'Macrogol 4000', 'Amriya > beaufour ipsen-france', 'Sachet', 'أكياس', NULL, '1', NULL, 'indications: preparation for colon surgery bowel preparation to endoscopic or radiological preparation for colon surgery preparation for digestive endoscopy. use and dosage the contents of a sachet must be diluted in water (mineral or tap) to obtain 1 lit', NULL, NULL, 1983, '2022-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19352, 'Fortre 10 sachets', 'فورتري 10 اكياس', '110', NULL, 'Iron supplement', 'Lactoferrin+multivitamins+minerals', 'Medcare > rameda', 'Sachet', 'أكياس', NULL, '1', 'يحتوي على الحديد', NULL, '6223003974909', NULL, 2864, '2023-02-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19353, 'Fortrustep 30 mg 6 f.c. tabs.', 'فورترستيب 30مجم 6 اقراص', '35', NULL, 'Delay action', 'Dapoxetine', 'Marcyrl co.', 'Tab', 'أقراص', '30 mg', '1', 'للتاخير للرجال', 'about dapoxetine dapoxetine is a short-acting selective serotonin reuptake inhibitor (ssri) marketed for the treatment of premature ejaculation in men. mechanism of action of dapoxetine the mechanism of action of dapoxetine in premature ejaculation is pre', '6223003571597', NULL, 1969, '2023-07-26', 0, 'For the treatment of premature ejaculation.', 'The drug''s mechanism of action is thought to be related to inhibition of neuronal reuptake of serotonin and subsequent potentiation of serotonin activity. The central ejaculatory neural circuit comprises spinal and cerebral areas that form a highly interconnected network. The sympathetic, parasympathetic, and somatic spinal centers, under the influence of sensory genital and cerebral stimuli integrated and processed at the spinal cord level, act in synergy to command physiologic events occurring during ejaculation. Experimental evidence indicates that serotonin (5-HT), throughout brain descending pathways, exerts an inhibitory role on ejaculation. To date, three 5-HT receptor subtypes (5-HT(1A), 5-HT(1B), and 5-HT(2C)) have been postulated to mediate 5-HT''s modulating activity on ejaculation.', 'Dapoxetine is a selective serotonin reuptake inhibitor currently undergoing trials through Alza (under license from GenuPro, a collaboration between Eli Lilly and PPD). Dapoxetine is a short-acting SSRI drug currently being considered for approval by the Food and Drug Administration (FDA) for the treatment of premature ejaculation in men, which would make it the first drug approved for such treatment. Despite two clinical trials finished in 2006, experts doubt it will be approved by the FDA soon because SSRIs come with undesirable side-effects after long-term use, such as psychiatric problems, dermatological reactions, increase in body weight, lower sex-drive, nausea, headache, upset stomach and weakness, thus not significantly outweighing the benefit of premature ejaculation medication versus the risks. By contrast with SSRIs approved for depression, which take 2 weeks or longer to reach steady-state concentration, dapoxetine has a unique pharmacokinetic profile, with a short time to maximum serum concentration (about 1 h) and rapid elimination (initial half-life of 1-2 h).', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19354, 'Fortrustep 60 mg 6 f.c. tabs.', 'فورترستيب 60 مجم 6 اقراص', '114', '78', 'Delay action', 'Dapoxetine', 'Marcyrl co.', 'Tab', 'أقراص', '60 mg', '1', 'للتأخير للرجال', 'about dapoxetine dapoxetine is a short-acting selective serotonin reuptake inhibitor (ssri) marketed for the treatment of premature ejaculation in men. mechanism of action of dapoxetine the mechanism of action of dapoxetine in premature ejaculation is pre', '6223003571597', NULL, 6261, '2025-01-27', 0, 'For the treatment of premature ejaculation.', 'The drug''s mechanism of action is thought to be related to inhibition of neuronal reuptake of serotonin and subsequent potentiation of serotonin activity. The central ejaculatory neural circuit comprises spinal and cerebral areas that form a highly interconnected network. The sympathetic, parasympathetic, and somatic spinal centers, under the influence of sensory genital and cerebral stimuli integrated and processed at the spinal cord level, act in synergy to command physiologic events occurring during ejaculation. Experimental evidence indicates that serotonin (5-HT), throughout brain descending pathways, exerts an inhibitory role on ejaculation. To date, three 5-HT receptor subtypes (5-HT(1A), 5-HT(1B), and 5-HT(2C)) have been postulated to mediate 5-HT''s modulating activity on ejaculation.', 'Dapoxetine is a selective serotonin reuptake inhibitor currently undergoing trials through Alza (under license from GenuPro, a collaboration between Eli Lilly and PPD). Dapoxetine is a short-acting SSRI drug currently being considered for approval by the Food and Drug Administration (FDA) for the treatment of premature ejaculation in men, which would make it the first drug approved for such treatment. Despite two clinical trials finished in 2006, experts doubt it will be approved by the FDA soon because SSRIs come with undesirable side-effects after long-term use, such as psychiatric problems, dermatological reactions, increase in body weight, lower sex-drive, nausea, headache, upset stomach and weakness, thus not significantly outweighing the benefit of premature ejaculation medication versus the risks. By contrast with SSRIs approved for depression, which take 2 weeks or longer to reach steady-state concentration, dapoxetine has a unique pharmacokinetic profile, with a short time to maximum serum concentration (about 1 h) and rapid elimination (initial half-life of 1-2 h).', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19355, 'Fortum 1 gm vial.', 'فورتام 1 جم فيال', '106', '73', 'Antibiotic.cephalosporin.third-generation', 'Ceftazidime', 'Glaxo smithkline', 'Vial', 'فيال', '1 gm', '1', NULL, 'about ceftazidime third generation cephalosporin antibiotic parenteral antibiotic. mechanism of action of ceftazidime ceftazidime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms b', '6221045000259', NULL, 10018, '2024-09-02', 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19356, 'Fortum 250 mg vial', 'فورتام 250مجم فيال', '24', '18', 'Antibiotic.cephalosporin.third-generation', 'Ceftazidime', 'Glaxo smithkline', 'Vial', 'فيال', '250 mg', '1', NULL, 'about ceftazidime third generation cephalosporin antibiotic parenteral antibiotic. mechanism of action of ceftazidime ceftazidime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms b', '6221045000266', NULL, 877, '2023-08-13', 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19357, 'Vitronate 120 ml syrup', 'فيترونات شراب 120 مل', '64', NULL, 'Multivitamin with iron', 'Ferrous bisglycinate 18mg+vit c 60mg+l-cystein 30 mg+cranberry extract 15mg+vit b1 0.6mg+vit b2 0.6mg+vit b3 4mg+vit b6 0.6mg+vit b12 259mg+folate 116mcg+pantothenic acid 2mg', 'Medicina', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 721, '2023-04-11', 0, 'Ferrous sulfate is used for the prevention and treatment of iron deficiency anemia in adults and children.[A190804,L2240,L11800]

', 'Iron is required to maintain optimal health, particularly for helping to form red blood cells (RBC) that carry oxygen around the body. A deficiency in iron indicates that the body cannot produce enough normal red blood cells.[A32514,L11800] Iron deficiency anemia occurs when body stores of iron decrease to very low levels, and the stored iron is insufficient to support normal red blood cell (RBC) production. Insufficient dietary iron, impaired iron absorption, bleeding, pregnancy, or loss of iron through the urine can lead to iron deficiency.[A32514,L11794]  Symptoms of iron deficiency anemia include fatigue, breathlessness, palpitations, dizziness, and headache.



Taking iron in supplement form, such as ferrous sulfate, allows for more rapid increases in iron levels when dietary supply and stores are not sufficient.[L2175] Iron is transported by the divalent metal transporter 1 (DMT1) across the endolysosomal membrane to enter the macrophage. It can then can be incorporated into ferritin and be stored in the macrophage or carried of the macrophage by ferroportin. This exported iron is  oxidized by the enzyme to ceruloplasmin to Fe3+, followed by sequestration by transferrin for transport in the serum to various sites, including the bone marrow for hemoglobin synthesis or into the liver.[A32524] Iron combines with porphyrin and globin chains to form hemoglobin, which is critical for oxygen delivery from the lungs to other tissues.[L2263]', 'Ferrous sulfate replenishes iron, an essential component in hemoglobin, myoglobin, and various enzymes. It replaces the iron that is usually found in hemoglobin and myoglobin. Iron participates in oxygen transport and storage, electron transport and energy metabolism, antioxidant and beneficial pro-oxidant functions, oxygen sensing, tissue proliferation and growth, as well as DNA replication and repair.[A32524,A32514]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19358, 'Resorayzen 200 ml electrolyte solution', 'ريسورايزن محلول الكتروليتي 200 مل', '75', NULL, 'Oral ors', 'Chloride+sodium+potasium+zinc', 'Medrayzen pharma', 'Solution', 'محلول', '200 ml', '1', NULL, NULL, NULL, NULL, 818, '2022-07-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19359, 'Fortymox plus ophthalmic sol. 5 ml', 'فورتيموكس بلس قطرة 5 مل', '39', '26', 'Antibiotic with glucocorticoid', 'Dexamethasone+moxifloxacin', 'Orchidia pharmaceutical industries', 'Sol', 'محلول', '5 ml', '1', NULL, NULL, '6223005441201', NULL, 3118, '2024-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19360, 'Fortzaar 100/25mg 8 tab.', 'فورتزار 100/25 مجم 8 قرص', '51', NULL, 'Antihypertensive. combined angiotensin blocker with diuretic', 'Hydrochlorothiazide+losartan', 'Merck sharp & dohme > soficopharm', 'Tab', 'أقراص', '25mg', '1', NULL, 'about hydrochlorothiazide thiazide derivatibve diuretic. mechanism of action of hydrochlorothiazide it is thiazide diuretic which exerts its action by acting at site-3(central dilating segment of early distal tubule). it binds to na+cl- symporter and inhi', '00366582504696', NULL, 1169, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19361, 'Forxiga 10mg 28 tabs.', 'فورسيجا 10مجم 28 قرص', '602', '460', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin', 'Astra zeneca', 'Tab', 'أقراص', '10mg', '2', 'علاج لمرضى السكر', NULL, NULL, NULL, 18929, '2024-09-05', 0, 'Dapagliflozin is indicated as an adjunct treatment, alongside diet and exercise, to improve glycemic control in patients ≥10 years of age with type 2 diabetes mellitus.[L51023,A6757,A6758] For patients with chronic kidney disease at risk of progression, dapagliflozin in used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure.[L46372] Dapagliflozin is also indicated to either reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors.[L46372] Combination products with dapagliflozin also exist, either as a dapagliflozin-saxagliptin or dapagliflozin-metformin hydrochloride formulation.[L38724,L38729] Both are used as an adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes.[L38724,L38729]', 'Dapagliflozin inhibits the sodium-glucose cotransporter 2(SGLT2) which is primarily located in the proximal tubule of the nephron.[A6757] SGLT2 facilitates 90% of glucose reabsorption in the kidneys and so its inhibition allows for glucose to be excreted in the urine.[A6757] This excretion allows for better glycemic control and potentially weight loss in patients with type 2 diabetes mellitus.[A6757] ', 'Dapagliflozin also reduces sodium reabsorption and increases the delivery of sodium to the distal tubule. This may influence several physiological functions including, but not restricted to, lowering both pre- and afterload of the heart and downregulation of sympathetic activity, and decreased intraglomerular pressure which is believed to be mediated by increased tubuloglomerular feedback.[L48246]



Increases in the amount of glucose excreted in the urine were observed in healthy subjects and in patients with type 2 diabetes mellitus following the administration of dapagliflozin. Dapagliflozin doses of 5 or 10 mg per day in patients with type 2 diabetes mellitus for 12 weeks resulted in excretion of approximately 70 grams of glucose in the urine per day at Week 12. A near-maximum glucose excretion was observed at the dapagliflozin daily dose of 20 mg. This urinary glucose excretion with dapagliflozin also results in increases in urinary volume. After discontinuation of dapagliflozin, on average, the elevation in urinary glucose excretion approaches baseline by about 3 days for the 10 mg dose.[L48246]



Dapagliflozin was not associated with clinically meaningful prolongation of QTc interval at daily doses up to 150 mg (15 times the recommended maximum dose) in a study of healthy subjects. In addition, no clinically meaningful effect on QTc interval was observed following single doses of up to 500 mg (50 times the recommended maximum dose) of dapagliflozin in healthy subjects.[L48246]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19362, 'Forxiga 5mg 28 tabs.', 'فورسيجا 5مجم 28 قرص', '602', '460', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin', 'Astra zeneca', 'Tab', 'أقراص', '5mg', '2', 'علاج لمرضى السكر', NULL, NULL, NULL, 3198, '2024-09-05', 0, 'Dapagliflozin is indicated as an adjunct treatment, alongside diet and exercise, to improve glycemic control in patients ≥10 years of age with type 2 diabetes mellitus.[L51023,A6757,A6758] For patients with chronic kidney disease at risk of progression, dapagliflozin in used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure.[L46372] Dapagliflozin is also indicated to either reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors.[L46372] Combination products with dapagliflozin also exist, either as a dapagliflozin-saxagliptin or dapagliflozin-metformin hydrochloride formulation.[L38724,L38729] Both are used as an adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes.[L38724,L38729]', 'Dapagliflozin inhibits the sodium-glucose cotransporter 2(SGLT2) which is primarily located in the proximal tubule of the nephron.[A6757] SGLT2 facilitates 90% of glucose reabsorption in the kidneys and so its inhibition allows for glucose to be excreted in the urine.[A6757] This excretion allows for better glycemic control and potentially weight loss in patients with type 2 diabetes mellitus.[A6757] ', 'Dapagliflozin also reduces sodium reabsorption and increases the delivery of sodium to the distal tubule. This may influence several physiological functions including, but not restricted to, lowering both pre- and afterload of the heart and downregulation of sympathetic activity, and decreased intraglomerular pressure which is believed to be mediated by increased tubuloglomerular feedback.[L48246]



Increases in the amount of glucose excreted in the urine were observed in healthy subjects and in patients with type 2 diabetes mellitus following the administration of dapagliflozin. Dapagliflozin doses of 5 or 10 mg per day in patients with type 2 diabetes mellitus for 12 weeks resulted in excretion of approximately 70 grams of glucose in the urine per day at Week 12. A near-maximum glucose excretion was observed at the dapagliflozin daily dose of 20 mg. This urinary glucose excretion with dapagliflozin also results in increases in urinary volume. After discontinuation of dapagliflozin, on average, the elevation in urinary glucose excretion approaches baseline by about 3 days for the 10 mg dose.[L48246]



Dapagliflozin was not associated with clinically meaningful prolongation of QTc interval at daily doses up to 150 mg (15 times the recommended maximum dose) in a study of healthy subjects. In addition, no clinically meaningful effect on QTc interval was observed following single doses of up to 500 mg (50 times the recommended maximum dose) of dapagliflozin in healthy subjects.[L48246]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19364, 'Fosavance once weekly 2 tab.', 'فوسافنس واحدة أسبوعيا 2 قرص', '105', NULL, 'Osteoporosis.bisphosphonates.plus vitamin d', 'Alendronate+vitamin d3', 'Merck sharp & dohme > global napi pharmaceuticals', 'Tab', 'أقراص', NULL, '1', NULL, '**therapeutic indications: fosavance is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin d insufficiency. fosavance reduces the risk of vertebral and hip fractures. **posology and method of administration the recommen', '6223002146482', NULL, 2079, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19365, 'Fosforon 3gm 1 sachet', 'فوسفورون 3جم 1 كيس', '39', NULL, 'Uti infection', 'Fosfomycin', 'Globe international pharmaceuticals', 'Sachet', 'أكياس', '3gm', '1', 'علاج العدوي في مجري البول', 'single-dose for treatment of urinary tract infections in adults.', NULL, NULL, 2715, '2022-05-16', 0, 'Fosfomycin is indicated for the treatment of uncomplicated cases of cystitis caused by susceptible strains of _Escherichia coli_ and _Enterococcus faecalis_.[L31818] Fosfomycin is not officially indicated for the treatment of pyelonephritis or perinephric abscess, although there have been reported cases of off-label usage in these situations.[L31818]', 'Fosfomycin exerts its bactericidal effects by binding covalently to a cysteine in the active site of the UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) enzyme, rendering it inactive. By preventing MurA from catalyzing the condensation of phosphoenolpyruvate (PEP) with UDP-N-acetylglucosamine (UNAG), fosfomycin inhibits the production of the peptidoglycan precursor UDP N-acetylmuramic acid (UDP-MurNAc).[A229338,L31818] Ultimately, the first step of bacterial cell wall synthesis is disrupted.[A230348]



In _Escherichia coli_, fosfomycin gains entry into bacterial cells via two mechanisms: the L-alpha-glycerophosphate system and the hexose-6-phosphate transporter system.[A229338]



Fosfomycin also has important effects on cell adhesion. For example, the adhesion of bacterial cells to urinary epithelial cells is reduced in the presence of fosfomycin. The adhesion of _Streptococcus pneumoniae_ and _Haemophilus influenzae_ to respiratory epithelial cells is also reduced[A229338]', 'Although used primarily to treat urinary tract infections, fosfomycin has been shown to act synergistically with other antibiotics against clinically relevant bacteria.[A229338] There is also growing interest in the potential of fosfomycin to treat more complex infections since it has retained activity against many difficult-to-treat strains of bacteria including methicillin-resistant _Staphylococcus aureus_ (MRSA) and multidrug-resistant enterobacteria.[A230358] Further, since fosfomycin has a unique and singular mechanism of action, the risk of cross-resistance with other antibiotics is low.[A230353,A230348]



Fosfomycin also demonstrates immunomodulating properties. For example, the antibiotic may influence components of the acute inflammatory cytokine response and enhances neutrophil phagocytic destruction of pathogens.[A229338,A230343]



Fosfomycin penetrates biofilms effectively and is capable of not only reducing or eliminating microorganisms in biofilms but can also alter the biofilm structure.[A229338,A230358]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19366, 'Foster 100/6mcg 120 doses inhaler', 'فوستر 100/6مكجم 120 جرعة استنشاق', '291', NULL, 'Bronchodilator.glucocorticoid steroid and short-acting b2 agonist', 'Beclomethasone+formoterol', 'Chiesi italy > pharma over seas', 'Inhaler', 'جهاز استنشاق', '6mcg', '1', 'موسع للشعب الهوائية', NULL, NULL, NULL, 3474, '2023-06-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19367, 'Fostimon 150 i.u. i.m./s.c. vial', 'فوستيمون 150 وحدة دولية فيال للحقن عضل/تحت الجلد', '1,128', '780', 'Infertility drugs.follicle stimulating hormone', 'Urofollitropin', 'Ibsa - switzerland > habib scientific office', 'Vial', 'فيال', NULL, '1', 'علاج العقم عند النساء وتأخر الانجاب عند النساء', 'indication for treatment of female infertility pharmacodynamics used for the treatment of female infertility urofollitropin or follicle stimulating hormone (fsh) stimulates ovarian follicular growth in women who do not have primary ovarian failure. fsh th', NULL, NULL, 22179, '2025-07-08', 0, 'For treatment of female infertility', 'FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, urofollitropin or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of urofollitropin is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19368, 'Fostimon 75 i.u. i.m./s.c. vial', 'فوستيمون 75وحدة دولية فيال حقن عضل/تحت الجلد', '566', '392', 'Infertility drugs.follicle stimulating hormone', 'Urofollitropin', 'Ibsa - switzerland > habib scientific office', 'Vial', 'فيال', NULL, '1', NULL, 'indication for treatment of female infertility pharmacodynamics used for the treatment of female infertility urofollitropin or follicle stimulating hormone (fsh) stimulates ovarian follicular growth in women who do not have primary ovarian failure. fsh th', NULL, NULL, 6453, '2025-08-31', 0, 'For treatment of female infertility', 'FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, urofollitropin or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of urofollitropin is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19369, 'Fostino 2% topical gel 15 gm', 'فوستينو 2% جل موضعي 15 جم', '8', NULL, 'Antibiotic topical', 'Fusidic acid', 'Zad', 'Gel', 'جل', '2%', '1', NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', NULL, NULL, 935, '2022-07-20', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19370, 'Fostinocort topical cream 20 gm', 'فوستينوكورت كريم موضعي 20 جم', '43', '29', 'Antibiotic with glucocorticoid', 'Betamethasone+fucidic acid', 'Zad', 'Cream', 'كريم', '20 gm', '1', NULL, 'description betamethasone is a type of medicine called a topical corticosteroid. corticosteroids are medicines used for reducing inflammation. skin inflammation in eczema occurs due to the irritation of the skin and is caused by the release of various sub', '6224001588013', NULL, 3485, '2024-07-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19371, 'Four lite lightening cream 50 gm', 'فور لايت كرين تفتيح 50جم', '150', NULL, 'Whitening topical', 'Tyrostat 11+licorice ex+vitamin (c+e)+bearberry ex+panthenol+allantoin+honey+stearic acid+almond oil', 'Italian cosmetics company > feel good canada', 'Cream', 'كريم', '50 gm', '1', NULL, '** ph5.5 soft healthy skin - unifies corrects and illuminates brown spots - pigmentation imperfection ** directions: apply to cleansed skin twice a day', NULL, NULL, 714, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19372, 'Four lite lightening lotion 50+ spf 100 gm', 'فور لايت لوشن تفتيح 50+ عامل حماية 100 جم', '159', NULL, 'Whitening topical', 'Octinoxate+cera alba+titanium dioxide+tyrostat 11+vitamin (c+e)+bearberry ext+panthenol+allantoin', 'Italian cosmetics company > feel good canada', 'Lotion', 'لوشن', '100 gm', '1', NULL, '** ph5.5 soft healthy skin - very high broad uva/uvb protection - whitening sun protection - sensitive skin ** directions: apply to face and body before sun exposure. reapply frequently especially after swimming or rubbing', NULL, NULL, 720, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19373, 'Four mix syrup 120 ml', 'فور ميكس شراب 120 مل', '8', NULL, 'Cough drugs', 'Guava leaves+thyme leaves+fennel', 'Sigma > pharma cure pharmaceuticals', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, '6224000651107', NULL, 679, '2022-07-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19375, 'Foxime 1 gm i.m./i.v. vial', 'فوكسيم 1 جرام فيال', '49', '27', 'Antibiotic.cephalosporin.third-generation', 'Cefotaxime', 'Tabuk pharmaceutical manufacturing company > al ansar for marketing', 'Vial', 'فيال', '1 gm', '1', NULL, 'about cefotaxime third generation cephalosporin parenteral antibiotic. mechanism of action of cefotaxime cefotaxime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhi', '6224011411134', NULL, 2111, '2024-12-07', 0, 'Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.', 'The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefotaxime shows high affinity for penicillin-binding proteins in the cell wall including PBP Ib and PBP III.', 'Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against <i>Pseudomonas aeruginosa</i>. Cefotaxime works by inhibiting bacterial cell wall biosynthesis. A positive feature of cefotaxime is that it display a resistance to penicillinases and is useful to treat infections that are resistant to penicillin derivatives.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19377, 'Foxime 500mg i.m./i.v.vial', 'فوكسيم 500 مجم فيال عضل/وريد', '29', '26.5', 'Antibiotic.cephalosporin.third-generation', 'Cefotaxime', 'Tabuk pharmaceutical manufacturing company > al ansar for marketing', 'Vial', 'فيال', '500mg', '1', NULL, 'about cefotaxime third generation cephalosporin parenteral antibiotic. mechanism of action of cefotaxime cefotaxime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhi', '6224011411042', NULL, 833, '2024-08-22', 0, 'Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.', 'The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefotaxime shows high affinity for penicillin-binding proteins in the cell wall including PBP Ib and PBP III.', 'Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against <i>Pseudomonas aeruginosa</i>. Cefotaxime works by inhibiting bacterial cell wall biosynthesis. A positive feature of cefotaxime is that it display a resistance to penicillinases and is useful to treat infections that are resistant to penicillin derivatives.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19378, 'Fragmin 2500i.u./0.2ml 10 prefilled syringe', 'فراجمين 2500 وحدة دولية / 0.2 مل 10 حقن', '146', NULL, 'Anticoagulant', 'Dalteparin sodium', 'Pfizer', 'Syringe', 'حقنة', '0.2ml', '10', NULL, NULL, NULL, NULL, 991, '2022-07-21', 0, 'Dalteparin is used as a prophylaxis for deep-vein thrombosis and pulmonary embolisms in patients undergoing general surgery (e.g., abdominal, gynecologic, urologic), and in patients with acute medical conditions (e.g. cancer, bed rest, heart failure, severe lung disease). It is also used in patients who have severely restricted mobility, which poses a risk for thromboembolic complications. 



Dalteparin is also used concomitantly with aspirin and/or other therapy (e.g., nitrates, β-adrenergic blockers, clopidogrel, platelet glycoprotein [GP] IIb/IIIa-receptor inhibitors) to reduce the risk of acute cardiac ischemic events. The patients who undergo this treatment combination have unstable angina or non-ST-segment elevation/non-Q-wave myocardial infarction (i.e., non-ST-segment elevation acute coronary syndromes).



It is also used in the prevention of clotting during hemodialysis and hemofiltration in connection with acute renal failure or chronic renal insufficiency.', 'Dalteparin potentiates the activity of ATIII, inhibiting the formation of both factor Xa and thrombin. The main difference between dalteparin and unfractionated heparin (UH) is that dalteparin preferentially inactivates factor Xa. As a result, only a slight increase in clotting time [(i.e. activated partial thomboplastin time (APTT)] is observed relative to UH. For this same reason, APTT is not used to monitor the effects of dalteparin except as an indicator for overdosage. ', 'Dalteparin has an antithrombin binding site that is essential for high affinity binding to the plasma protein antithrombin (ATIII). Anti-Xa activity of plasma is used as both as an estimate of clotting activity, and as a basis to determine dosage. Its use should be avoided in patients with a creatinine clearance less than 20mL/min. In these patients, unfractionated heparin should only be used. As for monitoring, active partial thromboplastin time (aPTT) will only increase at high doses of low molecular weight heparins (LMWH). Therefore, monitoring aPTT is not recommended. However, anti-Xa activity can be measured to monitor the efficacy of the LMWH. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19379, 'Fragmin 5000 i.u./0.2 ml 10 prefilled syringe', 'فراجمين 5000 وحدة دولية/0.2مل 10 سرنجات', '256', NULL, 'Anticoagulant', 'Dalteparin sodium', 'Pfizer', 'Syringe', 'حقنة', '0.2 ml', '10', NULL, NULL, NULL, NULL, 1092, '2022-07-08', 0, 'Dalteparin is used as a prophylaxis for deep-vein thrombosis and pulmonary embolisms in patients undergoing general surgery (e.g., abdominal, gynecologic, urologic), and in patients with acute medical conditions (e.g. cancer, bed rest, heart failure, severe lung disease). It is also used in patients who have severely restricted mobility, which poses a risk for thromboembolic complications. 



Dalteparin is also used concomitantly with aspirin and/or other therapy (e.g., nitrates, β-adrenergic blockers, clopidogrel, platelet glycoprotein [GP] IIb/IIIa-receptor inhibitors) to reduce the risk of acute cardiac ischemic events. The patients who undergo this treatment combination have unstable angina or non-ST-segment elevation/non-Q-wave myocardial infarction (i.e., non-ST-segment elevation acute coronary syndromes).



It is also used in the prevention of clotting during hemodialysis and hemofiltration in connection with acute renal failure or chronic renal insufficiency.', 'Dalteparin potentiates the activity of ATIII, inhibiting the formation of both factor Xa and thrombin. The main difference between dalteparin and unfractionated heparin (UH) is that dalteparin preferentially inactivates factor Xa. As a result, only a slight increase in clotting time [(i.e. activated partial thomboplastin time (APTT)] is observed relative to UH. For this same reason, APTT is not used to monitor the effects of dalteparin except as an indicator for overdosage. ', 'Dalteparin has an antithrombin binding site that is essential for high affinity binding to the plasma protein antithrombin (ATIII). Anti-Xa activity of plasma is used as both as an estimate of clotting activity, and as a basis to determine dosage. Its use should be avoided in patients with a creatinine clearance less than 20mL/min. In these patients, unfractionated heparin should only be used. As for monitoring, active partial thromboplastin time (aPTT) will only increase at high doses of low molecular weight heparins (LMWH). Therefore, monitoring aPTT is not recommended. However, anti-Xa activity can be measured to monitor the efficacy of the LMWH. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19380, 'France lait 1 milk 400 gm (army)', 'فرانس ليه 1 لبن 400 جرام', '55', NULL, 'Milk products.first stage (age 0-6 months)', 'Milk formula stage 1', 'Regilait > armed forces', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'not to replace mother s milk. for infants from birth to 6 months age. to be used within one month from opening.', '3043934012500', NULL, 1223, '2022-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19381, 'France lait 2 confort milk 400 gm', 'فرانس ليه 2 كومفرت لبن اطفال 400 جم', '110', NULL, 'Milk products.second stage (age 6-12 months)', 'Milk formula stage 2', 'Regilait > eva pharma', 'Unknown', 'غير محدد', '400 gm', '1', NULL, NULL, NULL, NULL, 764, '2022-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19382, 'France lait 1 to 3 milk 400 gm', 'فرانس ليه من 1-3 حليب 400 جرام', '75', NULL, 'Milk products.third stage (age 1-3 years)', 'Milk formula stage 3', 'Regilait > eva pharma', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'not to replace mother s milk. for infants from 1 to 3 years age. to be used within one month from opening.', '3043932161316', NULL, 758, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19383, 'France lait 2 milk 400 gm', 'فرانس ليه 2 حليب 400 جرام', '70', NULL, 'Milk products.second stage (age 6-12 months)', 'Milk formula stage 2', 'Regilait > eva pharma', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'not to replace mother s milk. for infants from 6 months to 1 year age. to be used within one month from opening.', '3043934012609', NULL, 757, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19384, 'France lait 2 milk 400 gm (army)', 'فرانس ليه 2 حليب 400 جرام', '55', NULL, 'Milk products.second stage (age 6-12 months)', 'Milk formula stage 2', 'Regilait > armed forces', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'not to replace mother s milk. for infants from 6 months to 1 year age. to be used within one month from opening.', NULL, NULL, 1424, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19386, 'France lait ar milk 400 gm', 'فرانس ليه اي ار حليب 400جم', '145', NULL, 'Milk products.anti-regurgitation milk', 'Anti-regurgitation milk formula', 'Regilait > eva pharma', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'not to replace mother s milk. for infants from birth to 12 months age. to be used within one month from opening.', NULL, NULL, 986, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19387, 'France lait lf milk 400 gm', 'فرانس ليه ال اف حليب 400 جرام', '145', NULL, 'Lactose free milk', 'Lactose free milk formula', 'Regilait > eva pharma', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'used mainly for diarrhea. from birth onwards. use milk within 4 weeks of opening.', NULL, NULL, 709, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19388, 'France lait pre milk 400 gm', 'فرانس ليه بري لبن 400 جرام', '155', NULL, 'Milk products.prematue milk formula', 'Premature milk formula', 'Regilait > eva pharma', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'specially formulated for preterm and low birth weight infants. it could be discontinued under medical advice after a weight of 3 kgm has been reached or until 2 months corrected age. to be used within one month from opening.', NULL, NULL, 889, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19389, 'Fraxiparine 0.3 ml 2 prefilled syringe', 'فراكسيبارين 0.3 مل 2 سرنجة معبأة', '31', NULL, 'Anticoagulant.low mwt heparin', 'Nadroparin calcium', 'Glaxo smithkline > modern pharma', 'Syringe', 'حقنة', '0.3 ml', '2', NULL, 'nadroparin is an anticoagulant belonging to a class of drugs called low molecular weight heparins (lmwhs). nadroparin is used in general and orthopedic surgery to prevent thromboembolic disorders (deep vein thrombosis and pulmonary embolism) and as treatm', NULL, NULL, 1397, '2022-07-08', 0, 'Nadroparin is used for prophylaxis of thromboembolic disorders and general surgery in orthopedic surgery, treatment of deep vein thrombosis, prevention of clotting during hemodialysis and treatment of unstable angina and non-Q wave myocardial infarction.', 'The mechanism of action for nadroparin is similar to all other LMWHs. Like all LMWHs, nadroparin has a pentasaccharide sequence which binds to ATIII, which potentiates the action of ATIII. This complex greatly accelerates the inactivation of factor Xa and factor IIa. As a result, the coagulation cascade is inhibited.', 'Nadroparin is a low molecular weight heparin that is composed of a heterogeneous mixture of sulfated polysaccaride glycosaminoglycan chains. Th mean molecular weight is approximately 4300 daltons. The ratio of anti-Xa activity to anti-IIa is 3.5:1 whereas it is about 1:1 for heparin. Its use should be avoided in patients with a creatinine clearance less than 40mL/min. In these patients, unfractionated heparin should only be used. As for monitoring, active partial thromboplastin time (aPTT) will only increase at high doses of low molecular weight heparins (LMWH). Therefore, monitoring aPTT is not recommended. However, anti-Xa activity can be measured to monitor the efficacy of the LMWH. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19390, 'Fraxiparine 0.6 ml 10 prefilled syringe', 'فراكسيبارين 0.6 مل 2 حقنة مملوءة مسبقا', '280', NULL, 'Anticoagulant.low mwt heparin', 'Nadroparin calcium', 'Aspen europe gmbh > phoenix-egypt', 'Syringe', 'حقنة', '0.6 ml', '10', NULL, 'nadroparin is an anticoagulant belonging to a class of drugs called low molecular weight heparins (lmwhs). nadroparin is used in general and orthopedic surgery to prevent thromboembolic disorders (deep vein thrombosis and pulmonary embolism) and as treatm', NULL, NULL, 1348, '2022-07-08', 0, 'Nadroparin is used for prophylaxis of thromboembolic disorders and general surgery in orthopedic surgery, treatment of deep vein thrombosis, prevention of clotting during hemodialysis and treatment of unstable angina and non-Q wave myocardial infarction.', 'The mechanism of action for nadroparin is similar to all other LMWHs. Like all LMWHs, nadroparin has a pentasaccharide sequence which binds to ATIII, which potentiates the action of ATIII. This complex greatly accelerates the inactivation of factor Xa and factor IIa. As a result, the coagulation cascade is inhibited.', 'Nadroparin is a low molecular weight heparin that is composed of a heterogeneous mixture of sulfated polysaccaride glycosaminoglycan chains. Th mean molecular weight is approximately 4300 daltons. The ratio of anti-Xa activity to anti-IIa is 3.5:1 whereas it is about 1:1 for heparin. Its use should be avoided in patients with a creatinine clearance less than 40mL/min. In these patients, unfractionated heparin should only be used. As for monitoring, active partial thromboplastin time (aPTT) will only increase at high doses of low molecular weight heparins (LMWH). Therefore, monitoring aPTT is not recommended. However, anti-Xa activity can be measured to monitor the efficacy of the LMWH. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19391, 'Fraxiparine 0.8 ml 2 prefilled syringe', 'فراكسيبارين 0.8مل 2 سرنجة معبأة', '70', NULL, 'Anticoagulant.low mwt heparin', 'Nadroparin calcium', 'Glaxo smithkline > modern pharma', 'Syringe', 'حقنة', '0.8 ml', '2', NULL, 'nadroparin is an anticoagulant belonging to a class of drugs called low molecular weight heparins (lmwhs). nadroparin is used in general and orthopedic surgery to prevent thromboembolic disorders (deep vein thrombosis and pulmonary embolism) and as treatm', NULL, NULL, 961, '2022-07-09', 0, 'Nadroparin is used for prophylaxis of thromboembolic disorders and general surgery in orthopedic surgery, treatment of deep vein thrombosis, prevention of clotting during hemodialysis and treatment of unstable angina and non-Q wave myocardial infarction.', 'The mechanism of action for nadroparin is similar to all other LMWHs. Like all LMWHs, nadroparin has a pentasaccharide sequence which binds to ATIII, which potentiates the action of ATIII. This complex greatly accelerates the inactivation of factor Xa and factor IIa. As a result, the coagulation cascade is inhibited.', 'Nadroparin is a low molecular weight heparin that is composed of a heterogeneous mixture of sulfated polysaccaride glycosaminoglycan chains. Th mean molecular weight is approximately 4300 daltons. The ratio of anti-Xa activity to anti-IIa is 3.5:1 whereas it is about 1:1 for heparin. Its use should be avoided in patients with a creatinine clearance less than 40mL/min. In these patients, unfractionated heparin should only be used. As for monitoring, active partial thromboplastin time (aPTT) will only increase at high doses of low molecular weight heparins (LMWH). Therefore, monitoring aPTT is not recommended. However, anti-Xa activity can be measured to monitor the efficacy of the LMWH. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19392, 'Free baby syrup 120 ml', 'فري بيبي شراب 120 مل', '60', '38', 'Antispasmodic', 'Caraway oil+dill oil+sodium bicarbonate', 'Delta pharma', 'Syrup', 'شراب', '120 ml', '1', NULL, 'to improve gastro-intestinal functions', '6221163003842', NULL, 938, '2025-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19393, 'Free care sugar 10 sachets', 'فري كير سكر 10 اكياس', '10', NULL, 'Sweetener', 'Sucralose+maltodextrin', 'Rameda', 'Sachet', 'أكياس', NULL, '1', NULL, '1 sachet is equivalent to 2 spoons of sugar.', NULL, NULL, 722, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19394, 'Free care sugar 50 sachets', 'فري كير سكر 50 كيس', '45', NULL, 'Sweetener', 'Sucralose+maltodextrin', 'Rameda', 'Sachet', 'أكياس', NULL, '1', NULL, '1 sachet is equivalent to 2 spoons of sugar.', NULL, NULL, 718, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19395, 'Free nose cleaning kit', 'فري نوز بخاخ منظف', '108', NULL, NULL, NULL, 'Pharmalink s.l. > aug pharma', 'Unknown', 'غير محدد', NULL, '1', NULL, 'nasal aspirator baby which is designed to remove nasal secretions and mucus', '8436542620260', NULL, 817, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19396, 'Free nose nasal spray 30 ml (0-6 years)', 'فري نوز بخاخ للاطفال 30 مل', '75', NULL, 'Nasal decongestant', 'Sea water+purified water', 'Pharmalink s.l. > aug pharma', 'Spray', 'بخاخ', '30 ml', '1', NULL, 'nasal decongestant spray for 0 - 6 years', '8436542622141', NULL, 1332, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19397, 'Free nose nasal spray 30 ml (6+ years)', 'فري نوز بخاخ للاطفال 30 مل (+6 سنوات)', '75', NULL, 'Nasal decongestant', 'Sea water+purified water', 'Pharmalink s.l. > aug pharma', 'Spray', 'بخاخ', '30 ml', '1', NULL, 'nasal decongestant spray for 6+ years', NULL, NULL, 1006, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19398, 'Free nose propolis nasal spray (+1 year) 20 ml', 'فري نوز بخاخ 20 مل', '89', NULL, 'Nasal decongestant', 'Saline solution+propolis+thyme', 'Pharmalink s.l. > aug pharma', 'Spray', 'بخاخ', '20 ml', '1', NULL, 'nasal decongestant with propolis and thyme. from 1 year and above. *recommended dose: 1-3 years: 1 spray 3 times a day from 3 years: 1-3 sprays 3 times daily', '8436542620307', NULL, 877, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19399, 'Free nose propolis nasal spray (+12 year) 20 ml', 'فري نوز بروبوليس(+12 سنة) بخاخ 20 مل', '89', NULL, 'Nasal decongestant', 'Saline solution+propolis+thyme+eucalyptus', 'Pharmalink s.l. > aug pharma', 'Spray', 'بخاخ', '20 ml', '1', 'علاج حالات احتقان الأنف واحتقان الجيوب الأنفية -- لترطيب تجاويف الأنف في البيئات الجافة -- تعزيز فعالية مزيلات الاحتقان العلاجية والحد من استخدامها', 'nasal decongestant with propolis and thyme. from 12 year and above. *recommended dose: 1 or 2 sprays 3 times a day', NULL, NULL, 1498, '2022-06-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19400, 'Free syrup 120 ml', 'فري شراب 120 مل', '30', '20', 'Anthelmintic', 'Artemisia+boswellia carterii+hazelnut oil+basel vinegar', 'Seutical pharma', 'Syrup', 'شراب', '120 ml', '1', NULL, 'it contain artemisia which has very strong action against all types of intestinal infections caused by: -ascaris lumbricoids (round worm) -entrobius vermicularis (pin worm) -ancylostoma duodenal and necator americanus (hook worm) -trichuris trichiura (whi', NULL, NULL, 1322, '2025-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19401, 'Frequefenacine 7.5mg 20 ext. rel. tab.', 'فريكويفيناسين 7.5مجم 20 قرص', '46', NULL, 'Urge incontinence', 'Darifenacin', 'Marcyrl co.', 'Tab', 'أقراص', '7.5mg', '2', 'علاج فرط نشاط المثانة -- سلس البول', NULL, '6223003570323', NULL, 1311, '2022-11-28', 0, 'For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.', 'Darifenacin selectively antagonizes the muscarinic M3 receptor. M3 receptors are involved in contraction of human bladder and gastrointestinal smooth muscle, saliva production, and iris sphincter function.', 'Darifenacin is a competitive muscarinic receptor antagonist. <i>In vitro</i> studies using human recombinant muscarinic receptor subtypes show that darifenacin has greater affinity for the M3 receptor than for the other known muscarinic receptors (9 and 12-fold greater affinity for M3 compared to M1 and M5, respectively, and 59-fold greater affinity for M3 compared to both M2 and M4). Muscarinic receptors play an important role in several major cholinergically mediated functions, including contractions of the urinary bladder smooth muscle and stimulation of salivary secretion. Adverse drug effects such as dry mouth, constipation and abnormal vision may be mediated through effects on M3 receptors in these organs.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19402, 'Frequegard 15 mg 7 ext. rel. f.c. tab.', 'فريكيوجارد 15 مجم 7 اقراص', '22', NULL, 'Urge incontinence', 'Darifenacin', 'Medizen pharmaceutical industries', 'Tab', 'أقراص', '15 mg', '1', NULL, 'symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with overactive bladder syndrome.', NULL, NULL, 674, '2022-07-29', 0, 'For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.', 'Darifenacin selectively antagonizes the muscarinic M3 receptor. M3 receptors are involved in contraction of human bladder and gastrointestinal smooth muscle, saliva production, and iris sphincter function.', 'Darifenacin is a competitive muscarinic receptor antagonist. <i>In vitro</i> studies using human recombinant muscarinic receptor subtypes show that darifenacin has greater affinity for the M3 receptor than for the other known muscarinic receptors (9 and 12-fold greater affinity for M3 compared to M1 and M5, respectively, and 59-fold greater affinity for M3 compared to both M2 and M4). Muscarinic receptors play an important role in several major cholinergically mediated functions, including contractions of the urinary bladder smooth muscle and stimulation of salivary secretion. Adverse drug effects such as dry mouth, constipation and abnormal vision may be mediated through effects on M3 receptors in these organs.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19403, 'Frequegard 7.5 mg 7 ext. rel. f.c. tab.', 'فريكيوجارد 7.5 مجم 7 اقراص', '17', NULL, 'Urge incontinence', 'Darifenacin', 'Medizen pharmaceutical industries', 'Tab', 'أقراص', '7.5 mg', '1', NULL, 'symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with overactive bladder syndrome.', NULL, NULL, 758, '2022-07-13', 0, 'For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.', 'Darifenacin selectively antagonizes the muscarinic M3 receptor. M3 receptors are involved in contraction of human bladder and gastrointestinal smooth muscle, saliva production, and iris sphincter function.', 'Darifenacin is a competitive muscarinic receptor antagonist. <i>In vitro</i> studies using human recombinant muscarinic receptor subtypes show that darifenacin has greater affinity for the M3 receptor than for the other known muscarinic receptors (9 and 12-fold greater affinity for M3 compared to M1 and M5, respectively, and 59-fold greater affinity for M3 compared to both M2 and M4). Muscarinic receptors play an important role in several major cholinergically mediated functions, including contractions of the urinary bladder smooth muscle and stimulation of salivary secretion. Adverse drug effects such as dry mouth, constipation and abnormal vision may be mediated through effects on M3 receptors in these organs.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19404, 'Fresh vag. gel 75 gm', 'فريش جيل مهبلي 75 جم', '75', '15.75', 'Vaginal care', NULL, 'Hi-care > pharma cure pharmaceuticals', 'Gel', 'جل', '75 gm', '1', 'للعناية المهبلية', 'deodorant gel peach scented', '6224000651145', NULL, 2351, '2025-04-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19405, 'Fresh way spray topical spray.', 'فريش واي بخاخ موضعي', '20', NULL, NULL, 'Chloroxylenol+undecylenic acid', 'Egyptian co. for adv. pharma. (ecap) > millenium pharma-egypt', 'Spray', 'بخاخ', NULL, '1', NULL, NULL, NULL, NULL, 862, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19406, 'Freshen cream 30 gm', 'فريش شين كريم 30جم', '25', NULL, 'Soothing topical', 'Lanolin+wheatgerm oil+glycerin+vit e+honey+beeswax+dimethicon+propolis+sesame oil+glyceryl monostear', 'Egyptian company for cosmetics > pharma 3', 'Cream', 'كريم', '30 gm', '1', NULL, 'skin soothing cream', NULL, NULL, 872, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19407, 'Freshen cream 50 gm', 'فريشن كريم 50 جم', '35', NULL, 'Soothing topical', 'Lanolin+wheatgerm oil+glycerin+vit e+honey+beeswax+dimethicon+propolis+sesame oil+glyceryl monostear', 'Egyptian company for cosmetics > pharma 3', 'Cream', 'كريم', '50 gm', '1', NULL, 'skin soothing cream', NULL, NULL, 964, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19408, 'Freshwal mouth wash 250 ml', 'فريشوال غسول فم 250 مل', '14', NULL, 'Oral care', 'Thymol+menthol crystals+sodium fluoride+clove oil+chlorhexidine digluconate', 'Hi-care > tadawi egypt', 'Mouth wash', 'غسول للفم', '250 ml', '1', NULL, NULL, NULL, NULL, 817, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19409, 'Fresubin 2 kcal drink 200ml', 'فريسوبين 2 كيلو كالوري شراب 200 مل', '110', '77.73', 'Dietary supplement', 'Fat+carbohydrates+protein', 'Fresenius kabi', 'Unknown', 'غير محدد', '200ml', '1', 'مكمل غذائي لزيادة الوزن -- مصدر للطاقة -- مصدر للبروتين والدهون', 'indications for patients with increased energy and protein needs and/or fluid restriction exemplary indications: renal failure requiring dialysis chronic obstructive pulmonary disease (copd) liver diseases and ascites cardiovascular diseases pressure ulce', NULL, NULL, 5874, '2024-06-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19410, 'Fresubin energy fibre 500 ml', 'فريسوبين انرجي فايبر 500 مل', '117', NULL, 'Dietary supplement', 'Fat+carbohydrates+protein', 'Fresenius kabi', 'Unknown', 'غير محدد', '500 ml', '1', 'مكمل غذائي', NULL, NULL, NULL, 1964, '2022-05-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19412, 'Frigofast ice spray 400 ml', 'فريجو فاست ايس سبراي 400 مل', '400', '150', 'Analgesic', NULL, 'Farmac-zabban > elegant care group', 'Spray', 'بخاخ', '400 ml', '1', 'اسبراي مسكن للالام -- يساعد علي تخفيف الالتهابات و الالام -- يقلل الالام العظام -- يستخدم في اصابات الملاعب', 'instant ice spray that works immediately in case of bruises and sprains.', '8000246006202', NULL, 6458, '2025-07-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19413, 'Friston bio-cleansing hair shampoo 250 ml', 'فريستون بايو شامبو للشعر 250 مل', '110', NULL, 'Hair care', 'Biotin+saw palmetto+aloe vera+garlic+ginseng+hydrolyzed keratin+panthenol+niacin', 'Leader cosmetics > ncs pharma', 'Amp', 'أمبول', '250 ml', '1', NULL, 'for fine & thinning hair. use: apply twice weekly. indications: -prevent hair fall. -increase hair density. -protect hair from harmful environmental conditions. -controls split ends and hair damage.', NULL, NULL, 711, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19414, 'Friston free hair shampoo 250 ml', 'فريستون فري شامبو للشعر 250 مل', '150', NULL, 'Hair care', 'Biotin+saw palmetto+aloe vera+garlic+ginseng+hydrolyzed keratin+panthenol+niacin', 'Leader cosmetics > ncs pharma', 'Amp', 'أمبول', '250 ml', '1', 'علاج تساقط الشعر', 'sulphate free. for fine & thinning hair. use: apply twice weekly. indications: -prevent hair fall. -increase hair density. -protect hair from harmful environmental conditions. -controls split ends and hair damage.', NULL, NULL, 2124, '2022-06-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19415, 'Friston hair lotion 120 ml', 'فريستون لوسيون 120 مل', '330', '280', 'Hair care', 'Biotin+saw palmetto+aloe vera+jojoba+wheat germ+garlic+ginseng', 'Leader cosmetics > ncs pharma', 'Lotion', 'لوشن', '120 ml', '1', NULL, 'use: apply twice daily.', NULL, NULL, 1875, '2025-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19416, 'Frizzi no hair serum 75 ml', 'فريزي نو هير سيروم 75 مل', '210', '175', 'Hair care', NULL, '> xcel pharma', 'Serum', 'سيروم', '75 ml', '1', NULL, NULL, '6225000141414', NULL, 854, '2024-06-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19417, 'Frizzi no kids hair serum 75 ml', 'فريزى نو كيدز سيرم للشعر - 75 جم', '210', '175', 'Hair care', NULL, '> xcel pharma', 'Serum', 'سيروم', '75 ml', '1', NULL, NULL, NULL, NULL, 1013, '2025-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19418, 'Froben 100mg 16 tab.', 'فروبن 100 مجم 16 قرص', '7', NULL, 'Nsaid.propionic acid derivatives', 'Flurbiprofen', 'Kahira > abbott laboratories', 'Tab', 'أقراص', '100mg', '2', NULL, 'about flurbiprofen nsaid oral phenylalkanoic acid derivative analgesic and anti-inflammatory anti arthritic. mechanism of action of flurbiprofen it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes both cox1 and cox2.in higher doses it', NULL, NULL, 874, '2022-07-16', 0, 'Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis. ', 'Similar to other NSAIAs, the anti-inflammatory effect of flurbiprofen occurs via reversible inhibition of cyclooxygenase (COX), the enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This effectively decreases the concentration of prostaglandins involved in inflammation, pain, swelling and fever. Flurbiprofen is a non-selective COX inhibitor and inhibits the activity of both COX-1 and -2. It is also one of the most potent NSAIAs in terms of prostaglandin inhibitory activity.', 'Flurbiprofen, a nonsteroidal anti-inflammatory agent (NSAIA) of the propionic acid class, is structually and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen, and has similar pharmacological actions to other prototypica NSAIAs. Flurbiprofen exhibits antiinflammatory, analgesic, and antipyretic activities. The commercially available flurbiprofen is a racemic mixture of (+)S- and (-) R-enantiomers. The S-enantiomer appears to possess most of the anti-inflammatory, while both enantiomers may possess analgesic activity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19420, 'Froben 5% top. gel 40 gm', 'فروبن 5% توب جل 40 جم', '17', NULL, 'Nsaid.propionic acid derivatives', 'Flurbiprofen', 'Kahira > abbott laboratories', 'Gel', 'جل', '5%', '1', NULL, 'about flurbiprofen nsaid oral phenylalkanoic acid derivative analgesic and anti-inflammatory anti arthritic. mechanism of action of flurbiprofen it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes both cox1 and cox2.in higher doses it', '6221068603703', NULL, 935, '2022-12-05', 0, 'Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis. ', 'Similar to other NSAIAs, the anti-inflammatory effect of flurbiprofen occurs via reversible inhibition of cyclooxygenase (COX), the enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This effectively decreases the concentration of prostaglandins involved in inflammation, pain, swelling and fever. Flurbiprofen is a non-selective COX inhibitor and inhibits the activity of both COX-1 and -2. It is also one of the most potent NSAIAs in terms of prostaglandin inhibitory activity.', 'Flurbiprofen, a nonsteroidal anti-inflammatory agent (NSAIA) of the propionic acid class, is structually and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen, and has similar pharmacological actions to other prototypica NSAIAs. Flurbiprofen exhibits antiinflammatory, analgesic, and antipyretic activities. The commercially available flurbiprofen is a racemic mixture of (+)S- and (-) R-enantiomers. The S-enantiomer appears to possess most of the anti-inflammatory, while both enantiomers may possess analgesic activity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19421, 'Froben 50mg 30 tab.', 'فروبن 50 مجم 30 قرص', '8', NULL, 'Nsaid.propionic acid derivatives', 'Flurbiprofen', 'Kahira > abbott laboratories', 'Tab', 'أقراص', '50mg', '3', NULL, 'about flurbiprofen nsaid oral phenylalkanoic acid derivative analgesic and anti-inflammatory anti arthritic. mechanism of action of flurbiprofen it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes both cox1 and cox2.in higher doses it', NULL, NULL, 940, '2022-07-24', 0, 'Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis. ', 'Similar to other NSAIAs, the anti-inflammatory effect of flurbiprofen occurs via reversible inhibition of cyclooxygenase (COX), the enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This effectively decreases the concentration of prostaglandins involved in inflammation, pain, swelling and fever. Flurbiprofen is a non-selective COX inhibitor and inhibits the activity of both COX-1 and -2. It is also one of the most potent NSAIAs in terms of prostaglandin inhibitory activity.', 'Flurbiprofen, a nonsteroidal anti-inflammatory agent (NSAIA) of the propionic acid class, is structually and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen, and has similar pharmacological actions to other prototypica NSAIAs. Flurbiprofen exhibits antiinflammatory, analgesic, and antipyretic activities. The commercially available flurbiprofen is a racemic mixture of (+)S- and (-) R-enantiomers. The S-enantiomer appears to possess most of the anti-inflammatory, while both enantiomers may possess analgesic activity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19424, 'Frositor 10 mg 10 f.c. tabs.', 'فروسيتور 10مجم 10 أقراص', '56', '37.5', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company', 'Tab', 'أقراص', '10 mg', '1', 'يستخدم لخفض الكوليسترول.', 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', '6223004710025', NULL, 1247, '2025-08-08', 0, 'The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia.[F4649]



The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.[F4652]



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Rosuvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A181421] Rosuvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Rosuvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL).[F4649] The overall effect is a decrease in plasma LDL and VLDL. 



In vitro and in vivo animal studies also demonstrate that rosuvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.



Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.[A181559]



Rosuvastatin exerts an anti-inflammatory effect on rat mesenteric microvascular endothelium by attenuating leukocyte rolling, adherence and transmigration.[A1807] The drug also modulates nitric oxide synthase (NOS) expression and reduces ischemic-reperfusion injuries in rat hearts.[A1787] Rosuvastatin increases the bioavailability of nitric oxide[A1807,A1799,A1787] by upregulating NOS[A1791] and by increasing the stability of NOS through post-transcriptional polyadenylation.[A1796] It is unclear as to how rosuvastatin brings about these effects though they may be due to decreased concentrations of mevalonic acid.', 'Rosuvastatin is a synthetic, enantiomerically pure antilipemic agent. It is used to lower total cholesterol, low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apoB), non-high density lipoprotein-cholesterol (non-HDL-C), and trigleride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease and high ratios are associated with higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, rosuvastatin reduces the risk of cardiovascular morbidity and mortality.[A181087, A181406]



Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]



**Skeletal Muscle Effects**



Cases of myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. These risks can occur at any dose level, but are increased at the highest dose (40 mg). Rosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age ≥ 65 years, inadequately treated hypothyroidism, renal impairment).



The risk of myopathy during treatment with rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies (such as [fenofibrate] or [niacin]), [gemfibrozil], [cyclosporine], [atazanavir]/[ritonavir], [lopinavir]/ritonavir, or [simeprevir].  Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors, including rosuvastatin, coadministered with [colchicine], and caution should therefore be exercised when prescribing these two medications together.[F4649] 



Real-world data from observational studies has suggested that 10-15% of people taking statins may experience muscle aches at some point during treatment.[A182258]



**Liver Enzyme Abnormalities**



Increases in serum transaminases have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. In most cases, the elevations were transient and resolved or improved on continued therapy or after a brief interruption in therapy. There were two cases of jaundice, for which a relationship to rosuvastatin therapy could not be determined, which resolved after discontinuation of therapy. There were no cases of liver failure or irreversible liver disease in these trials.[F4649]



**Endocrine Effects**



Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including rosuvastatin calcium tablets. Based on clinical trial data with rosuvastatin, in some instances these increases may exceed the threshold for the diagnosis of diabetes mellitus.[F4649]



An in vitro study found that [atorvastatin], [pravastatin], [rosuvastatin], and [pitavastatin] exhibited a dose-dependent cytotoxic effect on human pancreas islet β cells, with reductions in cell viability of 32, 41, 34 and 29%, respectively, versus control]. Moreover, insulin secretion rates were decreased by 34, 30, 27 and 19%, respectively, relative to control.[A182012]



HMG-CoA reductase inhibitors interfere with cholesterol synthesis and lower cholesterol levels and, as such, might theoretically blunt adrenal or gonadal steroid hormone production. Rosuvastatin demonstrated no effect upon nonstimulated cortisol levels and no effect on thyroid metabolism as assessed by TSH plasma concentration. In rosuvastatin treated patients, there was no impairment of adrenocortical reserve and no reduction in plasma cortisol concentrations. Clinical studies with other HMG-CoA reductase inhibitors have suggested that these agents do not reduce plasma testosterone concentration. The effects of HMG-CoA reductase inhibitors on male fertility have not been studied. The effects, if any, on the pituitarygonadal axis in premenopausal women are unknown.[F4652]



**Cardiovascular**



Ubiquinone levels were not measured in rosuvastatin clinical trials, however significant decreases in circulating ubiquinone levels in patients treated with other statins have been observed. The clinical significance of a potential long-term statin-induced deficiency of ubiquinone has not been established. It has been reported that a decrease in myocardial ubiquinone levels could lead to impaired cardiac function in patients with borderline congestive heart failure.[F4652]



**Lipoprotein A**



In some patients, the beneficial effect of lowered total cholesterol and LDL-C levels may be partly blunted by a concomitant increase in the Lipoprotein(a) [Lp(a)] concentrations. Present knowledge suggests the importance of high Lp(a) levels as an emerging risk factor for coronary heart disease. It is thus desirable to maintain and reinforce lifestyle changes in high-risk patients placed on rosuvastatin therapy.[F4652] Further studies have demonstrated statins affect Lp(a) levels differently in patients with dyslipidemia depending on their apo(a) phenotype; statins increase Lp(a) levels exclusively in patients with the low molecular weight apo(a) phenotype.[A181418]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19425, 'Frositor 10 mg 20 f.c. tabs.', 'فروسيتور 10 مجم 20 قرص', '112', '75', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company', 'Tab', 'أقراص', '10 mg', '2', NULL, 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', NULL, NULL, 1094, '2025-08-08', 0, 'The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia.[F4649]



The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.[F4652]



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Rosuvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A181421] Rosuvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Rosuvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL).[F4649] The overall effect is a decrease in plasma LDL and VLDL. 



In vitro and in vivo animal studies also demonstrate that rosuvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.



Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.[A181559]



Rosuvastatin exerts an anti-inflammatory effect on rat mesenteric microvascular endothelium by attenuating leukocyte rolling, adherence and transmigration.[A1807] The drug also modulates nitric oxide synthase (NOS) expression and reduces ischemic-reperfusion injuries in rat hearts.[A1787] Rosuvastatin increases the bioavailability of nitric oxide[A1807,A1799,A1787] by upregulating NOS[A1791] and by increasing the stability of NOS through post-transcriptional polyadenylation.[A1796] It is unclear as to how rosuvastatin brings about these effects though they may be due to decreased concentrations of mevalonic acid.', 'Rosuvastatin is a synthetic, enantiomerically pure antilipemic agent. It is used to lower total cholesterol, low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apoB), non-high density lipoprotein-cholesterol (non-HDL-C), and trigleride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease and high ratios are associated with higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, rosuvastatin reduces the risk of cardiovascular morbidity and mortality.[A181087, A181406]



Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]



**Skeletal Muscle Effects**



Cases of myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. These risks can occur at any dose level, but are increased at the highest dose (40 mg). Rosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age ≥ 65 years, inadequately treated hypothyroidism, renal impairment).



The risk of myopathy during treatment with rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies (such as [fenofibrate] or [niacin]), [gemfibrozil], [cyclosporine], [atazanavir]/[ritonavir], [lopinavir]/ritonavir, or [simeprevir].  Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors, including rosuvastatin, coadministered with [colchicine], and caution should therefore be exercised when prescribing these two medications together.[F4649] 



Real-world data from observational studies has suggested that 10-15% of people taking statins may experience muscle aches at some point during treatment.[A182258]



**Liver Enzyme Abnormalities**



Increases in serum transaminases have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. In most cases, the elevations were transient and resolved or improved on continued therapy or after a brief interruption in therapy. There were two cases of jaundice, for which a relationship to rosuvastatin therapy could not be determined, which resolved after discontinuation of therapy. There were no cases of liver failure or irreversible liver disease in these trials.[F4649]



**Endocrine Effects**



Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including rosuvastatin calcium tablets. Based on clinical trial data with rosuvastatin, in some instances these increases may exceed the threshold for the diagnosis of diabetes mellitus.[F4649]



An in vitro study found that [atorvastatin], [pravastatin], [rosuvastatin], and [pitavastatin] exhibited a dose-dependent cytotoxic effect on human pancreas islet β cells, with reductions in cell viability of 32, 41, 34 and 29%, respectively, versus control]. Moreover, insulin secretion rates were decreased by 34, 30, 27 and 19%, respectively, relative to control.[A182012]



HMG-CoA reductase inhibitors interfere with cholesterol synthesis and lower cholesterol levels and, as such, might theoretically blunt adrenal or gonadal steroid hormone production. Rosuvastatin demonstrated no effect upon nonstimulated cortisol levels and no effect on thyroid metabolism as assessed by TSH plasma concentration. In rosuvastatin treated patients, there was no impairment of adrenocortical reserve and no reduction in plasma cortisol concentrations. Clinical studies with other HMG-CoA reductase inhibitors have suggested that these agents do not reduce plasma testosterone concentration. The effects of HMG-CoA reductase inhibitors on male fertility have not been studied. The effects, if any, on the pituitarygonadal axis in premenopausal women are unknown.[F4652]



**Cardiovascular**



Ubiquinone levels were not measured in rosuvastatin clinical trials, however significant decreases in circulating ubiquinone levels in patients treated with other statins have been observed. The clinical significance of a potential long-term statin-induced deficiency of ubiquinone has not been established. It has been reported that a decrease in myocardial ubiquinone levels could lead to impaired cardiac function in patients with borderline congestive heart failure.[F4652]



**Lipoprotein A**



In some patients, the beneficial effect of lowered total cholesterol and LDL-C levels may be partly blunted by a concomitant increase in the Lipoprotein(a) [Lp(a)] concentrations. Present knowledge suggests the importance of high Lp(a) levels as an emerging risk factor for coronary heart disease. It is thus desirable to maintain and reinforce lifestyle changes in high-risk patients placed on rosuvastatin therapy.[F4652] Further studies have demonstrated statins affect Lp(a) levels differently in patients with dyslipidemia depending on their apo(a) phenotype; statins increase Lp(a) levels exclusively in patients with the low molecular weight apo(a) phenotype.[A181418]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19426, 'Frositor 5 mg 30 f.c. tabs.', 'فروسيتور 5 مجم 30 قرص', '93', '75', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company', 'Tab', 'أقراص', '5 mg', '3', NULL, 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', '6223004710018', NULL, 989, '2024-12-03', 0, 'The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia.[F4649]



The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.[F4652]



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Rosuvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A181421] Rosuvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Rosuvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL).[F4649] The overall effect is a decrease in plasma LDL and VLDL. 



In vitro and in vivo animal studies also demonstrate that rosuvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.



Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.[A181559]



Rosuvastatin exerts an anti-inflammatory effect on rat mesenteric microvascular endothelium by attenuating leukocyte rolling, adherence and transmigration.[A1807] The drug also modulates nitric oxide synthase (NOS) expression and reduces ischemic-reperfusion injuries in rat hearts.[A1787] Rosuvastatin increases the bioavailability of nitric oxide[A1807,A1799,A1787] by upregulating NOS[A1791] and by increasing the stability of NOS through post-transcriptional polyadenylation.[A1796] It is unclear as to how rosuvastatin brings about these effects though they may be due to decreased concentrations of mevalonic acid.', 'Rosuvastatin is a synthetic, enantiomerically pure antilipemic agent. It is used to lower total cholesterol, low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apoB), non-high density lipoprotein-cholesterol (non-HDL-C), and trigleride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease and high ratios are associated with higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, rosuvastatin reduces the risk of cardiovascular morbidity and mortality.[A181087, A181406]



Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]



**Skeletal Muscle Effects**



Cases of myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. These risks can occur at any dose level, but are increased at the highest dose (40 mg). Rosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age ≥ 65 years, inadequately treated hypothyroidism, renal impairment).



The risk of myopathy during treatment with rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies (such as [fenofibrate] or [niacin]), [gemfibrozil], [cyclosporine], [atazanavir]/[ritonavir], [lopinavir]/ritonavir, or [simeprevir].  Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors, including rosuvastatin, coadministered with [colchicine], and caution should therefore be exercised when prescribing these two medications together.[F4649] 



Real-world data from observational studies has suggested that 10-15% of people taking statins may experience muscle aches at some point during treatment.[A182258]



**Liver Enzyme Abnormalities**



Increases in serum transaminases have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. In most cases, the elevations were transient and resolved or improved on continued therapy or after a brief interruption in therapy. There were two cases of jaundice, for which a relationship to rosuvastatin therapy could not be determined, which resolved after discontinuation of therapy. There were no cases of liver failure or irreversible liver disease in these trials.[F4649]



**Endocrine Effects**



Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including rosuvastatin calcium tablets. Based on clinical trial data with rosuvastatin, in some instances these increases may exceed the threshold for the diagnosis of diabetes mellitus.[F4649]



An in vitro study found that [atorvastatin], [pravastatin], [rosuvastatin], and [pitavastatin] exhibited a dose-dependent cytotoxic effect on human pancreas islet β cells, with reductions in cell viability of 32, 41, 34 and 29%, respectively, versus control]. Moreover, insulin secretion rates were decreased by 34, 30, 27 and 19%, respectively, relative to control.[A182012]



HMG-CoA reductase inhibitors interfere with cholesterol synthesis and lower cholesterol levels and, as such, might theoretically blunt adrenal or gonadal steroid hormone production. Rosuvastatin demonstrated no effect upon nonstimulated cortisol levels and no effect on thyroid metabolism as assessed by TSH plasma concentration. In rosuvastatin treated patients, there was no impairment of adrenocortical reserve and no reduction in plasma cortisol concentrations. Clinical studies with other HMG-CoA reductase inhibitors have suggested that these agents do not reduce plasma testosterone concentration. The effects of HMG-CoA reductase inhibitors on male fertility have not been studied. The effects, if any, on the pituitarygonadal axis in premenopausal women are unknown.[F4652]



**Cardiovascular**



Ubiquinone levels were not measured in rosuvastatin clinical trials, however significant decreases in circulating ubiquinone levels in patients treated with other statins have been observed. The clinical significance of a potential long-term statin-induced deficiency of ubiquinone has not been established. It has been reported that a decrease in myocardial ubiquinone levels could lead to impaired cardiac function in patients with borderline congestive heart failure.[F4652]



**Lipoprotein A**



In some patients, the beneficial effect of lowered total cholesterol and LDL-C levels may be partly blunted by a concomitant increase in the Lipoprotein(a) [Lp(a)] concentrations. Present knowledge suggests the importance of high Lp(a) levels as an emerging risk factor for coronary heart disease. It is thus desirable to maintain and reinforce lifestyle changes in high-risk patients placed on rosuvastatin therapy.[F4652] Further studies have demonstrated statins affect Lp(a) levels differently in patients with dyslipidemia depending on their apo(a) phenotype; statins increase Lp(a) levels exclusively in patients with the low molecular weight apo(a) phenotype.[A181418]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19427, 'Frost gel 100 gm', 'فروست جل 100 جرام', '110', '95', 'Massage.topical analgesic.muscle', 'Menthol+chamomile+lavender+propylene glycol+glycerin', 'Macro group pharmaceuticals', 'Gel', 'جل', '100 gm', '1', 'مساج جل لالام العضلات', '*deep penetrating long lasting pain reliever cooling gel with the herbal power for relieving body sufferings *topical gel for relieving muscles & joints pain *relaxes tensed muscles & restores mobility. *can be massaged gently and evenly over tendons and', '6224000437664', NULL, 9809, '2025-01-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19428, 'Frost roll on 60 ml', 'فروست رول اون 60 مل', '75', '65', 'Analgesic', 'Racemic mentolis+chamomile extract+propylene glycol+glycerin', 'Macro group pharmaceuticals', 'Unknown', 'غير محدد', '60 ml', '1', NULL, '*fast acting cooling spray with the herbal power for relieving body sufferings *topical spray for restoring body comfort & calmness for relieving muscles & joints pain *relaxes tensed muscles & restores mobility *ideal for areas that are hard to reach or', '6224007384473', NULL, 1061, '2024-11-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19429, 'Frost topical spray 100 ml', 'فروست بخاخ 100 مل', '140', '115', 'Analgesic', 'Racemic mentolis+chamomile extract+propylene glycol+glycerin', 'Macro group pharmaceuticals', 'Spray', 'بخاخ', '100 ml', '1', 'بخاخ تبريد فوري للكدمات ومسكن للألم المزمن الناجم عن التهاب المفاصل أو العضلات', NULL, '6224000437664', NULL, 5644, '2025-01-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19430, 'Frozen-a spray 100 ml', 'فروزن-ايه سبراي بخاخ 100 مل', '175', NULL, 'Analgesic', 'Arnica extract', 'Uk medica limited > walfarm pharmaceuticals', 'Spray', 'بخاخ', '100 ml', '1', 'مسكن لالام الجسم ومضاد التهاب', '-it is a pain relief cold spray effective against joint pain and muscle strain swellings bruises crushing sprains. -use 2-3 times a day. -suitable for children over 3 years.', NULL, NULL, 2180, '2023-05-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19431, 'Fruital syrup 120 ml', 'فروتال شراب 120 مل', '29', '14', 'Vitamins', 'Vitamins', 'Cid', 'Syrup', 'شراب', '120 ml', '1', 'دعم الجسم بالفيتامينات اللازمة للنمو الصحي في حالة الحاجة إليها -- دعم المناعة لمقاومة العدوى', 'about vitaminssvitamins are substances that are found in foods we eat. the term vitamin is derived from the words vital and amine because vitamins are required for life and were originally thought to be amines. all vitamins are not amines. vitamins are di', '6221043011097', NULL, 4616, '2024-12-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19432, 'Frumos eye cream 25 ml', 'فروموس كريم للعين 25 مل', '135', NULL, 'Eye contour', NULL, 'Dbk pharma > marvel', 'Cream', 'كريم', '25 ml', '1', NULL, '** for dark circles ** ingredients: stearic acid + glyceryl stearate + cetearyl ascorbate + ceteareth-20 + paraffin oil + triethanolamine + glycerin + kojic acid + simethicone + citric acid + edta + linseed oil + carboxymethyl cellulose + retinyl palmitat', NULL, NULL, 695, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19433, 'Frusetone 20/100 mg 10 f.c.tab', 'فروسيتون 20/100مجم 10 قرص', '11', NULL, 'Diuretic', 'Furosemide+spironolactone', 'Pharco', 'Tab', 'أقراص', '100 mg', '1', NULL, 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', '6221151001850', NULL, 832, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19434, 'Frusetone 20/50mg 10 f.c. tabs.', 'فروزيتون 20/50 مجم 10 اقراص', '7', NULL, 'Diuretic', 'Furosemide+spironolactone', 'Pharco', 'Tab', 'أقراص', '50mg', '1', NULL, 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', '6221151001867', NULL, 834, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19435, 'Frustless 12.5mg 10 f.c. tabs.', 'فرستليس 12.5مجم 10 اقراص', '14', NULL, 'Psychiatric.antidepressants', 'Tianeptine sodium salt', 'Delta pharma', 'Tab', 'أقراص', '12.5mg', '1', 'علاج الاكتئاب -- علاج مشاكل النوم', 'it is a drug used primarily in the treatment of major depressive disorder although it may also be used to treat asthma or irritable bowel syndrome. chemically it is a tricyclic antidepressant (tca) but it has different pharmacological properties than typi', NULL, NULL, 1724, '2022-05-20', 0, 'Used primarily in the treatment of major depressive disorder and anxiety [A31969]. It is currently being studied for fibromyalgia pain treatment [L1426].', 'Recent studies suggest that tianeptine acts as a full agonist at the mu-type opioid receptor (MOR) [A33314], [A33316].   The mu opioid receptors are currently being studied as effective targets for antidepressant therapies [L2947]. It is believed that the clinical effects of tianeptine are owed to its modulation of these receptors  [A33314].  In addition to its actions on the opioid receptor, previous studies have owed its action to its effect on the serotonin receptor [A33317], [A33318], dopamine (D2/3) receptors [A33319], and glutamate receptors [A33315], [F134], as discussed below:



Tianeptine has challenged the monoaminergic hypothesis of depression, as well as the widely supported monoaminergic mechanisms whereby the action of most known antidepressants have been explained [L1414]. Specifically, this drug is thought to persistently alter glutamate receptor bursting of the hippocampal CA3 commissural associational synapse [A31971]. Current research suggests that tianeptine produces its antidepressant effects through the modulation of glutamate receptor activity (for example, AMPA receptors and NMDA receptors) and affect the release of brain-derived neurotrophic factor (BDNF), which impacts neural plasticity [A31986]. More recent studies by support the role of tianeptine in the modulation of glutaminergic activity in the amygdala, the emotional region of the brain associated with memories [A31971]. 



 Tianeptine reduces the hypothalamic-pituitary-adrenal response to stress, and thus prevents stress-related behavioral issues [A31986, A24914].  In rodents, the stress of acute restraint increases extracellular levels of glutamate in the basolateral amygdala an effect that was inhibited by tianeptine [A31971]. Interestingly, the SSRI fluoxetine increased extracellular glutamate levels in the basolateral amygdala regardless of stress conditions. These data demonstrate that the mechanism of action of tianeptine is distinct from SSRIs and support the hypothesis that the mechanism of action of tianeptine relates to alteration of glutaminergic activity in the amygdala and the hippocampus [A31971, A31969, A31986].



In addition to the above mechanisms, tianeptine is a unique antidepressant and anxiolytic medication that stimulates the uptake of serotonin (5-hydroxytryptamine; 5-HT), and 5-hydroxyindoleacetic acid (5-HIAA) in brain tissue [A31971]. 



Although the monoaminergic neurotransmitters serotonin (5-HT), noradrenaline (NA) and dopamine (DA) are proven to be related to the occurrence of depressive disorders, it is now recognized that monoamine deficits are not sufficient to explain the mechanism of action of antidepressant medications [A31971].  

', '



Analyses in large-scale epidemiologic surveys have shown that the anxiety disorders are widely comorbid with major depression. This makes antidepressant with anxiolytic properties particularly unique and attractive [A31971].



Tianeptine is effective in reducing depressive symptoms in mild to severe major depressive disorder and also alleviates anxious symptoms associated with depression without the need for coadministration of an anti-anxiety medication [A31971].   



These findings, however, are met with controversial data.  In a study of healthy volunteers, Tianeptine-treated subjects were less accurate at identifying facial expressions, suggesting a lack of improvement in the psychomotor symptoms of depression. The tianeptine group also showed reduced memory and reduced attentional vigilance to various stimuli [A31987].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19436, 'Fruzex 40mg 12 tab.', 'فروزكس 40 مجم 12 قرص', '3', NULL, 'Diuretic.loop', 'Furosemide', 'Misr', 'Tab', 'أقراص', '40mg', '2', NULL, 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', NULL, NULL, 837, '2022-07-30', 0, 'Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] 



Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659]



Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958]



Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408]', 'Furosemide promotes diuresis by blocking tubular reabsorption of sodium and chloride in the proximal and distal tubules, as well as in the thick ascending loop of Henle. This diuretic effect is achieved through the competitive inhibition of sodium-potassium-chloride cotransporters (NKCC2) expressed along these tubules in the nephron, preventing the transport of sodium ions from the lumenal side into the basolateral side for reabsorption. This inhibition results in increased excretion of water along with sodium, chloride, magnesium, calcium, hydrogen, and potassium ions.[L7961] As with other loop diuretics, furosemide decreases the excretion of uric acid.[T28] 



Furosemide exerts direct vasodilatory effects, which results in its therapeutic effectiveness in the treatment of acute pulmonary edema. Vasodilation leads to reduced responsiveness to vasoconstrictors, such as angiotensin II and noradrenaline, and decreased production of endogenous natriuretic hormones with vasoconstricting properties. It also leads to increased production of prostaglandins with vasodilating properties. Furosemide may also open potassium channels in resistance arteries.[T28] The main mechanism of action of furosemide is independent of its inhibitory effect on carbonic anhydrase and aldosterone.[L7958] ', 'Furosemide manages hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide is a potent loop diuretic that works to increase the excretion of Na+ and water by the kidneys by inhibiting their reabsorption from the proximal and distal tubules, as well as the loop of Henle.[L7958] It works directly acts on the cells of the nephron and indirectly modifies the content of the renal filtrate.[T28] Ultimately, furosemide increases the urine output by the kidney. Protein-bound furosemide is delivered to its site of action in the kidneys and secreted via active secretion by nonspecific organic transporters expressed at the luminal site of action.[A31831,L7958] 



Following oral administration, the onset of the diuretic effect is about 1 and 1.5 hours [L7958], and the peak effect is reached within the first 2 hours.[L7961] The duration of effect following oral administration is about 4-6 hours but may last up to 8 hours.[L9659] Following intravenous administration, the onset of effect is within 5 minutes, and the peak effect is reached within 30 minutes. The duration of action following intravenous administration is approximately 2 hours. Following intramuscular administration, the onset of action is somewhat delayed.[L7958]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19438, 'Fsh 75 i.u. 5 lyophilized pd. amps.', 'اف اس اتش 75 وحدة دولية 5 امبولات للحقن باودر مجفدة', '660', NULL, 'Infertility drugs.follicle stimulating hormone', 'Follitropin (recombinant fsh)', 'Sedico', 'Amp', 'أمبول', NULL, '5', 'يستخدم في النساء المصابات بالعقم للمساعدة في نمو المبايض الصحية (الناضجة) وإطلاق بيضة للمساعدة في الحمل', NULL, '6221042422054', NULL, 2883, '2023-06-14', 0, 'In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).', 'Follitropin is a recombinant form of endogenous follicle stimulating hormone (FSH). FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells.', 'Used for the treatment of female infertility, Follitropin beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Follitropin beta is the primary hormone responsible for follicular recruitment and development.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19440, 'Fucicort cream 20 gm', 'فيوسيكورت كريم 20 جرام', '70', '38', 'Antibiotic with glucocorticoid', 'Betamethasone+fucidic acid', 'Mina pharm > leo pharmaceutical products', 'Cream', 'كريم', '20 gm', '1', NULL, 'description betamethasone is a type of medicine called a topical corticosteroid. corticosteroids are medicines used for reducing inflammation. skin inflammation in eczema occurs due to the irritation of the skin and is caused by the release of various sub', '6222003702536', NULL, 4714, '2024-12-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19444, 'Fucidin 2% 10x30cm intertulle', 'فيوسيدين 2% 10*30 سم شاش معقم', '3', NULL, 'Antibiotic', 'Fusidic acid', 'Mina pharm > leo pharmaceutical products', 'Unknown', 'غير محدد', '2%', '1', NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', NULL, NULL, 933, '2022-06-21', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19447, 'Fucidin 2% cream 30 gm', 'فيوسيدين 2% كريم 30 جرام', '96', '53', 'Antibiotic topical', 'Fusidic acid', 'Mina pharm > leo pharmaceutical products', 'Cream', 'كريم', '2%', '1', NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', '6222003702321', NULL, 4920, '2024-11-26', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19449, 'Fucidin 2% ointment 20 gm', 'فيوسيدين 2% مرهم 20 جرام', '69', '37', 'Antibiotic', 'Fusidic acid', 'Mina pharm > leo pharmaceutical products', 'Ointment', 'مرهم', '2%', '1', NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', '6222003702543', NULL, 963, '2024-11-26', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19450, 'Fucidin 2% ointment 30 gm', 'فيوسيدين 2% مرهم 30 جرام', '96', '53', 'Antibiotic', 'Fusidic acid', 'Mina pharm > leo pharmaceutical products', 'Ointment', 'مرهم', '2%', '1', NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', '6222003702338', NULL, 1102, '2024-11-26', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19451, 'Fucin 2% 10x10cm sterile gauze dressing', 'فيوسين 2% 10×10 سم شاش معقم', '4', NULL, 'Antibiotic', 'Sodium fusidate', 'Alexandria', 'Unknown', 'غير محدد', '2%', '1', NULL, 'about sodium fusidate steroidal antibiotic (topical). mechanism of action of sodium fusidate sodium fusidate is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid from aminoacyl srna to the protei', NULL, NULL, 908, '2022-07-18', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19453, 'Fucin 2% 10x30cm sterile gauze dressing', 'فيوسين 2% 10×30 سم شاش معقم', '6', NULL, 'Antibiotic', 'Sodium fusidate', 'Alexandria', 'Unknown', 'غير محدد', '2%', '1', NULL, 'about sodium fusidate steroidal antibiotic (topical). mechanism of action of sodium fusidate sodium fusidate is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid from aminoacyl srna to the protei', NULL, NULL, 780, '2022-07-12', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19455, 'Fucithalmic 1% viscous eye drops 5 gm', 'فيوسيثالميك1% قطرة لزجة للعين 5جم', '37', NULL, 'Antibiotic', 'Fusidic acid', 'Amidpharm > chemipharm', 'Drops', 'نقط', '1%', '1', NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', '5060337261227', NULL, 1702, '2022-07-07', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19456, 'Chartoreg trio 5 / 12.5 / 80 mg 28 tabs.', 'شارتوريج تريو 5/12.5/80 مجم 28 قرص', '208', '159', 'Antihypertensive', 'Telmisartan+amlodipine+hydrochlorothiazide', 'Utopia', 'Tab', 'أقراص', '80 mg', '2', 'يستخدم فى علاج ارتفاع ضغط الدم', NULL, '6223012330277', NULL, 2866, '2024-11-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19457, 'Rowsta 200 mg 10sachets 20 gm', 'روستا 200 مجم 10 اكياس 20 جم', '120', '85', 'Protein', 'Sweet potato+isolated whey protein', 'Unitrade pharma', 'Sachet', 'أكياس', '200 mg', '1', 'مكمل غذائى يدعم وظائف الجسم المختلفة بدءاً من وظائف الدماغ وانتهاء بجهاز المناعة وقدرته على محاربة العدوى,', NULL, NULL, NULL, 2193, '2024-02-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19458, 'Fuci-top-c cream 15 gm', 'فيوسي توب سي كريم 15 جرام', '33', '21.5', 'Antibiotic with glucocorticoid', 'Betamethasone+fucidic acid', 'Hikma pharma', 'Cream', 'كريم', '15 gm', '1', 'مضاد حيوي لعلاج العدوي الجلدية والتهابات الجلد', 'description betamethasone is a type of medicine called a topical corticosteroid. corticosteroids are medicines used for reducing inflammation. skin inflammation in eczema occurs due to the irritation of the skin and is caused by the release of various sub', '6221000000676', NULL, 4579, '2024-12-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19459, 'Fumipan 150mg 10 s.r.f.c.tabs.(n/a yet)', 'فوميبان 150مجم 10 اقراص ممتدة المفعول', '12', NULL, 'Psychiatric.antidepressants', 'Bupropion', 'Sigma', 'Tab', 'أقراص', '150mg', '1', 'يستخدم كعلاج--الاكتئاب --الاقلاع عن التدخين.', NULL, NULL, NULL, 2388, '2023-03-03', 0, 'Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. 



When used in combination with [naltrexone] as the marketed product ContraveⓇ, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).



Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.[F4624]', 'Bupropion is a norepinephrine/dopamine-reuptake inhibitor (NDRI) that exerts its pharmacological effects by weakly inhibiting the enzymes involved in the uptake of the neurotransmitters norepinephrine and dopamine from the synaptic cleft, therefore prolonging their duration of action within the neuronal synapse and the downstream effects of these neurotransmitters. More specifically, bupropion binds to the norepinephrine transporter (NET) and the dopamine transporter (DAT).[A6399,A178810] 



Bupropion was originally classified as an "atypical" antidepressant because it does not exert the same effects as the classical antidepressants such as Monoamine Oxidase Inhibitors (MAOIs), Tricyclic Antidepressants (TCAs), or Selective Serotonin Reuptake Inhibitors (SSRIs). While it has comparable effectiveness to typical first-line options for the treatment of depression such as SSRIs,[A178798,A178804] bupropion is a unique option for the treatment of MDD as it lacks any clinically relevant serotonergic effects, typical of other mood medications, or any effects on histamine or adrenaline receptors.[A6399,A178840] Lack of activity at these receptors results in a more tolerable side effect profile; bupropion is less likely to cause sexual side effects, sedation, or weight gain as compared to SSRIs or TCAs, for example.[A178804,A178807]



When used as an aid to smoking cessation, bupropion is thought to confer its anti-craving and anti-withdrawal effects by inhibiting dopamine reuptake, which is thought to be involved in the reward pathways associated with nicotine, and through the antagonism of the nicotinic acetylcholinergic receptor (AChR), thereby blunting the effects of nicotine.[A178825,A1966,A16508] Furthermore, the stimulatory effects produced by bupropion in the central nervous system are similar to nicotine''s effects, making low doses of bupropion a suitable option as a nicotine substitute.[A179062]  



When used in combination with [naltrexone] in the marketed product ContraveⓇ for chronic weight management, the two components are thought to have effects on areas of the brain involved in the regulation of food intake. This includes the hypothalamus, which is involved in appetite regulation, and the mesolimbic dopamine circuit, which is involved in reward pathways.[L6562] Studies have shown that the combined activity of bupropion and [naltrexone] increase the firing rate of hypothalamic pro-opiomelanocortin (POMC) neurons and blockade of opioid receptor-mediated POMC auto-inhibition, which are associated with a reduction in food intake and increased energy expenditure.[L6562,A179038,A179050] This combination was also found to reduce food intake when injected directly into the ventral tegmental area of the mesolimbic circuit in mice, which is an area associated with the regulation of reward pathways.[L6562]', 'Bupropion is chemically unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitors, or other known antidepressant agents. Compared to classical tricyclic antidepressants, Bupropion is a relatively weak inhibitor of the neuronal uptake of norepinephrine and dopamine. In addition, Bupropion does not inhibit monoamine oxidase. Bupropion has been found to be essentially inactive at the serotonin transporter (SERT)(IC50 >10 000 nM),[A178810] however both bupropion and its primary metabolite hydroxybupropion have been found to block the function of cation-selective serotonin type 3A receptors (5-HT3ARs). 



Bupropion produces dose-related central nervous system (CNS) stimulant effects in animals, as evidenced by increased locomotor activity, increased rates of responding in various schedule-controlled operant behaviour tasks, and, at high doses, induction of mild stereotyped behaviour [FDA Label]. Due to these stimulant effects and selective activity at dopamine and norepinephrine receptors, bupropion has been identified as having an abuse potential.[FDA Label,A178846] Bupropion has a similar structure to the controlled substance [DB01560], and has been identified as having mild amphetamine-like activity, particularly when inhaled or injected.[A178846]



Bupropion is also known to lower the seizure threshold, making any pre-existing seizure conditions a contraindication to its use. This risk is exacerbated when bupropion is combined with other drugs or substances that lower the seizure threshold, such as [cocaine], or in clinical situations that would increase the risk of a seizure such as abrupt alcohol or benzodiazepine withdrawal.[FDA Label] As norepinephrine has been shown to have anticonvulsant properties, bupropion''s inhibitory effects on NET are thought to contribute to its pro-convulsant activity.[A178846]



Bupropion has been shown to increase blood pressure and pose a risk for exacerbation of unmanaged or pre-existing hypertension,[A178852,FDA Label] however, clinical trials of bupropion in smokers with CVD have not identified an increased incidence of CV events including stroke or heart attack.[A178855] In clinical trials, the mean increase in systolic blood pressure associated with the use of bupropion was found to be 1.3 mmHg.[FDA Label]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19460, 'Fumiron plus 30 caps.', 'فيوميرون بلس 30 كبسولة', '3', NULL, 'Anemia.iron supplement combined with folic acid', 'Ferrous fumarate+folic acid+vitamin c', 'Alexandria', 'Cap', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 963, '2022-07-24', 0, 'Ferrous sulfate is used for the prevention and treatment of iron deficiency anemia in adults and children.[A190804,L2240,L11800]

', 'Iron is required to maintain optimal health, particularly for helping to form red blood cells (RBC) that carry oxygen around the body. A deficiency in iron indicates that the body cannot produce enough normal red blood cells.[A32514,L11800] Iron deficiency anemia occurs when body stores of iron decrease to very low levels, and the stored iron is insufficient to support normal red blood cell (RBC) production. Insufficient dietary iron, impaired iron absorption, bleeding, pregnancy, or loss of iron through the urine can lead to iron deficiency.[A32514,L11794]  Symptoms of iron deficiency anemia include fatigue, breathlessness, palpitations, dizziness, and headache.



Taking iron in supplement form, such as ferrous sulfate, allows for more rapid increases in iron levels when dietary supply and stores are not sufficient.[L2175] Iron is transported by the divalent metal transporter 1 (DMT1) across the endolysosomal membrane to enter the macrophage. It can then can be incorporated into ferritin and be stored in the macrophage or carried of the macrophage by ferroportin. This exported iron is  oxidized by the enzyme to ceruloplasmin to Fe3+, followed by sequestration by transferrin for transport in the serum to various sites, including the bone marrow for hemoglobin synthesis or into the liver.[A32524] Iron combines with porphyrin and globin chains to form hemoglobin, which is critical for oxygen delivery from the lungs to other tissues.[L2263]', 'Ferrous sulfate replenishes iron, an essential component in hemoglobin, myoglobin, and various enzymes. It replaces the iron that is usually found in hemoglobin and myoglobin. Iron participates in oxygen transport and storage, electron transport and energy metabolism, antioxidant and beneficial pro-oxidant functions, oxygen sensing, tissue proliferation and growth, as well as DNA replication and repair.[A32524,A32514]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19461, 'Fun baby cream 30 gm', 'فان بيبي كريم 30 جم', '19', NULL, 'Moisturizing cream', 'Olive oil+lanlin+zinc oxide+aloe vera+panthenol+chamomile+glycerin', 'Egyption co for cosmetics > pharaohs', 'Cream', 'كريم', '30 gm', '1', NULL, NULL, NULL, NULL, 681, '2022-07-13', 0, 'In a clinical context, olive oil is used as a source of calories and fatty acids in patients requiring parenteral nutrition. A formulation called Clinolipid, comprising olive oil and [soybean oil], is indicated in all age groups, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.[L51013]', 'Fatty acids act as a substrate in energy production through beta-oxidation as well as important components of cell membrane structures and prescursors for bioactive molecules like prostaglandins.', 'Provides a source of calories and fatty acids.[L51013]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19462, 'Fungestic 1% topical cream 15 gm', 'فانجستك 1% كريم 15 جم', '14', NULL, 'Antifungals.allylamines', 'Butenafine hydrochloride', 'Egpi > rector pharma', 'Cream', 'كريم', '1%', '1', NULL, 'uses: this medication is used to treat a variety of fungal skin infections such as ringworm athlete s foot and jock itch. this medication is also used to treat a skin condition known as pityriasis (tinea versicolor) a fungal infection that causes a lighte', NULL, NULL, 827, '2022-07-17', 0, 'For the topical treatment of the following dermatologic infections: tinea (pityriasis) versicolor due to <i>M. furfur</i>, interdigital tinea pedis (athlete&rsquo;s foot), tinea corporis (ringworm) and tinea cruris (jock itch) due to <i>E. floccosum</i>, <i>T. mentagrophytes</i>, <i>T. rubrum</i>, and <i>T. tonsurans</i>.', 'Although the  mechanism of action has not been fully established, it has been suggested that butenafine, like allylamines, interferes with sterol biosynthesis (especially ergosterol) by inhibiting squalene monooxygenase, an enzyme responsible for converting squalene to 2,3-oxydo squalene. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Blockage of squalene monooxygenase also leads to a subsequent accumulation of squalene. When a high concentration of squalene is reached, it is thought to have an effect of directly kill fungal cells.', 'Butenafine is a synthetic antifungal agent that is structurally and pharmacologically related to allylamine antifungals. The exact mechanism of action has not been established, but it is suggested that butenafine''s antifungal activity is exerted through the alteration of cellular membranes, which results in increased membrane permeability, and growth inhibition. Butenafine is mainly active against dermatophytes and has superior fungicidal activity against this group of fungi when compared to that of terbinafine, naftifine, tolnaftate, clotrimazole, and bifonazole. It is also active against <i>Candida albicans</i> and this activity is superior to that of terbinafine and naftifine. Butenafine also generates low MICs for <i>Cryptococcus neoformans</i> and <i>Aspergillus spp.</i> as well.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19463, 'Fungibacid 28% nail soln. 5 ml', 'فانجيباسيد 28% محلول للاظافر مضاد للفطريات', '59', '40', 'Antifungals.imidazoles', 'Tioconazole', 'Debeiky > mash premiere', 'Sol', 'محلول', '28%', '1', 'مضاد للفطريات', 'indication for the local treatment of vulvovaginal candidiasis (moniliasis). mechanism of action tioconazole interacts with 14-a demethylase a cytochrome p-450 enzyme that converts lanosterol to ergosterol an essential component of the yeast membrane. in', '6222001401363', NULL, 2863, '2024-12-28', 0, 'For the local treatment of vulvovaginal candidiasis (moniliasis).', 'Tioconazole interacts with 14-&alpha; demethylase, a cytochrome P-450 enzyme that converts lanosterol to ergosterol, an essential component of the yeast membrane. In this way, tioconazole inhibits ergosterol synthesis, resulting in increased cellular permeability. Tioconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms and the uptake of purine, impair triglyceride and/or phospholipid biosynthesis, and inhibit the movement of calcium and potassium ions across the cell membrane by blocking the ion transport pathway known as the Gardos channel.', 'Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against <i>Candida albicans</i>, other species of the genus Candida, and against <i>Torulopsis glabrata</i>. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. In addition to its broad spectrum antifungal effects with tioconazole being effective against commonly occurring dermatophyte and yeast-like fungal species, tioconazole also has antibacterial effects on certain Gram-positive cocci bacteria.[L50166]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19466, 'Fungicare soap 80 gm', 'فانجيكير صابون 80 جرام', '50', '40', 'Soap', 'Resorcinol+salicylic acid+benzoic acid+cetrimide', 'Hi-care > pixel pharmaceutical company', 'Soap', 'صابون', '80 gm', '1', NULL, 'anti-fungal cleansing bar', '6224001661174', NULL, 2500, '2024-01-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19467, 'Fungicil 0.5% oint. 30 gm', 'فنجيسيل 0.5% مرهم 30 جم', '3', NULL, NULL, 'Chlorphenesin', 'Cid', 'Oint', 'مرهم', '0.5%', '1', NULL, 'primarily used as a pharmaceutical muscle relaxant which works by blocking nerve impulses that are sent to the brain. in cosmetics it is used as a preservative because of its anti-fungal and anti-bacterial properties. as a preservative it prevents various', NULL, NULL, 828, '2022-07-14', 0, 'Used, along with rest and physical therapy, to treat injuries and other painful muscular conditions. Investigated for use in trigeminal neuralgia (tic douloureux), a neuropathic disorder characterized by severe facial pain. Was investigated as a modulator of histamine release.', 'The mechanism of action of chlorphenesin is not well defined, and its effects are measured mainly by subjective responses. It is known that chlorphenesin acts in the central nervous system (CNS) rather than directly on skeletal muscle.', 'Chlorphenesin is a muscle relaxant. It blocks nerve impulses (or pain sensations) that are sent to the brain. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19468, 'Fungifree 100000 i.u./ml oral drops 30 ml', 'فانجيفري 100000 وحدة دولية/مل نقط 30 مل', '6', NULL, 'Antifungal.polyene', 'Nystatin', 'European egyptian pharm. ind.', 'Drops', 'نقط', '30 ml', '1', NULL, 'about nystatin polyene antifungal. mechanism of action of nystatin nystatin is a fungicidal as well as a fungistatic drug. it has high affinity for ergosterol present in the fungal cell membrane and bind with it and they orients in such a way that micropo', NULL, NULL, 833, '2022-07-27', 0, 'Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis.[L10686,L10728] It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections.[L10728] A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.®) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae.[L10731] It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.[L10776]



Nystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates,[A188565] though it is generally reserved as a second-line option after [fluconazole].', 'Nystatin is a channel-forming ionophore, meaning it exerts its therapeutic effect via formation of a membrane-spanning pore in the fungal plasma membrane.[A188592] The formation of this pore results in a change in membrane permeability that allows for leakage of intracellular contents and the subsequent disruption of electrochemical gradients necessary for proper cell function.[L10686,A188562] Selectivity for fungal cells over mammalian cells is due to nystatin’s greater binding affinity for ergosterol, a key sterol found in fungal cell walls, as opposed to its mammalian counterpart, cholesterol.[A16808]', 'Nystatin is an antifungal that is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It exerts its antifungal effects via disruption of the fungal cell membrane. Resistance to nystatin is minimal in _Candida albicans_, but tends to develop in other species of _Candida_.[L10686] Nystatin carries no significant activity against bacteria, protozoa, or viruses. It carries significant systemic toxicity and is currently unavailable in a formula appropriate for systemic use - its efficacy is currently restricted, therefore, to topical, oral, and gastrointestinal infections.[A188562]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19469, 'Fungilimit 200 mg 10 f.c.tabs.', 'فانجيليميت 200مجم 10 اقراص', '932', '651', 'Antifungals.triazoles', 'Voriconazole', 'Mash premiere', 'Tab', 'أقراص', '200 mg', '1', 'مضاد فطريات', NULL, '6224009799442', NULL, 12921, '2025-04-02', 0, 'For the treatment of esophageal candidiasis, cadidemia, invasive pulmonary aspergillosis, and serious fungal infections caused by <i>Scedosporium apiospermum</i> and <i>Fusarium</i> spp.[L9821, L15571] ', 'Voriconazole is used to treat fungal infections caused by a variety of organisms but including _Aspergillus spp._ and _Candida spp_. Voriconazole is a triazole antifungal exhibiting fungistatic activity against fungal pathogens.[A236050, A236045, L9821] Like other triazoles, voriconazole binds to 14-alpha sterol demethylase, also known as CYP51, and inhibits the demethylation of lanosterol as part of the ergosterol synthesis pathway in yeast and other fungi. The lack of sufficient ergosterol disrupts fungal cell membrane function and limits fungal cell growth. With fungal growth limited, the host''s immune system is able to clear the invading organism.', 'Voriconazole is a fungistatic triazole antifungal used to treat infections by inhibiting fungal growth.[L9821] It is known to cause hepatotoxic and photosensitivity reactions in some patients.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19471, 'Skeleto joint 30 tab', 'سكيليتو جوينت 30 قرص', '276', '237', 'Orthoarthritis', 'Glucosamine+methylsulfonylmethane+chodrotin+vitamin d3+bromelain+boswellia serrata extract', 'Proxy-care+organika', 'Tab', 'أقراص', NULL, '3', 'مكمل غذائي يحتوي على مجموعة من العناصر والفيتامينات التي تحافظ على صحة العظام والمفاصل', NULL, '6225000559332', NULL, 2485, '2025-06-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19474, 'Fungistatin 100 000i.u./ml 30ml susp.', 'فنجيستاتين 100000 وحدة دولية/مل 30 مل معلق', '9', NULL, 'Antifungal.polyene', 'Nystatin', 'Delta pharma', 'Susp', 'معلق', '30ml', '1', NULL, 'about nystatin polyene antifungal. mechanism of action of nystatin nystatin is a fungicidal as well as a fungistatic drug. it has high affinity for ergosterol present in the fungal cell membrane and bind with it and they orients in such a way that micropo', '6221163004009', NULL, 972, '2022-06-17', 0, 'Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis.[L10686,L10728] It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections.[L10728] A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.®) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae.[L10731] It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.[L10776]



Nystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates,[A188565] though it is generally reserved as a second-line option after [fluconazole].', 'Nystatin is a channel-forming ionophore, meaning it exerts its therapeutic effect via formation of a membrane-spanning pore in the fungal plasma membrane.[A188592] The formation of this pore results in a change in membrane permeability that allows for leakage of intracellular contents and the subsequent disruption of electrochemical gradients necessary for proper cell function.[L10686,A188562] Selectivity for fungal cells over mammalian cells is due to nystatin’s greater binding affinity for ergosterol, a key sterol found in fungal cell walls, as opposed to its mammalian counterpart, cholesterol.[A16808]', 'Nystatin is an antifungal that is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It exerts its antifungal effects via disruption of the fungal cell membrane. Resistance to nystatin is minimal in _Candida albicans_, but tends to develop in other species of _Candida_.[L10686] Nystatin carries no significant activity against bacteria, protozoa, or viruses. It carries significant systemic toxicity and is currently unavailable in a formula appropriate for systemic use - its efficacy is currently restricted, therefore, to topical, oral, and gastrointestinal infections.[A188562]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19475, 'Fungitranazole 100 mg 10 caps.', 'فانجيترانازول 100مجم 10 كبسولات', '32', NULL, 'Antifungals.triazoles', 'Itraconazole', 'Debeiky', 'Cap', 'كبسولة', '100 mg', '1', NULL, 'about itraconazole a synthetic triazole derivative systemic antifungal. mechanism of action of itraconazole itraconazole is a fungicidal or fungistatic depending on the drug concentrations. it inhibits the conversion of lanosterol to 14 demethyl lanostero', NULL, NULL, 1132, '2022-06-18', 0, 'Itraconazole is indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients:[L50051, L50056]



- Blastomycosis, pulmonary and extrapulmonary

- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, nonmeningeal histoplasmosis, and

- Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy



It is also indicated for the treatment of the following fungal infections in non-immunocompromised patients:[L50051]



- Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)

- Onychomycosis of the fingernail due to dermatophytes (tinea unguium).



Itraconazole oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis.[L50061]', 'Itraconazole mediates its antifungal activity by inhibiting 14α-demethylase, a fungal cytochrome P450 enzyme that converts lanosterol to ergosterol, a vital component of fungal cell membranes.[L50051] The azole nitrogen atoms in the chemical structure of itraconazole form a complex with the active site, or the haem iron, of the fungal enzyme to impede its function.[A34257, A263232] The accumulation of lanosterol and 14-methylated sterols results in increased permeability of the fungal cell membrane, and modified membrane-bound enzyme activity, and dysregulated chitin synthesis.[A34257, A263222, A263227] Other proposed mechanisms of action of itraconazole include the inhibition of fungal cytochrome c oxidative and peroxidative enzymes that also lead to the disruption of fungal cell membranes.[A34257]', 'Itraconazole is an antifungal agent that inhibits cell growth and promotes cell death of fungi.[A34257] It exhibits in vitro activity against _Blastomyces dermatitidis_, _Histoplasma capsulatum_, _Histoplasma duboisii_, _Aspergillus flavus_, _Aspergillus fumigatus_, and _Trichophyton_ species.[L50051]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19476, 'Fungitranazole 100 mg 4 caps.', 'فانجيترانازول 100 مجم 4 كبسولات', '16', NULL, 'Antifungals.triazoles', 'Itraconazole', 'Debeiky', 'Cap', 'كبسولة', '100 mg', '1', NULL, 'about itraconazole a synthetic triazole derivative systemic antifungal. mechanism of action of itraconazole itraconazole is a fungicidal or fungistatic depending on the drug concentrations. it inhibits the conversion of lanosterol to 14 demethyl lanostero', NULL, NULL, 853, '2022-07-12', 0, 'Itraconazole is indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients:[L50051, L50056]



- Blastomycosis, pulmonary and extrapulmonary

- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, nonmeningeal histoplasmosis, and

- Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy



It is also indicated for the treatment of the following fungal infections in non-immunocompromised patients:[L50051]



- Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)

- Onychomycosis of the fingernail due to dermatophytes (tinea unguium).



Itraconazole oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis.[L50061]', 'Itraconazole mediates its antifungal activity by inhibiting 14α-demethylase, a fungal cytochrome P450 enzyme that converts lanosterol to ergosterol, a vital component of fungal cell membranes.[L50051] The azole nitrogen atoms in the chemical structure of itraconazole form a complex with the active site, or the haem iron, of the fungal enzyme to impede its function.[A34257, A263232] The accumulation of lanosterol and 14-methylated sterols results in increased permeability of the fungal cell membrane, and modified membrane-bound enzyme activity, and dysregulated chitin synthesis.[A34257, A263222, A263227] Other proposed mechanisms of action of itraconazole include the inhibition of fungal cytochrome c oxidative and peroxidative enzymes that also lead to the disruption of fungal cell membranes.[A34257]', 'Itraconazole is an antifungal agent that inhibits cell growth and promotes cell death of fungi.[A34257] It exhibits in vitro activity against _Blastomyces dermatitidis_, _Histoplasma capsulatum_, _Histoplasma duboisii_, _Aspergillus flavus_, _Aspergillus fumigatus_, and _Trichophyton_ species.[L50051]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19480, 'Piatra 30 ml syrup', 'بياترا شراب 30 مل', '60', NULL, 'Hematinic', 'Iron(ferrous bisglycinate) + vitamin c + folic acid + vitamin b12', 'Guten tag pharma', 'Syrup', 'شراب', '30 ml', '1', NULL, NULL, NULL, NULL, 938, '2023-01-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19482, 'Halolan30 gm cream', 'هالولان كريم 30 جم', '40', NULL, 'Topical cream', 'Panthenol + lanolin + vitamin e + honey + aloe vera + olive oil', 'Helwan pharmaceuticals', 'Cream', 'كريم', '30 gm', '1', NULL, NULL, NULL, NULL, 915, '2022-10-15', 0, 'Panthenol (containing a racemic mixture of dexpanthenol and levopanthenol) is not currently available in any FDA-approved products and therefore does not have an indication.



Please see [DB09357] for FDA-approved uses of the dextrorotatory form of Panthenol. ', 'Panthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol, the active form of panthenol, is enzymatically cleaved to form pantothenic acid (Vitamin B5), which is an essential component of Coenzyme A that acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium [A32373].



Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].', 'Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19483, 'Furfact 320 mg 7 f.c. tab.', 'فورفاكت 320مجم 7 اقراص', '80', NULL, 'Antibiotic.quinolone', 'Gemifloxacin', 'Future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company', 'Tab', 'أقراص', '320 mg', '1', NULL, 'about gemifloxacin fourth-generation fluoroquinolone(respiratory) antibacterial oral broad-spectrum fluoroquinolone antibiotic. mechanism of action of gemifloxacin gemifloxacin act by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.', NULL, NULL, 1084, '2022-07-16', 0, 'For the treatment of bacterial infection caused by susceptible strains such as <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>H. parainfluenzae</i>, or <i>M. catarrhalis</i>, <i>S. pneumoniae</i> (including multi-drug resistant strains [MDRSP]), <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, or <i>K. pneumoniae</i>.', 'The bactericidal action of gemifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Gemifloxacin is a quinolone/fluoroquinolone antibiotic. Gemifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gemifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19484, 'Furfuril 200mg 12 cap.', 'فورفوريل 200مجم 12 كبسولة', '5', NULL, 'Antidiarrheal', 'Nifuroxazide', 'Organopharma', 'Cap', 'كبسولة', '200mg', '2', NULL, 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', NULL, NULL, 1038, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19485, 'Furfuril 220mg/5ml oral 60ml susp.', 'فورفوريل 220 مجم / 5 مل 60 مل معلق', '6', NULL, 'Antidiarrheal', 'Nifuroxazide', 'El-obour > organopharma', 'Susp', 'معلق', '220mg', '1', NULL, 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', NULL, NULL, 822, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19486, 'Furfuril 220mg/5ml oral susp. 90 ml', 'فورفوريل 220 مجم / 5 مل 90 مل معلق', '9', NULL, 'Antidiarrheal', 'Nifuroxazide', 'El-obour > organopharma', 'Susp', 'معلق', '220mg', '1', NULL, 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', NULL, NULL, 916, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19487, 'Furixdar 500 mg 10 tabs.', 'فيوريكسدار 500 مجم 10 اقراص', '10', NULL, 'Diuretic.loop', 'Furosemide', 'Rameda > pharmadar', 'Tab', 'أقراص', '500 mg', '1', NULL, 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', NULL, NULL, 970, '2022-07-18', 0, 'Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] 



Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659]



Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958]



Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408]', 'Furosemide promotes diuresis by blocking tubular reabsorption of sodium and chloride in the proximal and distal tubules, as well as in the thick ascending loop of Henle. This diuretic effect is achieved through the competitive inhibition of sodium-potassium-chloride cotransporters (NKCC2) expressed along these tubules in the nephron, preventing the transport of sodium ions from the lumenal side into the basolateral side for reabsorption. This inhibition results in increased excretion of water along with sodium, chloride, magnesium, calcium, hydrogen, and potassium ions.[L7961] As with other loop diuretics, furosemide decreases the excretion of uric acid.[T28] 



Furosemide exerts direct vasodilatory effects, which results in its therapeutic effectiveness in the treatment of acute pulmonary edema. Vasodilation leads to reduced responsiveness to vasoconstrictors, such as angiotensin II and noradrenaline, and decreased production of endogenous natriuretic hormones with vasoconstricting properties. It also leads to increased production of prostaglandins with vasodilating properties. Furosemide may also open potassium channels in resistance arteries.[T28] The main mechanism of action of furosemide is independent of its inhibitory effect on carbonic anhydrase and aldosterone.[L7958] ', 'Furosemide manages hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide is a potent loop diuretic that works to increase the excretion of Na+ and water by the kidneys by inhibiting their reabsorption from the proximal and distal tubules, as well as the loop of Henle.[L7958] It works directly acts on the cells of the nephron and indirectly modifies the content of the renal filtrate.[T28] Ultimately, furosemide increases the urine output by the kidney. Protein-bound furosemide is delivered to its site of action in the kidneys and secreted via active secretion by nonspecific organic transporters expressed at the luminal site of action.[A31831,L7958] 



Following oral administration, the onset of the diuretic effect is about 1 and 1.5 hours [L7958], and the peak effect is reached within the first 2 hours.[L7961] The duration of effect following oral administration is about 4-6 hours but may last up to 8 hours.[L9659] Following intravenous administration, the onset of effect is within 5 minutes, and the peak effect is reached within 30 minutes. The duration of action following intravenous administration is approximately 2 hours. Following intramuscular administration, the onset of action is somewhat delayed.[L7958]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19488, 'Furoretic 20 mg 30 tabs.', 'فيورورتيك 20مجم 30 قرص', '13', NULL, 'Diuretic.loop', 'Furosemide', 'Debeiky > vetopharm', 'Tab', 'أقراص', '20 mg', '3', NULL, 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', NULL, NULL, 805, '2022-08-02', 0, 'Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] 



Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659]



Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958]



Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408]', 'Furosemide promotes diuresis by blocking tubular reabsorption of sodium and chloride in the proximal and distal tubules, as well as in the thick ascending loop of Henle. This diuretic effect is achieved through the competitive inhibition of sodium-potassium-chloride cotransporters (NKCC2) expressed along these tubules in the nephron, preventing the transport of sodium ions from the lumenal side into the basolateral side for reabsorption. This inhibition results in increased excretion of water along with sodium, chloride, magnesium, calcium, hydrogen, and potassium ions.[L7961] As with other loop diuretics, furosemide decreases the excretion of uric acid.[T28] 



Furosemide exerts direct vasodilatory effects, which results in its therapeutic effectiveness in the treatment of acute pulmonary edema. Vasodilation leads to reduced responsiveness to vasoconstrictors, such as angiotensin II and noradrenaline, and decreased production of endogenous natriuretic hormones with vasoconstricting properties. It also leads to increased production of prostaglandins with vasodilating properties. Furosemide may also open potassium channels in resistance arteries.[T28] The main mechanism of action of furosemide is independent of its inhibitory effect on carbonic anhydrase and aldosterone.[L7958] ', 'Furosemide manages hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide is a potent loop diuretic that works to increase the excretion of Na+ and water by the kidneys by inhibiting their reabsorption from the proximal and distal tubules, as well as the loop of Henle.[L7958] It works directly acts on the cells of the nephron and indirectly modifies the content of the renal filtrate.[T28] Ultimately, furosemide increases the urine output by the kidney. Protein-bound furosemide is delivered to its site of action in the kidneys and secreted via active secretion by nonspecific organic transporters expressed at the luminal site of action.[A31831,L7958] 



Following oral administration, the onset of the diuretic effect is about 1 and 1.5 hours [L7958], and the peak effect is reached within the first 2 hours.[L7961] The duration of effect following oral administration is about 4-6 hours but may last up to 8 hours.[L9659] Following intravenous administration, the onset of effect is within 5 minutes, and the peak effect is reached within 30 minutes. The duration of action following intravenous administration is approximately 2 hours. Following intramuscular administration, the onset of action is somewhat delayed.[L7958]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19489, 'Furoretic 40 mg 30 tabs.', 'فيورورتيك 40 مجم 30 قرص', '14', NULL, 'Diuretic.loop', 'Furosemide', 'Debeiky > vetopharm', 'Tab', 'أقراص', '40 mg', '3', 'مدر قوي للبول يستخدم في حالات التورم والاستقساء المصاحبين لحالات القصور الكلوي الحاد والمزمن', 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', NULL, NULL, 859, '2022-07-21', 0, 'Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] 



Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659]



Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958]



Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408]', 'Furosemide promotes diuresis by blocking tubular reabsorption of sodium and chloride in the proximal and distal tubules, as well as in the thick ascending loop of Henle. This diuretic effect is achieved through the competitive inhibition of sodium-potassium-chloride cotransporters (NKCC2) expressed along these tubules in the nephron, preventing the transport of sodium ions from the lumenal side into the basolateral side for reabsorption. This inhibition results in increased excretion of water along with sodium, chloride, magnesium, calcium, hydrogen, and potassium ions.[L7961] As with other loop diuretics, furosemide decreases the excretion of uric acid.[T28] 



Furosemide exerts direct vasodilatory effects, which results in its therapeutic effectiveness in the treatment of acute pulmonary edema. Vasodilation leads to reduced responsiveness to vasoconstrictors, such as angiotensin II and noradrenaline, and decreased production of endogenous natriuretic hormones with vasoconstricting properties. It also leads to increased production of prostaglandins with vasodilating properties. Furosemide may also open potassium channels in resistance arteries.[T28] The main mechanism of action of furosemide is independent of its inhibitory effect on carbonic anhydrase and aldosterone.[L7958] ', 'Furosemide manages hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide is a potent loop diuretic that works to increase the excretion of Na+ and water by the kidneys by inhibiting their reabsorption from the proximal and distal tubules, as well as the loop of Henle.[L7958] It works directly acts on the cells of the nephron and indirectly modifies the content of the renal filtrate.[T28] Ultimately, furosemide increases the urine output by the kidney. Protein-bound furosemide is delivered to its site of action in the kidneys and secreted via active secretion by nonspecific organic transporters expressed at the luminal site of action.[A31831,L7958] 



Following oral administration, the onset of the diuretic effect is about 1 and 1.5 hours [L7958], and the peak effect is reached within the first 2 hours.[L7961] The duration of effect following oral administration is about 4-6 hours but may last up to 8 hours.[L9659] Following intravenous administration, the onset of effect is within 5 minutes, and the peak effect is reached within 30 minutes. The duration of action following intravenous administration is approximately 2 hours. Following intramuscular administration, the onset of action is somewhat delayed.[L7958]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19490, 'Furoretic 500 mg 20 tabs.', 'فيورورتيك 500مجم 20 قرص', '93', NULL, 'Diuretic.loop', 'Furosemide', 'Debeiky > vetopharm-egypt', 'Tab', 'أقراص', '500 mg', '2', 'مدر للبول.', 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', '6223006170285', NULL, 2843, '2022-05-14', 0, 'Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] 



Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659]



Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958]



Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408]', 'Furosemide promotes diuresis by blocking tubular reabsorption of sodium and chloride in the proximal and distal tubules, as well as in the thick ascending loop of Henle. This diuretic effect is achieved through the competitive inhibition of sodium-potassium-chloride cotransporters (NKCC2) expressed along these tubules in the nephron, preventing the transport of sodium ions from the lumenal side into the basolateral side for reabsorption. This inhibition results in increased excretion of water along with sodium, chloride, magnesium, calcium, hydrogen, and potassium ions.[L7961] As with other loop diuretics, furosemide decreases the excretion of uric acid.[T28] 



Furosemide exerts direct vasodilatory effects, which results in its therapeutic effectiveness in the treatment of acute pulmonary edema. Vasodilation leads to reduced responsiveness to vasoconstrictors, such as angiotensin II and noradrenaline, and decreased production of endogenous natriuretic hormones with vasoconstricting properties. It also leads to increased production of prostaglandins with vasodilating properties. Furosemide may also open potassium channels in resistance arteries.[T28] The main mechanism of action of furosemide is independent of its inhibitory effect on carbonic anhydrase and aldosterone.[L7958] ', 'Furosemide manages hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide is a potent loop diuretic that works to increase the excretion of Na+ and water by the kidneys by inhibiting their reabsorption from the proximal and distal tubules, as well as the loop of Henle.[L7958] It works directly acts on the cells of the nephron and indirectly modifies the content of the renal filtrate.[T28] Ultimately, furosemide increases the urine output by the kidney. Protein-bound furosemide is delivered to its site of action in the kidneys and secreted via active secretion by nonspecific organic transporters expressed at the luminal site of action.[A31831,L7958] 



Following oral administration, the onset of the diuretic effect is about 1 and 1.5 hours [L7958], and the peak effect is reached within the first 2 hours.[L7961] The duration of effect following oral administration is about 4-6 hours but may last up to 8 hours.[L9659] Following intravenous administration, the onset of effect is within 5 minutes, and the peak effect is reached within 30 minutes. The duration of action following intravenous administration is approximately 2 hours. Following intramuscular administration, the onset of action is somewhat delayed.[L7958]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19491, 'Scarno-sq 50gm gel', 'سكارنو اس كيو جل 50 جم', '335', '235', 'Gel for improve scars appearance & texture', 'Silicone gel+other active ingredients', 'S and q pharma', 'Gel', 'جل', '50gm', '1', NULL, NULL, NULL, NULL, 676, '2025-11-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19492, 'Furosemide 40mg/4ml 3 amp.', 'فيوروسيميد 40مجم/4مل 3 امبولات', '7', NULL, 'Diuretic.loop', 'Furosemide', 'Sedico', 'Amp', 'أمبول', '40mg', '3', NULL, 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', NULL, NULL, 1107, '2023-02-06', 0, 'Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] 



Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659]



Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958]



Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408]', 'Furosemide promotes diuresis by blocking tubular reabsorption of sodium and chloride in the proximal and distal tubules, as well as in the thick ascending loop of Henle. This diuretic effect is achieved through the competitive inhibition of sodium-potassium-chloride cotransporters (NKCC2) expressed along these tubules in the nephron, preventing the transport of sodium ions from the lumenal side into the basolateral side for reabsorption. This inhibition results in increased excretion of water along with sodium, chloride, magnesium, calcium, hydrogen, and potassium ions.[L7961] As with other loop diuretics, furosemide decreases the excretion of uric acid.[T28] 



Furosemide exerts direct vasodilatory effects, which results in its therapeutic effectiveness in the treatment of acute pulmonary edema. Vasodilation leads to reduced responsiveness to vasoconstrictors, such as angiotensin II and noradrenaline, and decreased production of endogenous natriuretic hormones with vasoconstricting properties. It also leads to increased production of prostaglandins with vasodilating properties. Furosemide may also open potassium channels in resistance arteries.[T28] The main mechanism of action of furosemide is independent of its inhibitory effect on carbonic anhydrase and aldosterone.[L7958] ', 'Furosemide manages hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide is a potent loop diuretic that works to increase the excretion of Na+ and water by the kidneys by inhibiting their reabsorption from the proximal and distal tubules, as well as the loop of Henle.[L7958] It works directly acts on the cells of the nephron and indirectly modifies the content of the renal filtrate.[T28] Ultimately, furosemide increases the urine output by the kidney. Protein-bound furosemide is delivered to its site of action in the kidneys and secreted via active secretion by nonspecific organic transporters expressed at the luminal site of action.[A31831,L7958] 



Following oral administration, the onset of the diuretic effect is about 1 and 1.5 hours [L7958], and the peak effect is reached within the first 2 hours.[L7961] The duration of effect following oral administration is about 4-6 hours but may last up to 8 hours.[L9659] Following intravenous administration, the onset of effect is within 5 minutes, and the peak effect is reached within 30 minutes. The duration of action following intravenous administration is approximately 2 hours. Following intramuscular administration, the onset of action is somewhat delayed.[L7958]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19493, 'Uni fresh 50 ml oral spray', 'يوني فريش سبراي للفم 50 مل', '55', NULL, 'Oral spray', 'Chlorhexedine+clove oil+thyme ext+ginger ext+chamomile ext+marshmallow ext+licorice ext+echinacea ext+vitamin e', 'Vidal pharma', 'Spray', 'بخاخ', '50 ml', '1', NULL, NULL, NULL, NULL, 770, '2023-02-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19494, 'Furosemide-alex 40mg 20 tab.', 'فيوروسيميد 40مجم 20 قرص', '10', NULL, 'Diuretic.loop', 'Furosemide', 'Alexandria', 'Tab', 'أقراص', '40mg', '2', NULL, 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', '6221042053609', NULL, 843, '2023-02-06', 0, 'Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] 



Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659]



Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958]



Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408]', 'Furosemide promotes diuresis by blocking tubular reabsorption of sodium and chloride in the proximal and distal tubules, as well as in the thick ascending loop of Henle. This diuretic effect is achieved through the competitive inhibition of sodium-potassium-chloride cotransporters (NKCC2) expressed along these tubules in the nephron, preventing the transport of sodium ions from the lumenal side into the basolateral side for reabsorption. This inhibition results in increased excretion of water along with sodium, chloride, magnesium, calcium, hydrogen, and potassium ions.[L7961] As with other loop diuretics, furosemide decreases the excretion of uric acid.[T28] 



Furosemide exerts direct vasodilatory effects, which results in its therapeutic effectiveness in the treatment of acute pulmonary edema. Vasodilation leads to reduced responsiveness to vasoconstrictors, such as angiotensin II and noradrenaline, and decreased production of endogenous natriuretic hormones with vasoconstricting properties. It also leads to increased production of prostaglandins with vasodilating properties. Furosemide may also open potassium channels in resistance arteries.[T28] The main mechanism of action of furosemide is independent of its inhibitory effect on carbonic anhydrase and aldosterone.[L7958] ', 'Furosemide manages hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide is a potent loop diuretic that works to increase the excretion of Na+ and water by the kidneys by inhibiting their reabsorption from the proximal and distal tubules, as well as the loop of Henle.[L7958] It works directly acts on the cells of the nephron and indirectly modifies the content of the renal filtrate.[T28] Ultimately, furosemide increases the urine output by the kidney. Protein-bound furosemide is delivered to its site of action in the kidneys and secreted via active secretion by nonspecific organic transporters expressed at the luminal site of action.[A31831,L7958] 



Following oral administration, the onset of the diuretic effect is about 1 and 1.5 hours [L7958], and the peak effect is reached within the first 2 hours.[L7961] The duration of effect following oral administration is about 4-6 hours but may last up to 8 hours.[L9659] Following intravenous administration, the onset of effect is within 5 minutes, and the peak effect is reached within 30 minutes. The duration of action following intravenous administration is approximately 2 hours. Following intramuscular administration, the onset of action is somewhat delayed.[L7958]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19495, 'Instamax panthenol cream 50 gm', 'انستاماكس بانثينول كريم 50 جم', '45', NULL, 'Soothing cream', 'Panthenol', 'Ubm pharma', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, '6223014460019', NULL, 1111, '2023-02-06', 0, 'Panthenol (containing a racemic mixture of dexpanthenol and levopanthenol) is not currently available in any FDA-approved products and therefore does not have an indication.



Please see [DB09357] for FDA-approved uses of the dextrorotatory form of Panthenol. ', 'Panthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol, the active form of panthenol, is enzymatically cleaved to form pantothenic acid (Vitamin B5), which is an essential component of Coenzyme A that acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium [A32373].



Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].', 'Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19496, 'Furyxel 200mg 10 capsules', 'فيوريكسل 200مجم 10 كبسولات', '13', NULL, 'Anti-ischemic', 'Naftidrofuryl', 'Hikma pharma', 'Capsule', 'كبسولة', '200mg', '1', 'علاج قصور الدورة الدموية -- يعمل علي تحسين وصول الدم لجميع اجزاء الجسم', 'naftidrofuryl oxalate works in two main ways. firstly it causes the blood vessels to widen. secondly it increases the ability of cells to remove waste products. in peripheral vascular diseases the blood vessels in the extremities are narrowed and the bloo', NULL, NULL, 2109, '2022-04-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19498, 'Fusi 2% cream 30 gm', 'فيوسي 2% كريم 30 جم', '79', '58', 'Topical antibiotic', 'Fusidic acid', 'Pharopharma', 'Cream', 'كريم', '2%', '1', NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', '6221094503787', NULL, 2200, '2025-06-22', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19499, 'Nerkardou 10 mg 30 orodispersible films', 'نيركاردو 10مجم 30 فيلم ذائب بالفم', '90', '75', 'Anti-hypertensive.beta blocker.selective b1', 'Bisoprolol fumarate', 'nerhadou international co.', 'Film', 'فيلم', '10 mg', '1', NULL, NULL, '6224011153348', NULL, 1238, '2025-07-15', 0, 'Bisoprolol is indicated for the treatment of mild to moderate hypertension.[L7219] It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.[A180460,A180463]', 'Though the mechanism of action of bisoprolol has not been fully elucidated in hypertension, it is thought that therapeutic effects are achieved through the antagonism of β-1adrenoceptors to result in lower cardiac output. Bisoprolol is a competitive, cardioselective β1-adrenergic antagonist. When β1-receptors (located mainly in the heart)[T640] are activated by adrenergic neurotransmitters such as epinephrine, both the blood pressure and heart rate increase, leading to greater cardiovascular work, increasing the demand for oxygen.  Bisoprolol reduces cardiac workload by decreasing contractility and the need for oxygen through competitive inhibition of β1-adrenergic receptors.[A180502,T640]



Bisoprolol is also thought to reduce the output of renin in the kidneys, which normally increases blood pressure. Additionally, some central nervous system effects of bisoprolol may include diminishing sympathetic nervous system output from the brain, decreasing blood pressure and heart rate.[L7219]', 'Bisoprolol decreases heart rate (chronotropy), decreases contractility (inotropy), and reduces blood pressure.[T640,L7219] The results of various clinical studies indicate that bisoprolol reduces cardiovascular mortality and all-cause mortality in patients with heart failure and decreased cardiac ejection fraction (EF).[A180466,A180505] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19500, 'Fusi 2% oint. 15 gm', 'فيوسي 2% مرهم 15 جم', '38', '35', 'Antibiotic', 'Sodium fusidate', 'Pharopharma', 'Oint', 'مرهم', '2%', '1', NULL, 'about sodium fusidate steroidal antibiotic (topical). mechanism of action of sodium fusidate sodium fusidate is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid from aminoacyl srna to the protei', '6221094500298', NULL, 1394, '2025-07-15', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19501, 'Fusi 2% oint. 30 gm', 'فيوسي 2% مرهم 30 جم', '68', '58', 'Antibiotic', 'Sodium fusidate', 'Pharopharma', 'Oint', 'مرهم', '2%', '1', NULL, 'about sodium fusidate steroidal antibiotic (topical). mechanism of action of sodium fusidate sodium fusidate is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid from aminoacyl srna to the protei', '6221094503794', NULL, 2837, '2025-08-18', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19502, 'Fusiderm 2% cream 15 gm', 'فيوسيديرم 2% كريم 15جم', '44', '30', 'Antibiotic topical', 'Fusidic acid', 'Eva pharma', 'Cream', 'كريم', '2%', '1', NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', '6223002450251', NULL, 1577, '2025-07-30', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19503, 'Raspberry ketone complex 20 caps', 'راسبيري كيتون كومبلكس 20 كبسولة', '499', NULL, 'Weight loss', 'Green tea+raspberry ketone powder+caffeine', 'Vitacare', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, NULL, NULL, 743, '2022-09-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19504, 'Fusiderm 2% oint. 15 gm', 'فيوسيدرم 2% مرهم 15 جم', '30', '19.5', 'Antibiotic', 'Sodium fusidate', 'Eva pharma', 'Oint', 'مرهم', '2%', '1', NULL, 'about sodium fusidate steroidal antibiotic (topical). mechanism of action of sodium fusidate sodium fusidate is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid from aminoacyl srna to the protei', '6223002450268', NULL, 1027, '2024-08-03', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19505, 'Fusidic acid 2% gel 15 gm', 'فيوسيديك اسيد 2% جل 15 جم', '9', NULL, 'Antibiotic topical', 'Fusidic acid', 'Sigma', 'Gel', 'جل', '2%', '1', NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', NULL, NULL, 2089, '2022-07-12', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19506, 'Fusidic plus topical cream 15gm', 'فيوسيديك بلس كريم 15 جم', '9', NULL, 'Antibiotic with glucocorticoid', 'Betamethasone+fucidic acid', 'Sigma', 'Cream', 'كريم', '15gm', '1', NULL, 'description betamethasone is a type of medicine called a topical corticosteroid. corticosteroids are medicines used for reducing inflammation. skin inflammation in eczema occurs due to the irritation of the skin and is caused by the release of various sub', NULL, NULL, 1456, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19508, 'Molnupiravir-eva 200mg 40 caps', 'مولنوبيرافير ايفا 200مجم 40 كبسولة', '461', '420', 'Antiviral', 'Molnupiravir', 'Eva pharma', 'Cap', 'كبسولة', '200mg', '4', 'مضاد فيروسات', NULL, NULL, NULL, 1618, '2025-12-14', 0, '[N4-hydroxycytidine] and its prodrug molnupiravir are being studied for its activity against a number of viral infections including influenza, MERS-CoV, and SARS-CoV-2.[A193014, A193029]



Molnupiravir is approved in the UK for reducing the risk of hospitalization and death in mild to moderate COVID-19 cases for patients at increased risk of severe disease (eg. with obesity, diabetes mellitus, heart disease, or are over 60 years old).[L39050,L39055]



In the US, molnupiravir is authorized for emergency use for the treatment of high-risk adults With mild to moderate COVID-19.[L39588]', 'Molnupiravir is hydrolyzed _in vivo_ to N4-hydroxycytidine, which is phosphorylated in tissue to the active 5’-triphosphate form, and incorporated into the genome of new virions, resulting in the accumulation of inactivating mutations, known as viral error catastrophe.[A193014,A193029] A [remdesivir] resistant mutant mouse hepatitis virus has also been shown to have increased sensitivity to N4-hydroxycytidine.[A193014]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19509, 'Futanorm 30 mg 10 tabs', 'فوتانورم 30مجم 10 اقراص', '20', NULL, 'Calcium channel blocker', 'Nimodipine', 'Future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '30 mg', '1', NULL, NULL, NULL, NULL, 1139, '2022-06-12', 0, 'For use as an adjunct to improve neurologic outcome following subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms by reducing the incidence and severity of ischemic deficits.', 'Although the precise mechanism of action is not known, nimodipine blocks intracellular influx of calcium through voltage-dependent and receptor-operated slow calcium channels across the membranes of myocardial, vascular smooth muscle, and neuronal cells. By specifically binding to L-type voltage-gated calcium channels, nimodipine inhibits the calcium ion transfer, resulting in the inhibition of vascular smooth muscle contraction. Evidence suggests that the dilation of small cerebral resistance vessels, with a resultant increase in collateral circulation, and/or a direct effect involving the prevention of calcium overload in neurons may be responsible for nimodipine''s clinical effect in patients with subarachnoid hemorrhage.', 'Nimodipine belongs to the class of pharmacological agents known as calcium channel blockers. Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured congenital aneurysms who are in good neurological condition post-ictus (e.g., Hunt and Hess Grades I-III). The contractile processes of smooth muscle cells are dependent upon calcium ions, which enter these cells during depolarization as slow ionic transmembrane currents. Nimodipine inhibits calcium ion transfer into these cells and thus inhibits contractions of vascular smooth muscle. In animal experiments, nimodipine had a greater effect on cerebral arteries than on arteries elsewhere in the body perhaps because it is highly lipophilic, allowing it to cross the blood brain barrier. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19510, 'Futapan 40mg 28 e.c. tabs.', 'فيوتابان 40مجم 28 قرص', '144', '112', 'Peptic ulcer.proton pump inhibitor', 'Pantoprazole', 'Future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '40mg', '2', 'يستخدم في علاج عسر الهضم ، ومرض الأرتجاع المعدي المريئي ، وللقضاء على بكتيريا هيليكوباكتر بيلوري (جرثومة المعدة) ،', NULL, '6223004191237', NULL, 24622, '2024-07-30', 0, '

**Pantoprazole Injection**:



**Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis**



Pantoprazole for injection is indicated for short-term treatment (7-10 days) of patients having gastroesophageal reflux disease (GERD) with a history of erosive esophagitis, as an alternative to oral medication in patients who are unable to continue taking pantoprazole delayed-release tablets. _Safety and efficacy of pantoprazole injection as the initial treatment of patients having GERD with a history of erosive esophagitis have not been demonstrated at this time_.[FDA label]



**Pathological Hypersecretion Associated with Zollinger-Ellison Syndrome**



Pantoprazole for injection is indicated for the treatment of pathological hypersecretory conditions associated with Zollinger-Ellison Syndrome or other neoplastic conditions.[FDA label]



**Pantoprazole delayed-release oral suspension**:



**Short-Term Treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD)**



Indicated in adults and pediatric patients five years of age and above for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis. For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been determined.[F3202]



**Maintenance of healing of erosive esophagitis**



Indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD.[F3202]



**Pathological hypersecretory conditions including Zollinger-Ellison syndrome**



Indicated for the long-term treatment of the above conditions.[F3202]', 'Hydrochloric acid (HCl) secretion into the gastric lumen is a process regulated mainly by the H(+)/K(+)-ATPase of the proton pump, expressed in high quantities by the parietal cells of the stomach.[A174295] ATPase is an enzyme on the parietal cell membrane that facilitates hydrogen and potassium exchange through the cell, which normally results in the extrusion of potassium and formation of HCl (gastric acid). 



Proton pump inhibitors such as pantoprazole are substituted _benzimidazole_ derivatives, weak bases, which accumulate in the acidic space of the parietal cell before being converted in the _canaliculi_  (small canal) of the gastric parietal cell, an acidic environment, to active _sulfenamide_ derivatives. This active form then makes disulfide bonds with important cysteines on the gastric acid pump, inhibiting its function.[A174247] Specifically, pantoprazole binds to the _sulfhydryl group_ of H+, K+-ATPase, which is an enzyme implicated in accelerating the final step in the acid secretion pathway. The enzyme is inactivated, inhibiting gastric acid secretion.[A174253] The inhibition of gastric acid secretion is stronger with proton pump inhibitors such as pantoprazole and lasts longer than with the H(2) antagonists.[A174295] ', 'This drug acts to decrease gastric acid secretion, which reduces stomach acidity. Pantoprazole administration leads to long-lasting inhibition of gastric acid secretion.[F3193]



**General Effects**



Pantoprazole has been shown to reduce acid reflux-related symptoms, heal inflammation of the esophagus, and improve patient quality of life more effectively than histamine-2 receptor antagonists (H2 blockers). This drug has an excellent safety profile and a low incidence of drug interactions. It can be used safely in various high-risk patient populations, including the elderly and those with renal failure or moderate hepatic dysfunction.[A174226]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as pantoprazole have been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]



PPIs such as pantoprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes [A177577, A177580]. 



**A note on laboratory testing abnormalities**



During treatment with antisecretory medicinal products such as pantoprazole, serum gastrin (a peptide hormone that stimulates secretion of gastric acid) increases in response to the decreased acid secretion caused by proton pump inhibition. The increased gastrin level may interfere with investigations for neuroendocrine tumors. Published evidence suggests that proton pump inhibitors should be stopped 14 days before chromogranin A (CgA) measurements. This permits chromogranin A levels, that might be falsely elevated after proton pump inhibitor treatment, to return to the normal reference range.[F3217] 



Reports have been made of false-positive results in urine screening tests for tetrahydrocannabinol (THC) in patients receiving the majority of proton pump inhibitors, including pantoprazole. A confirmatory method should be used.[F3217]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19511, 'Futapan 40 mg vial i.v.', 'فيوتابان 40مجم فيال وريد', '60', '45', 'Peptic ulcer.proton pump inhibitor', 'Pantoprazole', 'Future pharmaceutical industries (fpi)', 'Vial', 'فيال', '40 mg', '1', NULL, NULL, '6223004199691', NULL, 2378, '2024-03-30', 0, '

**Pantoprazole Injection**:



**Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis**



Pantoprazole for injection is indicated for short-term treatment (7-10 days) of patients having gastroesophageal reflux disease (GERD) with a history of erosive esophagitis, as an alternative to oral medication in patients who are unable to continue taking pantoprazole delayed-release tablets. _Safety and efficacy of pantoprazole injection as the initial treatment of patients having GERD with a history of erosive esophagitis have not been demonstrated at this time_.[FDA label]



**Pathological Hypersecretion Associated with Zollinger-Ellison Syndrome**



Pantoprazole for injection is indicated for the treatment of pathological hypersecretory conditions associated with Zollinger-Ellison Syndrome or other neoplastic conditions.[FDA label]



**Pantoprazole delayed-release oral suspension**:



**Short-Term Treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD)**



Indicated in adults and pediatric patients five years of age and above for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis. For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been determined.[F3202]



**Maintenance of healing of erosive esophagitis**



Indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD.[F3202]



**Pathological hypersecretory conditions including Zollinger-Ellison syndrome**



Indicated for the long-term treatment of the above conditions.[F3202]', 'Hydrochloric acid (HCl) secretion into the gastric lumen is a process regulated mainly by the H(+)/K(+)-ATPase of the proton pump, expressed in high quantities by the parietal cells of the stomach.[A174295] ATPase is an enzyme on the parietal cell membrane that facilitates hydrogen and potassium exchange through the cell, which normally results in the extrusion of potassium and formation of HCl (gastric acid). 



Proton pump inhibitors such as pantoprazole are substituted _benzimidazole_ derivatives, weak bases, which accumulate in the acidic space of the parietal cell before being converted in the _canaliculi_  (small canal) of the gastric parietal cell, an acidic environment, to active _sulfenamide_ derivatives. This active form then makes disulfide bonds with important cysteines on the gastric acid pump, inhibiting its function.[A174247] Specifically, pantoprazole binds to the _sulfhydryl group_ of H+, K+-ATPase, which is an enzyme implicated in accelerating the final step in the acid secretion pathway. The enzyme is inactivated, inhibiting gastric acid secretion.[A174253] The inhibition of gastric acid secretion is stronger with proton pump inhibitors such as pantoprazole and lasts longer than with the H(2) antagonists.[A174295] ', 'This drug acts to decrease gastric acid secretion, which reduces stomach acidity. Pantoprazole administration leads to long-lasting inhibition of gastric acid secretion.[F3193]



**General Effects**



Pantoprazole has been shown to reduce acid reflux-related symptoms, heal inflammation of the esophagus, and improve patient quality of life more effectively than histamine-2 receptor antagonists (H2 blockers). This drug has an excellent safety profile and a low incidence of drug interactions. It can be used safely in various high-risk patient populations, including the elderly and those with renal failure or moderate hepatic dysfunction.[A174226]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as pantoprazole have been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]



PPIs such as pantoprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes [A177577, A177580]. 



**A note on laboratory testing abnormalities**



During treatment with antisecretory medicinal products such as pantoprazole, serum gastrin (a peptide hormone that stimulates secretion of gastric acid) increases in response to the decreased acid secretion caused by proton pump inhibition. The increased gastrin level may interfere with investigations for neuroendocrine tumors. Published evidence suggests that proton pump inhibitors should be stopped 14 days before chromogranin A (CgA) measurements. This permits chromogranin A levels, that might be falsely elevated after proton pump inhibitor treatment, to return to the normal reference range.[F3217] 



Reports have been made of false-positive results in urine screening tests for tetrahydrocannabinol (THC) in patients receiving the majority of proton pump inhibitors, including pantoprazole. A confirmatory method should be used.[F3217]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19512, 'Futapramin 10 mg 30 f.c. tabs', 'فوتابرامين 10مجم 30 قرص', '78', '56.25', 'Psychiatric.antidepressants', 'Escitalopram', 'Future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '10 mg', '3', NULL, NULL, '6223004190483', NULL, 1887, '2024-07-18', 0, 'Escitalopram is indicated for the acute and maintenance treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years old and older and for the acute treatment of generalized anxiety disorder (GAD) in adults and pediatric patients 7 years old and older.[L8513,L8513] It is additionally indicated for symptomatic relief of obsessive-compulsive disorder (OCD) in Canada.[L8516]', 'Escitalopram, like other selective serotonin re-uptake inhibitors, enhances serotonergic activity by binding to the orthosteric (i.e. primary) binding site on the serotonin transporter (SERT), the same site to which endogenous 5-HT binds, and thus prevents the re-uptake of serotonin into the presynaptic neuron.[A185420,A39738,A185726] Escitalopram, along with [paroxetine], is also considered an allosteric serotonin re-uptake inhibitor - it binds to a secondary allosteric site on the SERT molecule to more strongly inhibit 5-HT re-uptake. Its combination of orthosteric and allosteric activity on SERT allows for greater extracellular 5-HT levels, a faster onset of action, and greater efficacy as compared to other SSRIs. [A185825,A185726] The sustained elevation of synaptic 5-HT eventually causes desensitization of 5-HT<sub>1A</sub> auto-receptors, which normally shut down endogenous 5-HT release in the presence of excess 5-HT - this desensitization may be necessary for the full clinical effect of SSRIs and may be responsible for their typically prolonged onset of action.[A185828,A185726]



Escitalopram has shown little-to-no binding affinity at a number of other receptors, such as histamine and muscarinic receptors, and minor activity at these off-targets may explain some of its adverse effects.[L8513,L8516,L8522,A185726]', 'Escitalopram belongs to a class of medications called selective serotonin re-uptake inhibitors (SSRIs). These agents cause an increase in serotonin levels in neuronal synapses by preventing the re-uptake of serotonin (5-HT) into the presynaptic terminals of serotonergic neurons.[A185420,A39738,L8513,L8516] As compared to other SSRIs, it appears to have a relatively quick onset of effect due to its potency.[A185819,A185822]



SSRIs as a class have been associated with abnormal bleeding, particularly in patients receiving concomitant therapy with other medications affecting hemostasis, and with the development of serotonin syndrome. Use escitalopram with caution in patients with a higher-than-baseline risk of bleeding and in patients receiving concomitant therapy with other serotonergic drugs. Escitalopram may also cause a discontinuation syndrome with abrupt removal of the drug, and should be slowly tapered if discontinuation of therapy is warranted.[L8513,L8516,L8522]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19513, 'Futapramin 20mg 30 f.c. tabs.', 'فوتابرامين 20مجم 30 قرص', '114', '78.75', 'Psychiatric.antidepressants', 'Escitalopram', 'Future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '20mg', '3', 'مضاد للإكتئاب', NULL, '6223004190490', NULL, 2720, '2024-03-30', 0, 'Escitalopram is indicated for the acute and maintenance treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years old and older and for the acute treatment of generalized anxiety disorder (GAD) in adults and pediatric patients 7 years old and older.[L8513,L8513] It is additionally indicated for symptomatic relief of obsessive-compulsive disorder (OCD) in Canada.[L8516]', 'Escitalopram, like other selective serotonin re-uptake inhibitors, enhances serotonergic activity by binding to the orthosteric (i.e. primary) binding site on the serotonin transporter (SERT), the same site to which endogenous 5-HT binds, and thus prevents the re-uptake of serotonin into the presynaptic neuron.[A185420,A39738,A185726] Escitalopram, along with [paroxetine], is also considered an allosteric serotonin re-uptake inhibitor - it binds to a secondary allosteric site on the SERT molecule to more strongly inhibit 5-HT re-uptake. Its combination of orthosteric and allosteric activity on SERT allows for greater extracellular 5-HT levels, a faster onset of action, and greater efficacy as compared to other SSRIs. [A185825,A185726] The sustained elevation of synaptic 5-HT eventually causes desensitization of 5-HT<sub>1A</sub> auto-receptors, which normally shut down endogenous 5-HT release in the presence of excess 5-HT - this desensitization may be necessary for the full clinical effect of SSRIs and may be responsible for their typically prolonged onset of action.[A185828,A185726]



Escitalopram has shown little-to-no binding affinity at a number of other receptors, such as histamine and muscarinic receptors, and minor activity at these off-targets may explain some of its adverse effects.[L8513,L8516,L8522,A185726]', 'Escitalopram belongs to a class of medications called selective serotonin re-uptake inhibitors (SSRIs). These agents cause an increase in serotonin levels in neuronal synapses by preventing the re-uptake of serotonin (5-HT) into the presynaptic terminals of serotonergic neurons.[A185420,A39738,L8513,L8516] As compared to other SSRIs, it appears to have a relatively quick onset of effect due to its potency.[A185819,A185822]



SSRIs as a class have been associated with abnormal bleeding, particularly in patients receiving concomitant therapy with other medications affecting hemostasis, and with the development of serotonin syndrome. Use escitalopram with caution in patients with a higher-than-baseline risk of bleeding and in patients receiving concomitant therapy with other serotonergic drugs. Escitalopram may also cause a discontinuation syndrome with abrupt removal of the drug, and should be slowly tapered if discontinuation of therapy is warranted.[L8513,L8516,L8522]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19514, 'Futarhomal 200mg 20 f.c. tabs', 'فوتارهومال 200 مجم 20 قرص', '40', NULL, 'Antiprotozoal.antimalarial.antirheumatic', 'Hydroxychloroquine sulphate', 'Future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '200mg', '2', 'مضاد للملاريا تستخدم فى علاج اعراض الذئبة الحمراء و الملاريا بسلالات معينة ، و علاج اعراض التهاب المفصل', NULL, NULL, NULL, 1292, '2022-06-16', 0, 'Hydroxychloroquine is indicated for the prophylaxis of malaria where chloroquine resistance is not reported, treatment of uncomplicated malaria (caused by _P. falciparum_, _P. malariae_, _P. ovale_, or _P. vivax_), chronic discoid lupus erythematosus, systemic lupus erythematosus, acute rheumatoid arthritis, and chronic rheumatoid arthritis.[L8072]', 'The exact mechanisms of hydroxychloroquine are unknown. It has been shown that hydroxychloroquine accumulates in the lysosomes of the malaria parasite, raising the pH of the vacuole.[A183074] This activity interferes with the parasite''s ability to proteolyse hemoglobin, preventing the normal growth and replication of the parasite.[A183074] Hydroxychloroquine can also interfere with the action of parasitic heme polymerase, an enzyme that uses ferriprotoporphyrin IX (FP) released from hemoglobin as a substrate to form beta-hematin. By reducing the activity of heme polymerase without inhibiting the release of FP, hydroxychloroquine leads to the accumulation of FP in a toxic form.[A183080]



Hydroxychloroquine accumulation in human organelles also raise their pH, which inhibits antigen processing, prevents the alpha and beta chains of the major histocompatibility complex (MHC) class II from dimerizing, inhibits antigen presentation of the cell, and reduces the inflammatory response.[A183074] Elevated pH in the vesicles may alter the recycling of MHC complexes so that only the high affinity complexes are presented on the cell surface.[A183074] Self peptides bind to MHC complexes with low affinity and so they will be less likely to be presented to autoimmune T cells.[A183074] Hydroxychloroquine also reduces the release of cytokines like interleukin-1 and tumor necrosis factor, possibly through inhibition of Toll-like receptors.[A183074,A198852]



The raised pH in endosomes, prevent virus particles (such as SARS-CoV and SARS-CoV-2) from utilizing their activity for fusion and entry into the cell.[A191625]



Hydroxychloroquine inhibits terminal glycosylation of ACE2, the receptor that SARS-CoV and SARS-CoV-2 target for cell entry.[A191628,A191625] ACE2 that is not in the glycosylated state may less efficiently interact with the SARS-CoV-2 spike protein, further inhibiting viral entry.[A191625]', 'Hydroxychloroquine affects the function of lysosomes in humans as well as plasmodia.[A183074] Altering the pH of the lysosomes reduces low-affinity self-antigen presentation in autoimmune diseases and interferes with the ability of plasmodia to proteolyze hemoglobin for their energy requirements.[A183074] Hydroxychloroquine has a long duration of action as it may be taken on a weekly basis for some indications.[L8072] Hydroxychloroquine may lead to severe hypoglycemia and so diabetic patients are advised to monitor their blood glucose levels.[L8072] 



Hydroxychloroquine is active against the erythrocytic forms of chloroquine-sensitive strains of P. falciparum, P. malariae, P. vivax, and P. ovale. Hydroxychloroquine is not active against the gametocytes and exoerythrocytic forms including the hypnozoite liver stage forms of P. vivax and P. ovale.[L47576] Hydroxychloroquine is not effective against malaria in areas where chloroquine resistance has been reported.[L8072]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19515, 'Futasole 2% cream 15 gm', 'فيوتاسول 2% كريم 15 جم', '15', NULL, 'Antibiotic topical', 'Sodium fusidate', 'Julphar', 'Cream', 'كريم', '2%', '1', NULL, 'about sodium fusidate steroidal antibiotic (topical). mechanism of action of sodium fusidate sodium fusidate is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid from aminoacyl srna to the protei', NULL, NULL, 1076, '2022-08-06', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19516, 'Centravita colin 100 ml syrup', 'سنترافيتا كولين شراب 100 مل', '250', NULL, 'Dietary supplement', 'Citicoline', 'Copad egypt', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, '6223011340543', NULL, 960, '2022-08-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19517, 'Futasone cream 15 gm', 'فوتازون كريم 15 جم', '10', NULL, 'Antibiotic with glucocorticoid', 'Betamethasone+fucidic acid', 'Julphar', 'Cream', 'كريم', '15 gm', '1', 'مضاد للإلتهاب، حيث يخفف من التورم، والاحمرار، والحكة، ويستخدم في حالات التهاب الجلد والأكزيما.', 'description betamethasone is a type of medicine called a topical corticosteroid. corticosteroids are medicines used for reducing inflammation. skin inflammation in eczema occurs due to the irritation of the skin and is caused by the release of various sub', '6291100080922', NULL, 1059, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19518, 'Futatreat 100mg/ml oral soln. 100 ml', 'فوتاتريت 100 مجم / مل 100 مل محلول بالفم', '88', '67', 'Anti-epileptic.pyrrolidine', 'Levetiracetam', 'Future pharmaceutical industries (fpi)', 'Sol', 'محلول', '100mg', '1', NULL, 'about levetiracetam it is s-enantiomer of etiracetam. anticonvulsant medication used to treat epilepsy. mechanism of action of levetiracetam the exact mechanism for levetiracetam is unknown. however the drug binds to a synaptic vesicle protein sv2a which', NULL, NULL, 838, '2025-09-17', 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19519, 'Futatreat 250mg 20 f.c. tab.', 'فيوتاتريت 250 مجم 20 قرص', '64', NULL, 'Anti-epileptic.pyrrolidine', 'Levetiracetam', 'Global napi pharmaceuticals > future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '250mg', '2', NULL, 'about levetiracetam it is s-enantiomer of etiracetam. anticonvulsant medication used to treat epilepsy. mechanism of action of levetiracetam the exact mechanism for levetiracetam is unknown. however the drug binds to a synaptic vesicle protein sv2a which', NULL, NULL, 1015, '2022-07-15', 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19520, 'Futatreat 500mg 20 f.c. tab.', 'فيوتاتريت 500 مجم 20 قرص', '112', '64', 'Anti-epileptic.pyrrolidine', 'Levetiracetam', 'Global napi pharmaceuticals > future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '500mg', '2', NULL, 'about levetiracetam it is s-enantiomer of etiracetam. anticonvulsant medication used to treat epilepsy. mechanism of action of levetiracetam the exact mechanism for levetiracetam is unknown. however the drug binds to a synaptic vesicle protein sv2a which', '6223004190230', NULL, 1365, '2023-09-08', 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19521, 'Futatreat 750mg 20 f.c. tab.', 'فيوتاتريت 750 مجم 20 قرص', '148', '112', 'Anti-epileptic.pyrrolidine', 'Levetiracetam', 'Future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '750mg', '2', NULL, NULL, '6223004190803', NULL, 1385, '2025-09-22', 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19522, 'Futavildix 50/850 mg 30 f.c. tablets', 'فوتافيلدكس 50/850 مجم 30 قرص', '192', '147', 'Anti-diabetic.combined secretagogues+sensitizers', 'Metformin hydrochloride+vildagliptin', 'Future pharmaceutical industries (fpi)', 'Tablet', 'أقراص', '850 mg', '3', 'لعلاج مرضى السكر', NULL, '6223004191022', NULL, 6220, '2024-06-27', 0, '**Metformin immediate-release formulations**

 

Metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients ≥10 years old with type 2 diabetes mellitus.[L40243]



**Metformin extended-release tablet (XR)**



The extended-release formulation of metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Safety in children has not been determined to this date.[L12207]



**Metformin combination products**



Metformin is a component of a variety of combination products with other anti-diabetic agents. It is indicated, along with diet and exercise, to improve glycemic control in adult patients with type 2 diabetes mellitus in combination with DPP-4 inhibitors ([sitagliptin], [linagliptin], [alogliptin], or [saxagliptin]),[L11479,L40248,L40253,L40258,L40263] in combination with SGLT2 inhibitors ([canagliflozin], [empagliflozin], [ertugliflozin], or [dapagliflozin]),[L11479,L30503,L1134,L13679,L38729] or in combination with [pioglitazone].[L11419]', 'Metformin''s mechanisms of action are unique from other classes of oral antihyperglycemic drugs. Metformin decreases blood glucose levels by decreasing hepatic glucose production (also called gluconeogenesis), decreasing the intestinal absorption of glucose, and increasing insulin sensitivity by increasing peripheral glucose uptake and utilization.[L12207] It is well established that metformin inhibits mitochondrial complex I activity, and it has since been generally postulated that its potent antidiabetic effects occur through this mechanism.[A36534, A36557]   The above processes lead to a decrease in blood glucose, managing type II diabetes and exerting positive effects on glycemic control.



After ingestion, the organic cation transporter-1 (OCT1) is responsible for the uptake of metformin into hepatocytes (liver cells). As this drug is positively charged, it accumulates in cells and in the mitochondria because of the membrane potentials across the plasma membrane as well as the mitochondrial inner membrane. Metformin inhibits mitochondrial complex I, preventing the production of mitochondrial ATP leading to increased cytoplasmic ADP:ATP and AMP:ATP ratios.[A36534] These changes activate AMP-activated protein kinase (AMPK), an enzyme that plays an important role in the regulation of glucose metabolism.[A176348] Aside from this mechanism, AMPK can be activated by a lysosomal mechanism involving other activators.  Following this process, increases in AMP:ATP ratio also inhibit _fructose-1,6-bisphosphatase_ enzyme, resulting in the inhibition of gluconeogenesis, while also inhibiting _adenylate cyclase_ and decreasing the production of cyclic adenosine monophosphate (cAMP),[A36534] a derivative of ATP used for cell signaling [A176351]. Activated AMPK phosphorylates two isoforms of acetyl-CoA carboxylase enzyme, thereby inhibiting fat synthesis and leading to fat oxidation, reducing hepatic lipid stores and increasing liver sensitivity to insulin.[A36534] 



In the intestines, metformin increases anaerobic glucose metabolism in enterocytes (intestinal cells), leading to reduced net glucose uptake and increased delivery of lactate to the liver. Recent studies have also implicated the gut as a primary site of action of metformin and suggest that the liver may not be as important for metformin action in patients with type 2 diabetes. Some of the ways metformin may play a role on the intestines is by promoting the metabolism of glucose by increasing glucagon-like peptide I (GLP-1) as well as increasing gut utilization of glucose.[A36534] 



In addition to the above pathway, the mechanism of action of metformin may be explained by other ways, and its exact mechanism of action has been under extensive study in recent years.[A36535, A36554, A36555, A36557]', '**General effects**



Insulin is an important hormone that regulates blood glucose levels.[T514] Type II diabetes is characterized by a decrease in sensitivity to insulin, resulting in elevations in blood glucose when the pancreas can no longer compensate. In patients diagnosed with type 2 diabetes, insulin is unable to exert adequate effects on tissues and cells (i.e. insulin resistance)[T514] and insulin deficiency may also be present.[L5753]



Metformin reduces hepatic production of glucose, decreases the intestinal absorption of glucose, and enhances insulin sensitivity by increasing both peripheral glucose uptake and utilization. In contrast with drugs of the sulfonylurea class, which lead to hyperinsulinemia, the secretion of insulin is unchanged with metformin use.[L12207]



**Effect on fasting plasma glucose (FPG) and Glycosylated hemoglobin (HbA1c)**



HbA1c is an important periodic measure of glycemic control used to monitor diabetic patients. Fasting plasma glucose is also a useful and important measure of glycemic control. In a 29-week clinical trial of subjects diagnosed with type II diabetes, metformin decreased the fasting plasma glucose levels by an average of 59 mg/dL from baseline, compared to an average increase of 6.3 mg/dL from baseline in subjects taking a placebo.[L12207]  Glycosylated hemoglobin (HbA1c) was decreased by about 1.4% in subjects receiving metformin, and increased by 0.4% in subjects receiving placebo only.[L12207]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19523, 'Futhalm 1% ophth. susp. 5 ml', 'فيوثالم 1% معلق للعين 5 مل', '14', NULL, 'Antibiotic', 'Fusidic acid', 'Sigma tec', 'Susp', 'معلق', '1%', '1', NULL, NULL, '6221172002010', NULL, 713, '2022-07-24', 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19524, 'Fytosid 100mg/5ml vial', 'فيتوسيد 100 مجم / 5 مل فيال', '75', '32', 'Antineoplastic', 'Etoposide', 'Fresenius kabi > egyptian group for import and export', 'Vial', 'فيال', '100mg', '1', NULL, NULL, NULL, NULL, 712, '2024-11-07', 0, 'For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme.', 'Etoposide inhibits DNA topoisomerase II, thereby inhibiting DNA re-ligation. This causes critical errors in DNA synthesis at the premitotic stage of cell division and can lead to apoptosis of the cancer cell. Etoposide is cell cycle dependent and phase specific, affecting mainly the S and G2 phases of cell division. Inhibition of the topoisomerase II alpha isoform results in the anti-tumour activity of etoposide. The drug is also capable of inhibiting the beta isoform but inhibition of this target is not associated with the anti-tumour activity. It is instead associated with the carcinogenic effect. ', 'Etoposide is an antineoplastic agent and an epipodophyllotoxin (a semisynthetic derivative of the podophyllotoxins). It inhibits DNA topoisomerase II, thereby ultimately inhibiting DNA synthesis. Etoposide is cell cycle dependent and phase specific, affecting mainly the S and G2 phases. Two different dose-dependent responses are seen. At high concentrations (10 &micro;g/mL or more), lysis of cells entering mitosis is observed. At low concentrations (0.3 to 10 &micro;g/mL), cells are inhibited from entering prophase. It does not interfere with microtubular assembly. The predominant macromolecular effect of etoposide appears to be the induction of DNA strand breaks by an interaction with DNA-topoisomerase II or the formation of free radicals.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19525, 'G.c. mol 6 eff. sachet', 'جي.سي. مول فوار 6 اكياس', '25', '17', 'Cold drugs', 'Guaifenesin+paracetamol(acetaminophen)+vitamin c', 'Pharco', 'Sachet', 'أكياس', NULL, '6', 'فوار فيتامين سي لتقوية المناعة للجسم ضد ادوار البرد والانفلونزا __ مسكن الالام و الالتهابات', 'paracetamol ... 325 mg guaifenesin ... 100 mg vitamin c ... 250 mg description an expectorant that also has some muscle relaxing action mechanism of action guaifenesin may act as an irritant to gastric vagal receptors and recruit efferent parasympathetic', '6221075180334', NULL, 12160, '2024-10-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19526, 'G.doux hair bath cream 200 ml', 'جي.دوكس حمام كريم للشعر 200 مل', '99', NULL, 'Hair care', NULL, 'Smartec pharm. & cosmetics > cosmocare', 'Cream', 'كريم', '200 ml', '1', NULL, 'hair nutrition formula - for dry & damaged hair. with shea butter olive oil jojoba oil argan oil', NULL, NULL, 675, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19527, 'G.doux hair serum 100 ml', 'جي دوكس هير سيرم 100 مل', '149', NULL, 'Hair care', NULL, 'Smartec pharm. & cosmetics > cosmocare', 'Serum', 'سيروم', '100 ml', '1', NULL, 'hair nutrition formula - for dry & damaged hair. with argan oil jojoba oil vitamin e uv filter', NULL, NULL, 1225, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19528, 'G.doux hair shampoo & balsam 200 ml', 'جي.دوكس شامبو وبلسم للشعر 200 مل', '185', '89', 'Hair care', NULL, 'Smartec pharm. & cosmetics > cosmocare', 'Amp', 'أمبول', '200 ml', '1', 'يستخدم للشعر الجاف والتالف', 'hair nutrition formula - for dry & damaged hair. with hydrolysed keratin balck seed oil jojoba oil argan oil', NULL, NULL, 1326, '2024-06-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19529, 'Gaba 100mg 10 caps.', 'جابا 100مجم 10 كبسولات', '7', NULL, 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Multi-apex > multipharma', 'Cap', 'كبسولة', '100mg', '1', 'علاج الصرع -- مسكن لالام الاعصاب', 'about gabapentin a gaba analogue anticonvulsant mood stabilizer. mechanism of action of gabapentin gabapentin is a gaba derivative and it bounds to lipophilic molecule. the mechanism of action of gabapentin is not exactly known. it crosses blood brain bar', NULL, NULL, 1167, '2022-08-28', 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19530, 'Gaba 750 mg 90 caps. illegal import)', 'جابا 750 مجم 90 كبسولة - استيراد', '0', '0', NULL, 'Gaba (gamma aminobutyric acid)', 'Puritans pride', 'Cap', 'كبسولة', '750 mg', '1', 'تحسين وظائف الجهاز العصبي', NULL, '025077176106', NULL, 1123, '2022-05-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19531, 'Gabalepsy 300mg 20 caps', 'جاباليبسي 300مجم 20 كبسولة', '90', NULL, 'Anti-epileptic.gaba analogs', 'Gabapentin', 'El-obour', 'Cap', 'كبسولة', '300mg', '2', 'مهديء عصبي -- مسكن للآلام العصبية', NULL, NULL, NULL, 1261, '2022-12-12', 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19532, 'Gabapentin 300 mg 30 f.c.tabs.', 'جابابنتين 300مجم 30 قرص', '96', '69', 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Unipharma co.', 'Tab', 'أقراص', '300 mg', '3', NULL, NULL, '6224008676386', NULL, 6034, '2024-11-03', 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19533, 'Gabapentin 100mg 30 f.c. tab.', 'جابابنتين 100مجم 30 قرص', '48', NULL, 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Unipharma co.', 'Tab', 'أقراص', '100mg', '3', NULL, NULL, NULL, NULL, 1203, '2024-07-27', 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19536, 'Gabimash 300mg 30 tab', 'جابيماش 300مجم 30 قرص', '114', '85.5', 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Mash premiere', 'Tab', 'أقراص', '300mg', '3', 'مهديء للاعصاب ومسكن عصبي قوي', NULL, '6224003225220', NULL, 8815, '2024-05-27', 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19537, 'Gabimash 800mg 20 tab', 'جابيماش 800مجم 20 قرص', '144', '165', 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Mash premiere', 'Tab', 'أقراص', '800mg', '2', NULL, NULL, '6223008440171', NULL, 1957, '2024-05-27', 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19539, 'Gablovac 150mg 10 capsule', 'جابلوفاك 150 مجم 10 كبسولات', '43', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Medizen pharmaceutical industries > gast pharma group-egypt', 'Capsule', 'كبسولة', '150mg', '1', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', '6224000888022', NULL, 1229, '2022-07-09', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19540, 'Emance hair ampoules 5 ampoules 10ml', 'ايمانس امبولات للشعر 5 امبولات * 10 مل', '248', NULL, 'Hair loss', NULL, 'Opti care pharma', 'Ampoule', 'أمبول', '10ml', '5', NULL, NULL, NULL, NULL, 1128, '2023-05-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19541, 'Gadacin cream 50 gm', 'جاداسين كريم 50 جرام', '55', NULL, 'Diaper rash', NULL, 'Al helou for perfume & cosmetics > champions pharma (pas)', 'Cream', 'كريم', '50 gm', '1', 'التهابات وتسلخات الحفاضات للاطفال', 'skin moisturizing & soothing', '6224008722991', NULL, 934, '2022-04-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19542, 'Gadovist 1 mmol/ml (7.5ml) prefilled syringe(n/a yet)', 'جادوفيست 1 مليمول / مل (7.5 مل) حقنة مملوءة مسبقًا', '374', NULL, NULL, 'Gadobutrol', 'Bayer schering > bayer healthcare', 'Syringe', 'حقنة', '7.5ml', '1', NULL, NULL, NULL, NULL, 439, '2022-08-06', 0, 'Gadobutrol is indicated for use with magnetic resonance imaging for the following diagnostic processes:[L49891]



- To detect and visualize areas with disrupted blood-brain barrier and/or abnormal vascularity of the central nervous system in adult and pediatric patients, including term neonates.

- To assess the presence and extent of malignant breast disease in adult patients

- To evaluate known or suspected supra-aortic or renal artery disease in adult and pediatric patients, including term neonates

- To assess myocardial perfusion (under stress and at rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease', 'In MRI, visualization of normal and pathological tissue depends in part on variations in the radiofrequency signal intensity that occur with differences in proton density, the spin-lattice or longitudinal relaxation times (T1), and the spin-spin or transverse relaxation time (T2).[L49891]



When placed in a magnetic field, gadobutrol shortens the T1 and T2 relaxation times. The extent of decrease of T1 and T2 relaxation times, and therefore the amount of signal enhancement obtained from gadobutrol, is based upon several factors including the concentration of gadobutrol in the tissue, the field strength of the MRI system, and the relative ratio of the longitudinal and transverse relaxation times. At the recommended dose, the T1 shortening effect is observed with the greatest sensitivity in T1-weighted magnetic resonance sequences. In T2*-weighted sequences, the induction of local magnetic field inhomogeneities by the large magnetic moment of gadolinium and at high concentrations (during bolus injection) leads to a signal decrease.[L49891]   ', 'Gadobutrol leads to distinct shortenings of relaxation times even in low concentrations. At pH 7, 37°C and 1.5 T, the

relaxivity (r1) - determined from the influence on the relaxation times (T1) of protons in plasma - is 5.2 L/(mmol·sec) and

the relaxivity (r2) - determined from the influence on the relaxation times (T2) - is 6.1 L/(mmol·sec). These relaxivities

display only slight dependence on the strength of the magnetic field.[L49891]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19543, 'Gallamine 40mg/2ml 10 amp.', 'جالامين 40مجم/2مل 10 امبولات', '131', NULL, NULL, 'Gallamine triethiodide', 'Alexandria', 'Amp', 'أمبول', '40mg', '10', NULL, 'description a synthetic nondepolarizing blocking drug. the actions of gallamine triethiodide are similar to those of tubocurarine but this agent blocks the cardiac vagus and may cause sinus tachycardia and occasionally hypertension and increased cardiac o', '6223000178362', NULL, 682, '2023-05-03', 0, 'For use as adjuncts to anesthesia to induce skeletal muscle relaxation and to facilitate the management of patients undergoing mechanical ventilation', 'It competes with acetylcholine (ACh) molecules and binds to muscarinic acetylcholine receptors on the post-synaptic membrane of the motor endplate. It acts by combining with the cholinergic receptor sites in muscle and competitively blocking the transmitter action of acetylcholine. It blocks the action of ACh and prevents activation of the muscle contraction process. It can also act on nicotinic presynaptic acetylcholine receptors which inhibits the release of ACh.', 'Gallamine Triethiodide is a nondepolarizing neuromuscular blocking drug (NDMRD) used as an adjunct to anesthesia to induce skeletal muscle relaxation. The actions of gallamine triethiodide are similar to those of tubocurarine, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. Muscle groups differ in their sensitivity to these types of relaxants with ocular muscles (controlling eyelids) being most sensitive, followed by the muscles of the neck, jaw, limbs and then abdomen. The diaphragm is the least sensitive muscle to NDMRDs. Although the nondepolarizing neuromuscular blocking drugs do not have the same adverse effects as succinylcholine, their onset of action is slower. They also have a longer duration of action, making them more suitable for maintaining neuromuscular relaxation during major surgical procedures.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19544, 'Galldepedra 300mg f.c. tabs.', 'جالديبيدرا 300 مجم اقراص', '13', NULL, 'Liver support supplements', 'Ursodeoxycholic acid', 'Egpi > jasper for pharmaceutical industries', 'Tab', 'أقراص', '300mg', '1', NULL, NULL, NULL, NULL, 1018, '2022-07-12', 0, 'Ursodeoxycholic acid is indicated for the treatment of patients with primary biliary cholangitis.[L44627] 



It is used for the short-term treatment of radiolucent, noncalcified gallbladder stones in patients selected for elective cholecystectomy. It is also used to prevent gallstone formation in obese patients experiencing rapid weight loss.[L44793]', 'Endogenous hydrophobic bile acids such as deoxycholic acid and chenodeoxycholic acid can exert hepatotoxic effects. Ursodeoxycholic acid is a hydrophilic bile acid that mediates its biological effects via several mechanisms. Ursodeoxycholic acid (UDCA) protects hepatocytes and cholangiocytes from bile acid-induced damage, such as reactive oxygen species (ROS)-induced inflammation and mitochondrial dysfunction.[A256267] UDCA was shown to reserve hepatocyte cell structures and stimulate anti-apoptotic pathways.[A256267,A256272,A256458,A256463] It was also shown to prevent the production of ROS by Kupffer cells and resident macrophages in the liver, thus attenuating oxidative stress in the liver.[A256267] 



UDCA can also change the hydrophobicity index of the bile acid pool: following oral administration, UDCA forms a major fraction of the human bile acid pool and competitively displaces the hydrophobic or more toxic bile acids.[A256272,A256267] It increases the absorption of hydrophilic bile acids.[A256267] There are several proposed mechanisms of choleretic actions of UDCA: UDCA increases intracellular calcium levels, stimulating transport proteins and vesicular exocytosis in cholestatic hepatocytes.[A256267] UDCA may also upregulate the expression of membrane transport proteins like the chloride-bicarbonate anion exchanger (AE2),[A256267,A256458] which is involved in biliary secretion and is often observed to be defective in primary biliary cholangitis.[A256448] In rats, UDCA reduced hepatic expression of major histocompatibility complex (MHC) class I antigens, suggesting immunomodulating effects.[A256267] UDCA acts as a partial agonist at the bile acid receptor, also known as the farnesoid X receptor (FXR), and has negligible effects on cholesterol and lipid synthesis.[A256272]', 'Ursodeoxycholic acid (UDCA) is a secondary bile acid with cytoprotectant, immunomodulating, and choleretic effects. It reduces the cholesterol fraction of biliary lipids.[A256267]



UDCA inhibits the absorption of cholesterol in the intestine and the secretion of cholesterol into bile, decreasing biliary cholesterol saturation.[A256267] UDCA increases bile acid flow and promotes the secretion of bile acids.[A256267,A256277,A256463]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19545, 'Tender skin whitening lotion 200 ml', 'تندر لوشن تفتيح للبشرة 200 مل', '130', NULL, 'Skin care.whitening', NULL, 'Derma 10', 'Lotion', 'لوشن', '200 ml', '1', NULL, NULL, NULL, NULL, 674, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19546, 'Galvus met 50/1000mg 30 f.c. tabs', 'جالفس ميت 50/1000مجم 30 قرص', '315', '238', 'Anti-diabetic.combined secretagogues+sensitizers', 'Metformin hydrochloride+vildagliptin', 'Novartis', 'Tab', 'أقراص', '1000mg', '3', 'حالات مرضي السكري', NULL, NULL, NULL, 12208, '2024-10-09', 0, '**Metformin immediate-release formulations**

 

Metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients ≥10 years old with type 2 diabetes mellitus.[L40243]



**Metformin extended-release tablet (XR)**



The extended-release formulation of metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Safety in children has not been determined to this date.[L12207]



**Metformin combination products**



Metformin is a component of a variety of combination products with other anti-diabetic agents. It is indicated, along with diet and exercise, to improve glycemic control in adult patients with type 2 diabetes mellitus in combination with DPP-4 inhibitors ([sitagliptin], [linagliptin], [alogliptin], or [saxagliptin]),[L11479,L40248,L40253,L40258,L40263] in combination with SGLT2 inhibitors ([canagliflozin], [empagliflozin], [ertugliflozin], or [dapagliflozin]),[L11479,L30503,L1134,L13679,L38729] or in combination with [pioglitazone].[L11419]', 'Metformin''s mechanisms of action are unique from other classes of oral antihyperglycemic drugs. Metformin decreases blood glucose levels by decreasing hepatic glucose production (also called gluconeogenesis), decreasing the intestinal absorption of glucose, and increasing insulin sensitivity by increasing peripheral glucose uptake and utilization.[L12207] It is well established that metformin inhibits mitochondrial complex I activity, and it has since been generally postulated that its potent antidiabetic effects occur through this mechanism.[A36534, A36557]   The above processes lead to a decrease in blood glucose, managing type II diabetes and exerting positive effects on glycemic control.



After ingestion, the organic cation transporter-1 (OCT1) is responsible for the uptake of metformin into hepatocytes (liver cells). As this drug is positively charged, it accumulates in cells and in the mitochondria because of the membrane potentials across the plasma membrane as well as the mitochondrial inner membrane. Metformin inhibits mitochondrial complex I, preventing the production of mitochondrial ATP leading to increased cytoplasmic ADP:ATP and AMP:ATP ratios.[A36534] These changes activate AMP-activated protein kinase (AMPK), an enzyme that plays an important role in the regulation of glucose metabolism.[A176348] Aside from this mechanism, AMPK can be activated by a lysosomal mechanism involving other activators.  Following this process, increases in AMP:ATP ratio also inhibit _fructose-1,6-bisphosphatase_ enzyme, resulting in the inhibition of gluconeogenesis, while also inhibiting _adenylate cyclase_ and decreasing the production of cyclic adenosine monophosphate (cAMP),[A36534] a derivative of ATP used for cell signaling [A176351]. Activated AMPK phosphorylates two isoforms of acetyl-CoA carboxylase enzyme, thereby inhibiting fat synthesis and leading to fat oxidation, reducing hepatic lipid stores and increasing liver sensitivity to insulin.[A36534] 



In the intestines, metformin increases anaerobic glucose metabolism in enterocytes (intestinal cells), leading to reduced net glucose uptake and increased delivery of lactate to the liver. Recent studies have also implicated the gut as a primary site of action of metformin and suggest that the liver may not be as important for metformin action in patients with type 2 diabetes. Some of the ways metformin may play a role on the intestines is by promoting the metabolism of glucose by increasing glucagon-like peptide I (GLP-1) as well as increasing gut utilization of glucose.[A36534] 



In addition to the above pathway, the mechanism of action of metformin may be explained by other ways, and its exact mechanism of action has been under extensive study in recent years.[A36535, A36554, A36555, A36557]', '**General effects**



Insulin is an important hormone that regulates blood glucose levels.[T514] Type II diabetes is characterized by a decrease in sensitivity to insulin, resulting in elevations in blood glucose when the pancreas can no longer compensate. In patients diagnosed with type 2 diabetes, insulin is unable to exert adequate effects on tissues and cells (i.e. insulin resistance)[T514] and insulin deficiency may also be present.[L5753]



Metformin reduces hepatic production of glucose, decreases the intestinal absorption of glucose, and enhances insulin sensitivity by increasing both peripheral glucose uptake and utilization. In contrast with drugs of the sulfonylurea class, which lead to hyperinsulinemia, the secretion of insulin is unchanged with metformin use.[L12207]



**Effect on fasting plasma glucose (FPG) and Glycosylated hemoglobin (HbA1c)**



HbA1c is an important periodic measure of glycemic control used to monitor diabetic patients. Fasting plasma glucose is also a useful and important measure of glycemic control. In a 29-week clinical trial of subjects diagnosed with type II diabetes, metformin decreased the fasting plasma glucose levels by an average of 59 mg/dL from baseline, compared to an average increase of 6.3 mg/dL from baseline in subjects taking a placebo.[L12207]  Glycosylated hemoglobin (HbA1c) was decreased by about 1.4% in subjects receiving metformin, and increased by 0.4% in subjects receiving placebo only.[L12207]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19547, 'Viocyst 30 f.c. tabs.', 'فيوسيست 30 قرص', '250', NULL, NULL, 'Myo-inositol powder+d-chiro-inositol+folic acid', 'Viomix', 'Tab', 'أقراص', NULL, '1', NULL, NULL, '6224011160100', NULL, 1281, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19549, 'Gamifed 10 sachets', 'جاميفيد 10 اكياس', '50', NULL, 'Iron supplement', 'Lactoferrin+iron+vitamin b complex+folic acid+vitamin c+cocoa powder+chocolate flavor', 'Medcare > swivel med', 'Sachet', 'أكياس', NULL, '1', NULL, 'lactoferrin is a bioactive 80-kda iron binding glycoprotein. dosage: 1 sachet to be dissolved in quarter glass of water and taken twice daily before meals.', NULL, NULL, 870, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19550, 'Ganamotil 50mg 30 f.c. tabs.', 'جاناموتيل 50 مجم 30 قرص', '26', NULL, 'Motility stimulant', 'Itopride', 'International drug agency (idi) > novell pharma', 'Tab', 'أقراص', '50mg', '3', NULL, NULL, '6223004071553', NULL, 1681, '2022-07-14', 0, 'Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).', 'Itopride has anticholinesterase (AchE) activity as well as dopamine D2 receptor antagonistic activity. It is well established that M3 receptors exist on the smooth muscle layer throughout the gut and acetylcholine (ACh) released from enteric nerve endings stimulates the contraction of smooth muscle through M3 receptors. The enzyme AChE hydrolyses the released ACh, inactivates it and thus inhibits the gastric motility leading to various digestive disorders. Besides ACh, dopamine is present in significant amounts in the gastrointestinal tract and has several inhibitory effects on gastrointestinal motility, including reduction of lower esophageal sphincter and intragastric pressure. These effects appear to result from suppression of ACh release from the myenteric motor neurons and are mediated by the D2 subtype of dopamine receptors. Itopride, by virtue of its dopamine D2 receptor antagonism, removes the inhibitory effects on Ach release. It also inhibits the enzyme AchE which prevents the degradation of ACh. The net effect is an increase in ACh concentration, which in turn, promotes gastric motility, increases the lower esophageal sphincter pressure, accelerates gastric emptying and improves gastro-duodenal coordination. This dual mode of action of Itopride is unique and different from the actions of other prokinetic agents available in the market.

', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19551, 'Exapine 20mg/0.2ml 2 prefilled syringes', 'اكسابين 20مجم/0.2مل 2 سرنجات معبأة', '109', '98', 'Anticoagulant.low mwt heparin', 'Enoxaparin sodium', 'Wadi elneel benta', 'Syringe', 'حقنة', '20mg', '2', NULL, 'about enoxaparin sodium a low molecular weight heparin anticoagulant. mechanism of action of enoxaparin sodium enoxaparin sodium is a low molecular weight heparin that accelerates formation of antithrombin iii- thrombin complex and deactivates thrombin an', NULL, NULL, 2113, '2023-09-25', 0, 'Enoxaparin is indicated for the prevention of ischemic complications in unstable angina and in non Q-wave myocardial infarction; it is indicated in conjunction with percutaneous intervention and/or other treatment for the management of acute ST elevation myocardial infarction.[L31393]



Enoxaparin is also indicated in the prophylaxis of DVT in abdominal surgery, hip replacement, knee replacement, or medical patients with severely restricted mobility during acute illness. Additionally, enoxaparin is indicated for the inpatient treatment of DVT with or without pulmonary embolism and the treatment of outpatient DVT without pulmonary embolism.[L31393]', 'Enoxaparin binds to antithrombin III, a serine protease inhibitor, forming a complex that irreversibly inactivates factor Xa, which is frequently used to monitor anticoagulation in the clinical setting.[A228318] Following factor Xa inactivation, enoxaparin is released and binds to other anti-thrombin molecules. Factor IIa (thrombin) is directly inhibited by enoxaparin, however with less potency than unfractionated heparin (UFH). [A188051] Due to the cascade of effects resulting from enoxaparin binding, thrombin is unable to convert fibrinogen to fibrin and form a clot, preventing thromboembolic events. 

 

', 'This drug has an immediate onset of action.[L31468] Enoxaparin increases Thrombin Time (TT) and activated partial thromboplastin time (aPTT), preventing and reducing thromboembolic complications such as DVT, pulmonary embolism, and ischemic cardiac complications.[A228128] Administered at 1.5 mg/kg subcutaneously in a pharmacodynamic study, enoxaparin led to a higher ratio of anti-Factor Xa to anti-Factor IIa activity (mean ±SD, 14.0±3.1) (based on areas under anti-Factor activity versus time curves) when compared to that of heparin (mean ±SD, 1.22±0.13). Increases in the TT and aPTT were 1.8 times those of the control group.[L31393]  Enoxaparin at 1 mg/kg subcutaneously every 12 hours led to aPTT values of 45 seconds or less in most patients. Average aPTT prolongation time on Day 1 was approximately 16% higher than on Day 4 of enoxaparin therapy.[L31393]



Caution is advised during treatment with enoxaparin - the risk of hemorrhage and thrombocytopenia is increased. In pregnant women with prosthetic mechanic heart valves, the risk of thromboembolism is increased.[L31393] 

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19552, 'Gandel cream 100 gm', 'جانديل كريم 100جم', '15', NULL, 'Hair removal', 'Thioglycolic acid+calcium hydroxide+tricloasn+jojoba oil+chamomile extract+licorice extract+vitamin', 'Egyptian company for cosmetics > pearla pharm co.', 'Cream', 'كريم', '100 gm', '1', NULL, '-this cream removes the hair rapidly and easily. -it whitens the dark areas and moisturizes the skin. -it s compatible with all types of the skin.', NULL, NULL, 635, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19553, 'Ganfort eye drops solution', 'جانفورت قطرة عين 5 مل', '125', NULL, 'Antiglaucoma', 'Bimatoprost+timolol', 'Allergan > soficopharm', 'Solution', 'محلول', NULL, '1', NULL, NULL, NULL, NULL, 1151, '2022-08-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19555, 'Ganvir 0.15% ophthalmic gel 10 gm', 'جانفير جل للعين 10 جم', '55', '42', 'Antiviral.nucleoside', 'Ganciclovir', 'Orchidia pharmaceutical industries', 'Gel', 'جل', '0.15%', '1', NULL, NULL, '6224000219628', NULL, 1958, '2023-09-08', 0, 'For induction and maintenance in the treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS). Also used in the treatment of severe cytomegalovirus (CMV) disease, including CMV pneumonia, CMV gastrointestinal disease, and disseminated CMV infections, in immunocompromised patients.', 'Ganciclovir''s antiviral activity inhibits virus replication. This inhibitory action is highly selective as the drug must be converted to the active form by a virus-encoded cellular enzyme, thymidine kinase (TK). TK catalyzes phosphorylation of ganciclovir to the monophosphate, which is then subsequently converted into the diphosphate by cellular guanylate kinase and into the triphosphate by a number of cellular enzymes. <i>In vitro</i>, ganciclovir triphosphate stops replication of herpes viral DNA. When used as a substrate for viral DNA polymerase, ganciclovir triphosphate competitively inhibits dATP leading to the formation of ''faulty'' DNA. This is where ganciclovir triphosphate is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand. Ganciclovir inhibits viral DNA polymerases more effectively than it does cellular polymerase, and chain elongation resumes when ganciclovir is removed.', 'Ganciclovir is a synthetic nucleoside analogue of 2''-deoxyguanosine that inhibits replication of herpes viruses both <i>in vitro</i> and <i>in vivo</i>. Sensitive human viruses include cytomegalovirus (CMV), herpes simplex virus -1 and -2 (HSV-1, HSV-2), Epstein-Barr virus (EBV) and varicella zoster virus (VZV), however clinical studies have been limited to assessment of efficacy in patients with CMV infection. Ganciclovir is a prodrug that is structurally similar to acyclovir. It inhibits virus replication by its encorporation into viral DNA. This encorporation inhibits dATP and leads to defective DNA, ceasing or retarding the viral machinery required to spread the virus to other cells.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19556, 'Gapsolox 150mg 10 caps.', 'جابسولوكس 150 مجم 10 كبسولات', '32', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Spimaco misr', 'Cap', 'كبسولة', '150mg', '1', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 790, '2022-07-12', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19558, 'Gaptin 250mg/5ml oral solution 120 ml', 'جابتن 250مجم/5مل شراب 120 مل', '45', NULL, 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Delta pharma', 'Solution', 'محلول', '250mg', '1', 'علاج الصرع -- يخفف الالام العصبية', 'about gabapentin a gaba analogue anticonvulsant mood stabilizer. mechanism of action of gabapentin gabapentin is a gaba derivative and it bounds to lipophilic molecule. the mechanism of action of gabapentin is not exactly known. it crosses blood brain bar', NULL, NULL, 1291, '2022-08-16', 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19561, 'Garamycin 0.1% cream 15 gm', 'جاراميسين 0.1% كريم 15 جم', '22', '14', 'Antibiotic.aminoglycoside', 'Gentamicin', 'Memphis > schering plough', 'Cream', 'كريم', '0.1%', '1', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6221050130057', NULL, 2478, '2024-06-23', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19562, 'Gertadino 5mg 20 tabs', 'جيرتادينو 5مجم 20 قرص', '30', NULL, 'Antihistamine.antiallergy', 'Desloratadine', 'Aig pharma', 'Tab', 'أقراص', '5mg', '2', NULL, NULL, NULL, NULL, 927, '2022-12-07', 0, 'For the relief of symptoms of seasonal allergic rhinitis, perennial (non-seasonal) allergic rhinitis. Desloratidine is also used for the sympomatic treatment of pruritus and urticaria (hives) associated with chronic idiopathic urticaria.', 'Like other H1-blockers, Desloratadine competes with free histamine for binding at H<sub>1</sub>-receptors in the GI tract, uterus, large blood vessels, and bronchial smooth muscle. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms (eg. nasal congestion, watery eyes) brought on by histamine.', 'Desloratadine is a long-acting second-generation H<sub>1</sub>-receptor antagonist which has a selective and peripheral H1-antagonist action. Histamine is a chemical that causes many of the signs that are part of allergic reactions, such as the swelling of tissues. Histamine is released from histamine-storing cells (mast cells) and attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cell to be "activated," releasing other chemicals which produce the effects that we associate with allergies. Desloratadine blocks one type of receptor for histamine (the H1 receptor) and thus prevents activation of cells by histamine. Unlike most other antihistamines, Desloratadine does not enter the brain from the blood and, therefore, does not cause drowsiness.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19563, 'Garamycin 20mg/2ml 6 amp.', 'جاراميسين 20 مجم/2مل 6 امبول', '66', '45', 'Aminoglycoside antibiotic', 'Gentamicin', 'Memphis > schering plough', 'Amp', 'أمبول', '20mg', '6', NULL, NULL, '6221050010175', NULL, 1028, '2025-02-12', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19564, 'Garamycin 40mg/ml 6 amp.', 'جاراميسين 40مجم/مل 6 أمبول', '72', '22.5', 'Aminoglycoside antibiotic', 'Gentamicin', 'Memphis > schering plough', 'Amp', 'أمبول', '40mg', '6', NULL, NULL, '6221050010205', NULL, 1156, '2025-02-13', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19565, 'Westadiab 25 mg 10 f.c. tabs.', 'ويستادياب 25مجم 10 اقراص', '76', NULL, 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Empagliflozin', 'Western pharmaceuticals industries', 'Tab', 'أقراص', '25 mg', '1', NULL, NULL, NULL, NULL, 1319, '2024-05-20', 0, 'Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in patients aged 10 years and older with type 2 diabetes. It is used either alone or in combination with [metformin] or [linagliptin].[L13679, L13673, L13688, L49449] It is also indicated to reduce the risk of cardiovascular death in adult patients with both type 2 diabetes mellitus and established cardiovascular disease, either alone or as a combination product with metformin.[L13688, L40778]



An extended-release combination product containing empagliflozin, metformin, and linagliptin was approved by the FDA in January 2020 for the improvement of glycemic control in adults with type 2 diabetes mellitus when used adjunctively with diet and exercise.[L11479]



Empagliflozin is also approved to reduce the risk of cardiovascular mortality and hospitalization due to heart failure in adult patients with heart failure, either alone or in combination with metformin.[L13688, L45578] It is also indicated in adults to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression.[L40778, L48255]



Empagliflozin is not approved for use in patients with type 1 diabetes.', 'The vast majority of glucose filtered through the glomerulus is reabsorbed within the proximal tubule, primarily via SGLT2 (sodium-glucose linked co-transporter-2) which is responsible for ~90% of the total glucose reabsorption within the kidneys. Na<sup>+</sup>/K<sup>+</sup>-ATPase on the basolateral membrane of proximal tubular cells utilize ATP to actively pump Na+ ions into the interstitium surrounding the tubule, establishing a Na<sup>+</sup> gradient within the tubular cell. SGLT2 on the apical membrane of these cells then utilize this gradient to facilitate secondary active co-transport of both Na+ and glucose out of the filtrate, thereby reabsorbing glucose back into the blood – inhibiting this co-transport, then, allows for a marked increase in glucosuria and decrease in blood glucose levels.[A203453] Empagliflozin is a potent inhibitor of renal SGLT2 transporters located in the proximal tubules of the kidneys and works to lower blood glucose levels via an increase in glucosuria.[L13688]



Empagliflozin also appears to exert cardiovascular benefits - specifically in the prevention of heart failure - independent of its blood glucose-lowering effects, though the exact mechanism of this benefit is not precisely understood. Several theories have been posited, including the potential inhibition of Na<sup>+</sup>/H<sup>+</sup> exchanger (NHE) 1 in the myocardium and NHE3 in the proximal tubule, reduction of pre-load via diuretic/natriuretic effects and reduction of blood pressure, prevention of cardiac fibrosis via suppression of pro-fibrotic markers, and reduction of pro-inflammatory adipokines.[A203456]', 'Empagliflozin lowers blood glucose levels by preventing glucose reabsorption in the kidneys, thereby increasing the amount of glucose excreted in the urine.[L13688] It has a relatively long duration of action requiring only once-daily dosing. Patients should be monitored closely for signs and symptoms of ketoacidosis regardless of blood glucose level as empagliflozin may precipitate diabetic ketoacidosis in the absence of hyperglycemia.[L13688] As its mechanism of action is contingent on the renal excretion of glucose, empagliflozin may be held in cases of acute kidney injury and/or discontinued in patients who develop chronic renal disease. 



The overexcretion of glucose creates a sugar-rich urogenital environment which increases the risk of urogenital infections in both male and female patients - monitor closely for signs and symptoms of developing infection.[L13688]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19566, 'Garcinia cambogia 500 mg 60 vegi caps. (illegal import)', 'جارسينيا كامبوجيا 500 مجم 60 كبسولة', '0', NULL, 'Weight loss', 'Garcinia cambogia+chromium+calcium', 'Puritans pride', 'Cap', 'كبسولة', '500 mg', '1', NULL, 'garcinia cambogia is a small pumpkin-shaped fruit that is native to indonesia. it is related to the superfruit mangosteen and is sometimes called tamarind brindleberry or camboge. garcinia cambogia has been used in ayurvedic practices for hundreds of year', NULL, NULL, 873, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19567, 'Garcinia cambogia 750 mg 60 caplets (illegal import)', 'جارسينيا كامبوجيا 750 مجم 60 كبسولة', '0', NULL, 'Weight loss', 'Garcinia cambogia+chromium+calcium', 'Puritans pride', 'Cap', 'كبسولة', '750 mg', '1', NULL, 'garcinia cambogia is a small pumpkin-shaped fruit that is native to indonesia. it is related to the superfruit mangosteen and is sometimes called tamarind brindleberry or camboge. garcinia cambogia has been used in ayurvedic practices for hundreds of year', NULL, NULL, 847, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19568, 'Gardasil vaccine vial', 'جاردازيل لقاح فيال', '1,341', '937.5', 'Vaccine', 'Human papillomavirus vaccine', 'Merck sharp & dohme > merck sharp & dohme scientific office', 'Vial', 'فيال', NULL, '1', NULL, NULL, NULL, NULL, 1887, '2024-10-21', 0, 'Human immunoglobulin G is indicated for the following conditions:



### Primary Immunodeficiency

- for the treatment of primary immunodeficiency in adult and pediatric patients[L39920, L39930, L39935, L39940, L39945, L39950, L39955, L39960, L39965, L39975, L39980, L40029, L40034, L40044]

- in combination with [hyaluronidase (human recombinant)] for the treatment of primary immunodeficiency in patients ≥2 years of age.[L42760]



### Immune Thrombocytopenic Purpura (ITP)

- for the treatment of acute or chronic immune thrombocytopenic purpura in adult and pediatric patients[L39940, L39950, L39960, L39965, L39970, L39975, L39980]



### Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

- for the treatment of CIDP in adult patients[L39955, L39965, L39975, L39980, L40034]

- in combination with hyaluronidase (human recombinant) as a maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP)[L40039]



### Multifocal Motor Neuropathy (MMN)

- for maintenance therapy to improve muscle strength and disability in adult patients with MMN[L39955]



### Prophylaxis of Bacterial Infection

- for the prevention of bacterial infections in patients with hypogammaglobulinemia and/or B-cell chronic lymphocytic leukemia[L39960]



### Coronary Artery Aneurysm Associated With Kawasaki Syndrome

- for the prevention of coronary artery aneurysms in pediatric patients with Kawasaki syndrome[L39960]



### Dermatomyositis

- for the treatment of dermatomyositis in adult patients[L39970]

', 'IVIg interacts with a number of different components of the immune system, including cytokines, complement, Fc receptors and several cell surface immunocompetent molecules. IVIg also impacts different effector cells of the immune system (B and T lymphocytes, dendritic cells, etc.) and regulates a wide range of genes. Its main mechanism of actions are believed to be Fc-dependent and F(ab'')2-dependent. IVIg competitively blocks gamma Fc receptors, preventing the binding and ingestion of phagocytes and suppressing platelet depletion. IVIg contains a number of different antobodies, which prevent infection by attaching to the surface of invading pathogens and aiding in their disposal before they can infect cells. Antibodies remove pathogens via complement activation, agglutination or precipitation, pathogen receptor blocking, macrophage “tagging” or neutralization (via binding) of pathogen toxins. Intact IVIg and F(ab′)2 fragments of IVIg can also neutralize the activity of various autoantibodies. By triggering the production of interleukin-1 receptor antagonist, IVIg modulates of the production of cytokines and cytokine antagonists. It also prevents the generation of the C5b-9 membrane attack complex and subsequent complement-mediated tissue damage by binding active complement components.', 'Used as a replacement therapy in inherited humoral immunodeficiency disorders such as severe combined immunodeficiency syndrome, x-linked agammaglobulinemia, and Wiskott-Aldrich Syndrome. The immunoglobulins target, bind and kill bacterial cells as well as viral particles. IgG is the monomeric immunoglobulin of which there are four subclasses (IgG1, IgG2, IgG3 and IgG4) in differing abundances (66%, 23%, 7% and 4%). IgAs represent about 15% of the immunoglobulins in the blood. These target inhaled or ingested pathogens.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19570, 'Gardinova 312mg/5ml 70ml susp.', 'جاردينوفا 312مجم/5مل 70 مل مضاد حيوي', '28', '14.4', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+clavulanic acid', 'Rameda > alfacure pharmaceuticals', 'Susp', 'معلق', '312mg', '1', NULL, 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', NULL, NULL, 918, '2025-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19571, 'Gardinova 457mg/5ml 70ml susp.', 'جاردينوفا 457مجم/5مل 70 مل', '87', '60.5', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+clavulanic acid', 'Rameda > alfacure pharmaceuticals', 'Susp', 'معلق', '457mg', '1', NULL, 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', NULL, NULL, 992, '2024-10-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19572, 'Gardocal mouth wash 250 ml', 'جاردوكال غسول للفم 250 مل', '39', NULL, 'Oral care', 'Triclosan+sodium fluoride+zinc chloride+xylitol', 'Sigma > concord pharmaceutical industries', 'Mouth wash', 'غسول للفم', '250 ml', '1', NULL, NULL, NULL, NULL, 841, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19573, 'Gardovas 5 mg 30 f.c. tabs', 'جاردوفاس 5مجم 30 اقراص', '1,809', '1386', 'Pulmonary hypertension', 'Ambrisentan', 'Aug pharma', 'Tab', 'أقراص', '5 mg', '3', 'ارتفاع ضغط الشريان الرئوي', NULL, NULL, NULL, 6354, '2025-02-24', 0, 'Ambrisentan is indicated for treatment of idiopathic (‘primary’) pulmonary arterial hypertension (IPAH) and pulmonary arterial hypertension (PAH) associated with connective tissue disease in patients with WHO functional class II or III symptoms. In the United States of America, ambrisentan is also indicated in combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability.', 'Endothelin-1 (ET-1) is an endogenous peptide that acts on the endothelin type A (ETA) and endothelin type B (ETB) receptors in vascular smooth muscle and endothelium. ETA-mediated actions include vasoconstriction and cell proliferation, whereas ETB predominantly mediates vasodilation, anti-proliferation, and ET-1 clearance. In patients with pulmonary arterial hypertension, ET-1 levels are increased and correlate with increased right arterial pressure and severity of disease.

Ambrisentan is one of several newly developed vasodilator drugs that selectively target the endothelin type A (ETA) receptor, inhibiting its action and preventing vasoconstriction. Selective inhibition of the ETA receptor prevents phospholipase C-mediated vasoconstriction and protein kinase C-mediated cell proliferation. Endothelin type B (ETB) receptor function is not significantly inhibited, and nitric oxide and prostacyclin production, cyclic GMP- and cyclic AMP-mediated vasodilation, and endothelin-1 (ET-1) clearance is preserved.', 'Ambrisentan 10 mg daily had no significant effect on the QTc interval, whereas a 40 mg daily dose of ambrisentan increased mean QTc at tmax by 5 ms with an upper 95% confidence limit of 9 ms. Significant QTc prolongation is not expected in patients taking ambrisentan without concomitant metabolic inhibitors. 

Plasma concentrations of B-type natriuretic peptide (BNP) in patients who received ambrisentan for 12 weeks were significantly decreased. Two Phase III placebo-controlled studies demonstrated a decrease in BNP plasma concentrations by 29% in the 2.5 mg group, 30% in the 5 mg group, and 45% in the 10 mg group (p < 0.001 for each dose group) and an increase by 11% in the placebo group.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19574, 'Gardex 10 sachets', 'جاردكس 10 اكياس', '55', '55', 'Support intestinal system', 'Protein+fatty acid+agar+probiotics', 'Healthy tech pharma > nutr-med pharma', 'Sachet', 'أكياس', NULL, '1', 'بروتين لامداد الجهاز المعوي', 'nutrition and immunity neonatal jaundice 3 sachets per day dissolve in 5 ml', NULL, NULL, 2493, '2024-10-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19576, 'Garlic odorless 1000 mg 100 softgels (puritans pride)', 'جارليك اودورليس 1000 مجم 100 قرص', '575', NULL, 'Antioxidant', 'Garlic', 'Puritans pride', 'Gel', 'جل', '1000 mg', '1', NULL, '-traditionally used for heart health -used for its antioxidant properties -traditionally used to help maintain healthy circulation -garlic has been traditionally used to support heart and cardiovascular health. its the natural ingredients in garlic that g', '614299512658', NULL, 826, '2022-08-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19579, 'Kiara-soft 120 gm cream', 'كيارا سوفت كريم 120 جم', '150', NULL, 'Anti-aging cream soothing& hydration cream for skin', 'Caffeine anhydrous+l carnitine hcl+panthenol+chamomile extract+ascorbic acid+tocopherol acetate+beta carotene+hydrolyzed collagen (marine source)+sodium hyaluronate+glycerin+triethanolamine', 'Eureka beauty foundation', 'Cream', 'كريم', '120 gm', '1', NULL, NULL, NULL, NULL, 812, '2024-06-15', 0, 'Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth.[T716,L9851] In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs.[L9899] Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.[T716,L9854,L9872]', 'The mechanism of action of caffeine is complex, as it impacts several body systems, which are listed below. The effects as they relate to various body systems are described as follows:



**General and cellular actions**



Caffeine exerts several actions on cells, but the clinical relevance is poorly understood. One probable mechanism is the inhibition of nucleotide phosphodiesterase enzymes, adenosine receptors, regulation of calcium handling in cells, and participates in adenosine receptor antagonism.[A187721,L9857] Phosphodiesterase enzymes regulate cell function via actions on second messengers cAMP and cGMP.[A187724] This causes lipolysis through activation of hormone-sensitive lipases, releasing fatty acids and glycerol.[T722]



**Respiratory**



The exact mechanism of action of caffeine in treating apnea related to prematurity is unknown, however, there are several proposed mechanisms, including respiratory center stimulation in the central nervous system, a reduced threshold to hypercapnia with increased response, and increased consumption of oxygen, among others.[L9851] The blocking of the adenosine receptors enhances respiratory drive via an increase in brain medullary response to carbon dioxide, stimulating ventilation and respiratory drive, while increasing contractility of the diaphragm.[T716]



**Central nervous system**



Caffeine demonstrates antagonism of all 4 adenosine receptor subtypes (A1, A2a, A2b, A3) in the central nervous system.[T716,L9851] Caffeine''s effects on alertness and combatting drowsiness are specifically related to the antagonism of the A2a receptor.[T716]



**Renal system**



Caffeine has diuretic effects due to is stimulatory effects on renal blood flow, increase in glomerular filtration, and increase in sodium excretion.[T716]



**Cardiovascular system**



Adenosine receptor antagonism at the A1 receptor by caffeine stimulates inotropic effects in the heart. Blocking of adenosine receptors promotes catecholamine release, leading to stimulatory effects occurring in the heart and the rest of the body.  In the blood vessels, caffeine exerts direct antagonism of adenosine receptors, causing vasodilation. It stimulates the endothelial cells in the blood vessel wall to release nitric oxide, potentiating blood vessel relaxation. Catecholamine release, however, antagonizes this and exerts inotropic and chronotropic effects on the heart, ultimately leading to vasoconstriction. Finally, caffeine is shown to raise systolic blood pressure measurements by 5 to 10 mmHg when it is not taken regularly, versus no effect in those who consume it regularly.[T716] The vasoconstricting effects of caffeine are beneficial in migraines and other types of headache, which are normally caused by vasodilation in the brain.[A187709,L9872]', 'Caffeine stimulates the central nervous system (CNS), heightening alertness, and sometimes causing restlessness and agitation. It relaxes smooth muscle, stimulates the contraction of cardiac muscle, and enhances athletic performance.[A298,T716,L9857] Caffeine promotes gastric acid secretion and increases gastrointestinal motility. It is often combined in products with analgesics and ergot alkaloids, relieving the symptoms of migraine and other types of headaches. Finally, caffeine acts as a mild diuretic.[T716]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19580, 'Gasec 20mg 7 caps.', 'جازيك 20مجم 7 كبسولات', '26', NULL, 'Peptic ulcer.proton pump inhibitor', 'Omeprazole', 'Mup > acino', 'Cap', 'كبسولة', '20mg', '1', NULL, NULL, NULL, NULL, 1265, '2023-04-18', 0, 'Omeprazole, according to the FDA label [FDA label] is a proton pump inhibitor (PPI) used for the following purposes:



• Treatment of active duodenal ulcer in adults 



• Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer

recurrence in adults 



• Treatment of active benign gastric ulcer in adults 



• Reduction of risk of upper gastrointestinal (GI) bleeding in critically ill adult patients.



• Treatment of symptomatic gastroesophageal reflux disease (GERD) in

patients 1 year of age and older 



• Treatment of erosive esophagitis (EE) due to acid-mediated GERD in

patients 1 month of age and older 



• Maintenance of healing of EE due to acid-mediated GERD in patients 1

year of age and older 



• Pathologic hypersecretory conditions in adults', 'Hydrochloric acid (HCl) secretion into the gastric lumen is a process regulated mainly by the H(+)/K(+)-ATPase of the proton pump [A175180], expressed in high quantities by the parietal cells of the stomach. ATPase is an enzyme on the parietal cell membrane that facilitates hydrogen and potassium exchange through the cell, which normally results in the extrusion of potassium and formation of HCl (gastric acid) [A174295].



Omeprazole is a member of a class of antisecretory compounds, the substituted _benzimidazoles_, that stop gastric acid secretion by selective inhibition of the _H+/K+ ATPase_ enzyme system. Proton-pump inhibitors such as omeprazole bind covalently to cysteine residues via disulfide bridges on the alpha subunit of the _H+/K+ ATPase_ pump, inhibiting gastric acid secretion for up to 36 hours [A175192].  This antisecretory effect is dose-related and leads to the inhibition of both basal and stimulated acid secretion, regardless of the stimulus [FDA label].  



**Mechanism of H. pylori eradication**



Peptic ulcer disease (PUD) is frequently associated with _Helicobacter pylori_ bacterial infection (NSAIDs) [A175195]. The treatment of H. pylori infection may include the addition of omeprazole or other proton pump inhibitors as part of the treatment regimen [FDA label], [A175198]. 

_H. pylori_ replicates most effectively at a neutral pH [A175213]. Acid inhibition in H. pylori eradication therapy, including proton-pump inhibitors such as omeprazole, raises gastric pH, discouraging the growth of H.pylori [A175198]. It is generally believed that proton pump inhibitors inhibit the _urease_ enzyme, which increases the pathogenesis of H. pylori in gastric-acid related conditions [A175216].   ', '**Effects on gastric acid secretion**



This drug decreases gastric acid secretion [FDA label]. After oral administration, the onset of the antisecretory effect of omeprazole is usually achieved within one hour, with the maximum effect occurring by 2 hours after administration. The inhibitory effect of omeprazole on acid secretion increases with repeated once-daily dosing, reaching a plateau after four days [FDA label].



**Effects on serum gastrin**



In studies of 200 or more patients, serum gastrin levels increased during the first 1-2 weeks of daily administration of therapeutic doses of omeprazole. This occurred in a parallel fashion with the inhibition of acid secretion. No further increase in serum gastrin occurred with continued omeprazole administration. Increased gastrin causes enterochromaffin-like cell hyperplasia and increased serum Chromogranin A (CgA) levels. The increased CgA levels may lead to false positive results in diagnostic studies for neuroendocrine tumors [FDA label].



**Enterochromaffin-like (ECL) cell effects**



Human gastric biopsy samples have been obtained from more than 3000 pediatric and adult patients treated with omeprazole in long-term clinical studies. The incidence of enterochromaffin-like cell hyperplasia in these studies increased with time; however, no case of ECL cell carcinoids, dysplasia, or neoplasia have been identified in these patients. These studies, however, are of insufficient in power and duration to draw conclusions on the possible influence of long-term administration of omeprazole in the development of any premalignant or malignant conditions [FDA label]. 



**Other effects**



Systemic effects of omeprazole in the central nervous system, cardiovascular and respiratory systems have not been found to date. Omeprazole, given in oral doses of 30 or 40 mg for 2-4 weeks, showed no effect on thyroid function, carbohydrate metabolism, or circulating levels of parathyroid hormone, cortisol, estradiol, testosterone, prolactin, cholecystokinin or secretin [FDA label]. 





', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19583, 'Gasmovac 5mg 20 tab. (n/a)', 'جاسموفاك 5مجم 20 قرص', '45', NULL, 'Selective 5ht4 agonist', 'Mosapride', 'Delta pharma > advocure', 'Tab', 'أقراص', '5mg', '2', NULL, NULL, '6224009460021', NULL, 1275, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19584, 'Gaspepsia soft gelatin 30 cap.', 'جاس بيبسيا 30 كبسولة', '40', NULL, 'Antiflatulent', 'Calcium carbonate+simethicone', 'Medizen pharmaceutical industries > egygel pharma for pharmaceutical industries-egypt', 'Cap', 'كبسولة', NULL, '3', NULL, 'about simethicone oral anti-foaming agent silicones antiflatulent. mechanism of action of simethicone this anti-gas (anti-flatulence) medication acts in the stomach and intestines to change the surface tension of gas bubbles enabling smaller bubbles to jo', NULL, NULL, 1518, '2022-08-15', 0, 'Calcium acetate is one of a number of calcium salts used to treat hyperphosphatemia (too much phosphate in the blood) in patients with kidney disease.', 'Calcium acetate and other calcium salts are phosphate binders. They work by binding with the phosphate in the food you eat, so that it is eliminated from the body without being absorbed.', 'Patients with advanced renal insufficiency (creatinine clearance less than 30 ml/min) exhibit phosphate retention and some degree of hyperphosphatemia. The retention of phosphate plays a pivotal role in causing secondary hyperparathyroidism associated with osteodystrophy, and soft-tissue calcification. The mechanism by which phosphate retention leads to hyperparathyroidism is not clearly delineated. Therapeutic efforts directed toward the control of hyperphosphatemia include reduction in the dietary intake of phosphate, inhibition of absorption of phosphate in the intestine with phosphate binders, and removal of phosphate from the body by more efficient methods of dialysis. The rate of removal of phosphate by dietary manipulation or by dialysis is insufficient. Dialysis patients absorb 40% to 80% of dietary phosphorus. Therefore, the fraction of dietary phosphate absorbed from the diet needs to be reduced by using phosphate binders in most renal failure patients on maintenance dialysis. Calcium acetate when taken with meals combines with dietary phosphate to form insoluble calcium phosphate which is excreted in the feces. Maintenance of serum phosphorus below 6.0 mg/dl is generally considered as a clinically acceptable outcome of treatment with phosphate binders. Calcium acetate is highly soluble at neutral pH, making the calcium readily available for binding to phosphate in the proximal small intestine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19585, 'Gast minoxy 5% topical solution', 'جاست مينوكسي 5% محلول', '35', NULL, 'Antihypertensives.hair regrowth.vasodilator agents', 'Minoxidil', 'Egyptian co. for adv. pharma. (ecap) > gast pharma group', 'Solution', 'محلول', '5%', '1', NULL, 'about minoxidil a potassium channel agonist direct-acting vasodilator hair- growth stimulant in androgenic alopecia. mechanism of action of minoxidil minoxidil works by activating pghs 1 (prostaglandin endoperoxide synthase-1) which helps promote hair gro', NULL, NULL, 823, '2022-07-12', 0, 'For the treatment of severe hypertension and in the topical treatment (regrowth) of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia.', 'Minoxidil is thought to promote the survival of human dermal papillary cells (DPCs) or hair cells by activating both extracellular signal-regulated kinase (ERK) and Akt and by preventing cell death by increasing the ratio of BCl<sup>-</sup>2/Bax. Minoxidil may stimulate the growth of human hairs by prolonging anagen through these proliferative and anti-apoptotic effects on DPCs. Minoxidil, when used as a vasodilator, acts by opening adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells. This vasodilation may also improve the viability of hair cells or hair follicles.', 'Minoxidil is an orally effective direct acting peripheral vasodilator that reduces elevated systolic and diastolic blood pressure by decreasing peripheral vascular resistance. Minoxidil is also used topically to treat androgenetic alopecia. Microcirculatory blood flow in animals is enhanced or maintained in all systemic vascular beds. In man, forearm and renal vascular resistance decline; forearm blood flow increases while renal blood flow and glomerular filtration rate are preserved. The predominant site of minoxidil action is arterial. Venodilation does not occur with minoxidil; thus, postural hypotension is unusual with its administration. The antihypertensive activity of minoxidil is due to its sulphate metabolite, minoxidil sulfate.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19587, 'Gastobenz 20% (25ml) top. spray sol.', 'جاستوبنز 20% سبراي 25 مل', '12', NULL, 'Analgesic.local anesthetic', 'Benzocaine', 'Egyptian co. for adv. pharma. (ecap) > gast pharma group', 'Sol', 'محلول', '20%', '1', NULL, 'about benzocaine ester local anesthetic mechanism of action of benzocaine it binds to sodium channel and reversibly stabilizes the neuronal membrane which decreases its permeability to sodium ions. this results the blocking of depolarization of the neuron', NULL, NULL, 1064, '2022-07-12', 0, 'Benzocaine is indicated for local anesthesia in dentistry, minor trauma, and as preparation for infiltrative anesthesia.[A231219] Benzocaine products are indicated for topical anesthesia in a wide variety of conditions including skin irritation,[L32454] oral pain,[L32459] and hemorrhoids.[L32464]', 'Benzocaine diffuses into nerve cells where it binds to sodium channels, preventing the channels from opening, and blocking the influx of sodium ions.[A231129,A6271,A231219] Nerve cells unable to allow sodium into cells cannot depolarize and conduct nerve impulses.[A6271,A231219]', 'Benzocaine is indicated for use as a topical anesthetic.[A231219] It has a duration of action of approximately 10 minutes[A231254] and a wide therapeutic window.[A231219] Patients should be counselled regarding the risks of methemoglobinemia.[A231219,A231234,A231244,A231249]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19588, 'Gastobenz 20% (50ml) top. spray sol.', 'جاستروبينز اسبراي للجلد', '20', NULL, 'Analgesic.local anesthetic', 'Benzocaine', 'Egyptian co. for adv. pharma. (ecap) > gast pharma group', 'Sol', 'محلول', '20%', '1', 'مخدر موضعي -- تخفيف الالام الناتجة عن الشرخ الشرجي -- علاج مشكلة سرعة القذف لدي الرجال', 'about benzocaine ester local anesthetic mechanism of action of benzocaine it binds to sodium channel and reversibly stabilizes the neuronal membrane which decreases its permeability to sodium ions. this results the blocking of depolarization of the neuron', NULL, NULL, 1300, '2022-05-12', 0, 'Benzocaine is indicated for local anesthesia in dentistry, minor trauma, and as preparation for infiltrative anesthesia.[A231219] Benzocaine products are indicated for topical anesthesia in a wide variety of conditions including skin irritation,[L32454] oral pain,[L32459] and hemorrhoids.[L32464]', 'Benzocaine diffuses into nerve cells where it binds to sodium channels, preventing the channels from opening, and blocking the influx of sodium ions.[A231129,A6271,A231219] Nerve cells unable to allow sodium into cells cannot depolarize and conduct nerve impulses.[A6271,A231219]', 'Benzocaine is indicated for use as a topical anesthetic.[A231219] It has a duration of action of approximately 10 minutes[A231254] and a wide therapeutic window.[A231219] Patients should be counselled regarding the risks of methemoglobinemia.[A231219,A231234,A231244,A231249]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19589, 'Hiberix vaccine 1mg 1ml', 'هيبيريكس لقاح 1مجم 1 مل', '50', NULL, 'Vaccine', 'Haemophilus influenza+tetanus toxoid', 'Glaxo smithkline > modern pharma', 'Unknown', 'غير محدد', '1mg', '1', NULL, NULL, NULL, NULL, 872, '2022-10-09', 0, 'Indicated for active immunization in pediatric patients 15 months through 4 years of age as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b. ', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19591, 'Gastrobiotic 550 mg 20 f.c. tab.', 'جاستروبيوتيك 550مجم 20 قرص', '344', NULL, 'Travelers diarrhea', 'Rifaximin', 'Andalous pharma', 'Tab', 'أقراص', '550 mg', '2', NULL, NULL, NULL, NULL, 1521, '2022-12-05', 0, 'Rifaximin has multiple indications by the FDA: for the treatment of patients (≥12 years of age) with traveller''s diarrhea caused by noninvasive strains of Escherichia coli; for the reduction of overt hepatic encephalopathy recurrence in patients ≥18 years of age; and in May 2015 it was approved for irritable bowel syndrome with diarrhea (IBS-D) treatment in adult men and women. ', 'Rifaximin acts by inhibiting RNA synthesis in susceptible bacteria by binding to the beta-subunit of bacterial deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase enzyme. This binding blocks translocation, which stops transcription.', 'Rifaximin is a structural analog of rifampin and a non-systemic, gastrointestinal site-specific antibiotic. This non-systemic property of the drug is due to the addition of a pyridoimidazole ring, which renders it non-absorbable. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis and contributes to restore intestinal microflora imbalance. Other studies have also shown rifaximin to be an pregnane X receptor (PXR) activator. As PXR is responsible for inhibiting the proinflammatory transcription factor NF-kappa B (NF-κB) and is inhibited in inflammatory bowel disease (IBD), rifaximin was proven to be effective for the treatment of IBS-D.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19592, 'Gast-reg 100 mg 30 tabs.', 'جاست ريج 100مجم 30 قرص', '72', '46.5', 'Antimuscarinic.irritable bowel syndrome', 'Trimebutine', 'Amoun', 'Tab', 'أقراص', '100 mg', '3', 'ارتجاع المريء وحرقان المعدة.', NULL, '6221025023834', NULL, 6327, '2024-07-14', 0, 'Indicated for symptomatic treatment of irritable bowel syndrome (IBS) and treatment of postoperative paralytic ileus following abdominal surgery. ', 'At high concentrations, trimebutine is shown to inhibit the extracellular Ca2+ influx in the smooth muscle cells through voltage dependent L-type Ca2+ channels and further Ca2+ release from intracellular Ca2+ stores [A19691, A19689]. Trimebutine is suggested to bind to the inactivated state of the calcium channel with high affinity. Reduced calcium influx attenuates membrane depolarization and decrease colon peristalsis. It also inhibits outward K+ currents in response to membrane depolarization of the GI smooth muscle cells at resting conditions through inhibition of delayed rectifier K+ channels and Ca2+ dependent K+ channels, which results in induced muscle contractions [A19691, A19695]. Trimebutine binds to mu opioid receptors with more selectivity compared to delta or kappa opioid receptors but with lower affinity than their natural ligands. Its metabolites (N-monodesmethyl-trimebutine or nor-trimebutine), are also shown to bind to opoid receptors on brain membranes and myenteric synaptosomes [A19692]. ', 'Trimebutine is a spasmolytic agent that acts directly on smooth muscle to modulate gastric motility. It shows a "dual function" that stimulates or inhibits spontaneous contractions depending on the concentration and prior contractile activity in the preparation. Targeting ion conductance that regulates GI motility, trimebutine inhibits the inward calcium currents and calcium-dependent potassium currents in a concentration-dependent manner [A19691]. At lower concentrations (1-10uM), trimebutine depolarizes the resting membrane potential without affecting the amplitude of contractions, which is thought to be mediated by inhibition of outward potassium currents. It is also shown to activate T-type Ca2+ channel and increase gastric emptying, intestinal and colonic contractility [A19690]. At higher concentrations (100-300uM), reduced amplitude of spontaneous contractions and action potentials is thought to be mediated by inhibition of L-type Ca2+ channels and inward calcium current [A19691]. Trimebutine mediates a local anesthetic action by acting as a weak agonist at mu opioid receptors.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19593, 'Gast-reg 100mg 5 supp', 'جاست ريج 100مجم 5 لبوسات', '5', NULL, 'Antimuscarinic.irritable bowel syndrome', 'Trimebutine', 'Amoun', 'Supp', 'لبوس', '100mg', '1', 'ارتجاع المريء وحرقان المعدة.', NULL, '6221025013019', NULL, 1493, '2022-12-05', 0, 'Indicated for symptomatic treatment of irritable bowel syndrome (IBS) and treatment of postoperative paralytic ileus following abdominal surgery. ', 'At high concentrations, trimebutine is shown to inhibit the extracellular Ca2+ influx in the smooth muscle cells through voltage dependent L-type Ca2+ channels and further Ca2+ release from intracellular Ca2+ stores [A19691, A19689]. Trimebutine is suggested to bind to the inactivated state of the calcium channel with high affinity. Reduced calcium influx attenuates membrane depolarization and decrease colon peristalsis. It also inhibits outward K+ currents in response to membrane depolarization of the GI smooth muscle cells at resting conditions through inhibition of delayed rectifier K+ channels and Ca2+ dependent K+ channels, which results in induced muscle contractions [A19691, A19695]. Trimebutine binds to mu opioid receptors with more selectivity compared to delta or kappa opioid receptors but with lower affinity than their natural ligands. Its metabolites (N-monodesmethyl-trimebutine or nor-trimebutine), are also shown to bind to opoid receptors on brain membranes and myenteric synaptosomes [A19692]. ', 'Trimebutine is a spasmolytic agent that acts directly on smooth muscle to modulate gastric motility. It shows a "dual function" that stimulates or inhibits spontaneous contractions depending on the concentration and prior contractile activity in the preparation. Targeting ion conductance that regulates GI motility, trimebutine inhibits the inward calcium currents and calcium-dependent potassium currents in a concentration-dependent manner [A19691]. At lower concentrations (1-10uM), trimebutine depolarizes the resting membrane potential without affecting the amplitude of contractions, which is thought to be mediated by inhibition of outward potassium currents. It is also shown to activate T-type Ca2+ channel and increase gastric emptying, intestinal and colonic contractility [A19690]. At higher concentrations (100-300uM), reduced amplitude of spontaneous contractions and action potentials is thought to be mediated by inhibition of L-type Ca2+ channels and inward calcium current [A19691]. Trimebutine mediates a local anesthetic action by acting as a weak agonist at mu opioid receptors.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19594, 'Nano flex 50 gm gel', 'نانو فليكس جل 50 جم', '189', NULL, 'Massage cream', 'Boswellia serrata resin extract+menthol+eucalyptus oil+lecithin+polysorbate 80+sorbitan stearate', 'Modern nano', 'Gel', 'جل', '50 gm', '1', '-- حالات الإمساك المزمن والقولون.', NULL, '6225000635913', NULL, 1000, '2024-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19595, 'Gast-reg 24mg/5ml 125ml susp', 'جاست ريج 24مجم/5مل 125 مل معلق', '33', '17.5', 'Antimuscarinic.irritable bowel syndrome', 'Trimebutine', 'Amoun', 'Susp', 'معلق', '24mg', '1', 'ارتجاع المريء وحرقان المعدة.', NULL, '6221025012005', NULL, 3551, '2024-11-07', 0, 'Indicated for symptomatic treatment of irritable bowel syndrome (IBS) and treatment of postoperative paralytic ileus following abdominal surgery. ', 'At high concentrations, trimebutine is shown to inhibit the extracellular Ca2+ influx in the smooth muscle cells through voltage dependent L-type Ca2+ channels and further Ca2+ release from intracellular Ca2+ stores [A19691, A19689]. Trimebutine is suggested to bind to the inactivated state of the calcium channel with high affinity. Reduced calcium influx attenuates membrane depolarization and decrease colon peristalsis. It also inhibits outward K+ currents in response to membrane depolarization of the GI smooth muscle cells at resting conditions through inhibition of delayed rectifier K+ channels and Ca2+ dependent K+ channels, which results in induced muscle contractions [A19691, A19695]. Trimebutine binds to mu opioid receptors with more selectivity compared to delta or kappa opioid receptors but with lower affinity than their natural ligands. Its metabolites (N-monodesmethyl-trimebutine or nor-trimebutine), are also shown to bind to opoid receptors on brain membranes and myenteric synaptosomes [A19692]. ', 'Trimebutine is a spasmolytic agent that acts directly on smooth muscle to modulate gastric motility. It shows a "dual function" that stimulates or inhibits spontaneous contractions depending on the concentration and prior contractile activity in the preparation. Targeting ion conductance that regulates GI motility, trimebutine inhibits the inward calcium currents and calcium-dependent potassium currents in a concentration-dependent manner [A19691]. At lower concentrations (1-10uM), trimebutine depolarizes the resting membrane potential without affecting the amplitude of contractions, which is thought to be mediated by inhibition of outward potassium currents. It is also shown to activate T-type Ca2+ channel and increase gastric emptying, intestinal and colonic contractility [A19690]. At higher concentrations (100-300uM), reduced amplitude of spontaneous contractions and action potentials is thought to be mediated by inhibition of L-type Ca2+ channels and inward calcium current [A19691]. Trimebutine mediates a local anesthetic action by acting as a weak agonist at mu opioid receptors.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19597, 'Gastrobiotic 200 mg 20 f.c.tab.', 'جاستروبيوتك 200مجم 20 قرص', '243', '162', 'Travelers diarrhea', 'Rifaximin', 'Andalous pharma', 'Tab', 'أقراص', '200 mg', '2', 'مطهر معوي للاسهال والنزلات المعوية', NULL, '6224000396817', NULL, 2563, '2025-11-03', 0, 'Rifaximin has multiple indications by the FDA: for the treatment of patients (≥12 years of age) with traveller''s diarrhea caused by noninvasive strains of Escherichia coli; for the reduction of overt hepatic encephalopathy recurrence in patients ≥18 years of age; and in May 2015 it was approved for irritable bowel syndrome with diarrhea (IBS-D) treatment in adult men and women. ', 'Rifaximin acts by inhibiting RNA synthesis in susceptible bacteria by binding to the beta-subunit of bacterial deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase enzyme. This binding blocks translocation, which stops transcription.', 'Rifaximin is a structural analog of rifampin and a non-systemic, gastrointestinal site-specific antibiotic. This non-systemic property of the drug is due to the addition of a pyridoimidazole ring, which renders it non-absorbable. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis and contributes to restore intestinal microflora imbalance. Other studies have also shown rifaximin to be an pregnane X receptor (PXR) activator. As PXR is responsible for inhibiting the proinflammatory transcription factor NF-kappa B (NF-κB) and is inhibited in inflammatory bowel disease (IBD), rifaximin was proven to be effective for the treatment of IBS-D.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19598, 'Gastrobiotic 550mg 30 f.c. tab.', 'جاستروبيوتيك 550مجم 30 قرص', '516', '360', 'Travelers diarrhea', 'Rifaximin', 'Andalous pharma', 'Tab', 'أقراص', '550mg', '3', 'حالات الاسهال المصحوبة للمسافرين بسبب الطعام والشراب المختلف عن بلدهم', NULL, '6223004693243', NULL, 18378, '2024-06-30', 0, 'Rifaximin has multiple indications by the FDA: for the treatment of patients (≥12 years of age) with traveller''s diarrhea caused by noninvasive strains of Escherichia coli; for the reduction of overt hepatic encephalopathy recurrence in patients ≥18 years of age; and in May 2015 it was approved for irritable bowel syndrome with diarrhea (IBS-D) treatment in adult men and women. ', 'Rifaximin acts by inhibiting RNA synthesis in susceptible bacteria by binding to the beta-subunit of bacterial deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase enzyme. This binding blocks translocation, which stops transcription.', 'Rifaximin is a structural analog of rifampin and a non-systemic, gastrointestinal site-specific antibiotic. This non-systemic property of the drug is due to the addition of a pyridoimidazole ring, which renders it non-absorbable. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis and contributes to restore intestinal microflora imbalance. Other studies have also shown rifaximin to be an pregnane X receptor (PXR) activator. As PXR is responsible for inhibiting the proinflammatory transcription factor NF-kappa B (NF-κB) and is inhibited in inflammatory bowel disease (IBD), rifaximin was proven to be effective for the treatment of IBS-D.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19600, 'Gastrodomina 20mg 20 tab.', 'جاسترودومينا 20 مجم 20 قرص', '28', '16', 'Peptic ulcer.anti-histamine.h2 antagonist', 'Famotidine', 'Mup > almirall prodes-spain', 'Tab', 'أقراص', '20mg', '2', 'علاج قرحة المعدة والاثني عشر -- علاج زيادة افرازات المعدة', 'about famotidine guanidine:thiazole derivative a histamine h2-receptor antagonist anti-secretory antiulcer. mechanism of action of famotidine famotidine is a h2 (histamine) receptor antagonist. histamine is the most potent stimulus of acid secretion and a', '6221508516716', NULL, 2126, '2024-10-21', 0, 'Famotidine is indicated in pediatric and adult patients (with the bodyweight of 40 kg and above) for the management of active duodenal ulcer (DU), active gastric ulcer, symptomatic non-erosive gastroesophageal reflux disease (GERD), and erosive esophagitis due to GERD, diagnosed by biopsy.[L11139]



It is also indicated in adult patients for the treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine neoplasias) and reduction of the risk of DU recurrence.[L11139]



The intravenous formulation of famotidine is available for some hospitalized patients with pathological hypersecretory conditions or intractable ulcers or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication.[L11142]



Over-the-counter famotidine is used for the management and prevention of heartburn caused by gastroesophageal reflux in children and adults. Off-label uses of famotidine include the reduction of NSAIDs-associated gastrointestinal effects, treatment of refractory urticarial, prevention of stress ulcer in critically-ill patients, and symptomatic relief of gastritis.[L11166,L11172]', 'Histamine acts as a local hormone that stimulates the acid output by parietal cells via a paracrine mechanism. Neuroendocrine cells called enterochromaffin-like (ECL) cells lie close to the parietal cells and regulate the basal secretion of histamine. Histamine release is also promoted from stimulation by acetylcholine and gastrin, a peptide hormone. Gastrin (G) cells release gastrin, which works on CCK<sub>2</sub> receptors on ECL cells. This action promotes the release of histamine from ECL cells. Upon release, histamine acts on H<sub>2</sub> receptors expressed on the basolateral membrane of parietal cells, leading to increased intracellular cAMP levels and activated proton pumps on parietal cells. Proton pump releases more protons into the stomach, thereby increasing the secretion of acid. [T28] In conditions that are associated with acid hypersecretion such as ulcers, there is a loss of regulation of acid secretion. Famotidine works on H<sub>2</sub> receptors and blocks the actions of histamine.[L11166]', 'Famotidine decreases the production of gastric acid, suppresses acid concentration and pepsin content, and decreases the volume of gastric secretion. Famotidine inhibits both basal and nocturnal gastric acid secretion, as well as acid secretion stimulated by food, caffeine, insulin, and pentagastrin.[L11139,L11142]



Famotidine has a dose-dependent therapeutic action, with the highest dose having the most extended duration of action and the highest inhibitory effect on gastric acid secretion. Following oral administration, the onset of action is within one hour, and the peak effect is reached within 1-3 hours. The duration of effect is about 10-12 hours.[A189459]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19605, 'Gastrofam 40mg/5ml susp. 60ml', 'جاستروفام 40 مجم/ 5ملي . 60 ملي', '6', NULL, 'Peptic ulcer.anti-histamine.h2 antagonist', 'Famotidine', 'Alfacure pharmaceuticals', 'Susp', 'معلق', '40mg', '1', 'علاج قرحة المرئ والمعدة -- علاج إرتجاع المرئ -- علاج الحموضة', 'about famotidine guanidine:thiazole derivative a histamine h2-receptor antagonist anti-secretory antiulcer. mechanism of action of famotidine famotidine is a h2 (histamine) receptor antagonist. histamine is the most potent stimulus of acid secretion and a', NULL, NULL, 1139, '2022-05-12', 0, 'Famotidine is indicated in pediatric and adult patients (with the bodyweight of 40 kg and above) for the management of active duodenal ulcer (DU), active gastric ulcer, symptomatic non-erosive gastroesophageal reflux disease (GERD), and erosive esophagitis due to GERD, diagnosed by biopsy.[L11139]



It is also indicated in adult patients for the treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine neoplasias) and reduction of the risk of DU recurrence.[L11139]



The intravenous formulation of famotidine is available for some hospitalized patients with pathological hypersecretory conditions or intractable ulcers or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication.[L11142]



Over-the-counter famotidine is used for the management and prevention of heartburn caused by gastroesophageal reflux in children and adults. Off-label uses of famotidine include the reduction of NSAIDs-associated gastrointestinal effects, treatment of refractory urticarial, prevention of stress ulcer in critically-ill patients, and symptomatic relief of gastritis.[L11166,L11172]', 'Histamine acts as a local hormone that stimulates the acid output by parietal cells via a paracrine mechanism. Neuroendocrine cells called enterochromaffin-like (ECL) cells lie close to the parietal cells and regulate the basal secretion of histamine. Histamine release is also promoted from stimulation by acetylcholine and gastrin, a peptide hormone. Gastrin (G) cells release gastrin, which works on CCK<sub>2</sub> receptors on ECL cells. This action promotes the release of histamine from ECL cells. Upon release, histamine acts on H<sub>2</sub> receptors expressed on the basolateral membrane of parietal cells, leading to increased intracellular cAMP levels and activated proton pumps on parietal cells. Proton pump releases more protons into the stomach, thereby increasing the secretion of acid. [T28] In conditions that are associated with acid hypersecretion such as ulcers, there is a loss of regulation of acid secretion. Famotidine works on H<sub>2</sub> receptors and blocks the actions of histamine.[L11166]', 'Famotidine decreases the production of gastric acid, suppresses acid concentration and pepsin content, and decreases the volume of gastric secretion. Famotidine inhibits both basal and nocturnal gastric acid secretion, as well as acid secretion stimulated by food, caffeine, insulin, and pentagastrin.[L11139,L11142]



Famotidine has a dose-dependent therapeutic action, with the highest dose having the most extended duration of action and the highest inhibitory effect on gastric acid secretion. Following oral administration, the onset of action is within one hour, and the peak effect is reached within 1-3 hours. The duration of effect is about 10-12 hours.[A189459]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19606, 'Gastroloc plus 20/1100mg 20 caps.', 'جاسترولوك بلس 20/1100مجم 20 كبسولة', '36', NULL, 'Peptic ulcer.proton pump inhibitor', 'Omeprazole+sodium bicarbonate', 'Sigmatec', 'Cap', 'كبسولة', '1100mg', '2', NULL, 'about omeprazole proton pump inhibitor substituted benzimidazole anti-secretory antiulcer. mechanism of action of omeprazole omeprazole is a proton pump inhibitor and it is a prodrug. after administration it diffuses in to the parietal cell of the stomach', NULL, NULL, 946, '2024-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19607, 'Gastrolux 76% injection', 'جاسترولوكس 76% حقن', '85', NULL, NULL, 'Amidotrizoic acid+meglumine salt+sodium amidotrizoate', 'Sanochemia diagnostic international-germany > osteo test center', 'Injection', 'حقن', '76%', '1', NULL, NULL, NULL, NULL, 771, '2022-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19609, 'Dasiword 50 mg 60 f.c.tabs.', 'داسيورد 50 مجم 60 قرص', '9,600', NULL, 'Antineoplastic', 'Dasatinib', 'Hikma pharma', 'Tab', 'أقراص', '50 mg', '6', NULL, NULL, '6221000000362', NULL, 1482, '2023-05-25', 0, 'Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, as well as adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib, and adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy. Dasatinib is also indicated for the treatment of pediatric patients 1 year of age and older with Ph+ CML in chronic phase or newly diagnosed Ph+ ALL in combination with chemotherapy.[L45171]', 'Dasatinib is a tyrosine kinase inhibitor with several targets. At nanomolar concentrations, it inhibits BCR-ABL, SRC family (SRC, LCK, YES, FYN), c-KIT, EPHA2, and PDGFR&beta;.[A2224,A11377,L45171] In patients with chronic myeloid leukemia (CML), the tyrosine kinase activity of BCR-ABL is deregulated, leading to the growth, proliferation and survival of cancerous hematopoietic cells. Dasatinib binds to the active and inactive conformation of the ABL kinase domain with a higher affinity than imatinib.[A33432] In chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) cell lines overexpressing BCR-ABL, dasatinib inhibits cell growth. Also, dasatinib has _in vitro_ activity against leukemic cell lines that are either sensitive or resistant to imatinib.[L45171] It has been suggested that dasatinib is able to overcome imatinib resistance caused by BCR-ABL kinase domain mutations because it does not require interaction with some of the residues involved in those mutations.[A33432,L45171]', 'Dasatinib is an orally available small-molecule multikinase inhibitor.[A11377] During clinical trials, less than 1% of patients treated with dasatinib had QTc prolongation as an adverse reaction, and 1% experienced a QTcF higher than 500 ms. The use of dasatinib is also associated with myelosuppression, bleeding-related events, fluid retention, cardiovascular toxicity, pulmonary arterial hypertension, severe dermatologic reactions, tumor lysis syndrome and hepatotoxicity. It may also cause embryo-fetal toxicity and lead to adverse reactions associated with bone growth and development in pediatric patients.[L45171]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19612, 'فريدة معطر جو', 'معطر جو فريدة', '65', NULL, NULL, NULL, 'Company', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, '6224007537923', NULL, 680, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19614, 'Rivaflowva 10mg 20 film coated tab', 'ريفافلوفا 10 مجم 20 قرص', '210', NULL, 'Antiplatelet.direct factor xa inhibitor', 'Rivaroxaban', 'Gypto pharma', 'Tab', 'أقراص', '10mg', '2', NULL, NULL, '6224008874225', NULL, 1243, '2022-07-24', 0, 'Rivaroxaban is indicated for the prevention of venous thromboembolic events (VTE) in patients who have undergone total hips replacements and total knee replacement surgery; prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); to reduce risk of recurrent DVT and/or PE. Rivaroxaban is also indicated, in combination with aspirin, for reducing the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease. Its use is also not recommended in those with severe renal impairment (<30mL/min).[L12819]



Rivaroxaban is also indicated for the treatment and prevention of VTE in pediatric patients (from birth to 18 years of age) and for thromboprophylaxis in pediatric patients ≥2 years old with congenital heart disease following the Fontan procedure.[L12819]

', 'Rivaroxaban competitively inhibits free and clot bound factor Xa. Factor Xa is needed to activate prothrombin (factor II) to thrombin (factor IIa). Thrombin is a serine protease that is required to activate fibrinogen to fibrin, which is the loose meshwork that completes the clotting process. Since one molecule of factor Xa can generate more than 1000 molecules of thrombin, selective inhibitors of factor Xa are profoundly useful in terminating the amplification of thrombin generation. The action of rivaroxaban is irreversible.

 

', 'Rivaroxaban is an anticoagulant which binds directly to factor Xa. Thereafter, it effectively blocks the amplification of the coagulation cascade, preventing the formation of thrombus. Rivaroxaban is a unqiue anticoagulant for two reasons. First of all, it is does not involve antithrombin III (ATIII) to exert its anticoagulant effects. Secondly, it is an oral agent whereas the widely used unfractionated heparin and low molecular weight heparins are for parenteral use only. Although the activated partial thromboplastin time (aPTT) and HepTest (a test developed to assay low molecular weight heparins) are prolonged in a dose-dependant manner, neither test is recommended for the assessment of the pharmacodynamic effects of rivaroxaban. Anti-Xa activity and inhibition of anti-Xa activity monitoring is also not recommended despite being influenced by rivaroxaban.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19616, 'Hulio 40mg/0.8ml 2 pref. pens', 'هوليو 40مجم/0.8مل 2 قلم معبأ', '11,680', NULL, NULL, NULL, 'Company', 'Pen', 'قلم', '40mg', '2', NULL, NULL, NULL, NULL, 766, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19621, 'Gatipram 3mg/ml ophth. soln. 5 ml', 'جاتيبرام 3مجم/مل قطرة عين 5 مل', '14', NULL, 'Antibiotic.quinolone', 'Gatifloxacin', 'Kahira > modern office for import', 'Sol', 'محلول', '3mg', '1', NULL, NULL, NULL, NULL, 845, '2023-05-04', 0, 'For the treatment of bronchitis, sinusitis, community-acquired pneumonia, and skin infections (abscesses, wounds) caused by S. pneumoniae, H. influenzae, S. aureus, M. pneumoniae, C. pneumoniae, L. pneumophila, S. pyogenes', 'The bactericidal action of Gatifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone antibacterial agent for oral or intravenous administration. is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gatifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19622, 'Gatistar 0.5% ophth. soln. 5 ml', 'جاتيستار 0.5% قطرة عين 5 مل', '62', '45', 'Antibiotic.quinolone', 'Gatifloxacin', 'Orchidia pharmaceutical industries', 'Sol', 'محلول', '0.5%', '1', NULL, NULL, '6224000219864', NULL, 1129, '2025-04-08', 0, 'For the treatment of bronchitis, sinusitis, community-acquired pneumonia, and skin infections (abscesses, wounds) caused by S. pneumoniae, H. influenzae, S. aureus, M. pneumoniae, C. pneumoniae, L. pneumophila, S. pyogenes', 'The bactericidal action of Gatifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone antibacterial agent for oral or intravenous administration. is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gatifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19623, 'Gatyxel 0.3% ophthalmic soln. 5 ml', 'جاتيكسيل 0.3% قطرة عين 5 مل', '18', '18', 'Antibiotic.quinolone', 'Gatifloxacin', 'Orchidia pharmaceutical industries', 'Sol', 'محلول', '0.3%', '1', NULL, NULL, '6224000219413', NULL, 1512, '2024-05-27', 0, 'For the treatment of bronchitis, sinusitis, community-acquired pneumonia, and skin infections (abscesses, wounds) caused by S. pneumoniae, H. influenzae, S. aureus, M. pneumoniae, C. pneumoniae, L. pneumophila, S. pyogenes', 'The bactericidal action of Gatifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone antibacterial agent for oral or intravenous administration. is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gatifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19625, 'Gaviscon liquid 24 sachets 10 ml', 'جافيسكون اكياس 24 كيس / 10 مل', '288', '216', 'Antacid', 'Sodium alginate+sodium bicarbonate+calcium carbonate', 'Reckitt benckiser healthcare > united partners company', 'Sachet', 'أكياس', '10 ml', '24', 'مضاد للحموضة', NULL, '5000158071896', NULL, 7728, '2025-04-21', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19626, 'Gazik eye contour cream 30 gm', 'جازيك كريم كونتور العين 30 جم', '75', NULL, 'Eye contour', 'Kojic acid+hyaluoronic acid+glycerin+vitamin a+elastin+collagen+liquorice', 'Hi-care > pure pharmaceuticals', 'Cream', 'كريم', '30 gm', '1', NULL, 'eye contour cream to reduce dark circles and puffiness under the eye.', NULL, NULL, 814, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19627, 'Gazik eye contour cream 60 gm', 'جازيك كريم كونتور العين 60 جم', '130', NULL, 'Eye contour', 'Kojic acid+hyaluoronic acid+glycerin+vitamin a+elastin+collagen+liquorice', 'Hi-care > pure pharmaceuticals', 'Cream', 'كريم', '60 gm', '1', NULL, 'eye contour cream to reduce dark circles and puffiness under the eye.', NULL, NULL, 774, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19628, 'Gazyvaro 1000mg/40ml vial i.v. inf.', 'جازيفارو 1000 مجم / 40 مل فيال', '126,300', '85000', 'Antineoplastic', 'Obinutuzumab', 'F.hoffman la roche', 'Vial', 'فيال', '1000mg', '1', NULL, 'gazyvaro is the first type ii glycoengineered antibody to target cells that have the cd20 marker on their surface. these cells are central to many blood cancers including common forms of lymphoma and leukemia.', NULL, NULL, 1611, '2025-11-04', 0, 'Obinutuzumab, in combination with [chlorambucil], is indicated for the treatment of patients with previously untreated chronic lymphocytic leukemia.[L50617]



It is also used to treat follicular lymphoma, in combination with [bendamustine] followed by monotherapy, in patients who relapsed after or are refractory to, a [rituximab]-containing regimen.[L50617]



Obinutuzumab is also used in combination with chemotherapy followed by monotherapy to treat previously untreated stage II bulky, III or IV follicular lymphoma in adult patients achieving at least a partial remission.[L50617]', 'In contrast to rituximab, which is a classic type I CD20 antibody, obinutuzumab binds to type II CD20 antibodies. This allows obinutuzumab to have a much higher induction of antibody-dependant cytotoxicity and a higher direct cytotoxic effect than the classic CD20 antibodies.

', 'Obinutuzumab is more potent than rituximab in depleting B-cells, antitumor activity, and tumor regression.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19630, 'Gedazole 500mg 20 tab.', 'جيدازول 500 مجم 20 قرص', '34', '10.5', 'Antiprotozoal.nitroimidazole', 'Metronidazole', 'Jedco int. co. for pharmaceuticals', 'Tab', 'أقراص', '500mg', '2', NULL, 'about metronidazole a nitroimidazole antibiotic anti-infective antiprotozoal amebicide. mechanism of action of metronidazole metronidazole is nitro imidazoles which have broad spectrum cidal activity against protozoa and some anaerobic bacteria. its selec', NULL, NULL, 1005, '2024-12-11', 0, 'Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient''s sexual partners, bacterial vaginosis,[L7432, L49811] certain types of amebiasis, and various anaerobic infections.[A181057, L49811] The above anaerobic infections may occur on the skin and skin structures, the abdomen, the heart, reproductive organs, central nervous system, and the respiratory system. Some may also be present in the bloodstream in cases of septicemia. Common infections treated by metronidazole are Bacteroides species infections, Clostridium infections, and Fusobacterium infections, as well as Peptococcus and Peptostreptococcus infections.[L3754] Topical formulations of metronidazole are indicated for the treatment of inflammatory lesions of rosacea.[L45166]



It is also used off-label in the treatment of Crohn''s disease, as a prophylactic agent after surgery[A181039], and in the treatment of Helicobacter pylori infection.[A181045] It has also been studied in the prevention of preterm births and to treat periodontal disease.[A1391,A181078]', 'The exact mechanism of action of metronidazole has not been fully established, however, it is possible that an intermediate in the reduction of metronidazole which is only made by anaerobic bacteria and protozoa, binds deoxyribonucleic acid and electron-transport proteins of organisms, blocking nucleic acid synthesis.[L3754]

After administration, metronidazole enters cells by passive diffusion. Following this, ferredoxin or flavodoxin reduce its nitro group to nitro radicals.

The redox potential of the electron transport portions of anaerobic or microaerophilic microorganisms renders metronidazole selective to these organisms, which cause nitro group reduction, leading to the production of toxic metabolites. These include N-(2-hydroxyethyl) oxamic acid and acetamide, which may damage DNA of replicating organisms.[A181039]', 'Metronidazole treats amebiasis, trichomoniasis, and giardiasis, exerting both antibacterial and antiprotozoal activities.[L7432] Metronidazole is an effective treatment for some anaerobic bacterial infections.[A181057] Metronidazole has shown antibacterial activity against the majority of obligate anaerobes, however, during in vitro studies, it does not demonstrate significant action against facultative anaerobes or obligate aerobes.[L3754] The nitro group reduction of metronidazole by anaerobic organisms is likely responsible for the drug''s antimicrobial cytotoxic effects, causing DNA strand damage to microbes.[A181039,A181045]



A note on convulsions and neuropathy and carcinogenesis



It is important to be aware of the risk of peripheral neuropathy and convulsions associated with metronidazole, especially at higher doses. If convulsions or numbness of an extremity occur, discontinue the drug immediately.[L3754] Metronidazole has been found to be carcinogenic in mice and rats. The relevance to this effect in humans is unknown. It is advisable to only administer metronidazole when clinically necessary and only for its approved indications.[L7474]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19633, 'Gedimadel 3mg 30 tab.', 'جيديماديل 3 مجم 30 قرص', '27', '17.5', 'Anti-diabetic.secretagogues.sulfonylurea', 'Glimepiride', 'Jedco int. co. for pharmaceuticals', 'Tab', 'أقراص', '3mg', '3', NULL, 'indications : this medication is a sulfonylurea antidiabetic agent prescribed for type 2 diabetes. it works by causing the pancreas to produce insulin dosage : the recommended starting dose is 1-2 mg once daily with food.maximum: 2mg/day contraindications', NULL, NULL, 849, '2024-03-22', 0, 'Glimepiride is indicated for the management of type 2 diabetes in adults as an adjunct to diet and exercise to improve glycemic control as monotherapy. 



It may also be indicated for use in combination with metformin or insulin to lower blood glucose in patients with type 2 diabetes whose high blood sugar levels cannot be controlled by diet and exercise in conjunction with an oral hypoglycemic (a drug used to lower blood sugar levels) agent alone.[L10322]', 'ATP-sensitive potassium channels on pancreatic beta cells that are gated by intracellular ATP and ADP. The hetero-octomeric complex of the channel is composed of four pore-forming Kir6.2 subunits and four regulatory sulfonylurea receptor (SUR) subunits. Alternative splicing allows the formation of channels composed of varying subunit isoforms expressed at different concentrations in different tissues.[A177730] In pancreatic beta cells, ATP-sensitive potassium channels play a role as essential metabolic sensors and regulators that couple membrane excitability with glucose-stimulated insulin secretion (GSIS).[A177727] When there is a decrease in the ATP:ADP ratio, the channels are activated and open, leading to K+ efflux from the cell, membrane hyperpolarization, and suppression of insulin secretion.[A177727] In contrast, increased uptake of glucose into the cell leads to elevated intracellular ATP:ADP ratio, leading to the closure of channels and membrane depolarization. Depolarization leads to activation and opening of the voltage-dependent Ca2+ channels and consequently an influx of calcium ions into the cell.[A177727] Elevated intracellular calcium levels causes the contraction of the filaments of actomyosin responsible for the exocytosis of insulin granules stored in vesicles.[A177715] Glimepiride blocks the ATP-sensitive potassium channel by binding non-specifically to the B sites of both sulfonylurea receptor-1 (SUR1) and sulfonylurea receptor-2A (SUR2A) subunits as well as the A site of SUR1 subunit of the channel to promote insulin secretion from the beta cell.[A177715] ', 'Glimepiride stimulates the secretion of insulin granules from the pancreatic beta cells and improves the sensitivity of peripheral tissues to insulin to increase peripheral glucose uptake, thus reducing plasma blood glucose levels and glycated hemoglobin (HbA1C) levels. A multi-center, randomized, placebo-controlled clinical trial evaluated the efficacy of glimepiride (1–8 mg) as monotherapy titrated over 10 weeks compared with placebo in T2DM subjects who were not controlled by diet alone.[A177703] In this study, there was a reduction in fasting plasma glucose (FPG) by 46 mg/dL, post-prandial glucose (PPG) by 72 mg/dL, and HbA1c by 1.4% more than the placebo.[A177703] In another randomized study comprising of patients with T2DM receiving either placebo or one of the three doses (1, 4, or 8 mg) of glimepiride during a 14-week study period, all glimepiride regimens significantly reduced FPG, PPG, and HbA1c values (P < 0.001) compared to placebo by the end of the study period.[A177703] The 4- and 8-mg doses of glimepiride were more effective than the 1-mg dose; however, the 4-mg dose provided a nearly maximal antihyperglycemic effect.[A177703]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19634, 'Gedimadel 4 mg 30 tab.', 'جيديماديل 4 مجم 30 قرص', '30', '15', 'Anti-diabetic.secretagogues.sulfonylurea', 'Glimepiride', 'Jedco int. co. for pharmaceuticals', 'Tab', 'أقراص', '4 mg', '3', NULL, 'indications : this medication is a sulfonylurea antidiabetic agent prescribed for type 2 diabetes. it works by causing the pancreas to produce insulin dosage : the recommended starting dose is 1-2 mg once daily with food.maximum: 2mg/day contraindications', NULL, NULL, 711, '2024-03-22', 0, 'Glimepiride is indicated for the management of type 2 diabetes in adults as an adjunct to diet and exercise to improve glycemic control as monotherapy. 



It may also be indicated for use in combination with metformin or insulin to lower blood glucose in patients with type 2 diabetes whose high blood sugar levels cannot be controlled by diet and exercise in conjunction with an oral hypoglycemic (a drug used to lower blood sugar levels) agent alone.[L10322]', 'ATP-sensitive potassium channels on pancreatic beta cells that are gated by intracellular ATP and ADP. The hetero-octomeric complex of the channel is composed of four pore-forming Kir6.2 subunits and four regulatory sulfonylurea receptor (SUR) subunits. Alternative splicing allows the formation of channels composed of varying subunit isoforms expressed at different concentrations in different tissues.[A177730] In pancreatic beta cells, ATP-sensitive potassium channels play a role as essential metabolic sensors and regulators that couple membrane excitability with glucose-stimulated insulin secretion (GSIS).[A177727] When there is a decrease in the ATP:ADP ratio, the channels are activated and open, leading to K+ efflux from the cell, membrane hyperpolarization, and suppression of insulin secretion.[A177727] In contrast, increased uptake of glucose into the cell leads to elevated intracellular ATP:ADP ratio, leading to the closure of channels and membrane depolarization. Depolarization leads to activation and opening of the voltage-dependent Ca2+ channels and consequently an influx of calcium ions into the cell.[A177727] Elevated intracellular calcium levels causes the contraction of the filaments of actomyosin responsible for the exocytosis of insulin granules stored in vesicles.[A177715] Glimepiride blocks the ATP-sensitive potassium channel by binding non-specifically to the B sites of both sulfonylurea receptor-1 (SUR1) and sulfonylurea receptor-2A (SUR2A) subunits as well as the A site of SUR1 subunit of the channel to promote insulin secretion from the beta cell.[A177715] ', 'Glimepiride stimulates the secretion of insulin granules from the pancreatic beta cells and improves the sensitivity of peripheral tissues to insulin to increase peripheral glucose uptake, thus reducing plasma blood glucose levels and glycated hemoglobin (HbA1C) levels. A multi-center, randomized, placebo-controlled clinical trial evaluated the efficacy of glimepiride (1–8 mg) as monotherapy titrated over 10 weeks compared with placebo in T2DM subjects who were not controlled by diet alone.[A177703] In this study, there was a reduction in fasting plasma glucose (FPG) by 46 mg/dL, post-prandial glucose (PPG) by 72 mg/dL, and HbA1c by 1.4% more than the placebo.[A177703] In another randomized study comprising of patients with T2DM receiving either placebo or one of the three doses (1, 4, or 8 mg) of glimepiride during a 14-week study period, all glimepiride regimens significantly reduced FPG, PPG, and HbA1c values (P < 0.001) compared to placebo by the end of the study period.[A177703] The 4- and 8-mg doses of glimepiride were more effective than the 1-mg dose; however, the 4-mg dose provided a nearly maximal antihyperglycemic effect.[A177703]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19635, 'Gedovete 0.1% cream 30 gm', 'جيدوفيت 0.1% كريم 30 جم', '8', NULL, 'Glucocorticoid', 'Betamethasone', 'Jedco int. co. for pharmaceuticals', 'Cream', 'كريم', '0.1%', '1', NULL, 'betamethasone about betamethasone potent glucocorticoid anti-inflammatory immunosuppressent. mechanism of action of betamethasone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structura', NULL, NULL, 724, '2022-07-18', 0, 'As a member of the corticosteroid family, betamethasone is indicated for the treatment of several inflammatory conditions. As topical monotherapy, betamethasone is indicated to relieve pruritic and inflammatory symptoms of corticosteroid-responsive-dermatoses.[L11991,L10782,L11997] Betamethasone can be used topically in combination with a vitamin D analog such as calcipotriene to treat plaque psoriasis.[L12000] The corticosteroid is also available as an injectable suspension and can be used to manage a range of inflammatory conditions including endocrine disorders, gastrointestinal disorders, and rheumatic disorders among other conditions.[L11994]

', 'Glucocorticoids inhibit neutrophil apoptosis and demargination, and inhibit NF-Kappa B and other inflammatory transcription factors.[A187463] They also inhibit phospholipase A2, leading to decreased formation of arachidonic acid derivatives.[A187463] In addition, glucocorticoids promote anti-inflammatory genes like interleukin-10.[A187463]



Corticosteroids like betamethasone can act through nongenomic and genomic pathways.[A31458] The genomic pathway is slower and occurs when glucocorticoids activate glucocorticoid receptors and initiate downstream effects that promote transcription of anti-inflammatory genes including phosphoenolpyruvate carboxykinase (PEPCK), IL-1-receptor antagonist, and tyrosine amino transferase (TAT).[A31458] On the other hand, the nongenomic pathway is able to elicit a quicker response by modulating T-cell, platelet and monocyte activity through the use of existing membrane-bound receptors and second messengers.[A31458]', 'Corticosteroids bind to the glucocorticoid receptor inhibiting pro-inflammatory signals, while promoting anti-inflammatory signals.[A187463] Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces.[A187463] Patients who require long-term treatment with a corticosteroid should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.[A187463]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19636, 'Gel x oral gel 300 ml', 'جل اكس جل للفم 300 مل', '350', NULL, 'Oral care', 'Aqua+pvp+taurine+zinc gluconate+peg-40+castor oil+sodium saccharin+sodium hydroxide+aroma', 'Bmg pharma > phoenix marketing group', 'Gel', 'جل', '300 ml', '1', NULL, 'indications: symptomatic treatment of pain of oral cavity lesions such as mucositis stomatitis due to radiotherapy chemotherapy pharmacological therapy and labial mucosa lesion. dosage 15ml per application 2 or 3 times per day. description oral rinse that', NULL, NULL, 519, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19637, 'Gel x oral spray 100 ml', 'جل اكس سبراي للفم 100مل', '390', NULL, 'Oral care', 'Aqua+pvp+taurine+zinc gluconate+peg-40+castor oil+sodium saccharin+aroma', 'Bmg pharma > phoenix marketing group', 'Gel', 'جل', '100 ml', '1', NULL, 'indications symptomatic treatment of signs and symptoms associated with oral cavity lesion such as mucositis stomatitis due to radiotherapy chemotherapy pharmacological therapy and labial mucosa lesion. dosage spray 2 or 3 times at least twice a day. desc', NULL, NULL, 427, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19638, 'Gelatexin oral pwd. 10 sachets', 'جيلاتيكسين باودر 10 اكياس', '195', '110', 'Antirheumatic.osteoarthritis.anabolic agents', 'Gelatin (collagen) hydrolysate+vitamin c', 'Pharma zad > summit pharm trading', 'Gel', 'جل', NULL, '1', NULL, 'for health joints use: 1 sachet in a glass add 100 ml of water stirr well till dissolve then drink daily for 3 months', NULL, NULL, 1436, '2024-07-29', 0, 'Gelatin is used for weight loss and for treating osteoarthritis, rheumatoid arthritis, and brittle bones (osteoporosis). Some people also use it for strengthening bones, joints, and fingernails. Gelatin is also used for improving hair condition and to shorten the recovery after exercise and sports-related injury [L2113]. Gelatin is used in preparations of foods, cosmetics, and medicine [L2113].



Plasma volume expander in hypovolaemic shock [L2115]. Haemostatic [L2115].



Gelatin-based hydrogels are being used in drug delivery and tissue engineering because they are able to promote cell adhesion and proliferation. In addition, these hydrogels can be used as wound dressings because of their attractive fluid absorbance properties. Manufacturing technologies such as ultraviolet stereolithography and two-photon polymerization can be used to prepare structures containing photosensitive gelatin-based hydrogels [L2111].', 'It works as a hemostatic by providing a physical framework within which clotting may occur [L2115].



As a volume expander, gelatin remains in the vascular space. When used in the treatment of hypovolaemia gelatin can produce a significant increase in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery, increasing volume and pressure [L2117].



For intravascular volume expansion, the majority or gelatins produce an effect which is almost equivalent to of which are mild, although severe reactions albumin, with a duration of action of 3 to 4 hours to have been reported [L2118].



Gelatin or collagen chains suspended in solution can be covalently cross-linked to form matrices that are able to swell in the presence of aqueous solutions, forming what are called _gelatin hydrogels_. Hydrogels, characterized by their hydrophilicity and insolubility in water, have the capability of swelling into an equilibrium volume while maintaining their shape. The chemical cross-linkers used may be either small bifunctional molecules or polyfunctional macromolecules, for example, glutaraldehyde [L2122].', 'Gelatin contains collagen, which is one of the materials that make up cartilage and bone [L2113].



In addition to their well-established value as a nutritional protein source, collagen and collagen-derived products may exhibit various potential biological activities on cells and the extracellular matrix through the corresponding food-derived peptides post-ingestion.  This could justify their applications in dietary supplements and pharmaceutical agents [A32426].



Gelatin is a protein that is used as a hemostatic in surgical procedures.  It is also used as a plasma volume expander in hypovolemic shock. Gelatin rods structures may also be used to temporarily block tear outflow in cases of dry eye [L2115].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19639, 'Gelcosicone susp. 180ml', 'جيلكوسيكون معلق 180 مل', '4', NULL, 'Antacid', 'Aluminium hydroxide+dimethicone+magnesium oxide', 'Kahira', 'Susp', 'معلق', '180ml', '1', NULL, 'about aluminium hydroxide antacid antidote protectant( topical) in hyperacidity; hyperphosphatemia. mechanism of action of aluminium hydroxide it neutralizes and reduces stomach acid relieving heartburn (acid reflux gerd) and indigestion. this results inc', NULL, NULL, 873, '2022-07-13', 0, NULL, 'Aluminum Acetate is an astringent.  An astrignent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application.  The shrinkage or constriction is through osmotic flow of water (or other fluids) away from the area where the astringent was applied.  Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete''s foot. ', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19640, 'Gelinose delicate moisturuzing gel 20gm', 'جيلينوز جل مرطب 20 جم', '50', '45', 'Moisturizing topicals', 'Propylene glycol+aloe vera+sodium chloride+carbomer+sodium hydroxide+panthenol+methyl paraben', 'Leader cosmetics > pharmacia elite', 'Gel', 'جل', '20gm', '1', 'جل مرطب للجلد __ يعمل علي تنعيم وترطيب الجلد __ يساعد علي تفتيح لون البشرة و توحيد لون البشرة', NULL, '6224003068957', NULL, 2755, '2025-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19641, 'Gelofusine i.v. infusion.', 'جيلوفوسين محلول وريدي', '192', '48', 'Plasma expander', 'Gelatin+sodium chloride+sodium hydroxide', 'B-braun medical ag-switerland > sunny medical', 'Gel', 'جل', NULL, '1', NULL, 'gelofusine ecobag is normally given to immobile patients in a controlled setting (e.g. emergency treatment acute treatment in a hospital or a day therapy unit) and this excludes the likelihood of driving and using machines. gelofusine ecobag is a so-calle', NULL, NULL, 705, '2024-11-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19642, 'Geltex 10 sachets', 'جيلتكس 10 اكياس', '98', NULL, 'Antirheumatic.osteoarthritis.anabolic agents', 'Gelatin (collagen) hydrolysate+calcium carbonate+vitamin c', 'Medcare > omega international group', 'Gel', 'جل', NULL, '1', 'مكمل غذائى لدعم صحة المفاصل والعظام والجهاز المناعى', 'for health joints use: 1 sachet in a glass add 100 ml of water stirr well till dissolve then drink daily for 3 months', NULL, NULL, 987, '2022-07-09', 0, 'Gelatin is used for weight loss and for treating osteoarthritis, rheumatoid arthritis, and brittle bones (osteoporosis). Some people also use it for strengthening bones, joints, and fingernails. Gelatin is also used for improving hair condition and to shorten the recovery after exercise and sports-related injury [L2113]. Gelatin is used in preparations of foods, cosmetics, and medicine [L2113].



Plasma volume expander in hypovolaemic shock [L2115]. Haemostatic [L2115].



Gelatin-based hydrogels are being used in drug delivery and tissue engineering because they are able to promote cell adhesion and proliferation. In addition, these hydrogels can be used as wound dressings because of their attractive fluid absorbance properties. Manufacturing technologies such as ultraviolet stereolithography and two-photon polymerization can be used to prepare structures containing photosensitive gelatin-based hydrogels [L2111].', 'It works as a hemostatic by providing a physical framework within which clotting may occur [L2115].



As a volume expander, gelatin remains in the vascular space. When used in the treatment of hypovolaemia gelatin can produce a significant increase in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery, increasing volume and pressure [L2117].



For intravascular volume expansion, the majority or gelatins produce an effect which is almost equivalent to of which are mild, although severe reactions albumin, with a duration of action of 3 to 4 hours to have been reported [L2118].



Gelatin or collagen chains suspended in solution can be covalently cross-linked to form matrices that are able to swell in the presence of aqueous solutions, forming what are called _gelatin hydrogels_. Hydrogels, characterized by their hydrophilicity and insolubility in water, have the capability of swelling into an equilibrium volume while maintaining their shape. The chemical cross-linkers used may be either small bifunctional molecules or polyfunctional macromolecules, for example, glutaraldehyde [L2122].', 'Gelatin contains collagen, which is one of the materials that make up cartilage and bone [L2113].



In addition to their well-established value as a nutritional protein source, collagen and collagen-derived products may exhibit various potential biological activities on cells and the extracellular matrix through the corresponding food-derived peptides post-ingestion.  This could justify their applications in dietary supplements and pharmaceutical agents [A32426].



Gelatin is a protein that is used as a hemostatic in surgical procedures.  It is also used as a plasma volume expander in hypovolemic shock. Gelatin rods structures may also be used to temporarily block tear outflow in cases of dry eye [L2115].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19643, 'Gemcitabine actavis 1 gm i.v. vial(n/a)', 'جيمسيتابين اكتافيس 1 جم فيال', '658', NULL, 'Antineoplastic', 'Gemcitabine', 'Actavis > multipharma', 'Tab', 'أقراص', '1 gm', '1', NULL, NULL, NULL, NULL, 632, '2022-08-01', 0, 'Gemcitabine is a chemotherapeutic agent used as monotherapy or in combination with other anticancer agents. 



In combination with [carboplatin], it is indicated for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.[L32950]



Gemcitabine in combination with [paclitaxel] is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated.[L32950]



In combination with [cisplatin], gemcitabine is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer (NSCLC).[L32950] Dual therapy with cisplatin is also used to treat patients with Stage IV (locally advanced or metastatic) transitional cell carcinoma (TCC) of the bladder.[L32955]



Gemcitabine is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. Gemcitabine is indicated for patients previously treated with [fluorouracil].[L32950]', 'Gemcitabine is a potent and specific deoxycytidine analog. After uptake into malignant cells, gemcitabine is phosphorylated by deoxycytidine kinase to form gemcitabine monophosphate, which is then converted to the active compounds, gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). These active metabolites are nucleosides that mediate antitumour effects. dFdCTP competes with deoxycytidine triphosphate (dCTP) for incorporation into DNA, thereby competitively inhibiting DNA chain elongation. The non-terminal position of dFdCTP in the DNA chain prevents detection of dFdCTP in the chain and repair by proof-reading 3′5′-exonuclease: this process is referred to as "masked DNA chain termination." Incorporation of dFdCTP into the DNA chain ultimately leads to chain termination, DNA fragmentation, and apoptotic cell death of malignant cells.[A233140,A233145,L32950]



Gemcitabine has self-potentiating pharmacological actions that can increase the probability of successful incorporation of gemcitabine triphosphate into the DNA chain: dFdCDP inhibits ribonucleotide reductase, an enzyme responsible for catalyzing the reactions that generate dCTP for DNA synthesis. Since dFdCDP reduces the levels of dCTP, there is less competition for gemcitabine triphosphate for incorporation into DNA.[A233140,L32950] Gemcitabine can also reduce metabolism and elimination of active metabolites from the target ce1l, prolonging high intracellular concentrations of the active metabolites. Such self-potentiating effects are not present with [cytarabine].[A233140]', 'Gemcitabine is a nucleoside analog that mediates its antitumour effects by promoting apoptosis of malignant cells undergoing DNA synthesis. More specifically, it blocks the progression of cells through the G1/S-phase boundary.[L32950] Gemcitabine demonstrated cytotoxic effects against a broad range of cancer cell lines _in vitro_. It displayed schedule-dependent antitumour activity in various animal models and xenografts from human non-small cell lung cancer (NSCLC) and pancreatic cancer.[A233140] Therefore, the antineoplastic effects of gemcitabine are enhanced through prolonged infusion time rather than higher dosage.[A233140] Gemcitabine inhibited the growth of human xenografts from carcinoma of the lung, pancreas, ovaries, head and neck, and breast. In mice, gemcitabine inhibited the growth of human tumour xenografts from the breast, colon, lung or pancreas by 69 to 99%. In clinical trials of advanced NSCLC, gemcitabine monotherapy produced objective response rates ranging from 18 to 26%, with a median duration of response ranging from 3.3 to 12.7 months. Overall median survival time was 6.2 to 12.3 months. The combined use of cisplatin and gemcitabine produced better objective response rates compared to monotherapy. In patients with advanced pancreatic cancer, objective response rates in patients ranged from 5.to 12%, with a median survival duration of 3.9 to 6.3 months.[A233145] In Phase II trials involving patients with metastatic breast cancer, treatment with gemcitabine alone or with adjuvant chemotherapies resulted in response rate ranging from 13 to 42% and median survival duration ranging from 11.5 to 17.8 months. In metastatic bladder cancer, gemcitabine has a response rate 20 to 28%. In Phase II trials of advanced ovarian cancer, patients treated with gemcitabine had response rate of 57.1%, with progression free survival of 13.4 months and median survival of 24 months.[A233140]



Gemcitabine causes dose-limiting myelosuppression, such as anemia, leukopenia, neutropenia, and thrombocytopenia; however, events leading to discontinuation tend to occur less than 1% of the patients. Gemcitabine can elevate ALT, AST and alkaline phosphatase levels.[A233145]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19644, 'Gemcitabine actavis 200mg i.v.vial(n/a)', 'جيمسيتابين اكتافيس 200 مجم فيال', '154', NULL, 'Antineoplastic', 'Gemcitabine', 'Actavis > multipharma', 'Tab', 'أقراص', '200mg', '1', NULL, NULL, NULL, NULL, 668, '2022-07-30', 0, 'Gemcitabine is a chemotherapeutic agent used as monotherapy or in combination with other anticancer agents. 



In combination with [carboplatin], it is indicated for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.[L32950]



Gemcitabine in combination with [paclitaxel] is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated.[L32950]



In combination with [cisplatin], gemcitabine is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer (NSCLC).[L32950] Dual therapy with cisplatin is also used to treat patients with Stage IV (locally advanced or metastatic) transitional cell carcinoma (TCC) of the bladder.[L32955]



Gemcitabine is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. Gemcitabine is indicated for patients previously treated with [fluorouracil].[L32950]', 'Gemcitabine is a potent and specific deoxycytidine analog. After uptake into malignant cells, gemcitabine is phosphorylated by deoxycytidine kinase to form gemcitabine monophosphate, which is then converted to the active compounds, gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). These active metabolites are nucleosides that mediate antitumour effects. dFdCTP competes with deoxycytidine triphosphate (dCTP) for incorporation into DNA, thereby competitively inhibiting DNA chain elongation. The non-terminal position of dFdCTP in the DNA chain prevents detection of dFdCTP in the chain and repair by proof-reading 3′5′-exonuclease: this process is referred to as "masked DNA chain termination." Incorporation of dFdCTP into the DNA chain ultimately leads to chain termination, DNA fragmentation, and apoptotic cell death of malignant cells.[A233140,A233145,L32950]



Gemcitabine has self-potentiating pharmacological actions that can increase the probability of successful incorporation of gemcitabine triphosphate into the DNA chain: dFdCDP inhibits ribonucleotide reductase, an enzyme responsible for catalyzing the reactions that generate dCTP for DNA synthesis. Since dFdCDP reduces the levels of dCTP, there is less competition for gemcitabine triphosphate for incorporation into DNA.[A233140,L32950] Gemcitabine can also reduce metabolism and elimination of active metabolites from the target ce1l, prolonging high intracellular concentrations of the active metabolites. Such self-potentiating effects are not present with [cytarabine].[A233140]', 'Gemcitabine is a nucleoside analog that mediates its antitumour effects by promoting apoptosis of malignant cells undergoing DNA synthesis. More specifically, it blocks the progression of cells through the G1/S-phase boundary.[L32950] Gemcitabine demonstrated cytotoxic effects against a broad range of cancer cell lines _in vitro_. It displayed schedule-dependent antitumour activity in various animal models and xenografts from human non-small cell lung cancer (NSCLC) and pancreatic cancer.[A233140] Therefore, the antineoplastic effects of gemcitabine are enhanced through prolonged infusion time rather than higher dosage.[A233140] Gemcitabine inhibited the growth of human xenografts from carcinoma of the lung, pancreas, ovaries, head and neck, and breast. In mice, gemcitabine inhibited the growth of human tumour xenografts from the breast, colon, lung or pancreas by 69 to 99%. In clinical trials of advanced NSCLC, gemcitabine monotherapy produced objective response rates ranging from 18 to 26%, with a median duration of response ranging from 3.3 to 12.7 months. Overall median survival time was 6.2 to 12.3 months. The combined use of cisplatin and gemcitabine produced better objective response rates compared to monotherapy. In patients with advanced pancreatic cancer, objective response rates in patients ranged from 5.to 12%, with a median survival duration of 3.9 to 6.3 months.[A233145] In Phase II trials involving patients with metastatic breast cancer, treatment with gemcitabine alone or with adjuvant chemotherapies resulted in response rate ranging from 13 to 42% and median survival duration ranging from 11.5 to 17.8 months. In metastatic bladder cancer, gemcitabine has a response rate 20 to 28%. In Phase II trials of advanced ovarian cancer, patients treated with gemcitabine had response rate of 57.1%, with progression free survival of 13.4 months and median survival of 24 months.[A233140]



Gemcitabine causes dose-limiting myelosuppression, such as anemia, leukopenia, neutropenia, and thrombocytopenia; however, events leading to discontinuation tend to occur less than 1% of the patients. Gemcitabine can elevate ALT, AST and alkaline phosphatase levels.[A233145]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19645, 'Gemcitabin-ebewe 2 gm vial', 'جيمسيتابين ايبوي 2 جم فيال', '1,900', '1285', 'Antineoplastic', 'Gemcitabine', 'Ebewe > novartis scientific office', 'Tab', 'أقراص', '2 gm', '1', NULL, 'about gemcitabine antimetabolite a nucleoside(pyrimidine) analog antineoplastic. mechanism of action of gemcitabine gemcitabine is metabolized intracellularly to 2 active metabolites gemcitabine diphosphate and gemcitabine triphosphate by the enzyme nucle', NULL, NULL, 810, '2025-01-14', 0, 'Gemcitabine is a chemotherapeutic agent used as monotherapy or in combination with other anticancer agents. 



In combination with [carboplatin], it is indicated for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.[L32950]



Gemcitabine in combination with [paclitaxel] is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated.[L32950]



In combination with [cisplatin], gemcitabine is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer (NSCLC).[L32950] Dual therapy with cisplatin is also used to treat patients with Stage IV (locally advanced or metastatic) transitional cell carcinoma (TCC) of the bladder.[L32955]



Gemcitabine is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. Gemcitabine is indicated for patients previously treated with [fluorouracil].[L32950]', 'Gemcitabine is a potent and specific deoxycytidine analog. After uptake into malignant cells, gemcitabine is phosphorylated by deoxycytidine kinase to form gemcitabine monophosphate, which is then converted to the active compounds, gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). These active metabolites are nucleosides that mediate antitumour effects. dFdCTP competes with deoxycytidine triphosphate (dCTP) for incorporation into DNA, thereby competitively inhibiting DNA chain elongation. The non-terminal position of dFdCTP in the DNA chain prevents detection of dFdCTP in the chain and repair by proof-reading 3′5′-exonuclease: this process is referred to as "masked DNA chain termination." Incorporation of dFdCTP into the DNA chain ultimately leads to chain termination, DNA fragmentation, and apoptotic cell death of malignant cells.[A233140,A233145,L32950]



Gemcitabine has self-potentiating pharmacological actions that can increase the probability of successful incorporation of gemcitabine triphosphate into the DNA chain: dFdCDP inhibits ribonucleotide reductase, an enzyme responsible for catalyzing the reactions that generate dCTP for DNA synthesis. Since dFdCDP reduces the levels of dCTP, there is less competition for gemcitabine triphosphate for incorporation into DNA.[A233140,L32950] Gemcitabine can also reduce metabolism and elimination of active metabolites from the target ce1l, prolonging high intracellular concentrations of the active metabolites. Such self-potentiating effects are not present with [cytarabine].[A233140]', 'Gemcitabine is a nucleoside analog that mediates its antitumour effects by promoting apoptosis of malignant cells undergoing DNA synthesis. More specifically, it blocks the progression of cells through the G1/S-phase boundary.[L32950] Gemcitabine demonstrated cytotoxic effects against a broad range of cancer cell lines _in vitro_. It displayed schedule-dependent antitumour activity in various animal models and xenografts from human non-small cell lung cancer (NSCLC) and pancreatic cancer.[A233140] Therefore, the antineoplastic effects of gemcitabine are enhanced through prolonged infusion time rather than higher dosage.[A233140] Gemcitabine inhibited the growth of human xenografts from carcinoma of the lung, pancreas, ovaries, head and neck, and breast. In mice, gemcitabine inhibited the growth of human tumour xenografts from the breast, colon, lung or pancreas by 69 to 99%. In clinical trials of advanced NSCLC, gemcitabine monotherapy produced objective response rates ranging from 18 to 26%, with a median duration of response ranging from 3.3 to 12.7 months. Overall median survival time was 6.2 to 12.3 months. The combined use of cisplatin and gemcitabine produced better objective response rates compared to monotherapy. In patients with advanced pancreatic cancer, objective response rates in patients ranged from 5.to 12%, with a median survival duration of 3.9 to 6.3 months.[A233145] In Phase II trials involving patients with metastatic breast cancer, treatment with gemcitabine alone or with adjuvant chemotherapies resulted in response rate ranging from 13 to 42% and median survival duration ranging from 11.5 to 17.8 months. In metastatic bladder cancer, gemcitabine has a response rate 20 to 28%. In Phase II trials of advanced ovarian cancer, patients treated with gemcitabine had response rate of 57.1%, with progression free survival of 13.4 months and median survival of 24 months.[A233140]



Gemcitabine causes dose-limiting myelosuppression, such as anemia, leukopenia, neutropenia, and thrombocytopenia; however, events leading to discontinuation tend to occur less than 1% of the patients. Gemcitabine can elevate ALT, AST and alkaline phosphatase levels.[A233145]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19646, 'Gemcitabin-ebewe 200 mg vial', 'جيمسيتابين ايبوي 200 مجم فيال', '290', '173', 'Antineoplastic', 'Gemcitabine', 'Ebewe > novartis scientific office', 'Tab', 'أقراص', '200 mg', '1', NULL, 'about gemcitabine antimetabolite a nucleoside(pyrimidine) analog antineoplastic. mechanism of action of gemcitabine gemcitabine is metabolized intracellularly to 2 active metabolites gemcitabine diphosphate and gemcitabine triphosphate by the enzyme nucle', NULL, NULL, 828, '2025-01-14', 0, 'Gemcitabine is a chemotherapeutic agent used as monotherapy or in combination with other anticancer agents. 



In combination with [carboplatin], it is indicated for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.[L32950]



Gemcitabine in combination with [paclitaxel] is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated.[L32950]



In combination with [cisplatin], gemcitabine is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer (NSCLC).[L32950] Dual therapy with cisplatin is also used to treat patients with Stage IV (locally advanced or metastatic) transitional cell carcinoma (TCC) of the bladder.[L32955]



Gemcitabine is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. Gemcitabine is indicated for patients previously treated with [fluorouracil].[L32950]', 'Gemcitabine is a potent and specific deoxycytidine analog. After uptake into malignant cells, gemcitabine is phosphorylated by deoxycytidine kinase to form gemcitabine monophosphate, which is then converted to the active compounds, gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). These active metabolites are nucleosides that mediate antitumour effects. dFdCTP competes with deoxycytidine triphosphate (dCTP) for incorporation into DNA, thereby competitively inhibiting DNA chain elongation. The non-terminal position of dFdCTP in the DNA chain prevents detection of dFdCTP in the chain and repair by proof-reading 3′5′-exonuclease: this process is referred to as "masked DNA chain termination." Incorporation of dFdCTP into the DNA chain ultimately leads to chain termination, DNA fragmentation, and apoptotic cell death of malignant cells.[A233140,A233145,L32950]



Gemcitabine has self-potentiating pharmacological actions that can increase the probability of successful incorporation of gemcitabine triphosphate into the DNA chain: dFdCDP inhibits ribonucleotide reductase, an enzyme responsible for catalyzing the reactions that generate dCTP for DNA synthesis. Since dFdCDP reduces the levels of dCTP, there is less competition for gemcitabine triphosphate for incorporation into DNA.[A233140,L32950] Gemcitabine can also reduce metabolism and elimination of active metabolites from the target ce1l, prolonging high intracellular concentrations of the active metabolites. Such self-potentiating effects are not present with [cytarabine].[A233140]', 'Gemcitabine is a nucleoside analog that mediates its antitumour effects by promoting apoptosis of malignant cells undergoing DNA synthesis. More specifically, it blocks the progression of cells through the G1/S-phase boundary.[L32950] Gemcitabine demonstrated cytotoxic effects against a broad range of cancer cell lines _in vitro_. It displayed schedule-dependent antitumour activity in various animal models and xenografts from human non-small cell lung cancer (NSCLC) and pancreatic cancer.[A233140] Therefore, the antineoplastic effects of gemcitabine are enhanced through prolonged infusion time rather than higher dosage.[A233140] Gemcitabine inhibited the growth of human xenografts from carcinoma of the lung, pancreas, ovaries, head and neck, and breast. In mice, gemcitabine inhibited the growth of human tumour xenografts from the breast, colon, lung or pancreas by 69 to 99%. In clinical trials of advanced NSCLC, gemcitabine monotherapy produced objective response rates ranging from 18 to 26%, with a median duration of response ranging from 3.3 to 12.7 months. Overall median survival time was 6.2 to 12.3 months. The combined use of cisplatin and gemcitabine produced better objective response rates compared to monotherapy. In patients with advanced pancreatic cancer, objective response rates in patients ranged from 5.to 12%, with a median survival duration of 3.9 to 6.3 months.[A233145] In Phase II trials involving patients with metastatic breast cancer, treatment with gemcitabine alone or with adjuvant chemotherapies resulted in response rate ranging from 13 to 42% and median survival duration ranging from 11.5 to 17.8 months. In metastatic bladder cancer, gemcitabine has a response rate 20 to 28%. In Phase II trials of advanced ovarian cancer, patients treated with gemcitabine had response rate of 57.1%, with progression free survival of 13.4 months and median survival of 24 months.[A233140]



Gemcitabine causes dose-limiting myelosuppression, such as anemia, leukopenia, neutropenia, and thrombocytopenia; however, events leading to discontinuation tend to occur less than 1% of the patients. Gemcitabine can elevate ALT, AST and alkaline phosphatase levels.[A233145]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19651, 'Gemifloxacin 320 mg 5 f.c. tab.', 'جيميفلوكساسين 320مجم 5 قرص', '54', NULL, 'Antibiotic.quinolone', 'Gemifloxacin', 'Pharopharma', 'Tab', 'أقراص', '320 mg', '1', NULL, 'about gemifloxacin fourth-generation fluoroquinolone(respiratory) antibacterial oral broad-spectrum fluoroquinolone antibiotic. mechanism of action of gemifloxacin gemifloxacin act by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.', '6221094076045', NULL, 986, '2022-07-08', 0, 'For the treatment of bacterial infection caused by susceptible strains such as <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>H. parainfluenzae</i>, or <i>M. catarrhalis</i>, <i>S. pneumoniae</i> (including multi-drug resistant strains [MDRSP]), <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, or <i>K. pneumoniae</i>.', 'The bactericidal action of gemifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Gemifloxacin is a quinolone/fluoroquinolone antibiotic. Gemifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gemifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19652, 'Gemifloxactive 320 mg 5 f.c. tab.', 'جيميفلوكساكتيف 320 مجم 5 قرص', '54', NULL, 'Antibiotic.quinolone', 'Gemifloxacin', 'Atco pharma > champions pharma (pas)', 'Tab', 'أقراص', '320 mg', '1', NULL, 'about gemifloxacin fourth-generation fluoroquinolone(respiratory) antibacterial oral broad-spectrum fluoroquinolone antibiotic. mechanism of action of gemifloxacin gemifloxacin act by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.', '6224008722069', NULL, 1001, '2022-07-20', 0, 'For the treatment of bacterial infection caused by susceptible strains such as <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>H. parainfluenzae</i>, or <i>M. catarrhalis</i>, <i>S. pneumoniae</i> (including multi-drug resistant strains [MDRSP]), <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, or <i>K. pneumoniae</i>.', 'The bactericidal action of gemifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Gemifloxacin is a quinolone/fluoroquinolone antibiotic. Gemifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gemifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19656, 'Gemoxacin 320 mg 5 f.c. tab.', 'جيموكساسين 320مجم 5 قرص', '45', NULL, 'Antibiotic.quinolone', 'Gemifloxacin', 'El-obour > dawaa pharma', 'Tab', 'أقراص', '320 mg', '1', NULL, 'about gemifloxacin fourth-generation fluoroquinolone(respiratory) antibacterial oral broad-spectrum fluoroquinolone antibiotic. mechanism of action of gemifloxacin gemifloxacin act by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.', '6223003571207', NULL, 874, '2022-07-07', 0, 'For the treatment of bacterial infection caused by susceptible strains such as <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>H. parainfluenzae</i>, or <i>M. catarrhalis</i>, <i>S. pneumoniae</i> (including multi-drug resistant strains [MDRSP]), <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, or <i>K. pneumoniae</i>.', 'The bactericidal action of gemifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Gemifloxacin is a quinolone/fluoroquinolone antibiotic. Gemifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gemifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19657, 'Gemoxacin 320 mg 7 f.c. tab.', 'جيموكساسين 320 مجم 7 اقراص', '68', NULL, 'Antibiotic.quinolone', 'Gemifloxacin', 'El-obour > dawaa pharma', 'Tab', 'أقراص', '320 mg', '1', 'مضاد حيوى واسع المدى لعلاج العديد من الالتهابات', 'about gemifloxacin fourth-generation fluoroquinolone(respiratory) antibacterial oral broad-spectrum fluoroquinolone antibiotic. mechanism of action of gemifloxacin gemifloxacin act by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.', '6223003571207', NULL, 778, '2022-07-24', 0, 'For the treatment of bacterial infection caused by susceptible strains such as <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>H. parainfluenzae</i>, or <i>M. catarrhalis</i>, <i>S. pneumoniae</i> (including multi-drug resistant strains [MDRSP]), <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, or <i>K. pneumoniae</i>.', 'The bactericidal action of gemifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Gemifloxacin is a quinolone/fluoroquinolone antibiotic. Gemifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gemifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19660, 'Gena rose 200ml', 'جينا روز 200 مل', '24', NULL, 'Vaginal cleanser', 'Citric acid+aloe vera extract+tea tree oil+chlorhexidine+triclosan+chamomile ext+sage oil+menthol crystals+thyme oil', 'Leader cosmetics > pharmacia elite', 'Unknown', 'غير محدد', '200ml', '1', NULL, 'vaginal cleanser', NULL, NULL, 652, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19661, 'Genanu 10 sachets', 'جينانو 10 اكياس', '115', NULL, 'Antirheumatic.osteoarthritis.anabolic agents', 'Gelatin (collagen) hydrolysate+calcium carbonate+magnesium+calcium ascorbate+vitamin e+sucralose', 'Rameda', 'Sachet', 'أكياس', NULL, '1', 'يستخدم في حالات الروماتيزم والتهاب المفاصل', NULL, NULL, NULL, 969, '2022-05-31', 0, 'Gelatin is used for weight loss and for treating osteoarthritis, rheumatoid arthritis, and brittle bones (osteoporosis). Some people also use it for strengthening bones, joints, and fingernails. Gelatin is also used for improving hair condition and to shorten the recovery after exercise and sports-related injury [L2113]. Gelatin is used in preparations of foods, cosmetics, and medicine [L2113].



Plasma volume expander in hypovolaemic shock [L2115]. Haemostatic [L2115].



Gelatin-based hydrogels are being used in drug delivery and tissue engineering because they are able to promote cell adhesion and proliferation. In addition, these hydrogels can be used as wound dressings because of their attractive fluid absorbance properties. Manufacturing technologies such as ultraviolet stereolithography and two-photon polymerization can be used to prepare structures containing photosensitive gelatin-based hydrogels [L2111].', 'It works as a hemostatic by providing a physical framework within which clotting may occur [L2115].



As a volume expander, gelatin remains in the vascular space. When used in the treatment of hypovolaemia gelatin can produce a significant increase in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery, increasing volume and pressure [L2117].



For intravascular volume expansion, the majority or gelatins produce an effect which is almost equivalent to of which are mild, although severe reactions albumin, with a duration of action of 3 to 4 hours to have been reported [L2118].



Gelatin or collagen chains suspended in solution can be covalently cross-linked to form matrices that are able to swell in the presence of aqueous solutions, forming what are called _gelatin hydrogels_. Hydrogels, characterized by their hydrophilicity and insolubility in water, have the capability of swelling into an equilibrium volume while maintaining their shape. The chemical cross-linkers used may be either small bifunctional molecules or polyfunctional macromolecules, for example, glutaraldehyde [L2122].', 'Gelatin contains collagen, which is one of the materials that make up cartilage and bone [L2113].



In addition to their well-established value as a nutritional protein source, collagen and collagen-derived products may exhibit various potential biological activities on cells and the extracellular matrix through the corresponding food-derived peptides post-ingestion.  This could justify their applications in dietary supplements and pharmaceutical agents [A32426].



Gelatin is a protein that is used as a hemostatic in surgical procedures.  It is also used as a plasma volume expander in hypovolemic shock. Gelatin rods structures may also be used to temporarily block tear outflow in cases of dry eye [L2115].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19662, 'Genarose vag.douche 200 ml', 'جيناروز دوش مهبلي 200 مل', '70', '20', 'Vaginal wash', 'Citric acid+thyme oil+saga oil+menthol crystals+aloe vera extract', 'Leader cosmetics > pharmacia elite', 'Unknown', 'غير محدد', '200 ml', '1', NULL, NULL, '6223003031619', NULL, 797, '2025-11-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19663, 'Geneca ray sun screen spf 50+ cream 100 gm', 'جينيكا راي صن سكرين عامل حماية 50+ كريم 100 جم', '145', NULL, 'Sun block', 'Sun protection formula', '> bio geneca pharmaceuticals', 'Cream', 'كريم', '100 gm', '1', NULL, NULL, NULL, NULL, 857, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19664, 'Geneca ray sun screen spf 50+ cream 50 gm', 'جينيكا راي صن سكرين بمعامل حماية 50+ كريم 50 جم', '90', NULL, 'Sun block', 'Sun protection formula', '> bio geneca pharmaceuticals', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 1159, '2022-08-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19665, 'Geneca ray sun screen spf 50+ lotion 100 ml', 'جينيكا راي صن سكرين عامل حماية +50 لوشن 100 ملي', '145', NULL, 'Sun block', 'Sun protection formula', '> bio geneca pharmaceuticals', 'Lotion', 'لوشن', '100 ml', '1', NULL, NULL, NULL, NULL, 854, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19666, 'Geneca ray sun screen spf 50+ lotion 200 ml', 'جينيكا راي صن سكرين بمعامل حماية 50 لوسيون 200 مل', '220', NULL, 'Sun block', 'Sun protection formula', '> bio geneca pharmaceuticals', 'Lotion', 'لوشن', '200 ml', '1', NULL, NULL, NULL, NULL, 715, '2022-08-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19668, 'Genecalcin 2000 i.u./dose nasal spray', 'جينيكالسين 2000 وحدة دولية / جرعة بخاخ للأنف', '105', NULL, 'Osteoporosis.antiresorptives', 'Calcitonin', 'Genepharm-greece > sunny medical', 'Spray', 'بخاخ', NULL, '1', NULL, 'prescribed for: injectable calcitonin is used to treat osteoporosis and paget s disease. injectable calcitonin also is used to treat seriously elevated blood calcium levels. the nasal spray is used only for osteoporosis in women who are at least 5 years p', NULL, NULL, 918, '2022-07-13', 0, 'Investigated for use/treatment in myocardial infarction, heart disease, and asthma.', 'While current drugs for treating HF and MI have a single mechanism of action, CGRP appears to work on several levels: for example, it (1) increases local blood flow enhancing hemodynamic proficiency; (2) protects heart muscle cells from the damage due to lack of oxygen (ischemia); and, (3) modulates the immune system by boosting anti-inflammatory cytokine expression while suppressing pro-inflammatory cytokines, which reduces the inflammatory response to provide a cardioprotective effect. All these actions are meant to minimize heart muscle damage and subsequent scar tissue formation, while promoting the healing process.', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19669, 'Geneduovir 90/400mg 28 tablets', 'جينيدوفير 90/400 مجم 28 قرص', '1,100', NULL, 'Hepatitis c treatment', 'Ledipasvir+sofosbuvir', 'Pharmed healthcare > genesis pharmaceuticals', 'Tablet', 'أقراص', '400mg', '2', NULL, 'indications and usage: it is a hepatitis c virus (hcv) nucleotide analog ns5b polymerase inhibitor indicated for the treatment of chronic hepatitis c (chc) infection as a component of a combination antiviral treatment regimen. *efficacy has been establish', NULL, NULL, 944, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19670, 'Geneleukim 300mcg vial', 'جينيلوكيم 300مكجم فيال', '470', '420', 'Human granulocyte colony-stimulating factor (g-csf)', 'Filgrastim', 'Shandong geneleuk biopharmaceutical co. > united partners company', 'Vial', 'فيال', '300mcg', '1', 'مضاد حيوي قوي يستخدم في حالات الاورام والسرطانات -- حالات نقل النخاع في مرضي السرطان', 'about filgrastim a cytokine glycoprotein a human granulocyte colony-stimulating factor (g-csf) analog immunostimulant. mechanism of action of filgrastim filgrastim is a cytokine glycoprotein that stimulates proliferation differentiation and functional act', NULL, NULL, 3249, '2025-08-16', 0, 'Filgrastim is indicated to decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever.[L40714]



Filgrastim is indicated for reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia.[L40714]



Filgrastim is indicated to reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation.[L40714]



Filgrastim is indicated for the mobilization of autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis.[L40714]



Filgrastim is indicated for chronic administration to reduce the incidence and duration of sequelae of neutropenia (e.g.‚ fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia.[L40714]



Filgrastim is indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation.[L40714]', 'Neutrophils are critical granulocytes involved in the acute inflammatory response and host defences against bacterial infections.[A245873] They also contribute to long-term adaptive immunity by promoting immediate host immune response and attracting other cells, such as macrophages and dendritic cells. As neutrophils promote both the initiation and the maintenance of inflammation at sites of infection, suppressed neutrophil responses lead to extreme susceptibility to infection.[A35605] Low neutrophil levels, or neutropenia, caused by chronic neutropenia, myelosuppressive chemotherapy, and radiation therapy increases the risk of infection and related events.[A245868] Neutropenia caused by chemotherapy or radiation therapy can further progress into febrile neutropenia, which is associated with an elevated risk for life-threatening systemic infections and chemotherapy-associated morbidity and mortality.[A35591]



The production and release of functional neutrophils from the bone marrow are normally regulated by granulocyte colony-stimulating factors (G-CSF), which are major cytokine regulators of neutrophilic granulocytes.[A35605] G-CSFs act on hematopoietic cells by binding to specific cell surface receptors to stimulate the proliferation‚ differentiation‚ and maturation of neutrophil progenitors. G-CSF also induces some end-cell functional activation of neutrophils, including enhanced phagocytic ability‚ priming of the cellular metabolism associated with respiratory burst‚ antibody-dependent killing, and the increased expression of some cell surface antigens.[L40714]  Filgrastim is a short-acting recombinant G-CSF that mimics the biological actions of endogenous G-CSF. It also facilitates the release of neutrophils from the bone marrow into the blood to reduce the incidence of infection and manage neutropenia.[A245858, A245868]', 'Filgrastim is used to reduce the incidence, severity and duration of neutropenia and febrile neutropenia in patients undergoing cytotoxic chemotherapy. In clinical trials in patients, filgrastim reduced the duration of febrile neutropenia, antibiotic use, and hospitalization after induction chemotherapy for acute myelogenous leukemia or myeloablative therapy followed by bone marrow transplantation; however, the incidence of fever and documented infections were not reduced in either setting.[L40719] 



Filgrastim is also used to mobilize hematopoietic progenitor cells into the peripheral blood in order to reduce the risk for bleeding complications and the need for platelet transfusions. Recipients of allogeneic PBPCs mobilized with filgrastim experienced significantly more rapid hematological recovery, leading to a significant decrease in time to unsupported platelet recovery when compared with allogeneic bone marrow transplantation.[L40719] 



Filgrastim causes a dose-dependent increase in circulating neutrophil counts within 24 hours of administration. Filgrastim can also cause a minor increase in monocyte and lymphocyte counts, but the clinical significance of these effects is unknown.[L40714] In some patients, filgrastim also caused a minor increase in the number of circulating eosinophils and basophils relative to baseline; however, these patients may already have had elevated eosinophils and basophils prior to filgrastim treatment. Following termination of filgrastim therapy, circulating neutrophil counts decrease by 50% within one to two days, and to normal levels within one to seven days. As with other hematopoietic growth factors, G-CSF has shown _in vitro_ stimulating properties on human endothelial cells.[L40719] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19671, 'Genesemide 20mg/5ml syrup 120 ml', 'جينيسيمايد 20مجم/5مل شراب 120 مل', '56', '42.5', 'Diuretic.loop', 'Furosemide', 'Medizen pharmaceutical industries > vodachem pharmaceuticals', 'Syrup', 'شراب', '20mg', '1', 'شراب مدر للبول فى حالة أمراض القلب ، و الكلى ، و الكبد حيث أنه يخلص الجسم من كمية المياه الزائدة', 'description a benzoic-sulfonamide-furan. it is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. mechanism of action furosemide a loop diuretic inhibits water reabsorption in the nephron by blocking the', NULL, NULL, 1902, '2025-06-19', 0, 'Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] 



Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659]



Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958]



Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408]', 'Furosemide promotes diuresis by blocking tubular reabsorption of sodium and chloride in the proximal and distal tubules, as well as in the thick ascending loop of Henle. This diuretic effect is achieved through the competitive inhibition of sodium-potassium-chloride cotransporters (NKCC2) expressed along these tubules in the nephron, preventing the transport of sodium ions from the lumenal side into the basolateral side for reabsorption. This inhibition results in increased excretion of water along with sodium, chloride, magnesium, calcium, hydrogen, and potassium ions.[L7961] As with other loop diuretics, furosemide decreases the excretion of uric acid.[T28] 



Furosemide exerts direct vasodilatory effects, which results in its therapeutic effectiveness in the treatment of acute pulmonary edema. Vasodilation leads to reduced responsiveness to vasoconstrictors, such as angiotensin II and noradrenaline, and decreased production of endogenous natriuretic hormones with vasoconstricting properties. It also leads to increased production of prostaglandins with vasodilating properties. Furosemide may also open potassium channels in resistance arteries.[T28] The main mechanism of action of furosemide is independent of its inhibitory effect on carbonic anhydrase and aldosterone.[L7958] ', 'Furosemide manages hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome. Furosemide is a potent loop diuretic that works to increase the excretion of Na+ and water by the kidneys by inhibiting their reabsorption from the proximal and distal tubules, as well as the loop of Henle.[L7958] It works directly acts on the cells of the nephron and indirectly modifies the content of the renal filtrate.[T28] Ultimately, furosemide increases the urine output by the kidney. Protein-bound furosemide is delivered to its site of action in the kidneys and secreted via active secretion by nonspecific organic transporters expressed at the luminal site of action.[A31831,L7958] 



Following oral administration, the onset of the diuretic effect is about 1 and 1.5 hours [L7958], and the peak effect is reached within the first 2 hours.[L7961] The duration of effect following oral administration is about 4-6 hours but may last up to 8 hours.[L9659] Following intravenous administration, the onset of effect is within 5 minutes, and the peak effect is reached within 30 minutes. The duration of action following intravenous administration is approximately 2 hours. Following intramuscular administration, the onset of action is somewhat delayed.[L7958]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19673, 'Genettera 25 mg 10 cap.', 'جينيتيرا 25 مجم 10 كبسولات', '85', NULL, 'Attention-deficit hyperactivity disorder', 'Atomoxetine', 'Debeiky > genesis pharmaceuticals', 'Cap', 'كبسولة', '25 mg', '1', NULL, 'description: atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (adhd). dose: dosing of children and adolescents up to 70 kg body weight initial: the recommended dose is 0.5 mg/kg and increas', NULL, NULL, 817, '2022-07-10', 0, 'Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults.', 'Atomoxetine is known to be a potent and selective inhibitor of the norepinephrine transporter (NET),[A175723] which prevents cellular reuptake of norepinephrine throughout the brain, which is thought to improve the symptoms of ADHD. More recently, positron emission tomography (PET) imaging studies in rhesus monkeys have shown that atomoxetine also binds to the serotonin transporter (SERT),[A178111] and blocks the N-methyl-d-aspartate (NMDA) receptor,[A18263] indicating a role for the glutamatergic system in the pathophysiology of ADHD. ', 'Atomoxetine is a selective norepinephrine (NE) reuptake inhibitor used for the treatment of attention deficit hyperactivity disorder (ADHD). Atomoxetine has been shown to specifically increase norepinephrine and dopamine within the prefrontal cortex, which results in improved ADHD symptoms.[A18262, A18262, F4639]



Due to atomoxetine''s noradrenergic activity, it also has effects on the cardiovascular system such as increased blood pressure and tachycardia.[T244] Sudden deaths, stroke, and myocardial infarction have been reported in patients taking atomoxetine at usual doses for ADHD. Atomoxetine should be used with caution in patients whose underlying medical conditions could be worsened by increases in blood pressure or heart rate such as certain patients with hypertension, tachycardia, or cardiovascular or cerebrovascular disease. It should not be used in patients with severe cardiac or vascular disorders whose condition would be expected to deteriorate if they experienced clinically important increases in blood pressure or heart rate. Although the role of atomoxetine in these cases is unknown, consideration should be given to not treating patients with clinically significant cardiac abnormalities. Patients who develop symptoms such as exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease during atomoxetine treatment should undergo a prompt cardiac evaluation.[F4639]



In general, particular care should be taken in treating ADHD in patients with comorbid bipolar disorder because of concern for possible induction of a mixed/manic episode in patients at risk for bipolar disorder. Treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without a prior history of psychotic illness or mania can be caused by atomoxetine at usual doses. If such symptoms occur, consideration should be given to a possible causal role of atomoxetine, and discontinuation of treatment should be considered.[F4639]



Atomoxetine capsules increased the risk of suicidal ideation in short-term studies in children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). All pediatric patients being treated with atomoxetine  should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases.[F4639]



Postmarketing reports indicate that atomoxetine can cause severe liver injury. Although no evidence of liver injury was detected in clinical trials of about 6000 patients, there have been rare cases of clinically significant liver injury that were considered probably or possibly related to atomoxetine use in postmarketing experience. Rare cases of liver failure have also been reported, including a case that resulted in a liver transplant. Atomoxetine should be discontinued in patients with jaundice or laboratory evidence of liver injury, and should not be restarted. Laboratory testing to determine liver enzyme levels should be done upon the first symptom or sign of liver dysfunction (e.g., pruritus, dark urine, jaundice, right upper quadrant tenderness, or unexplained “flu like” symptoms).[F4639]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19674, 'Genexol 6mg/ml (100mg) i.v.infusion', 'جينيكسول 6مجم/مل (100 مجم) محلول وريدي', '1,000', NULL, 'Antineoplastic', 'Paclitaxel', 'Samyang corporation-korea > egyptian promotion center', 'Unknown', 'غير محدد', '6mg', '1', NULL, 'about paclitaxel taxane derivative microtubule inhibitor(mitotic inhibitor) antineoplastic. mechanism of action of paclitaxel drug binds specifically to the beta- tubuline and then enhances the polymerization of tubuline to stable microtubules. it also in', NULL, NULL, 807, '2022-11-17', 0, 'Used in the treatment of Kaposi''s sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer.', 'Paclitaxel interferes with the normal function of microtubule growth. Whereas drugs like colchicine cause the depolymerization of microtubules in vivo, paclitaxel arrests their function by having the opposite effect; it hyper-stabilizes their structure. This destroys the cell''s ability to use its cytoskeleton in a flexible manner. Specifically, paclitaxel binds to the &beta; subunit of tubulin. Tubulin is the "building block" of mictotubules, and the binding of paclitaxel locks these building blocks in place. The resulting microtubule/paclitaxel complex does not have the ability to disassemble. This adversely affects cell function because the shortening and lengthening of microtubules (termed dynamic instability) is necessary for their function as a transportation highway for the cell. Chromosomes, for example, rely upon this property of microtubules during mitosis. Further research has indicated that paclitaxel induces programmed cell death (apoptosis) in cancer cells by binding to an apoptosis stopping protein called Bcl-2 (B-cell leukemia 2) and thus arresting its function.', 'Paclitaxel is a taxoid antineoplastic agent indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast cancer. Paclitaxel is a novel antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization. This stability results in the inhibition of the normal dynamic reorganization of the microtubule network that is essential for vital interphase and mitotic cellular functions. In addition, paclitaxel induces abnormal arrays or "bundles" of microtubules throughout the cell cycle and multiple asters of microtubules during mitosis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19676, 'Gengigel 0.2% gingival gel 20 ml', 'جنجيجل 0.2% جل 20 مل', '330', '290', 'Oral care', 'Hyaluronan', 'Ricerfarma > biotech egypt', 'Gel', 'جل', '0.2%', '1', NULL, 'especially for the acute stage of periodontal disease treatment a more concentrated high molecular weight hyaluronic acid for immediate treatment of patients with periodontal disease. a film of gel applied to the gingival tissue with a gentle massage prod', '8033087660012', NULL, 1128, '2024-06-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19677, 'Gengigel 0.54% teething gel 20 ml', 'جنجيجل 0.54% جل تسنين 20 مل', '380', '330', 'Oral care', 'Hyaluronan', 'Ricerfarma > biotech egypt', 'Gel', 'جل', '0.54%', '1', NULL, 'it is an oral gel consisting of an innovative patented mucoadhesive polymer matrix that adheres to the teeth and gums for a long time forming an invisible flexible strong film that performs an effective protective action. reduces pain and swelling during', NULL, NULL, 790, '2024-06-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19678, 'Gengigel baby 0.2% oral gel 15 ml', 'جينجيجيل بيبي 0.2% جل 15 مل', '60', NULL, 'Oral care', 'Hyaluronan', 'Ricerfarma > biotech egypt', 'Gel', 'جل', '0.2%', '1', NULL, 'helps in relieving teething symptoms.', NULL, NULL, 736, '2022-08-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19679, 'Gengigel mouthrinse mouth wash 150 ml', 'جينجيجيل غسول للفم 150 مل', '350', '300', 'Oral care', 'Hyaluronan', 'Ricerfarma > biotech egypt', 'Gel', 'جل', '150 ml', '1', NULL, 'helps in reducing inflammation and speeding heal', NULL, NULL, 628, '2024-06-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19680, 'Genica moist cream 100 gm', 'جينيكا مويست كريم 100 جرام', '145', '125', 'Moisturizing topical', 'Shea butter+ coconut oil + olive oil+ aloe vera +glycerin +panthenol caprylic+capric triglyceride', '> bio geneca pharmaceuticals', 'Cream', 'كريم', '100 gm', '1', 'مرطب وملطف للجلد', NULL, '6224008992165', NULL, 10217, '2025-08-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19681, 'Genica ray sun screen spf 50+ cream 100 gm', 'جينيكا راي صن سكرين spf50+ كريم 100 جرام', '165', NULL, 'Sun block', 'Sun protection formula', '> bio geneca pharmaceuticals', 'Cream', 'كريم', '100 gm', '1', 'كريم الحماية من الشمس', 'broad spectrum. uva/uvb protection. - provides intense uvb protection - water resistant (80 minutes) - suitable for all skin types', NULL, NULL, 6856, '2023-02-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19682, 'Genica ray sun screen spf 50+ cream 50 gm', 'جينيكا راي صن سكرين عامل حماية 50+ كريم 100 جم', '145', '110', 'Sun block', 'Sun protection formula', '> bio geneca pharmaceuticals', 'Cream', 'كريم', '50 gm', '1', NULL, 'broad spectrum. uva/uvb protection. - provides intense uvb protection - water resistant (80 minutes) - suitable for all skin types', NULL, NULL, 1103, '2024-04-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19683, 'Genica ray sun screen spf 50+ lotion 100 ml', 'جينيكا راي صن سكرين اس بي اف 50+ لوشن 100 مل', '198', '165', 'Sun block', 'Sun protection formula', '> bio geneca pharmaceuticals', 'Lotion', 'لوشن', '100 ml', '1', 'الحماية من اشعة الشمس', 'broad spectrum. uva/uvb protection. - provides intense uvb protection - water resistant (80 minutes) - suitable for all skin types', NULL, NULL, 1406, '2025-08-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19684, 'Genica ray sun screen spf 50+ lotion 200 ml', 'جينيكا راي صن سكرين معامل حماية 50+ لوشن 200 مل', '250', NULL, 'Sun block', 'Sun protection formula', '> bio geneca pharmaceuticals', 'Lotion', 'لوشن', '200 ml', '1', NULL, 'broad spectrum. uva/uvb protection. - provides intense uvb protection - water resistant (80 minutes) - suitable for all skin types', NULL, NULL, 1862, '2022-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19685, 'Genion vaginal solution 250 ml', 'جينيون محلول تشطيف غسول مهبلي 250 مل', '33', NULL, 'Vaginal wash', 'Chlorhexdine+tea tree+thyme+menthol+chamomile+camphor', 'Ecc > yevira', 'Solution', 'محلول', '250 ml', '1', NULL, NULL, NULL, NULL, 809, '2022-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19686, 'Genkystar 320 mg 7 f.c. tab.', 'جينكيستار 320مجم 7 قرص', '77', NULL, 'Antibiotic.quinolone', 'Gemifloxacin', 'Debeiky > tristar', 'Tab', 'أقراص', '320 mg', '1', 'مضاد حيوي', 'about gemifloxacin fourth-generation fluoroquinolone(respiratory) antibacterial oral broad-spectrum fluoroquinolone antibiotic. mechanism of action of gemifloxacin gemifloxacin act by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.', NULL, NULL, 1585, '2022-04-18', 0, 'For the treatment of bacterial infection caused by susceptible strains such as <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>H. parainfluenzae</i>, or <i>M. catarrhalis</i>, <i>S. pneumoniae</i> (including multi-drug resistant strains [MDRSP]), <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, or <i>K. pneumoniae</i>.', 'The bactericidal action of gemifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination.', 'Gemifloxacin is a quinolone/fluoroquinolone antibiotic. Gemifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Gemifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19687, 'Genmycin 0.3% cream 15 gm', 'جينمايسين 0.3% كريم 15 جم', '7', NULL, 'Antibiotic topical', 'Gentamicin', 'Hikma pharma > chemipharm', 'Cream', 'كريم', '0.3%', '1', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6222006500542', NULL, 814, '2022-12-05', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19688, 'Genmycin 0.3% oint. 15 gm', 'جينمايسين 0.3% مرهم. 15 جرام', '7', NULL, 'Antibiotic topical', 'Gentamicin', 'Hikma pharma > chemipharm', 'Oint', 'مرهم', '0.3%', '1', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6222006500559', NULL, 861, '2022-12-05', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19689, 'Genmycin plus topical cream 15 gm', 'جينمايسين بلس كريم موضعي 15 جم', '6', NULL, 'Antibiotic topical', 'Betamethasone+gentamicin', 'Chemipharm', 'Cream', 'كريم', '15 gm', '1', NULL, 'uses: this medication contains an antibiotic which helps prevent or treat an infection and a steroid which reduces inflammation. it is used in the treatment of various eye (ophthalmic) or ear (otic) conditions.', '6222006501181', NULL, 1227, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19690, 'Genogerm 12 sachets 5 gm', 'جينوجيرم 5 جم 12 كيس', '40', NULL, 'Dietary supplement', 'Royal jelly+bee pollen+wheat germ', 'Nutrixia > infinity pharm', 'Sachet', 'أكياس', '5 gm', '1', NULL, 'use: 1 sachets in half glass of warm water once daily', NULL, NULL, 826, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19691, 'Genoria intimate wash 10 sachets x 7.5 ml', 'جينوريا غسول 10 اكياس 7.5 مل', '20', NULL, 'Vaginal care', 'Bearberry+vitamin c+liquorice+tea tree oil+chamomile+chlorhexidine+sls', 'Egpi > pharma cruise medical', 'Sachet', 'أكياس', '7.5 ml', '1', NULL, 'available in lemon and rose fragrances.', NULL, NULL, 794, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19692, 'Genoria intimate wash 250 ml', 'جينوريا غسول 250 مل', '43', NULL, 'Vaginal wash', 'Bearberry+vitamin c+liquorice+tea tree oil+chamomile+chlorhexidine+sls', 'Egpi > pharma cruise medical', 'Unknown', 'غير محدد', '250 ml', '1', NULL, NULL, NULL, NULL, 739, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19693, 'Genotropin 4 i.u.vial', 'جينوتروبين 4 وحدة دولية فيال', '110', NULL, 'Human growth hormone', 'Somatropin', 'Pfizer', 'Vial', 'فيال', NULL, '1', NULL, NULL, NULL, NULL, 4291, '2022-05-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19694, 'Genove fluidbase 15% aha gel forte 30ml', 'جينوفي سائل 15% جل فورت 30 مل', '149', NULL, 'Skin care', 'Glycolic acid+lactic acid', 'Laboratorio genove s.a. >', 'Gel', 'جل', '15%', '1', NULL, 'quickly absorbed oil free 15% aha gel for rough dry thickened skins treatment. fluidbase 15% aha gel eliminates the accumulated dead cells and leaves a healthier looking skin with smoother texture and suppleness. fluidbase 15% aha gel is also highly recom', NULL, NULL, 640, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19695, 'Genove fluidbase eye contour gel 20ml', 'جينوفي جل كونتور للعين 20 مل', '134', NULL, 'Eye contour', 'Aha firming extracts vitamin c and e', 'Laboratorio genove s.a. >', 'Gel', 'جل', '20ml', '1', NULL, 'prevents the loss of elasticity of connective tissues. minimises wrinkles that form around the eyes. replenishes skin s moisture level. lifting effect. use: apply on clean dry skin with a gentle massage 1 or 2 twice a day. do not apply on eyes and mucous', NULL, NULL, 858, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19697, 'Genove fluidbase lightening gel 30ml', 'جينوفي فلويد بيز جل تفتيح 30 مل', '134', NULL, 'Whitening topical', NULL, 'Laboratorio genove s.a. >', 'Gel', 'جل', '30ml', '1', NULL, 'fluidbase lightening gel is a treatment for the correction of brown spots. formula that recovers skin s natural homogeneity. its new formula with 3 lightening active ingredients a soft exfoliating agent a collagen activator and sun filters provides effici', '8423372040009', NULL, 920, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19698, 'Genove fluidbase max cream 30ml', 'جينوفي فلويد بيز ماكس كريم 30 مل', '204', NULL, 'Skin care', 'Hyaluronic acid acetyl glutamyl heptapeptide-1 pentapetide-3 aldenine (hydrolyzed soy protein hyd', 'Laboratorio genove s.a. >', 'Cream', 'كريم', '30ml', '1', 'العناية بالبشرة', 'fluidbase max reduces the depth of the wrinkles caused by repeated contraction of the facial muscles especially around the eyes the forehead and other areas affected by expression lines. fluidbase max is formulated with aldenine a combination of peptides', NULL, NULL, 770, '2022-05-28', 0, 'The intra-articular preparations of hyaluronic acid are indicated for knee pain associated with osteoarthritis.[L32228] Hyaluronic acid is used in cosmetic applications to prevent and reduce the appearance of wrinkles on the face, and as a dermal filler to correct facial imperfections or other imperfections on other parts of the body.[L32208,L32223] It is frequently an ingredient in topical applications for wound healing and symptomatic treatment of skin irritation from various causes.[L32198] Hyaluronic acid may also be indicated in ophthalmological preparations or oral capsules to treat discomfort caused by dry eyes or conjunctivitis and for its protective qualities during and before eye surgery.[A230128,L32213] Finally, hyaluronic acid can be used off-label to coat the bladder for relief of interstitial cystitis symptoms.[A230533]', 'General principles and hyaluronic acid receptor binding 



Hyaluronic acid works by two basic mechanisms: serving as a passive structural molecule or serving as signaling molecule, depending on the molecule size. The physicochemical properties of high molecular weight HA contribute to passive structural effects, demonstrating hygroscopicity and viscoelasticity and improving hydration, water balance, and structural integrity. As a signalling  molecule interacting with proteins, HA causes several opposing effects based on molecular weight: pro- or anti-inflammatory effects, promotion or inhibition of cell migration, and activating or inhibiting cell division.[A230133] 



Hyaluronic acid exerts its therapeutic effects through binding to three primary types of cell surface receptors: CD44 (a membrane glycoprotein), the receptor for hyaluronate-mediated motility (RHAMM), and the Intercellular Adhesion Molecule 1 (ICAM-1). CD44 is considered the most widely distributed receptor for hyaluronic acid, demonstrating cellular interactions with osteopontin, collagen, and matrix metalloproteinases (MMPs).  High and low molecular weight hyaluronic acids demonstrate differing molecular and cellular mechanisms in their interaction with CD44 receptors. Some examples of these effects include modification of chondrocyte survival pathways in addition to alteration of apoptosis pathways.  Lymphatic vessel endothelial hyaluronan receptor (LYVE-1), and hyaluronic acid receptor for endocytosis (HARE), (also known as Stabilin-2) also bind to hyaluronic acid.[A230128] 



Hyaluronic acid for skin conditions and cosmetics



Hyaluronic acid''s anionic proprieties cause it to attract water and induce swelling, increasing tissue volume and skin structural integrity. The aging process is associated with reduced production of skin hyaluronic acid and collagen, causing the appearance of wrinkles and the loss of facial volume. Dermal fillers of hyaluronic acid replace lost tissue volume, imparting a full and youthful appearance to skin that has lost its elasticity. Hyaluronic acid fillers contain cross-linked hyaluronic acid particles, rendering a concentrated substance with resistance to various forms of physical and chemical breakdown. The cosmetic benefits of hyaluronic acid filler may last up to 6 months, depending on the brand and technique used for injection.[L32193] Additionally, dermal hyaluronic acid fillers are known to increase the production of fibroblasts[L32193], supporting wound healing and offering relief from irritating and inflammatory skin conditions.[A230118]





Hyaluronic acid for joint pain



Most cells in the human body are capable of synthesizing HA. It is a primary component of the extracellular matrix (ECM) and can be found in bone marrow, cartilage, and synovial fluid in joints.[A230128] In osteoarthritis, the concentration of naturally occurring hyaluronic acid gradually decreases, lowering the viscosity of synovial fluid that protects joints from excess friction. Administration of intra-articular hyaluronic acid increases viscosity of synovial joint fluid, reducing friction and subsequently relieving painful arthritic symptoms.[L32193]





Hyaluronic acid for ophthalmic conditions and ophthalmological procedures



Solutions of hyaluronic acid with a concentration greater than 0.1% moisturize the surface of the eyes to treat symptoms of dry eye while improving the stabilization of tear film, replenishing deficiencies of HA, reducing friction, and preventing binding of foreign substances to the ocular tissue.[A230128,L32193] Hyaluronic acid is frequently used during and after ophthalmological surgeries and plays important roles by virtue of its moisturizing, viscoelastic, and protective properties. It promotes tissue healing of the corneal epithelium and other parts of the eye following ophthalmological surgery, minimizing the risk of adhesions and free radical formation.[A230128]

', 'HA has long-acting lubricant, shock absorbing, joint stabilizing, and water balancing properties.[A230128,L32193] It is similar to the naturally occurring glycosaminoglycan (GAG) in joints. Hyaluronic acid works by acting as a lubricant and shock absorber, facilitating joint mobility and thereby reducing osteoarthritic pain.  Hyaluronic acid has antioxidative, anti-inflammatory, and analgesic effects.[A230128] The water-balancing properties and viscoelasticity of hyaluronic acid are beneficial in cosmetic injections, imparting volume and reducing the appearance of imperfections and wrinkles.[L32193] Due to the abovementioned properties, HA has a protective effect on the eyes and cornea.[A230133]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19699, 'Genove genocutan anti-dandruff shampoo 250ml', 'جينوفي جينوكيوتان شامبو ضد القشرة 250 مل', '159', NULL, 'Hair care', 'Zinc piritione+tea tree oil', 'Laboratorio genove s.a.', 'Amp', 'أمبول', '250ml', '1', NULL, 'genovï- has developed an antidandruff shampoo which has active ingredients that give provend andruff protection. genocuta n andidandruff is formulated to help protect against dandruff anddry scalp. apart from treating excessively dryhair genocuta n antida', NULL, NULL, 763, '2022-08-03', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19700, 'Genove genocutan biosulphur shampoo 250ml', 'جينوفي جينوكيوتان شامبو 250 مل', '159', NULL, 'Hair care', 'Biosulphur+tea tree oil', 'Laboratorio genove s.a.', 'Amp', 'أمبول', '250ml', '1', NULL, 'genocuta n biosulfur shampoo has a 2% content of biosulfur which makes of it an ideal treatment for excessively oily hair. together with biolsulfur melaleuca alternifolio and hydrolized keratin help control oil and remove the excess of secretions. biosulf', NULL, NULL, 979, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19701, 'Genove genocutan extramild shampoo 250ml', 'جينوفي جينوكيوتان اكستراميلد شامبو 250 مل', '120', NULL, 'Hair care', 'Anionic tensioactives and softanfoters', 'Laboratorio genove s.a.', 'Amp', 'أمبول', '250ml', '1', NULL, 'genocuta n extrasuave shampoo can be used alternatively as a complement for antidandruff dry scalp or excessively oily hair treatments. itis also strongly recommended for damaged or colour-treated hair. use: massage into wet hair rinse and repeat if requi', NULL, NULL, 638, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19702, 'Genove genovan extreme spf 40 - 125ml', 'جينوفي جينوفان اكستريم معامل حماية 40-125 مل', '59', NULL, 'Sun block', NULL, 'Laboratorio genove s.a.', 'Unknown', 'غير محدد', '125ml', '1', NULL, 'genove has developed genovan extreme a sunscreen lotion that provides uva and uvb protection. genovan extreme is an innovative uva/uvb sunscreen recommended for all skin types. ensures protection from sunburn and early skin photoaging. use: apply genovan', NULL, NULL, 711, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19703, 'Genove hair repair serum 30ml', 'جينوفي سيروم لإصلاح الشعر 30 مل', '114', NULL, 'Hair care', NULL, 'Laboratorio genove s.a. >', 'Serum', 'سيروم', '30ml', '1', NULL, 'oil-free formula that repairs hair fibre and protects it against dryness and dehydration. use: apply gently with fingertips on dry or wet hair.', NULL, NULL, 789, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19704, 'Genove hand cream 50ml', 'جينوفي كريم يد 50 مل', '59', NULL, 'Skin care', NULL, 'Laboratorio genove s.a. >', 'Cream', 'كريم', '50ml', '1', NULL, 'genovï- moisturising hand cream protects nourishes and moisturises dry skin. helps repair cracked dry skins. use: apply as often as needed on hands elbows knees and ankles.', NULL, NULL, 809, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19705, 'Genove lip balm 15ml', 'جينوفي مرطب شفاه 15 مل', '0', NULL, NULL, NULL, 'Laboratorio genove s.a.', 'Unknown', 'غير محدد', '15ml', '1', NULL, 'genovï- lip balm combines oily acids lipids and vitamins necessary to moisture lips skin and and regenerate damaged tissues. genovï- lip balm with sweet almonds oil and wheat germ intensively nourishes and softens dry cracked lips. protects from damage ca', NULL, NULL, 794, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19706, 'Genove nail repair 10ml', 'جينوفي لاصلاح الاظافر 10 مل', '84', NULL, 'Nail care', 'Panthenol aqua propylene glycol urea polyacrylamide paraffin laureth-7 hydrolysed elastin com', 'Laboratorio genove s.a.', 'Unknown', 'غير محدد', '10ml', '1', NULL, 'nail repair gel nourishes and strengthens weak nails. rich formula for intensive care of dry cuticles brittle and weak nails. use?: apply a thin layer of nail repair around cuticles massage gently into the nails concentrating on the nail bed area.', NULL, NULL, 907, '2022-07-28', 0, 'Panthenol (containing a racemic mixture of dexpanthenol and levopanthenol) is not currently available in any FDA-approved products and therefore does not have an indication.



Please see [DB09357] for FDA-approved uses of the dextrorotatory form of Panthenol. ', 'Panthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol, the active form of panthenol, is enzymatically cleaved to form pantothenic acid (Vitamin B5), which is an essential component of Coenzyme A that acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium [A32373].



Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].', 'Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19707, 'Genove pilo-peptan anti hair-loss lotion 125ml', 'جينوفي بيلوبيبتان لوشن مضاد لتساقط الشعر 125 مل', '259', NULL, 'Hair care', 'Pygeum africanum vital hair & scal complex hamamelis extract camomille extract ginseng extract', 'Laboratorio genove s.a. >', 'Lotion', 'لوشن', '125ml', '1', NULL, 'pilopeptan anti hair-loss lotion helps preventing hair loss by stimulating the anagen or growing phase of hair increasing local microcirculation and activating hair follicles. pilopeptan hair-loss lotion strengthens hair and slows the progression of hair', NULL, NULL, 631, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19708, 'Genove pilo-peptan anti hair-loss shampoo 250 ml', 'جينوفي بيلوبيبتان شامبو لتساقط الشعر 250 مل', '169', NULL, 'Hair care', 'Hidrolized keratin panthenol vital hair & scalp complex poliquaternium 7', 'Laboratorio genove s.a. >', 'Amp', 'أمبول', '250 ml', '1', NULL, 'pilopeptan anti hair-loss shampoo helps preventing hair loss by stimulating the anagen or growing phase of hair increasing local microcirculation and activating hair follicles. gently cleanses strengthens hair and slows the progression of hair loss provid', NULL, NULL, 790, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19709, 'Genove pilopeptan woman hair repair serum 30ml', 'جينوفي بيلوبيبتان سيروم إصلاح الشعر للسيدات 30 مل', '89', NULL, 'Hair care', NULL, 'Laboratorio genove s.a.', 'Serum', 'سيروم', '30ml', '1', NULL, 'pilopeptan woman hair repair serum is an oil-free serum that repairs hair fibre as it protects against dryness and dehydration. it also prevents hair from getting curly even with cool and rainy weather. pilopeptan woman hair repair serum has a uvb sunscre', NULL, NULL, 909, '2023-05-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19710, 'Gentacure cream 15 gm', 'جنتاكيور كريم 15 جم', '9', NULL, 'Antibiotic with glucocorticoid', 'Betamethasone+gentamicin', 'Debeiky > phoenix for advanced products', 'Cream', 'كريم', '15 gm', '1', NULL, 'uses: this medication contains an antibiotic which helps prevent or treat an infection and a steroid which reduces inflammation. it is used in the treatment of various eye (ophthalmic) or ear (otic) conditions. how to use: for best results this medication', NULL, NULL, 1154, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19712, 'Gental 0.1% top. oint. 15 gm', 'جينتال 0.1% مرهم 15 جم', '6', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Julphar', 'Oint', 'مرهم', '0.1%', '1', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 712, '2022-07-23', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19713, 'Gentamicin 0.1% top. cream 15 gm (memphis)', 'جنتاميسين 0.1% كريم 15 جرام (ممفيس)', '4', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Memphis', 'Cream', 'كريم', '0.1%', '1', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 1218, '2022-07-12', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19714, 'Gentamicin 20mg/2ml i.m./i.v. 100 amps.', 'جنتاميسين 20 مجم / 2 مل 100 امبول', '83', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Memphis', 'Amp', 'أمبول', '20mg', '100', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 814, '2022-07-13', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19716, 'Gentamicin 40mg/ml i.v./i.m. 100 amps.', 'جنتاميسين 40 مجم / مل عضل وريد 100 امبول', '117', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Memphis', 'Amp', 'أمبول', '40mg', '100', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 832, '2022-07-30', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19718, 'Gentamicin 80mg/2ml 100 amps.', 'جنتاميسين 80مجم / 2 مل 100 امبول', '233', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Memphis', 'Amp', 'أمبول', '80mg', '100', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 1224, '2022-07-12', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19719, 'Gentamicin 80mg/2ml 3 amps.', 'جنتاميسين 80مجم/2مل 3 امبولات', '7', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Memphis', 'Amp', 'أمبول', '80mg', '3', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6223000170694', NULL, 956, '2023-05-02', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19720, 'Gentamicin sulphate 40mg/ml amp.usp 23', 'جنتاميسين سلفات 40 مجم / مل امبول', '4', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Sedico', 'Amp', 'أمبول', '40mg', '1', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 950, '2022-07-16', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19722, 'Gentamicin sulphate-cid 40mg 3 amp.', 'جنتاميسين سلفات-سيد 40 مجم 3 امبولات', '5', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Cid', 'Amp', 'أمبول', '40mg', '3', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 852, '2022-07-22', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19723, 'Gentamicin sulphate-cid 80 mg 3 amp.', 'جنتاميسين سلفات سيد 80 مجم 3 امبولات', '41', '8', 'Aminoglycoside antibiotic', 'Gentamicin', 'Cid', 'Amp', 'أمبول', '80 mg', '3', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 847, '2024-10-30', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19725, 'Gentamicin-alex 20mg/2ml 6 amp.', 'جنتاميسين 20مجم/2مل 6 امبولات اسكندرية', '12', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Alexandria', 'Amp', 'أمبول', '20mg', '6', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 766, '2023-05-02', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19726, 'Gentamicin-alex 40mg/ml 6 amps.', 'جنتاميسين أليكس - 40 مجم / مل 6 أمبول.', '20', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Alexandria', 'Amp', 'أمبول', '40mg', '6', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 834, '2022-07-12', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19727, 'Gentamicin-alex 80mg/2ml 3 amp. i.m/i.v inj.', 'جنتاميسين اليكس 80 مجم / 2 مل 3 امبولات', '53', '40.5', 'Aminoglycoside antibiotic', 'Gentamicin', 'Alexandria', 'Inj', 'حقن', '80mg', '3', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 2233, '2024-12-22', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19728, 'Gentamicin-sigma 0.1% top. cream 15 gm', 'جنتاميسين سيجما 0.1% كريم 15 جم', '4', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Sigma', 'Cream', 'كريم', '0.1%', '1', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 867, '2022-07-14', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19730, 'Gentamicin-sigma 20mg/2ml 6 amp. for im/iv', 'جنتاميسين سيجما 20 مجم / 2 مل 6 امبولات', '11', NULL, 'Antibiotics.aminoglycosides', 'Gentamicin', 'Sigma tec', 'Amp', 'أمبول', '20mg', '6', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 746, '2022-07-20', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19731, 'Gentamicin-sigma 40mg/ml 3 amp. for i.m/i.v', 'جنتاميسين سيجما 40 مجم / مل 3 امبولات', '9', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Sigma tec', 'Amp', 'أمبول', '40mg', '3', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', NULL, NULL, 984, '2022-07-20', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19732, 'Gentamytrex 5mg/gm eye.oint. 3 gm', 'جنتاميتركس 5 مجم / جم مرهم عين 3 جم', '6', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Mina pharm > dr.mann-germany', 'Oint', 'مرهم', '5mg', '1', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6222003700716', NULL, 720, '2022-07-23', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19733, 'Gentamytrex ophthiole 5mg/ml eye dps. 5 ml', 'جنتاميتركس 5 مجم / مل قطرة 5 مل', '5', NULL, 'Aminoglycoside antibiotic', 'Gentamicin', 'Mina pharm > dr.mann-germany', 'Unknown', 'غير محدد', '5mg', '1', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6222003700662', NULL, 820, '2022-07-16', 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19734, 'Wook-first gel 60 gm', 'ووك فيرست جل 60 جم', '65', NULL, NULL, NULL, 'Actada', 'Gel', 'جل', '60 gm', '1', NULL, NULL, NULL, NULL, 813, '2022-09-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19735, 'Freshcare 30 ml spray', 'فريش كير سبراي للانف 30 مل', '65', NULL, 'Nasal spray', 'Sea water + hyaluronic acid + panthenol', 'Mpco', 'Spray', 'بخاخ', '30 ml', '1', NULL, NULL, NULL, NULL, 918, '2022-08-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19736, 'Genteal eye gel 10 gm', 'جينتيال جل للعين 10 جم', '30', NULL, 'Eye lubricant', 'Carbomer+hypromellose', 'Excelvision ag switzerland > united company for trading & distribution', 'Gel', 'جل', '10 gm', '1', 'مرطب للعين.', 'mechanism of action hydroxypropyl cellulose is a derivative of cellulose that is soluble in both water and organic solvents. it is particularly good at trapping water and producing a film that serves as a barrier to water loss. hydroxypropyl cellulose pos', '5413895025785', NULL, 1128, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19737, 'Genuphil woman 30 sachets', 'جينوفيل وومان 30 كيس', '745', NULL, 'Antirheumatic.osteoarthritis.anabolic agents', 'Chondroitin+glucosamine+methyl sulphonyl methane', 'Eva pharma', 'Sachet', 'أكياس', NULL, '1', 'حالات التهاب المفاصل والغضاريف -- حالات الروماتيزم -- تقليل الام المفاصل والركبة -- زيادة لزوجة السائل الغضروفي -- تقليل التورم الناتج من الالتهاب', NULL, '6223004510595', NULL, 7028, '2023-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19738, 'Genuphil original syrup 250ml', 'جينوفيل اوريجينال شراب 250 مل', '120', '105', 'Antirheumatic.osteoarthritis.anabolic agents', 'Chondroitin+glucosamine+methyl sulphonyl methane', 'Eva pharma', 'Syrup', 'شراب', '250ml', '1', 'لبناء انسجة المفاصل والغضاريف -- مضاد لالتهاب المفاصل والعظام -- مضاد للروماتيزم', 'chondroitin is a naturally occuring substancce formed of sugar chains. it is believed to help the body maintain fluid and flexibility in the joints. glucosamine is a naturally occuring substance that is believed to help develop and renew cartilage and kee', '6223002450329', NULL, 2579, '2025-10-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19740, 'Genvical calcium chocolate 20 soft chews pieces', 'جينفيكال كالسيوم شوكولاتة 20 قطعة', '50', NULL, 'Calcium supplement', 'Calcium+vitamin d3+magnesium', 'Family pharmacia > vamira pharmaceuticals', 'Piece', 'قطعة', NULL, '2', NULL, NULL, NULL, NULL, 853, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19741, 'Geo nicotal 750mg 30 s.r.tabs.', 'جيو نيكوتال 750 مجم 30 قرص', '51', NULL, 'Nicotinic acid', 'Nicotinic acid', 'Marcyrl co. > geopharma-egypt', 'Tab', 'أقراص', '750mg', '3', NULL, 'mechanism of action of nicotinic acid niacin refers to nicotinic acid as well as nicotinamide which exerts it`s action by influencing metabolic reactions. it is converted in to coenzymes ncotinamide adenine dinucleotide (nad) and its phosphate ncotinamide', '6223003570897', NULL, 1233, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19742, 'Geo oralog oral paste 15 gm', 'جيو اورالوج معجون للفم 15 جرام', '34', '10', 'Anti-inflammatory.glucocorticoid.', 'Triamcinolone acetonide', 'Marcyrl co. > geopharma-egypt', 'Unknown', 'غير محدد', '15 gm', '1', 'مضاد للالتهاب للفم واللثة --', 'about triamcinolone acetonide a synthetic glucocorticoid topical anti-inflammatory(steroidal). mechanism of action of triamcinolone acetonide the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes', NULL, NULL, 1199, '2025-04-20', 0, 'Triamcinolone hexacetonide injections are indicated for intralesional administration in alopecia areata, discoid lupus erythematosus, keloids, and necrobiosis lipoidica diabeticorum.[L8246] This formulation can also be used for localized hypertrophic infiltrated inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus, and psoriatic plaques.[L8246]



Triamcinolone acetonide spray and cream are indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.[L8249,L8258] A triamcinolone acetonide 10mg/mL or 40mg/mL injection is indicated intra-articularly for acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, and synovitis of osteoarthritis.[L8252,L8255] The same 10mg/mL injection is indicated by the intralesional route for the treatment of alopecia areata, discoid lupus erythematosus, keloids, necrobiosis lipoidica diabeticorum, and tumors of an aponeurosis or tendon.[L8252] This formulation can also be used for localized hypertrophic infiltrated inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus, and psoriatic plaques.[L8252] The 40mg/mL injection is indicated intramuscularly for controlling severe allergic conditions such as asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity, perennial or seasonal allergic rhinitis, serum sickness, and transfusion reactions; treatment of bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, Stevens-Johnson syndrome, congenital adrenal hyperplasia, hypercalcemia in

cancer, nonsuppurative thyroiditis, autoimmune hemolytic anemia, Diamond-Blackfan anemia, pure red cell aplasia, secondary thrombocytopenia, trichinosis, tuberculous meningitis, acute exacerbations of multiple sclerosis or cerebral edema, sympathetic ophthalmia, temporal arteritis, uveitis, ocular inflammation, berylliosis, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis, dermatomyositis, polymyositis, and systemic lupus erythematosus; adjunct treatment of adrenocortical insufficiency, regional enteritis, ulcerative colitis, fulminating or disseminated pulmonary tuberculosis, acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis; palliative management of leukemia and lymphoma; induction of diuresis or remission of proteinuria in idiopathic nephrotic syndrome or lupus erythematosus.[L8255] A triamcinolone intravitreal injection is indicated for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions.[L8261] The intravitreal injection is also used for visualization during vitrectomy.[L8261] An extended release suspension is indicated intra-articularly for management of pain in osteoarthritis of the knee.[L8264]



A triamcinolone acetonide suspension for injection into the suprachoroidal space is indicated for the treatment of macular edema associated with uveitis.[L38963]', 'Corticosteroids like triamcinolone inhibit phospholipase A2 on cell membranes, preventing the breakdown of lysosomal membranes of leukocytes, which in turn prevent the formation of arachidonic acid, which decrease expression of cyclooxygenase and lipoxygenase, inhibiting synthesis of prostaglandins and leukotrienes.[A184463] Anti-inflammatory activity occurs via reversal of vascular dilation and reducing permeability, which prevents macrophage and leukocyte migration.[A184463] Triamcinolone also inhibits nuclear factor kappa-B, which decreases the production of pro-inflammatory signals such as interleukin-6, interleukin-8, and monocyte chemoattractant protein-1.[A184463]', 'Triamcinolone is a corticosteroid with anti-inflammatory properties.[A184463] These properties are used to treat inflammation in conditions that affect various organs and tissues.[L8261] Triamcinolone should not be administered as an epidural injection.[L8246,L8252,L8255,L8261,L8264]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19745, 'Gerdcare 5 mg 30 f.c.tab', 'جيردكير 5مجم 30 قرص', '90', '67.5', 'Selective 5ht4 agonist', 'Mosapride', 'Mepaco > pharma green', 'Tab', 'أقراص', '5 mg', '3', 'علاج القولون العصبي -- يقلل من تقلصات المعدة', NULL, '6225000579514', NULL, 2777, '2024-11-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19747, 'Germ clear top. antiseptic sol. 4 litre (net price)', 'جيرم كلير محلول 4 لتر', '240', NULL, 'Antiseptic', 'Chloroxylenol', 'Debeiky', 'Sol', 'محلول', NULL, '1', NULL, 'chloroxylenol also known as para-chloro-meta-xylenol (pcmx) is an antiseptic and disinfectant agent used for skin disinfection and cleaning surgical instruments. it is also commonly used in antibacterial soaps wound-cleansing applications and household an', NULL, NULL, 801, '2022-07-10', 0, 'The predominant medical applications for which chloroxylenol is formally indicated for therapeutic use is as an application to the skin for use in cuts, bites, stings, abrasions, and for use as antiseptic hand cleaner [L1992].', 'As a phenol antiseptic, it is believed that the hydroxyl -OH groups of the chloroxylenol molecule binds to certain proteins on the cell membrane of bacteria, and disrupts the membrane so as to allow the contents of the bacterial cell to leak out [A1351]. This allows chloroxylenol to enter the bacterial cell to bind further with more proteins and enzymes to disable the cell''s functioning [A1351]. At particularly high concentrations of chloroxylenol, the protein and nucleic acid content of targeted bacterial cells become coagulated and cease to function, leading to rapid cell death [A1351].', 'Chloroxylenol is a substituted phenol which has been widely used for many years as an ingredient of antiseptic and disinfectant products intended for external use [L1999]. It is known to be bactericidal in low concentration to a wide range of Gram positive and Gram negative bacteria [L1999].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19748, 'Germ clear top. antiseptic sol. 500 ml (net price)', 'جيرم كلير محلول 500 مل', '36', NULL, 'Antiseptic', 'Chloroxylenol', 'Debeiky', 'Sol', 'محلول', '500 ml', '1', NULL, 'chloroxylenol also known as para-chloro-meta-xylenol (pcmx) is an antiseptic and disinfectant agent used for skin disinfection and cleaning surgical instruments. it is also commonly used in antibacterial soaps wound-cleansing applications and household an', NULL, NULL, 660, '2022-07-29', 0, 'The predominant medical applications for which chloroxylenol is formally indicated for therapeutic use is as an application to the skin for use in cuts, bites, stings, abrasions, and for use as antiseptic hand cleaner [L1992].', 'As a phenol antiseptic, it is believed that the hydroxyl -OH groups of the chloroxylenol molecule binds to certain proteins on the cell membrane of bacteria, and disrupts the membrane so as to allow the contents of the bacterial cell to leak out [A1351]. This allows chloroxylenol to enter the bacterial cell to bind further with more proteins and enzymes to disable the cell''s functioning [A1351]. At particularly high concentrations of chloroxylenol, the protein and nucleic acid content of targeted bacterial cells become coagulated and cease to function, leading to rapid cell death [A1351].', 'Chloroxylenol is a substituted phenol which has been widely used for many years as an ingredient of antiseptic and disinfectant products intended for external use [L1999]. It is known to be bactericidal in low concentration to a wide range of Gram positive and Gram negative bacteria [L1999].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19749, 'Germa mix powder 300 gm', 'جيرما مكس بودرة 30 جم', '49', NULL, 'Weight loss', 'Whey protein+wheat germ+phytosterols', 'Apotix pharmaceuticals', 'Powder', 'بودرة', '300 gm', '1', 'يقوي المناعة -- تقوية الذاكرة والصحة العقلية', 'helps in weight loss', NULL, NULL, 919, '2022-05-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19750, 'Germa powder 8 sachets', 'جيرما بودرة 8 اكياس', '80', NULL, 'Dietary supplement', 'Natural wheat germ oil', 'Mpi', 'Powder', 'بودرة', NULL, '1', NULL, '-suitable for all family members -use: 1-2 tablespoonful to be mixed with milk youghurt juice green salad fruit salad and bakeries.', NULL, NULL, 1119, '2022-07-26', 0, NULL, 'The predominant targets of NK cells are ‘stressed’ cells with downregulated expression of class I MHC (MHC-I), a common mechanism used by malignant or virus-infected cells to evade recognition by the body’s immune system. In response to encountering these cells, NK cells release two types of proteins, perforins and granzyme B, which attack the target cell’s membrane, damage its organelles, and trigger apoptosis. NK Cell immunotherapy is an emerging anti-cancer strategy, as these cells are able to exert effects without activating the graft-versus-host disease cascade. In addition, their broad mechanism allows for generally safe administration of NK cells that are not immunologically matched to a patient. ', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19751, 'Germa-fruity powder', 'جيرما-فروتي بودرة', '35', NULL, 'Dietary supplement', 'Wheat germ oil+fruit mix', 'Lemaco egypt > nutra fit international', 'Powder', 'بودرة', NULL, '1', NULL, 'use: 1 tablespoonful to cup of water or milk once or several times daily', '6223003448523', NULL, 641, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19752, 'Germatrix (110g) spray', 'جيرماتريكس 110 جرام سبراي', '17', NULL, 'Antibiotic topical', 'Bacitracin+neomycin+polymyxin', 'Sigma', 'Spray', 'بخاخ', NULL, '1', NULL, 'mechanism of action of bacitracin bacitracin is an antibiotic produced by the strain of bacillus subtilis. it acts by inhibiting bacterial cell wall synthesis. it is active against a variety of gram positive and a few gram negative organisms. mechanism of', NULL, NULL, 936, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19753, 'Germatrix (85g) spray', 'جرماتريكس (85 جم) بخاخ', '14', NULL, 'Antibiotic topical', 'Bacitracin+neomycin+polymyxin', 'Sigma', 'Spray', 'بخاخ', NULL, '1', NULL, 'mechanism of action of bacitracin bacitracin is an antibiotic produced by the strain of bacillus subtilis. it acts by inhibiting bacterial cell wall synthesis. it is active against a variety of gram positive and a few gram negative organisms. mechanism of', NULL, NULL, 846, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19754, 'Germovid powder 450 gm', 'جيرموفيد بودرة 450 جم', '60', NULL, 'Vitamin e', 'Natural wheat germ oil', 'Nilco > lavida group', 'Powder', 'بودرة', '450 gm', '1', NULL, '-suitable for all family members -use: 1-2 tablespoonful to be mixed with milk youghurt juice green salad fruit salad and bakeries.', NULL, NULL, 900, '2022-07-24', 0, NULL, 'The predominant targets of NK cells are ‘stressed’ cells with downregulated expression of class I MHC (MHC-I), a common mechanism used by malignant or virus-infected cells to evade recognition by the body’s immune system. In response to encountering these cells, NK cells release two types of proteins, perforins and granzyme B, which attack the target cell’s membrane, damage its organelles, and trigger apoptosis. NK Cell immunotherapy is an emerging anti-cancer strategy, as these cells are able to exert effects without activating the graft-versus-host disease cascade. In addition, their broad mechanism allows for generally safe administration of NK cells that are not immunologically matched to a patient. ', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19755, 'Gervital 20 capsules', 'جيرفيتال 20 كبسولة', '18', NULL, 'Antioxidant', 'Grape seeds extract', 'Mepaco', 'Capsule', 'كبسولة', NULL, '2', 'مكمل غذائى مضاد للاكسدة يستخدم فى علاج قصور الأوعية والشرايين والدوالى وضعف الشعيرات الدموية وقصور الشعيرات الدموية للعين فى حالات البول السكرى والتورم والتليف الذى يحدث بعد بعض الجراحات و يساعد على منع تصلب الشرايين ومضاعفاتها مثل أمراض القلب وجلطات المخ ويساعد فى حالات تساقط الشعر ومقاومة الأمراض المختلفة والإجهاد فى العمل .', 'anti-oxidant', '6223002211715', NULL, 1122, '2023-04-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19756, 'Brexpiprazole clavita pharma 4 mg 30 f.c.tabs.', 'بريكسبيبرازول كلافيتا فارما 4 مجم 30 قرص', '216', '166.5', 'Psychiatric.antipsychotics', 'Brexpiprazole', 'Clavita pharma', 'Tab', 'أقراص', '4 mg', '3', NULL, NULL, NULL, NULL, 826, '2024-08-13', 0, 'Brexpiprazole is indicated as adjunctive therapy to antidepressants for the treatment of major depressive disorder in adults.[L39568] It is also indicated for the treatment of schizophrenia in patients 13 years of age and older.[L39568]



Brexpiprazole is also indicated for the treatment of agitation associated with dementia due to Alzheimer’s disease; however, it is not indicated as an as-needed (“prn”) treatment for this condition.[L46417]', 'Although the exact mechanism of action of brexpiprazole in psychiatric disorders has not been fully elucidated, the efficacy of brexpiprazole may be attributed to combined partial agonist activity at 5-HT<sub>1A</sub> and dopamine D2 receptors, and antagonist activity at 5-HT<sub>2A</sub> receptors. Brexpiprazole binds to these receptors with subnanomolar affinities.[A7782, A259626, L46417] These therapeutic targets have been implicated in psychiatric conditions such as schizophrenia and depression. Partial D2 receptor agonism allows the drug to stimulate D2 receptors under low dopamine conditions, while attenuating their activation when dopamine levels are high. Partial agonism at 5-HT<sub>1A</sub> receptors may be tied to improved memory function and cognitive performance. Antagonism at α-adrenergic receptors has also been implicated in schizophrenia and depression.[A182186, A259641]', 'Brexpiprazole is an atypical antipsychotic agent used to ameliorate the symptoms of psychiatric conditions, such as cognitive deficits and affective symptoms.[A182186] Brexpiprazole has affinity (expressed as Ki) for multiple monoaminergic receptors including serotonin 5-HT<sub>1A</sub> (0.12 nM), 5-HT<sub>2A</sub> (0.47 nM), 5-HT<sub>2B</sub> (1.9 nM), 5-HT<sub>7</sub> (3.7 nM), dopamine D2 (0.30 nM), D3 (1.1 nM), and noradrenergic α<sub>1A</sub> (3.8 nM), α<sub>1B</sub> (0.17 nM), α<sub>1D</sub> (2.6 nM), and α<sub>2C</sub> (0.59 nM) receptors. Brexpiprazole acts as a partial agonist at the 5-HT<sub>1A</sub>, D2, and D3 receptors and as an antagonist at 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>7</sub>, α<sub>1A</sub>, α<sub>1B</sub>, α<sub>1D</sub>, and α<sub>2C</sub> receptors. Brexpiprazole also exhibits affinity for histamine H1 receptor (19 nM) and for muscarinic M1 receptor (67% inhibition at 10 µM).[L46417]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19757, 'Gesicrest 10mg/ml vial for i.v. inf. 50 ml (n/a)', 'جيسكريست 10 مجم / مل فيال 50 مل', '9', NULL, 'Antipyretic', 'Paracetamol(acetaminophen)', 'Global pharmaceutical industries > novell pharma', 'Vial', 'فيال', '10mg', '1', NULL, 'about paracetamol acetanilide derivative non narcotic analgesic antipyretic. mechanism of action of paracetamol paracetamol has analgesic and antipyretic action. it is more active on cyclo-oxygenase enzyme in brain. peripherally it is a poor inhibitor of', NULL, NULL, 923, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19758, 'Gesicrest 10mg/ml vial for i.v. inf. 50 ml', 'جيسكريست 10 مجم / مل فيال 50 مل', '9', NULL, 'Antipyretic', 'Paracetamol(acetaminophen)', 'Global pharmaceutical industries > novell pharma', 'Vial', 'فيال', '10mg', '1', NULL, NULL, NULL, NULL, 822, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19759, 'Gesiket 75 mg 20 caps.', 'جيسيكيت 75 مجم 20 كبسولة', '18', NULL, 'Nsaid.propionic acid derivatives', 'Ketoprofen', 'El-obour > atm pharmaceutical industries', 'Cap', 'كبسولة', '75 mg', '2', NULL, 'about ketoprofen nsaid propionic acid derivative analgesic antipyretic antiinflammatory. mechanism of action of ketoprofen it inhibits cyclo oxygenase enzymes both cox1 and cox2.these cyclooxygenase enzyme catalyses the synthesis of prostaglandins from ar', '6225000082809', NULL, 875, '2022-12-05', 0, 'For symptomatic treatment of acute and chronic rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, primary dysmenorrhea and mild to moderate pain associated with musculotendinous trauma (sprains and strains), postoperative (including dental surgery) or postpartum pain.', 'The anti-inflammatory effects of ketoprofen are believed to be due to inhibition cylooxygenase-2 (COX-2), an enzyme involved in prostaglandin synthesis via the arachidonic acid pathway. This results in decreased levels of prostaglandins that mediate pain, fever and inflammation. Ketoprofen is a non-specific cyclooxygenase inhibitor and inhibition of COX-1 is thought to confer some of its side effects, such as GI upset and ulceration. Ketoprofen is thought to have anti-bradykinin activity, as well as lysosomal membrane-stabilizing action. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. ', 'Ketoprofen is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties. Ketoprofen has pharmacologic actions similar to those of other prototypical NSAIDs, which inhibit prostaglandin synthesis. Ketoprofen is used to treat rheumatoid arthritis, osteoarthritis, dysmenorrhea, and alleviate moderate pain.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19760, 'Gesirelax 20 f.c. tabs.', 'جيسي ريلاكس 20 قرص', '57', '20', 'Cns.analgesic.skeletal muscle relaxant', 'Ibuprofen+methocarbamol', 'Mash premiere', 'Tab', 'أقراص', NULL, '2', NULL, 'muscle relaxant', '6222001400724', NULL, 1281, '2023-11-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19761, 'Geskan spray 100 ml', 'جيسكان بخاخ 100 مل', '50', NULL, 'Antiseptic', 'Alcohol 70%+zinc sulfate+salicylic acid+vitamin e+chamomile extract+glycerin', 'Macro group pharmaceuticals', 'Spray', 'بخاخ', '100 ml', '1', NULL, '* spray with astringent soothing & protective properties with vitamin e *possesses astringent soothing & anti-oxidant properties. *effectively helps in care of newborn s umbilical cord stump. how to use - apply a suitable amount of geskan spray on the nee', '6224000437589', NULL, 1105, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19763, 'Gesprital 30 mg 1 tablet', 'جسبريتال 30 مجم 1 قرص', '45', NULL, 'Emergency contraception', 'Ulipristal acetate', 'Hi-pharm > atco pharma', 'Tablet', 'أقراص', '30 mg', '1', NULL, 'ulipristal is a selective progesterone receptor modulator used for the purposes of emergency contraception and for the treatment of uterine fibroids . it is a derivative of 19-norprogesterone and has both antagonistic and partial agonist activity at the p', NULL, NULL, 1546, '2022-07-13', 0, 'As the product Ella (available in Canada and the US), ulipristal is indicated for use as emergency contraception after unprotected intercourse or possible contraceptive failure when administered within 120 hours (5 days) after unprotected intercourse or a known or suspected contraceptive failure. As the product Fibristal (available in Canada), ulipristal is indicated for treatment of the signs and symptoms of uterine fibroids in adult women.', 'The exact mechanism of action of ulipristal has been heavily debated [FDA Label] [A18504, A175372, A175375, A175378]. On one hand, the majority of official prescribing information labels, monographs, and prior research studies for ulipristal indicated as an emergency contraceptive suggest that its primary mechanism of action revolves around inhibiting or delaying ovulation by suppressing surges in LH that result in the postponement of follicular rupture [A18504, L5575, F3772].



Conversely, some of the latest investigations pertaining to ulipristal''s mechanism of action as an emergency contraceptive propose that it principally elicits its action by preventing embryo implantation, as opposed to preventing ovulation [A175372, A175375, A175378]. Although previous investigations have shown that ulipristal essentially has the ability to prevent ovulation equivalent to placebo (ie. null effect or ability) when administered during LH peaks one to two days before ovulation, the agent still demonstrates a stable and consistently high contraceptive effect of approximately >=80% when used at this time [A175372]. Subsequently, current studies attempt to investigate how ulipristal could elicit emergency contraception via ovulation prevention under circumstances where ovulation had already clearly been observed [A175372, A175375, A175378]. Endometrial biopsy samples studied from such circumstances in such investigations subsequently show that the administered ulipristal causes endometrial tissue to become inhospitable and unsuitable for embryo implantation where a variety of genes characteristic of receptive, pro-gestational endometrium are downregulated [A175372, A175375, A175378]. 



Nevertheless, most if not all proposed mechanisms commonly agree that ulipristal ultimately demonstrates its pharmacological effects by binding to human progesterone receptors and prevents natural, endogenous progesterone from occupying such receptors [A18504, L5575, F3772, A175372, A175375, A175378]. Regardless, however, considering current and on-going research into ulipristal''s ability to prevent embryo implantation, the notion that the medication can elicit post-fertilization effects potentially raises alerts and/or ethical debates over the use of ulipristal owing to potential abortifacient activity [A18504, A175372, A175375, A175378], which is considered to be on par or equipotent to that of mifepristone [F3769]. Attention should be drawn to the fact that some prescribing information, however, such as the US FDA label for ulipristal indicated for emergency contraception, has included new supplementary commentary since 2018 that directly warns about ulipristal not being indicated for termination of existing pregnancies and suggesting that ulipristal use may confer alterations to the endometrium that may affect implantation and contribute to efficacy [FDA Label]. 



In the treatment of fibroids, ulipristal has been shown to exert direct actions on fibroids reducing their size through inhibition of cell proliferation and induction of apoptosis.', 'Ulipristal is a selective, reversible progestin receptor modulator and its tissue targets include the uterus, cervix, ovaries, and hypothalamus. Ulipristal may act as an agonist or antagonist in the presence or absence of progesterone based on the tissue target. If given mid-follicular phase, development of the follicle growth is delayed and estradiol concentrations decrease. If given at the time when luteinizing hormone peaks, follicular rapture is delayed by several days.  If given early-luteal phase, a decrease in endometrial thickness can be observed. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19764, 'Gesto 30 capsules', 'جيستو 30 كبسولة', '26', NULL, 'Git disturbances', 'Peppermint oil+ginger oil+chamomile oil+fennel oil+caraway oil', 'Arab caps > napco', 'Capsule', 'كبسولة', NULL, '3', NULL, 'improve gastro-intestinal functions', NULL, NULL, 864, '2022-07-22', 0, 'Indicated for the over-the-counter use for:



-the symptomatic relief of minor spasms of the gastrointestinal tract, flatulence and abdominal pain, especially in patients with irritable bowel syndrome.



-the temporary relief of itching associated with insect bites, eczema, minor burn, sunburn, minor skin irritations, minor cuts, scrapes, atopic dermatitis and other skin disorders.



-the temporary symptomatic relief of mild joint and muscle pain as a local topical analgesic.



-the temporary relief of tension-type headache.', 'Dose-dependent antispasmodic effect of peppermint oil is largely mediated by its menthol constituent [A33056]. It is proposed that peppermint oil relaxes gastrointestinal smooth muscle and attenuates contractile responses by reducing the influx of extracellular calcium ions. In rabbit jejunum smooth muscle cells investigated via whole cell clamp configuration technique, peppermint oil was shown to inhibit the potential-dependent calcium currents in a concentration-dependent manner [A33056]. Both a reduction in peak current amplitude and an increase in the rate of current decay were observed, indicating that the pharmacological activity peppermint oil resembles that of dihydropyridine calcium antagonists [A33056]. In a rat small intestine study, peppermint oil in the intestinal lumen inhibited enterocyte glucose uptake via a direct action on the brush border membrane and inhibited intestinal secretion [A33056]. There is also evidence that menthol is an antagonist of L-type Ca2+ channels via interacting with dihydropyridine binding sites and blocks the currents of low-voltage-activated calcium channels [A33056]. Peppermint oil may facilitate hair growth by promoting the conservation of vascularization of hair dermal papilla, which may contribute to the induction of early anagen stage of active growth phase of hair follicles [A33044]. ', 'Peppermint oil induces a dose-related antispasmodic effects on the gastrointestinal smooth muscles [A33056]. A meta-analysis study and additional clinical studies of patients with IBS demonstrated that the treatment with peppermint oil improves abdominal symptoms compared to the placebo group, resulting in reduced severity of abdominal pain, decreased abdominal distension, reduced stool frequency, and reduced flatulence [A33055, A33057]. The use of enteric-coated peppermint oil was shown to be effective in reducing gastrointestinal symptoms of non-ulcer dyspepsia [A33055]. In rats, peppermint oil promoted a time-dependent choleretic  effect in increasing bile production and biliary output [A33056]. In randomized controlled trials, topical application of peppermint oil was associated with a significant analgesic effect and a reduction in headache intensity compared to placebo [A33055]. In a study of C57BL/6 mice, topical application of peppermint oil for 4 weeks was associated with a prominent hair growth effects; a significant increase in dermal thickness, follicle number, and follicle depth [A33044]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19766, 'Gevarcut 200 mg 10 f.c. tabs.', 'جيفاركوت 200 مجم 10 أقراص', '13', NULL, 'Anti-ischemic', 'Naftidrofuryl', 'El-obour > repharma pharmaceuticals', 'Tab', 'أقراص', '200 mg', '1', NULL, 'naftidrofuryl oxalate works in two main ways. firstly it causes the blood vessels to widen. secondly it increases the ability of cells to remove waste products. in peripheral vascular diseases the blood vessels in the extremities are narrowed and the bloo', NULL, NULL, 1172, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19767, 'Giga white cream 50 gm', 'جيجا وايت 50جم كريم', '70', NULL, 'Whitening topical', NULL, 'El-helou perfumes & cosmetics > four benifits pharmaceuticals', 'Cream', 'كريم', '50 gm', '1', 'كريم تفتيح وترطيب البشرة وعلاج الكلف والتصبغات', 'whitening cream', NULL, NULL, 1683, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19768, 'Gigazocin 200mg/5ml pd. oral susp. 25 ml', 'جيجازوسين 200 مجم / 5 مل معلق 25 مل', '17', NULL, 'Antibiotic.macrolide', 'Azithromycin', 'T3a pharma > pioneer pharmaceutical industries', 'Susp', 'معلق', '200mg', '1', NULL, 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. dose: adult: po- respiratory tract skin and soft tissue infections- 500 mg once daily for 3 days. or 500mg on day 1 followed by 250mg on days 2 to 5. typhoid- 500 mg', NULL, NULL, 783, '2022-07-25', 0, 'Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin [FDA label].



Azithromycin is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the microorganisms listed in the specific conditions below. Recommended dosages, duration of therapy and considerations for various patient populations may vary among these infections. Refer to the FDA label and "Indications" section of this drug entry for detailed information [FDA label]. 



**Adults**:



Acute bacterial exacerbations of chronic obstructive pulmonary disease due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Acute bacterial sinusitis due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.

Uncomplicated skin and skin structure infections due to _Staphylococcus aureus_, _Streptococcus pyogenes_, or _Streptococcus agalactiae_. Abscesses usually require surgical drainage.



Urethritis and cervicitis due to _Chlamydia trachomatis_ or _Neisseria gonorrhoeae_.



Genital ulcer disease in men due to _Haemophilus ducreyi_ (chancroid). Due to the small number of women included in clinical trials, the efficacy of azithromycin in the treatment of chancroid in women has not been established.



**Pediatric Patients**



Acute otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy.



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.', 'In order to replicate, bacteria require a specific process of protein synthesis, enabled by ribosomal proteins [A6505]. Azithromycin binds to the 23S rRNA of the bacterial 50S ribosomal subunit. It stops bacterial protein synthesis by inhibiting the transpeptidation/translocation step of protein synthesis and by inhibiting the assembly of the 50S ribosomal subunit [FDA label], [A14179]. This results in the control of various bacterial infections [A174193], [FDA label].   The strong affinity of macrolides, including azithromycin, for bacterial ribosomes, is consistent with their broad‐spectrum antibacterial activities [A174193].





Azithromycin is highly stable at a low pH, giving it a longer serum half-life and increasing its concentrations in tissues compared to erythromycin [A174175]. 



', 'Macrolides stop bacterial growth by inhibiting protein synthesis and translation, treating bacterial infections [A174175].

Azithromycin has additional immunomodulatory effects and has been used in chronic respiratory inflammatory diseases for this purpose [A174172].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19769, 'Gigazocin 500mg 5 caps.', 'جيجازوسين 500 مجم 5 كبسولات', '23', NULL, 'Antibiotic.macrolide', 'Azithromycin', 'Egpi > pioneer pharmaceutical industries', 'Cap', 'كبسولة', '500mg', '1', NULL, 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. dose: adult: po- respiratory tract skin and soft tissue infections- 500 mg once daily for 3 days. or 500mg on day 1 followed by 250mg on days 2 to 5. typhoid- 500 mg', NULL, NULL, 916, '2022-07-27', 0, 'Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin [FDA label].



Azithromycin is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the microorganisms listed in the specific conditions below. Recommended dosages, duration of therapy and considerations for various patient populations may vary among these infections. Refer to the FDA label and "Indications" section of this drug entry for detailed information [FDA label]. 



**Adults**:



Acute bacterial exacerbations of chronic obstructive pulmonary disease due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Acute bacterial sinusitis due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.

Uncomplicated skin and skin structure infections due to _Staphylococcus aureus_, _Streptococcus pyogenes_, or _Streptococcus agalactiae_. Abscesses usually require surgical drainage.



Urethritis and cervicitis due to _Chlamydia trachomatis_ or _Neisseria gonorrhoeae_.



Genital ulcer disease in men due to _Haemophilus ducreyi_ (chancroid). Due to the small number of women included in clinical trials, the efficacy of azithromycin in the treatment of chancroid in women has not been established.



**Pediatric Patients**



Acute otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy.



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.', 'In order to replicate, bacteria require a specific process of protein synthesis, enabled by ribosomal proteins [A6505]. Azithromycin binds to the 23S rRNA of the bacterial 50S ribosomal subunit. It stops bacterial protein synthesis by inhibiting the transpeptidation/translocation step of protein synthesis and by inhibiting the assembly of the 50S ribosomal subunit [FDA label], [A14179]. This results in the control of various bacterial infections [A174193], [FDA label].   The strong affinity of macrolides, including azithromycin, for bacterial ribosomes, is consistent with their broad‐spectrum antibacterial activities [A174193].





Azithromycin is highly stable at a low pH, giving it a longer serum half-life and increasing its concentrations in tissues compared to erythromycin [A174175]. 



', 'Macrolides stop bacterial growth by inhibiting protein synthesis and translation, treating bacterial infections [A174175].

Azithromycin has additional immunomodulatory effects and has been used in chronic respiratory inflammatory diseases for this purpose [A174172].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19770, 'Gilda pell cream 60 ml', 'جيلدا بيل كريم 60 مل', '39', NULL, 'Healing topical', 'Hyaluronic acid+centella ext+honey+nigella sativa oil+shea butter+zinc oxide+vit.(e+a)+dimethicone', 'El helou for cosmetics > egypt new pharma (enp)', 'Cream', 'كريم', '60 ml', '1', NULL, 'emollient cream ** ingredients: hyaluronic acid + centella ext. + honey + nigella sativa oil + shea butter + zinc oxide + vitamin e & a + dimethicone + dexapanthenol + propolis + exclusive combination of natural components & vitamins', NULL, NULL, 1283, '2022-06-18', 0, 'The intra-articular preparations of hyaluronic acid are indicated for knee pain associated with osteoarthritis.[L32228] Hyaluronic acid is used in cosmetic applications to prevent and reduce the appearance of wrinkles on the face, and as a dermal filler to correct facial imperfections or other imperfections on other parts of the body.[L32208,L32223] It is frequently an ingredient in topical applications for wound healing and symptomatic treatment of skin irritation from various causes.[L32198] Hyaluronic acid may also be indicated in ophthalmological preparations or oral capsules to treat discomfort caused by dry eyes or conjunctivitis and for its protective qualities during and before eye surgery.[A230128,L32213] Finally, hyaluronic acid can be used off-label to coat the bladder for relief of interstitial cystitis symptoms.[A230533]', 'General principles and hyaluronic acid receptor binding 



Hyaluronic acid works by two basic mechanisms: serving as a passive structural molecule or serving as signaling molecule, depending on the molecule size. The physicochemical properties of high molecular weight HA contribute to passive structural effects, demonstrating hygroscopicity and viscoelasticity and improving hydration, water balance, and structural integrity. As a signalling  molecule interacting with proteins, HA causes several opposing effects based on molecular weight: pro- or anti-inflammatory effects, promotion or inhibition of cell migration, and activating or inhibiting cell division.[A230133] 



Hyaluronic acid exerts its therapeutic effects through binding to three primary types of cell surface receptors: CD44 (a membrane glycoprotein), the receptor for hyaluronate-mediated motility (RHAMM), and the Intercellular Adhesion Molecule 1 (ICAM-1). CD44 is considered the most widely distributed receptor for hyaluronic acid, demonstrating cellular interactions with osteopontin, collagen, and matrix metalloproteinases (MMPs).  High and low molecular weight hyaluronic acids demonstrate differing molecular and cellular mechanisms in their interaction with CD44 receptors. Some examples of these effects include modification of chondrocyte survival pathways in addition to alteration of apoptosis pathways.  Lymphatic vessel endothelial hyaluronan receptor (LYVE-1), and hyaluronic acid receptor for endocytosis (HARE), (also known as Stabilin-2) also bind to hyaluronic acid.[A230128] 



Hyaluronic acid for skin conditions and cosmetics



Hyaluronic acid''s anionic proprieties cause it to attract water and induce swelling, increasing tissue volume and skin structural integrity. The aging process is associated with reduced production of skin hyaluronic acid and collagen, causing the appearance of wrinkles and the loss of facial volume. Dermal fillers of hyaluronic acid replace lost tissue volume, imparting a full and youthful appearance to skin that has lost its elasticity. Hyaluronic acid fillers contain cross-linked hyaluronic acid particles, rendering a concentrated substance with resistance to various forms of physical and chemical breakdown. The cosmetic benefits of hyaluronic acid filler may last up to 6 months, depending on the brand and technique used for injection.[L32193] Additionally, dermal hyaluronic acid fillers are known to increase the production of fibroblasts[L32193], supporting wound healing and offering relief from irritating and inflammatory skin conditions.[A230118]





Hyaluronic acid for joint pain



Most cells in the human body are capable of synthesizing HA. It is a primary component of the extracellular matrix (ECM) and can be found in bone marrow, cartilage, and synovial fluid in joints.[A230128] In osteoarthritis, the concentration of naturally occurring hyaluronic acid gradually decreases, lowering the viscosity of synovial fluid that protects joints from excess friction. Administration of intra-articular hyaluronic acid increases viscosity of synovial joint fluid, reducing friction and subsequently relieving painful arthritic symptoms.[L32193]





Hyaluronic acid for ophthalmic conditions and ophthalmological procedures



Solutions of hyaluronic acid with a concentration greater than 0.1% moisturize the surface of the eyes to treat symptoms of dry eye while improving the stabilization of tear film, replenishing deficiencies of HA, reducing friction, and preventing binding of foreign substances to the ocular tissue.[A230128,L32193] Hyaluronic acid is frequently used during and after ophthalmological surgeries and plays important roles by virtue of its moisturizing, viscoelastic, and protective properties. It promotes tissue healing of the corneal epithelium and other parts of the eye following ophthalmological surgery, minimizing the risk of adhesions and free radical formation.[A230128]

', 'HA has long-acting lubricant, shock absorbing, joint stabilizing, and water balancing properties.[A230128,L32193] It is similar to the naturally occurring glycosaminoglycan (GAG) in joints. Hyaluronic acid works by acting as a lubricant and shock absorber, facilitating joint mobility and thereby reducing osteoarthritic pain.  Hyaluronic acid has antioxidative, anti-inflammatory, and analgesic effects.[A230128] The water-balancing properties and viscoelasticity of hyaluronic acid are beneficial in cosmetic injections, imparting volume and reducing the appearance of imperfections and wrinkles.[L32193] Due to the abovementioned properties, HA has a protective effect on the eyes and cornea.[A230133]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19771, 'Gilenya 0.5mg 28 caps', 'جيلينيا 0.5 مجم 28 كبسولة', '16,850', '15807', 'Immunosuppressants', 'Fingolimod', 'Novartis', 'Cap', 'كبسولة', '0.5mg', '2', NULL, NULL, NULL, NULL, 4345, '2025-01-16', 0, 'Fingolimod is indicated for the treatment of patients aged 10 and above with relapsing forms of multiple sclerosis, which may include clinically isolated syndrome, relapsing-remitting disease, as well as active secondary progressive disease.[L12651,L44346]', 'Sphingosine‐1‐phosphate (S1P) is an important phospholipid that binds to various G‐protein‐coupled receptor subtypes, which can be identified as S1P1–5R. S1P and the receptors it binds to perform regular functions in the immune, cardiovascular, pulmonary, and nervous systems.[A189321,A192744] S1P can be expressed ubiquitously, playing an important role in regulating inflammation.  S1P1R, S1P2R, and S1P3R receptors can be found in the cardiovascular, immune, and central nervous systems. S1P4R is found on lymphocytic and hematopoietic cells, while S1P5R expression is found only on the spleen (on natural killer cells) or in the central nervous system.[A189333]



The active form of the drug, fingolimod phosphate, is a sphingosine 1-phosphate receptor modulator that exerts its mechanism of action in MS by binding to various sphingosine 1-phosphate receptors (1, 3, 4, and 5). It suppresses the exit of lymphocytes from lymph nodes, leading to a lower level of lymphocytes circulating in the peripheral circulation. This reduces the inflammation that is associated with MS. The mechanism of action of fingolimod is not fully understood but may be related to reduced lymphocyte circulation into the central nervous system.[A176474,L12651]



Immune modulating treatment such as fingolimod is not typically employed for SARS-CoV-2 pneumonia. Despite this, with the tissue findings of pulmonary edema and hyaline membrane formation, the timely use of immune modulators such as fingolimod can be considered to prevent acute respiratory distress syndrome (ARDS) associated with COVID-19.[L12654]', 'In multiple sclerosis, fingolimod binds to sphingosine receptors, reducing its associated neuroinflammation.[L12651]In COVID-19, it may reduce lung inflammation and improve the clinical outcomes of patients with this disease.[L12654] 



Fingolimod causes a transient reduction in heart rate and AV conduction during treatment initiation. It has the potential to prolong the QT interval.[L12654]





 ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19774, 'Bioprex 10 mg 30 f.c.tabs.', 'بيوبريكس 10 مجم 30 قرص', '195', '160', 'Psychiatric.antipsychotics', 'Olanzapine', 'Clavita pharma', 'Tab', 'أقراص', '10 mg', '3', NULL, NULL, '6224011023061', NULL, 1164, '2025-03-25', 0, 'Olanzapine was initially used orally and intramuscularly for the chronic treatment of schizophrenia in patients over 13 years old and other psychiatric disorders such as bipolar I disorder including mixed or manic episodes.[A177014] 



Olanzapine is also indicated, in combination with lithium or valproate for the short-term treatment of acute manic or mixed episodes associated with bipolar I disorder in adults.[FDA label]



As well, olanzapine is indicated, in combination with fluoxetine for the treatment of episodes of depression associated with bipolar disorder type 1 and treatment-resistant depression in patients over 10 years old.[A177014]



Olanzapine is also approved for the management of psychomotor agitation associated with schizophrenia and bipolar I mania.[FDA label]



Schizophrenia is a complex biochemical brain disorder that affects the person''s ability to differentiate reality. It is usually observed as the presence of delusions, hallucinations, social withdrawal and disturbed thinking.[L5936]



Bipolar disorder is a mental health condition defined by periods of extreme mood disturbances. It is categorized in different types from which type 1 is known to involve episodes of severe mania and often depression while type 2 presents less severe forms of mania.[L5939]



Olanzapine is also indicated in combination with [samidorphan] for the treatment of bipolar I disorder, either as an adjunct to lithium or valproate or as monotherapy for the acute treatment of manic or mixed episodes or as maintenance therapy, and for the treatment of schizophrenia in adults.[L34359]', 'The activity of olanzapine is achieved by the antagonism of multiple neuronal receptors including the dopamine receptor D1, D2, D3 and D4 in the brain, the serotonin receptors 5HT2A, 5HT2C, 5HT3 and 5HT6, the alpha-1 adrenergic receptor, the histamine receptor H1 and multiple muscarinic receptors.[A176993, A176999]



As abovementioned, olanzapine presents a wide profile of targets, however, its antagonistic effect towards the dopamine D2 receptor in the mesolimbic pathway is key as it blocks dopamine from having a potential action at the post-synaptic receptor. The binding of olanzapine to the dopamine D2 receptors is easily dissociable and hence, it allows for a certain degree of dopamine neurotransmission.[A177014]



On the other hand, olanzapine acts in the serotonin 5HT2A receptors in the frontal cortex in a similar manner than the reported on dopamine D2 receptors. This determined effect allows for a decrease in adverse effects.[A177014]', 'The effect of olanzapine in the D2 receptor is reported to produce the positive effects of this drug such as a decrease in hallucinations, delusions, disorganized speech, disorganized thought, and disorganized behavior. On the other hand, its effect on the serotonin 5HT2A receptor prevents the onset of anhedonia, flat affect, alogia, avolition and poor attention.[A177014] Based on the specific mechanism of action, olanzapine presents a higher affinity for the dopamine D2 receptor when compared to the rest of the dopamine receptor isotypes. This characteristic significantly reduces the presence of side effects.[T554]



Clinical trials for the original use of olanzapine demonstrated significant effectiveness in the treatment of schizophrenia and bipolar disorder in adults and acute manic or mixed episodes associated with bipolar disorder in adolescents.[A177008]



The effect of olanzapine on dopamine and serotonin receptors has been suggested to reduce chemotherapy-induced nausea and vomiting as those receptors are suggested to be involved in this process. For this effect, several clinical trials have been conducted and it has been shown that olanzapine can produce a significant increase in total control of nausea and vomiting.[A176993] In a high-level study of the effect of olanzapine for this condition, a complete response on the delay phase was observed in 84% of the individual and control of emesis of over 80% despite the phase.[A176999]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19775, 'Ginger root 550 mg 100 caps. (illegal import)', 'جينجر روت 550مجم 100 كبسولة', '0', NULL, NULL, 'Ginger', 'Puritans pride', 'Cap', 'كبسولة', '550 mg', '1', NULL, 'supports digestive health** helps alleviate occasional motion sickness** the active constituents in ginger promote digestive health.** ginger is also good for alleviating occasional motion sickness.** dose: 1 capsule twice daily preferably with meals.', NULL, NULL, 870, '2022-10-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19776, 'Ginipin 10 sachets 10 gm', 'جينبين 10جم 10اكياس', '250', '195', 'Anti-rheumatic.osteoarthritis.anabolic agents', 'Collagen+vitamin e+vitamin c+calcium+magnesium', 'Med care > parkville pharmaceuticals', 'Sachet', 'أكياس', '10 gm', '1', NULL, '*super collagen with vitamins c + e ï- skin hair nail and joint support. use: once daily. empty the contents of one sachet on a cup of water and stir well', '6224008073246', NULL, 1001, '2024-05-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19777, 'Ginko 40mg/ml oral soln. 30 ml', 'جينكو 40 مجم / مل محلول للفم 30 مل', '40', '25', 'Anti-ischemic', 'Ginkgo biloba', 'Mepaco', 'Sol', 'محلول', '40mg', '1', NULL, NULL, '6223002219988', NULL, 1233, '2024-07-29', 0, '_Ginkgo biloba_ does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use.[A232379] It is available in over-the-counter herbal products mostly for oral use, to improve memory and cognitive problems. ', 'Two key active ingredients in _ginkgo biloba_ are terpene lactones (notably ginkgolides and diterpenes) and ginkgo flavone glycosides (notably ginkgetin, bilobetin, and sciadopitysin), which are present at varying concentrations. _Ginkgo biloba_ extract EGb 761 is the standardized extract of _ginkgo biloba_ used in studies, which contains 6% terpenoids and 24% flavonoid glycosides. Animal studies have shown that _ginkgo biloba_ works on several neurotransmitter pathways and brain structures. Flavones were shown to inhibit lipid peroxidation; inhibit the uptake of serotonin, dopamine, and norepinephrine; and inhibit platelet aggregation.[A232404] Terpene lactones may also act as potent antagonists of the platelet-activating factor and may possess anti-ischemic and fibrinolytic effects.[A232379] They were also shown to downregulate adrenal peripheral benzodiazepine receptors and increase adrenocorticotropic hormone levels.[A232404] _Ginkgo biloba_ also reversibly inhibits monoamine oxidase A; and modestly inhibits anticholinesterase activity,[A232379, A232389] leading to enhanced cholinergic transmission in the brain.[A232394] 



Several studies suggest that _ginkgo biloba_ exerts neuroprotective effects by reducing free radical production in the prefrontal cortex, which may explain its improvement on short-term memory. _Ginkgo biloba_ extract acts as a free radical scavenger, protecting neurons from oxidative damage and apoptosis related to aging, cerebral ischemia, and neurodegenerative disorders.[A232379] _Ginkgo biloba_ also inhibits amyloid-β neurotoxicity and protects against hypoxic challenges and increased oxidative stress.[A232389] One study showed that bilobalide, a terpene lactone, delays the onset of hypoxic glycolysis.[A232404] _Ginkgo biloba_ has the potential to regulate metabolism, stabilize the membrane, and promote vasodilation. In the arterial endothelium, EGb stimulated the release of endogenous relaxing factors, such as endothelium-derived relaxing factor and prostacyclin. In the inflammatory environment that causes tissue damage, EGb promoted nitric oxide production, leading to enhanced peripheral and cerebral blood flow.[A232379] ', '_Ginkgo biloba_ is a herbal ingredient with demonstrated antioxidant, vasoactive, antiapoptotic, anti-inflammatory, antiplatelet, and fibrinolytic properties.[A232389, A232399] _Ginkgo biloba_ has been investigated for use in a variety of medical conditions, but the most extensively studied area is in the context of cognitive impairment and neurodegenerative disorders. _Ginkgo biloba_ was examined as a potential nootropic agent or cognitive enhancer but research findings supporting the therapeutic efficacy of _ginkgo biloba_ extract (EGb) in dementia remain controversial. Some clinical studies of dementia that were up to one year long showed that EGb improves the cognitive performance and social functioning of patients. However, other studies did not support its clinical benefit for patients with cognitive impairment and dementia. Numerous meta-analysis studies showed insufficient evidence of the effectiveness of EGb in reducing both all-cause dementia incidence and Alzheimer''s disease-associated dementia incidence in elderly patients with normal cognition or with mild cognitive impairment. Additionally, there is no up-to-date evidence that demonstrates the benefit of the long-term use of standardized EGb in reducing the risk of progression to Alzheimer''s disease. A 2012 meta-analysis did not support the use of EGb in enhancing cognitive function in healthy adults.[A232379]



In the context of cardiovascular diseases, a limited number of studies showed that EGb improved mortality or neurological recovery in the post-stroke period, reduced cognitive and neurological impairment after acute ischemic stroke, and improved blood flow in the coronary artery in patients with coronary artery disease. However, a systemic review found no statistical or clinically significant benefit of EGb for patients with peripheral arterial disease or hypertension. Overall, there is a lack of strong evidence in the use of EGb for the treatment or prevention of cardiovascular diseases.[A232379]



In a small trial, the use of EGb as an adjunctive treatment with citalopram improved depressive symptoms and cognitive function in patients with depression.[A232379] _Ginkgo biloba_ was also investigated as a potential treatment for antidepressant-induced sexual dysfunction.[A2434] Another study showed EGb improving the symptoms of tardive dyskinesia. There is insufficient evidence to prove the effectiveness of EGb in these psychiatric disorders. Limited studies have investigated the role of _ginkgo biloba_ in the treatment of vertigo, tinnitus, vitiligo, macular degeneration, and glaucoma, as well as the prevention of acute mountain sickness. As results are either preliminary or controversial, more quality research is warranted.[A232379]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19779, 'Ginko cemix 30 caps.', 'جينكو سيميكس 30 كبسولة', '45', NULL, NULL, 'Grape seeds extract+ginko biloba extract', 'Arab caps > andalous medical', 'Cap', 'كبسولة', NULL, '3', 'يحسن من تدفق الدورة الدموية -- يحسن الذاكرة', NULL, NULL, NULL, 910, '2022-05-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19780, 'Gusto 30 tabs', 'جيستو 30 قرص', '150', '75', 'Calcium+vitamin d+vitamin c+magnesium', 'Calcium+vitamin d+vitamin c+magnesium', 'Bms pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 2066, '2024-10-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19781, 'Ginko topical gel 20 gm', 'جنكو جل موضعي 20 جم', '10', NULL, 'Blood circulation inhancer', 'Ginkgo biloba+troxerutin', 'Sedico > mepaco', 'Gel', 'جل', '20 gm', '1', NULL, 'mechanism of action of ginkgo biloba the mechanism of action of ginkgo is believed to be produced by its functions as a neuroprotective agent an antioxidant a free-radical scavenger a membrane stabilizer and an inhibitor of platelet-activating factor via', NULL, NULL, 1205, '2022-07-20', 0, '_Ginkgo biloba_ does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use.[A232379] It is available in over-the-counter herbal products mostly for oral use, to improve memory and cognitive problems. ', 'Two key active ingredients in _ginkgo biloba_ are terpene lactones (notably ginkgolides and diterpenes) and ginkgo flavone glycosides (notably ginkgetin, bilobetin, and sciadopitysin), which are present at varying concentrations. _Ginkgo biloba_ extract EGb 761 is the standardized extract of _ginkgo biloba_ used in studies, which contains 6% terpenoids and 24% flavonoid glycosides. Animal studies have shown that _ginkgo biloba_ works on several neurotransmitter pathways and brain structures. Flavones were shown to inhibit lipid peroxidation; inhibit the uptake of serotonin, dopamine, and norepinephrine; and inhibit platelet aggregation.[A232404] Terpene lactones may also act as potent antagonists of the platelet-activating factor and may possess anti-ischemic and fibrinolytic effects.[A232379] They were also shown to downregulate adrenal peripheral benzodiazepine receptors and increase adrenocorticotropic hormone levels.[A232404] _Ginkgo biloba_ also reversibly inhibits monoamine oxidase A; and modestly inhibits anticholinesterase activity,[A232379, A232389] leading to enhanced cholinergic transmission in the brain.[A232394] 



Several studies suggest that _ginkgo biloba_ exerts neuroprotective effects by reducing free radical production in the prefrontal cortex, which may explain its improvement on short-term memory. _Ginkgo biloba_ extract acts as a free radical scavenger, protecting neurons from oxidative damage and apoptosis related to aging, cerebral ischemia, and neurodegenerative disorders.[A232379] _Ginkgo biloba_ also inhibits amyloid-β neurotoxicity and protects against hypoxic challenges and increased oxidative stress.[A232389] One study showed that bilobalide, a terpene lactone, delays the onset of hypoxic glycolysis.[A232404] _Ginkgo biloba_ has the potential to regulate metabolism, stabilize the membrane, and promote vasodilation. In the arterial endothelium, EGb stimulated the release of endogenous relaxing factors, such as endothelium-derived relaxing factor and prostacyclin. In the inflammatory environment that causes tissue damage, EGb promoted nitric oxide production, leading to enhanced peripheral and cerebral blood flow.[A232379] ', '_Ginkgo biloba_ is a herbal ingredient with demonstrated antioxidant, vasoactive, antiapoptotic, anti-inflammatory, antiplatelet, and fibrinolytic properties.[A232389, A232399] _Ginkgo biloba_ has been investigated for use in a variety of medical conditions, but the most extensively studied area is in the context of cognitive impairment and neurodegenerative disorders. _Ginkgo biloba_ was examined as a potential nootropic agent or cognitive enhancer but research findings supporting the therapeutic efficacy of _ginkgo biloba_ extract (EGb) in dementia remain controversial. Some clinical studies of dementia that were up to one year long showed that EGb improves the cognitive performance and social functioning of patients. However, other studies did not support its clinical benefit for patients with cognitive impairment and dementia. Numerous meta-analysis studies showed insufficient evidence of the effectiveness of EGb in reducing both all-cause dementia incidence and Alzheimer''s disease-associated dementia incidence in elderly patients with normal cognition or with mild cognitive impairment. Additionally, there is no up-to-date evidence that demonstrates the benefit of the long-term use of standardized EGb in reducing the risk of progression to Alzheimer''s disease. A 2012 meta-analysis did not support the use of EGb in enhancing cognitive function in healthy adults.[A232379]



In the context of cardiovascular diseases, a limited number of studies showed that EGb improved mortality or neurological recovery in the post-stroke period, reduced cognitive and neurological impairment after acute ischemic stroke, and improved blood flow in the coronary artery in patients with coronary artery disease. However, a systemic review found no statistical or clinically significant benefit of EGb for patients with peripheral arterial disease or hypertension. Overall, there is a lack of strong evidence in the use of EGb for the treatment or prevention of cardiovascular diseases.[A232379]



In a small trial, the use of EGb as an adjunctive treatment with citalopram improved depressive symptoms and cognitive function in patients with depression.[A232379] _Ginkgo biloba_ was also investigated as a potential treatment for antidepressant-induced sexual dysfunction.[A2434] Another study showed EGb improving the symptoms of tardive dyskinesia. There is insufficient evidence to prove the effectiveness of EGb in these psychiatric disorders. Limited studies have investigated the role of _ginkgo biloba_ in the treatment of vertigo, tinnitus, vitiligo, macular degeneration, and glaucoma, as well as the prevention of acute mountain sickness. As results are either preliminary or controversial, more quality research is warranted.[A232379]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19782, 'Ginkoberry 10 caps.', 'جينكوبيري 10 كبسولات', '10', NULL, 'Antioxidant', 'Bilberry+ginkgo biloba', 'Eimc', 'Cap', 'كبسولة', NULL, '1', NULL, 'these natural extracts contain powerful antioxidants that counteract free radicals. the formula is designed to help prevent cellular damage and even reverse it. designed to support your eye health.', NULL, NULL, 1195, '2022-06-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19783, 'Ginkobonina 40mg 28 f.c.tab.', 'جينكوبونينا 40 مجم 28 قرص', '60', NULL, 'Anti-ischemic', 'Ginkgo biloba', 'Aug pharma', 'Tab', 'أقراص', '40mg', '4', 'علاج القلق -- تحسين الذاكرة -- علاج الصداع والدوخة والدوار', NULL, '6223005465252', NULL, 2177, '2022-05-29', 0, '_Ginkgo biloba_ does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use.[A232379] It is available in over-the-counter herbal products mostly for oral use, to improve memory and cognitive problems. ', 'Two key active ingredients in _ginkgo biloba_ are terpene lactones (notably ginkgolides and diterpenes) and ginkgo flavone glycosides (notably ginkgetin, bilobetin, and sciadopitysin), which are present at varying concentrations. _Ginkgo biloba_ extract EGb 761 is the standardized extract of _ginkgo biloba_ used in studies, which contains 6% terpenoids and 24% flavonoid glycosides. Animal studies have shown that _ginkgo biloba_ works on several neurotransmitter pathways and brain structures. Flavones were shown to inhibit lipid peroxidation; inhibit the uptake of serotonin, dopamine, and norepinephrine; and inhibit platelet aggregation.[A232404] Terpene lactones may also act as potent antagonists of the platelet-activating factor and may possess anti-ischemic and fibrinolytic effects.[A232379] They were also shown to downregulate adrenal peripheral benzodiazepine receptors and increase adrenocorticotropic hormone levels.[A232404] _Ginkgo biloba_ also reversibly inhibits monoamine oxidase A; and modestly inhibits anticholinesterase activity,[A232379, A232389] leading to enhanced cholinergic transmission in the brain.[A232394] 



Several studies suggest that _ginkgo biloba_ exerts neuroprotective effects by reducing free radical production in the prefrontal cortex, which may explain its improvement on short-term memory. _Ginkgo biloba_ extract acts as a free radical scavenger, protecting neurons from oxidative damage and apoptosis related to aging, cerebral ischemia, and neurodegenerative disorders.[A232379] _Ginkgo biloba_ also inhibits amyloid-β neurotoxicity and protects against hypoxic challenges and increased oxidative stress.[A232389] One study showed that bilobalide, a terpene lactone, delays the onset of hypoxic glycolysis.[A232404] _Ginkgo biloba_ has the potential to regulate metabolism, stabilize the membrane, and promote vasodilation. In the arterial endothelium, EGb stimulated the release of endogenous relaxing factors, such as endothelium-derived relaxing factor and prostacyclin. In the inflammatory environment that causes tissue damage, EGb promoted nitric oxide production, leading to enhanced peripheral and cerebral blood flow.[A232379] ', '_Ginkgo biloba_ is a herbal ingredient with demonstrated antioxidant, vasoactive, antiapoptotic, anti-inflammatory, antiplatelet, and fibrinolytic properties.[A232389, A232399] _Ginkgo biloba_ has been investigated for use in a variety of medical conditions, but the most extensively studied area is in the context of cognitive impairment and neurodegenerative disorders. _Ginkgo biloba_ was examined as a potential nootropic agent or cognitive enhancer but research findings supporting the therapeutic efficacy of _ginkgo biloba_ extract (EGb) in dementia remain controversial. Some clinical studies of dementia that were up to one year long showed that EGb improves the cognitive performance and social functioning of patients. However, other studies did not support its clinical benefit for patients with cognitive impairment and dementia. Numerous meta-analysis studies showed insufficient evidence of the effectiveness of EGb in reducing both all-cause dementia incidence and Alzheimer''s disease-associated dementia incidence in elderly patients with normal cognition or with mild cognitive impairment. Additionally, there is no up-to-date evidence that demonstrates the benefit of the long-term use of standardized EGb in reducing the risk of progression to Alzheimer''s disease. A 2012 meta-analysis did not support the use of EGb in enhancing cognitive function in healthy adults.[A232379]



In the context of cardiovascular diseases, a limited number of studies showed that EGb improved mortality or neurological recovery in the post-stroke period, reduced cognitive and neurological impairment after acute ischemic stroke, and improved blood flow in the coronary artery in patients with coronary artery disease. However, a systemic review found no statistical or clinically significant benefit of EGb for patients with peripheral arterial disease or hypertension. Overall, there is a lack of strong evidence in the use of EGb for the treatment or prevention of cardiovascular diseases.[A232379]



In a small trial, the use of EGb as an adjunctive treatment with citalopram improved depressive symptoms and cognitive function in patients with depression.[A232379] _Ginkgo biloba_ was also investigated as a potential treatment for antidepressant-induced sexual dysfunction.[A2434] Another study showed EGb improving the symptoms of tardive dyskinesia. There is insufficient evidence to prove the effectiveness of EGb in these psychiatric disorders. Limited studies have investigated the role of _ginkgo biloba_ in the treatment of vertigo, tinnitus, vitiligo, macular degeneration, and glaucoma, as well as the prevention of acute mountain sickness. As results are either preliminary or controversial, more quality research is warranted.[A232379]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19784, 'Ginkobonina plus 30 h.g. caps.', 'جينكوبونينا بلس 30 كبسولة', '75', NULL, 'Blood circulation inhancer', 'Ginkgo biloba+troxerutin', 'Aug pharma', 'Cap', 'كبسولة', NULL, '1', '1- تحسين الأداء العقلي و تقوية الذاكرة.', NULL, '6223005463364', NULL, 9157, '2023-02-02', 0, '_Ginkgo biloba_ does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use.[A232379] It is available in over-the-counter herbal products mostly for oral use, to improve memory and cognitive problems. ', 'Two key active ingredients in _ginkgo biloba_ are terpene lactones (notably ginkgolides and diterpenes) and ginkgo flavone glycosides (notably ginkgetin, bilobetin, and sciadopitysin), which are present at varying concentrations. _Ginkgo biloba_ extract EGb 761 is the standardized extract of _ginkgo biloba_ used in studies, which contains 6% terpenoids and 24% flavonoid glycosides. Animal studies have shown that _ginkgo biloba_ works on several neurotransmitter pathways and brain structures. Flavones were shown to inhibit lipid peroxidation; inhibit the uptake of serotonin, dopamine, and norepinephrine; and inhibit platelet aggregation.[A232404] Terpene lactones may also act as potent antagonists of the platelet-activating factor and may possess anti-ischemic and fibrinolytic effects.[A232379] They were also shown to downregulate adrenal peripheral benzodiazepine receptors and increase adrenocorticotropic hormone levels.[A232404] _Ginkgo biloba_ also reversibly inhibits monoamine oxidase A; and modestly inhibits anticholinesterase activity,[A232379, A232389] leading to enhanced cholinergic transmission in the brain.[A232394] 



Several studies suggest that _ginkgo biloba_ exerts neuroprotective effects by reducing free radical production in the prefrontal cortex, which may explain its improvement on short-term memory. _Ginkgo biloba_ extract acts as a free radical scavenger, protecting neurons from oxidative damage and apoptosis related to aging, cerebral ischemia, and neurodegenerative disorders.[A232379] _Ginkgo biloba_ also inhibits amyloid-β neurotoxicity and protects against hypoxic challenges and increased oxidative stress.[A232389] One study showed that bilobalide, a terpene lactone, delays the onset of hypoxic glycolysis.[A232404] _Ginkgo biloba_ has the potential to regulate metabolism, stabilize the membrane, and promote vasodilation. In the arterial endothelium, EGb stimulated the release of endogenous relaxing factors, such as endothelium-derived relaxing factor and prostacyclin. In the inflammatory environment that causes tissue damage, EGb promoted nitric oxide production, leading to enhanced peripheral and cerebral blood flow.[A232379] ', '_Ginkgo biloba_ is a herbal ingredient with demonstrated antioxidant, vasoactive, antiapoptotic, anti-inflammatory, antiplatelet, and fibrinolytic properties.[A232389, A232399] _Ginkgo biloba_ has been investigated for use in a variety of medical conditions, but the most extensively studied area is in the context of cognitive impairment and neurodegenerative disorders. _Ginkgo biloba_ was examined as a potential nootropic agent or cognitive enhancer but research findings supporting the therapeutic efficacy of _ginkgo biloba_ extract (EGb) in dementia remain controversial. Some clinical studies of dementia that were up to one year long showed that EGb improves the cognitive performance and social functioning of patients. However, other studies did not support its clinical benefit for patients with cognitive impairment and dementia. Numerous meta-analysis studies showed insufficient evidence of the effectiveness of EGb in reducing both all-cause dementia incidence and Alzheimer''s disease-associated dementia incidence in elderly patients with normal cognition or with mild cognitive impairment. Additionally, there is no up-to-date evidence that demonstrates the benefit of the long-term use of standardized EGb in reducing the risk of progression to Alzheimer''s disease. A 2012 meta-analysis did not support the use of EGb in enhancing cognitive function in healthy adults.[A232379]



In the context of cardiovascular diseases, a limited number of studies showed that EGb improved mortality or neurological recovery in the post-stroke period, reduced cognitive and neurological impairment after acute ischemic stroke, and improved blood flow in the coronary artery in patients with coronary artery disease. However, a systemic review found no statistical or clinically significant benefit of EGb for patients with peripheral arterial disease or hypertension. Overall, there is a lack of strong evidence in the use of EGb for the treatment or prevention of cardiovascular diseases.[A232379]



In a small trial, the use of EGb as an adjunctive treatment with citalopram improved depressive symptoms and cognitive function in patients with depression.[A232379] _Ginkgo biloba_ was also investigated as a potential treatment for antidepressant-induced sexual dysfunction.[A2434] Another study showed EGb improving the symptoms of tardive dyskinesia. There is insufficient evidence to prove the effectiveness of EGb in these psychiatric disorders. Limited studies have investigated the role of _ginkgo biloba_ in the treatment of vertigo, tinnitus, vitiligo, macular degeneration, and glaucoma, as well as the prevention of acute mountain sickness. As results are either preliminary or controversial, more quality research is warranted.[A232379]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19785, 'Ginkofit 10 caps.', 'جنكوفيت 10 كبسولات', '33', '99', 'Multivitamins', 'Royal jelly+ginseng+ginko biloba', 'Pharopharma', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, '6221094088659', NULL, 1766, '2024-01-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19787, 'Ginkor topical gel 20 gm', 'جينكور جل موضعي 20 جم', '10', NULL, 'Blood circulation inhancer', 'Ginkgo biloba+troxerutin', 'Arab drug company. > beaufour ipsen-france', 'Gel', 'جل', '20 gm', '1', NULL, 'mechanism of action of ginkgo biloba the mechanism of action of ginkgo is believed to be produced by its functions as a neuroprotective agent an antioxidant a free-radical scavenger a membrane stabilizer and an inhibitor of platelet-activating factor via', NULL, NULL, 888, '2022-07-19', 0, '_Ginkgo biloba_ does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use.[A232379] It is available in over-the-counter herbal products mostly for oral use, to improve memory and cognitive problems. ', 'Two key active ingredients in _ginkgo biloba_ are terpene lactones (notably ginkgolides and diterpenes) and ginkgo flavone glycosides (notably ginkgetin, bilobetin, and sciadopitysin), which are present at varying concentrations. _Ginkgo biloba_ extract EGb 761 is the standardized extract of _ginkgo biloba_ used in studies, which contains 6% terpenoids and 24% flavonoid glycosides. Animal studies have shown that _ginkgo biloba_ works on several neurotransmitter pathways and brain structures. Flavones were shown to inhibit lipid peroxidation; inhibit the uptake of serotonin, dopamine, and norepinephrine; and inhibit platelet aggregation.[A232404] Terpene lactones may also act as potent antagonists of the platelet-activating factor and may possess anti-ischemic and fibrinolytic effects.[A232379] They were also shown to downregulate adrenal peripheral benzodiazepine receptors and increase adrenocorticotropic hormone levels.[A232404] _Ginkgo biloba_ also reversibly inhibits monoamine oxidase A; and modestly inhibits anticholinesterase activity,[A232379, A232389] leading to enhanced cholinergic transmission in the brain.[A232394] 



Several studies suggest that _ginkgo biloba_ exerts neuroprotective effects by reducing free radical production in the prefrontal cortex, which may explain its improvement on short-term memory. _Ginkgo biloba_ extract acts as a free radical scavenger, protecting neurons from oxidative damage and apoptosis related to aging, cerebral ischemia, and neurodegenerative disorders.[A232379] _Ginkgo biloba_ also inhibits amyloid-β neurotoxicity and protects against hypoxic challenges and increased oxidative stress.[A232389] One study showed that bilobalide, a terpene lactone, delays the onset of hypoxic glycolysis.[A232404] _Ginkgo biloba_ has the potential to regulate metabolism, stabilize the membrane, and promote vasodilation. In the arterial endothelium, EGb stimulated the release of endogenous relaxing factors, such as endothelium-derived relaxing factor and prostacyclin. In the inflammatory environment that causes tissue damage, EGb promoted nitric oxide production, leading to enhanced peripheral and cerebral blood flow.[A232379] ', '_Ginkgo biloba_ is a herbal ingredient with demonstrated antioxidant, vasoactive, antiapoptotic, anti-inflammatory, antiplatelet, and fibrinolytic properties.[A232389, A232399] _Ginkgo biloba_ has been investigated for use in a variety of medical conditions, but the most extensively studied area is in the context of cognitive impairment and neurodegenerative disorders. _Ginkgo biloba_ was examined as a potential nootropic agent or cognitive enhancer but research findings supporting the therapeutic efficacy of _ginkgo biloba_ extract (EGb) in dementia remain controversial. Some clinical studies of dementia that were up to one year long showed that EGb improves the cognitive performance and social functioning of patients. However, other studies did not support its clinical benefit for patients with cognitive impairment and dementia. Numerous meta-analysis studies showed insufficient evidence of the effectiveness of EGb in reducing both all-cause dementia incidence and Alzheimer''s disease-associated dementia incidence in elderly patients with normal cognition or with mild cognitive impairment. Additionally, there is no up-to-date evidence that demonstrates the benefit of the long-term use of standardized EGb in reducing the risk of progression to Alzheimer''s disease. A 2012 meta-analysis did not support the use of EGb in enhancing cognitive function in healthy adults.[A232379]



In the context of cardiovascular diseases, a limited number of studies showed that EGb improved mortality or neurological recovery in the post-stroke period, reduced cognitive and neurological impairment after acute ischemic stroke, and improved blood flow in the coronary artery in patients with coronary artery disease. However, a systemic review found no statistical or clinically significant benefit of EGb for patients with peripheral arterial disease or hypertension. Overall, there is a lack of strong evidence in the use of EGb for the treatment or prevention of cardiovascular diseases.[A232379]



In a small trial, the use of EGb as an adjunctive treatment with citalopram improved depressive symptoms and cognitive function in patients with depression.[A232379] _Ginkgo biloba_ was also investigated as a potential treatment for antidepressant-induced sexual dysfunction.[A2434] Another study showed EGb improving the symptoms of tardive dyskinesia. There is insufficient evidence to prove the effectiveness of EGb in these psychiatric disorders. Limited studies have investigated the role of _ginkgo biloba_ in the treatment of vertigo, tinnitus, vitiligo, macular degeneration, and glaucoma, as well as the prevention of acute mountain sickness. As results are either preliminary or controversial, more quality research is warranted.[A232379]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19788, 'Ginocal 24 tabs.', 'جينوكال 24 قرص', '155', '45', 'Calcium supplement', 'Calcium carbonate+magnesium citrate+vitamin d3+zinc+selenium+vitamin c', 'Medcare > vortex', 'Tab', 'أقراص', NULL, '2', 'مصدر للكالسيوم وفيتامين د -- مصدر للطاقة', NULL, '6224001079306', NULL, 2784, '2025-08-16', 0, 'Calcium acetate is one of a number of calcium salts used to treat hyperphosphatemia (too much phosphate in the blood) in patients with kidney disease.', 'Calcium acetate and other calcium salts are phosphate binders. They work by binding with the phosphate in the food you eat, so that it is eliminated from the body without being absorbed.', 'Patients with advanced renal insufficiency (creatinine clearance less than 30 ml/min) exhibit phosphate retention and some degree of hyperphosphatemia. The retention of phosphate plays a pivotal role in causing secondary hyperparathyroidism associated with osteodystrophy, and soft-tissue calcification. The mechanism by which phosphate retention leads to hyperparathyroidism is not clearly delineated. Therapeutic efforts directed toward the control of hyperphosphatemia include reduction in the dietary intake of phosphate, inhibition of absorption of phosphate in the intestine with phosphate binders, and removal of phosphate from the body by more efficient methods of dialysis. The rate of removal of phosphate by dietary manipulation or by dialysis is insufficient. Dialysis patients absorb 40% to 80% of dietary phosphorus. Therefore, the fraction of dietary phosphate absorbed from the diet needs to be reduced by using phosphate binders in most renal failure patients on maintenance dialysis. Calcium acetate when taken with meals combines with dietary phosphate to form insoluble calcium phosphate which is excreted in the feces. Maintenance of serum phosphorus below 6.0 mg/dl is generally considered as a clinically acceptable outcome of treatment with phosphate binders. Calcium acetate is highly soluble at neutral pH, making the calcium readily available for binding to phosphate in the proximal small intestine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19791, 'Ginseng 100 mg 24 s.g. caps.', 'جنسنج 100مجم 24 كبسولة', '8', NULL, 'General tonic', 'Ginseng', 'Pharco', 'Cap', 'كبسولة', '100 mg', '2', 'مقوي عام', 'about ginseng steroid glycosides. mechanism of action of ginseng it contains chemicals called ginsenosides that seem to affect insulin levels in the body and lower blood sugar. other chemicals called polysaccharides might affect the immune system. indicat', '6223000011126', NULL, 1864, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19792, 'Ginseng 85 mg 20 caps. (n/a)', 'جنسنج 85مجم 20 كبسولة', '5', NULL, 'General tonic', 'Ginseng', 'Arab drug company.', 'Cap', 'كبسولة', '85 mg', '2', 'علاج القئ والتهابات المعدة -- علاج الدوخة والتشنجات -- علاج فقدان الشهية والارق', 'about ginseng steroid glycosides. mechanism of action of ginseng it contains chemicals called ginsenosides that seem to affect insulin levels in the body and lower blood sugar. other chemicals called polysaccharides might affect the immune system. indicat', '6223002211517', NULL, 940, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19793, 'Ginseng 1000mg with lecithin 30 capsules', 'جنسنج 1000مجم مع ليسيثين 30 كبسولة', '700', NULL, 'Multivitamins', 'Ginseng+lecithin', 'Company', 'Capsule', 'كبسولة', '1000mg', '3', NULL, 'promotes physical performance and immune function.** complex includes royal jelly concentrate vitamin b-12 as well as panax american and chinese red ginseng extracts. ginseng contains naturally occurring ginsenosides which play a role in well-being.** thi', NULL, NULL, 922, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19794, 'Ginseng syrup 120 ml', 'جنسنج شراب 120 مل', '5', NULL, 'General tonic', 'Ginseng', 'Pharco', 'Syrup', 'شراب', '120 ml', '1', 'مقوي عام', 'about ginseng steroid glycosides. mechanism of action of ginseng it contains chemicals called ginsenosides that seem to affect insulin levels in the body and lower blood sugar. other chemicals called polysaccharides might affect the immune system. indicat', '6221151001041', NULL, 1037, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19795, 'Paxotreve 10 sachets', 'باكسوتريف 10 اكياس', '220', NULL, 'Anti-rheumatic.osteoarthritis.anabolic agents', 'Hydrolyzed marine collagen+magnesium+vitamin c+sodium hyaluronate', 'Paxal pharmaceutical', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, NULL, NULL, 886, '2022-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19796, 'Ginsotex 10 capsules', 'جنسوتكس 10 كبسولات', '110', '50', 'Tonic for men', 'Ginseng+royal jelly+ginko biloba+bee pollen+bee propolis', 'Grand pharma > national arabian company', 'Capsule', 'كبسولة', NULL, '1', 'مقوي للرجال', NULL, NULL, NULL, 2213, '2025-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (19797, 'Giotrif 30 mg 28 f.c. tabs.', 'جيوتريف 30 مجم 28 قرص', '13,810', NULL, 'Antineoplastic.egfr inhibitor', 'Afatinib', 'Boehringer ingelheim > egyptian pharmaceutical trading company', 'Tab', 'أقراص', '30 mg', '4', NULL, 'afatinib is a targeted therapy. afatinib is classified as a tyrosine kinase inhibitor; epidermal growth factor receptor (egfr) inhibitor. indications: - non-small cell lung cancer metastatic egfr mutation-positive: first-line treatment of metastatic non-s', NULL, NULL, 593, '2022-08-06', 0, 'Afatinib is a kinase inhibitor indicated as monotherapy [L2937] for the first-line [FDA Label] treatment of (a) Epidermal Growth Factor Receptor (EGFR) TKI (tyrosine kinase inhibitor)-naive adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have non-resistant EGFR mutations as detected by an FDA-approved test [FDA Label], and (b) adult patients with locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy [FDA Label, L2937].



Recently, as of January 2018, the US FDA approved a supplemental New Drug Application for Boehringer Ingelheim''s Gilotrif (afatinib) for the first line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test [L2939]. The new label includes data on three additional EGFR mutations: L861Q, G719X and S768I [L2939].', 'Afatinib is a potent and selective, irreversible ErbB family blocker [L2937]. Afatinib covalently binds to and irreversibly blocks signaling from all homo and heterodimers formed by the ErbB family members EGFR (ErbB1), HER2 (ErbB2), ErbB3 and ErbB4 [L2937].



In particular, afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling [FDA Label]. Certain mutations in EGFR, including non-resistant mutations in its kinase domain, can result in increased autophosphorylation of the receptor, leading to receptor activation, sometimes in the absence of ligand binding, and can support cell proliferation in NSCLC [FDA Label]. Non-resistant mutations are defined as those occurring in exons constituting the kinase domain of EGFR that lead to increased receptor activation and where efficacy is predicted by 1) clinically meaningful tumor shrinkage with the recommended dose of afatinib and/or 2) inhibition of cellular proliferation or EGFR tyrosine kinase phosphorylation at concentrations of afatinib sustainable at the recommended dosage according to validated methods [FDA Label]. The most commonly found of these mutations are exon 21 L858R substitutions and exon 19 deletions [FDA Label].



Moreover, afatinib demonstrated inhibition of autophosphorylation and/or in vitro proliferation of cell lines expressing wild-type EGFR and in those expressing selected EGFR exon 19 deletion mutations, exon 21 L858R mutations, or other less common non-resistant mutations, at afatinib concentrations achieved in patients [FDA Label]. In addition, afatinib inhibited in vitro proliferation of cell lines overexpressing HER2 [FDA Label].', 'Aberrant ErbB signaling triggered by receptor mutations, and/or amplification, and/or receptor ligand overexpression contributes to the malignant phenotype [L2937]. Mutation in EGFR defines a distinct molecular subtype of lung cancer [L2937].



In non-clinical disease models with ErbB pathway deregulation, afatinib as a single agent effectively blocks ErbB receptor signaling resulting in tumor growth inhibition or tumor regression [L2937]. NSCLC tumors with common activating EGFR mutations (Del 19, L858R) and several less common EGFR mutations in exon 18 (G719X) and exon 21 (L861Q) are particularly sensitive to afatinib treatment in non-clinical and clinical settings [L2937]. Limited non-clinical and/or clinical activity was observed in NSCLC tumors with insertion mutations in exon 20 [L2937].



The acquisition of a secondary T790M mutation is a major mechanism of acquired resistance to afatinib and gene dosage of the T790M-containing allele correlates with the degree of resistance in vitro [L2937]. The T790M mutation is found in approximately 50% of patients'' tumors upon disease progression on afatinib, for which T790M targeted EGFR TKIs may be considered as a next line treatment option [L2937]. Other potential mechanisms of resistance to afatinib have been suggested preclinically and MET gene amplification has been observed clinically [L2937].



At the same time, the effect of multiple doses of afatinib (50 mg once daily) on cardiac electrophysiology and the QTc interval was evaluated in an open-label, single-arm study in patients with relapsed or refractory solid tumors [FDA Label]. Ultimately, no large changes in the mean QTc interval (i.e., >20 ms) were detected in the study [FDA Label].', 'DrugBank', 0, 0, 0);
